Citrus Sinensis ID: 020561
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 324 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.966 | 0.634 | 0.739 | 1e-134 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.864 | 0.571 | 0.775 | 1e-128 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.774 | 0.612 | 0.620 | 1e-91 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.777 | 0.611 | 0.617 | 3e-90 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.765 | 0.627 | 0.599 | 6e-88 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.777 | 0.647 | 0.596 | 2e-86 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.820 | 0.624 | 0.602 | 2e-85 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.820 | 0.624 | 0.577 | 8e-83 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.663 | 0.552 | 0.631 | 2e-80 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.660 | 0.521 | 0.675 | 3e-80 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 244/330 (73%), Positives = 265/330 (80%), Gaps = 17/330 (5%)
Query: 1 MGFDGENGKVKKASWDSSKSKA---KKKKKKVEDEVEVEEEEE-----TGCWVKLRFFGS 52
MG D K +W S K K K KKK D+ + EEE +GCWVK RF
Sbjct: 1 MGLDAVKAK---GNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIG 57
Query: 53 CISSRSKVDSSVSG------TSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 106
CI S+S +D+S S T T ESKS N+ S DQP V S+TTTSNAES+SST +
Sbjct: 58 CIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVI 117
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 118 SEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 177
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 178 AVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 237
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
FRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 238 FRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLA 297
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
KD P+ KTHVSTRVMGTYGYAAPEYVMT
Sbjct: 298 KDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 327
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-128, Method: Compositional matrix adjust.
Identities = 217/280 (77%), Positives = 242/280 (86%)
Query: 37 EEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSN 96
EEE GCWVK R+ C SS S V++S++ +++ S+S S DQP V S+TTTSN
Sbjct: 42 EEEANGCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSN 101
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
AES+ ST + EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTA
Sbjct: 102 AESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 161
Query: 157 PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
PVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEF
Sbjct: 162 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEF 221
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +Y
Sbjct: 222 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEY 281
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
NAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMT
Sbjct: 282 NAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 321
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 167/269 (62%), Positives = 198/269 (73%), Gaps = 18/269 (6%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C+S++ K +SS G ST Y++K + +V S T E E
Sbjct: 1 MGICLSAQVKAESS--GASTKYDAKDIGSLGSKASSVSVRPSPRT------------EGE 46
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ F+F +LK ATRNFRP+S+LGEGGFGCVFKGWI+E +PGTGL +AVK
Sbjct: 47 ILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVK 106
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN DG QGH+EWLAEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR
Sbjct: 107 KLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 166
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
L PL W +R+K+ALGAAKGLAFLH R VIYRDFKTSNILLD++YNAKLSDFGLA
Sbjct: 167 GLYFQPLSWKLRLKVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDSEYNAKLSDFGLA 225
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
KDGP GDK+HVSTRVMGT+GYAAPEY+ T
Sbjct: 226 KDGPIGDKSHVSTRVMGTHGYAAPEYLAT 254
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 166/269 (61%), Positives = 197/269 (73%), Gaps = 17/269 (6%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C+S++ K S G S Y S ND+ + ++ I + + E E
Sbjct: 1 MGICLSAQIKAVSP--GASPKYMSSEANDSLGSKSSSVSIRTN-----------PRTEGE 47
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+ +AVK
Sbjct: 48 ILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVK 107
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR
Sbjct: 108 KLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 167
Query: 230 S---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGLA
Sbjct: 168 GSYFQPLSWTLRLKVALGAAKGLAFLH-NAETSVIYRDFKTSNILLDSEYNAKLSDFGLA 226
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
KDGP GDK+HVSTR+MGTYGYAAPEY+ T
Sbjct: 227 KDGPTGDKSHVSTRIMGTYGYAAPEYLAT 255
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 160/267 (59%), Positives = 192/267 (71%), Gaps = 19/267 (7%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
GSC SSR K D +G S+ S + AA K E E
Sbjct: 1 MGSCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAA---------------AQKTEGE 45
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL +AVK
Sbjct: 46 ILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVK 105
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLENHLFRR
Sbjct: 106 KLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRR 165
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLSDFGLA
Sbjct: 166 GAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGLA 224
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+DGP GD ++VSTRVMGTYGYAAPEY+
Sbjct: 225 RDGPMGDLSYVSTRVMGTYGYAAPEYM 251
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 161/270 (59%), Positives = 198/270 (73%), Gaps = 18/270 (6%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C S+R K D + +ST SK SRD + S+ S S + E E
Sbjct: 1 MGGCFSNRIKTDIA---SSTWLSSKFL---SRD--------GSKGSSTASFSYMPRTEGE 46
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+ +AVK
Sbjct: 47 ILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVK 106
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLENHLFRR
Sbjct: 107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLSDFGLA
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLA 225
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
+DGP GD +HVSTRVMGT GYAAPEY+ T
Sbjct: 226 RDGPMGDNSHVSTRVMGTQGYAAPEYLATG 255
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 162/269 (60%), Positives = 199/269 (73%), Gaps = 3/269 (1%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNS-STSKLEE 108
G+C+ S +KVDSS + S S+ +S+ + S + S + S T + E
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+ VAV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
K L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 229 R-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
R + PL W+IRMK+A+GAAKGL FLH +A+ VIYRDFK +NILLDA++N+KLSDFGLAK
Sbjct: 181 RGAQPLTWAIRMKVAIGAAKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLSDFGLAK 239
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
GP GDKTHVST+VMGT+GYAAPEYV T
Sbjct: 240 AGPTGDKTHVSTQVMGTHGYAAPEYVATG 268
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 8e-83, Method: Compositional matrix adjust.
Identities = 157/272 (57%), Positives = 198/272 (72%), Gaps = 6/272 (2%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQ----PAAAVISSTTTSNAESNSSTSK 105
G+C+ S +KVD+S + S + +S+ P+ +S +T ++ T +
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
E E+ + L+ FTFN+LK AT+NFR ++LLGEGGFGCVFKGWI++ +PG+G+
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 166 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
VAVK L +G QGHKEWL EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 226 LFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
LFRR + PL W+IRMK+A+GAAKGL FLH EA+ VIYRDFK +NILLDAD+NAKLSDFG
Sbjct: 181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
LAK GP GD THVST+V+GT+GYAAPEYV T
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATG 271
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 139/220 (63%), Positives = 176/220 (80%), Gaps = 5/220 (2%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
++ K E E+ ++ ++ F+FN+LKLATRNFR +S++GEGGFGCVF+GW++E P K
Sbjct: 31 ATAHKTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKS 90
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 220
+GL +AVK LN DG QGH+EWL E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +G
Sbjct: 91 SSGLVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKG 150
Query: 221 SLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
SLENHLF + PL W +R+K+AL AAKGLAFLH + + VIYRD K SNILLD+D+
Sbjct: 151 SLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDF 209
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
NAKLSDFGLA+DGP G++++VSTRVMGT+GYAAPEYV T
Sbjct: 210 NAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTG 249
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 150/222 (67%), Positives = 176/222 (79%), Gaps = 8/222 (3%)
Query: 99 SNSSTSKLEEELKVA---SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
S+ ST + ++ + +++ FT +L+ T++FRP+ +LGEGGFG V+KG+I++N
Sbjct: 34 SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93
Query: 156 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215
+K L VAVK LN +GLQGH+EWL EVNFLG L H NLVKLIGYC EDD RLLVYE
Sbjct: 94 VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150
Query: 216 FMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
FM RGSLENHLFR++ PL WS RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
DY AKLSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMT
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 251
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 324 | ||||||
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.975 | 0.638 | 0.870 | 1e-161 | |
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.944 | 0.636 | 0.870 | 1e-158 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.972 | 0.641 | 0.878 | 1e-153 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.956 | 0.639 | 0.868 | 1e-152 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.969 | 0.644 | 0.893 | 1e-151 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.969 | 0.644 | 0.896 | 1e-151 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.944 | 0.618 | 0.821 | 1e-151 | |
| 357486605 | 492 | Serine/threonine protein kinase-like pro | 0.854 | 0.563 | 0.928 | 1e-146 | |
| 224100247 | 478 | predicted protein [Populus trichocarpa] | 0.941 | 0.638 | 0.858 | 1e-146 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.935 | 0.502 | 0.830 | 1e-144 |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1475), Expect = e-161, Method: Compositional matrix adjust.
Identities = 282/324 (87%), Positives = 292/324 (90%), Gaps = 8/324 (2%)
Query: 1 MGFDGENG-KVKKASWDSSKSKAKKKKKK-VEDEV------EVEEEEETGCWVKLRFFGS 52
MG E+G + K +SW+ K K + KKK+ V + +V EE ETGCW K RF GS
Sbjct: 1 MGLGSEDGNRAKASSWEVCKPKGRNKKKQDVSNSSGGASPGDVVEEAETGCWFKFRFIGS 60
Query: 53 CISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKV 112
CISSRSKVDSSVSGTSTH ESKSTNDTSRDQP A ISSTTTSNAESNSSTSKLEEELK+
Sbjct: 61 CISSRSKVDSSVSGTSTHCESKSTNDTSRDQPTAPTISSTTTSNAESNSSTSKLEEELKI 120
Query: 113 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN
Sbjct: 121 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 180
Query: 173 HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
HDGLQGHKEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP
Sbjct: 181 HDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 240
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG
Sbjct: 241 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 300
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTA 316
DKTHVSTRVMGTYGYAAPEYVMT
Sbjct: 301 DKTHVSTRVMGTYGYAAPEYVMTG 324
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1456), Expect = e-158, Method: Compositional matrix adjust.
Identities = 276/317 (87%), Positives = 290/317 (91%), Gaps = 11/317 (3%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 119
VDSS+SGTSTHYE++STNDTSRDQP A V+SSTTTSNAESNSSTSKLEEELKVASRLRKF
Sbjct: 51 VDSSISGTSTHYENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRLRKF 110
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 111 SFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 170
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
KEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRM
Sbjct: 171 KEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRM 230
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVST
Sbjct: 231 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVST 290
Query: 300 RVMGTYGYAAPEYVMTA 316
RVMGTYGYAAPEYVMT
Sbjct: 291 RVMGTYGYAAPEYVMTG 307
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-153, Method: Compositional matrix adjust.
Identities = 282/321 (87%), Positives = 291/321 (90%), Gaps = 6/321 (1%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETG--CWVKLRFFGSCISSRS 58
MG GENGKV + SWD KSK +KKKK D EVEE E CWV+LRF GSCISSRS
Sbjct: 1 MGLGGENGKVVE-SWDVCKSKGGRKKKKKGDAEEVEEGAEAEAGCWVRLRFIGSCISSRS 59
Query: 59 KVDSSVS--GTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASR 115
KVD+SVS G STHY ESKSTNDTSRDQP A +SSTTTSNAESNSSTSKLEEELK+ASR
Sbjct: 60 KVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSTSKLEEELKIASR 119
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
LRKF+FNDLK ATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 120 LRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 179
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
LQGHKEWLAEVNFLGDLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPW
Sbjct: 180 LQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPW 239
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT
Sbjct: 240 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 299
Query: 296 HVSTRVMGTYGYAAPEYVMTA 316
HVSTRVMGTYGYAAPEYVMT
Sbjct: 300 HVSTRVMGTYGYAAPEYVMTG 320
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1398), Expect = e-152, Method: Compositional matrix adjust.
Identities = 278/320 (86%), Positives = 290/320 (90%), Gaps = 10/320 (3%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG ENGKV + SWD KSK +KKKK E E E GCWV+LRF GSCISSRSKV
Sbjct: 1 MGLGAENGKVVE-SWDVCKSKGRKKKKGDE-----GGEAEAGCWVRLRFIGSCISSRSKV 54
Query: 61 DSSVSG--TSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSS-TSKLEEELKVASRL 116
D+SVSG TSTHY ESKSTNDTSRDQP A +SSTTTSNAESNSS TSKLEEELK+ASRL
Sbjct: 55 DTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSSTSKLEEELKIASRL 114
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
RKF+FN+LKLATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL
Sbjct: 115 RKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 174
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
QGHKEWLAEVNFLGDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWS
Sbjct: 175 QGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWS 234
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTH
Sbjct: 235 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTH 294
Query: 297 VSTRVMGTYGYAAPEYVMTA 316
VSTRVMGTYGYAAPEYVMT
Sbjct: 295 VSTRVMGTYGYAAPEYVMTG 314
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1395), Expect = e-151, Method: Compositional matrix adjust.
Identities = 284/318 (89%), Positives = 294/318 (92%), Gaps = 4/318 (1%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEE+EETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEKEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 118
VDSSVSGTST+Y ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEE KV+SRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESNSSTSKLEEEFKVSSRLRK 118
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVS
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVS 298
Query: 299 TRVMGTYGYAAPEYVMTA 316
TRVMGTYGYAAPEYVMT
Sbjct: 299 TRVMGTYGYAAPEYVMTG 316
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1391), Expect = e-151, Method: Compositional matrix adjust.
Identities = 285/318 (89%), Positives = 294/318 (92%), Gaps = 4/318 (1%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEEEEETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEEEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 118
VDSSVSGTST+Y ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEELKVASRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESNSSTSKLEEELKVASRLRK 118
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YN+KLSDFGLAKDGPEGDKTHVS
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSKLSDFGLAKDGPEGDKTHVS 298
Query: 299 TRVMGTYGYAAPEYVMTA 316
TRVMGTYGYAAPEYVMT
Sbjct: 299 TRVMGTYGYAAPEYVMTG 316
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1388), Expect = e-151, Method: Compositional matrix adjust.
Identities = 272/331 (82%), Positives = 285/331 (86%), Gaps = 25/331 (7%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHY--------ESKSTN------DTSRDQPAAAVISSTTTSNAESNSSTSK 105
VDSS+SGTSTHY E +S N RDQP A V+SSTTTSNAESNSSTSK
Sbjct: 51 VDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSSTSK 110
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
LEEELKVASRLRKF+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT
Sbjct: 111 LEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 170
Query: 166 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
VAVKTLNHDGLQGHKEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENH
Sbjct: 171 VAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 230
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
LFRR+LPLPW+IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGL
Sbjct: 231 LFRRALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGL 290
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT
Sbjct: 291 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 321
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357486605|ref|XP_003613590.1| Serine/threonine protein kinase-like protein [Medicago truncatula] gi|355514925|gb|AES96548.1| Serine/threonine protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 524 bits (1349), Expect = e-146, Method: Compositional matrix adjust.
Identities = 260/280 (92%), Positives = 267/280 (95%), Gaps = 3/280 (1%)
Query: 40 ETGCWVKLRFFGSCISSRSKVDSSVSGTST--HY-ESKSTNDTSRDQPAAAVISSTTTSN 96
+TGCWV LRF GSCISSRSKVDSSVSG+ T HY ESKSTNDTSR Q A VISSTTTSN
Sbjct: 42 KTGCWVGLRFIGSCISSRSKVDSSVSGSGTSTHYAESKSTNDTSRGQRTAPVISSTTTSN 101
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
AESNSST+KLEEELK+ASRLRKF+FN+LKLATRNFRPES LGEGGFGCVFKGWIEENGTA
Sbjct: 102 AESNSSTTKLEEELKIASRLRKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTA 161
Query: 157 PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEF
Sbjct: 162 PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHQNLVKLIGYCIEDDQRLLVYEF 221
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
MPRGSLENHLFRRS+PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY
Sbjct: 222 MPRGSLENHLFRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 281
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT
Sbjct: 282 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 321
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100247|ref|XP_002311801.1| predicted protein [Populus trichocarpa] gi|222851621|gb|EEE89168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1346), Expect = e-146, Method: Compositional matrix adjust.
Identities = 272/317 (85%), Positives = 279/317 (88%), Gaps = 12/317 (3%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG E GKVK +SWD KSK +KKK + + GCWVKLR G CISSRSKV
Sbjct: 1 MGLGSEEGKVK-SSWDVCKSKERKKK----------DGTKAGCWVKLRLVGGCISSRSKV 49
Query: 61 DSSVSGT-STHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 119
DSSVSGT ESKS NDTS DQPA V+SS+TTSN ESNSS SKLEEELKVASRLRKF
Sbjct: 50 DSSVSGTICESTESKSINDTSTDQPAVPVVSSSTTSNTESNSSLSKLEEELKVASRLRKF 109
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 110 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 169
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
KEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM
Sbjct: 170 KEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 229
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD PEGDKTHVST
Sbjct: 230 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEGDKTHVST 289
Query: 300 RVMGTYGYAAPEYVMTA 316
RVMGTYGYAAPEYVMT
Sbjct: 290 RVMGTYGYAAPEYVMTG 306
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1329), Expect = e-144, Method: Compositional matrix adjust.
Identities = 274/330 (83%), Positives = 281/330 (85%), Gaps = 27/330 (8%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
+G DGE G+ SWD KSK KKKK+ EEETGCW KL F GSCISSRSKV
Sbjct: 115 LGGDGEKGE----SWDVEKSKGKKKKEV--------TEEETGCWTKLWFIGSCISSRSKV 162
Query: 61 DSSVSGTSTH--------------YESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 106
DSS+SG STH ESKSTN TSRDQP A +ISSTTTSNAESNSSTSKL
Sbjct: 163 DSSISGISTHCDKSTYVLTSCIALAESKSTN-TSRDQPVAPIISSTTTSNAESNSSTSKL 221
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEELKV+SRLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 222 EEELKVSSRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 281
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVKTLNHDGLQ W AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 282 AVKTLNHDGLQVLSIWQAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 341
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
FRRS+PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 342 FRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 401
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTA 316
KDGPEGDKTHVSTRVMGTYGYAAPEYVMT
Sbjct: 402 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 431
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 324 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.848 | 0.557 | 0.743 | 5.5e-109 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.845 | 0.559 | 0.718 | 3.2e-104 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.638 | 0.456 | 0.888 | 1.9e-99 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.648 | 0.496 | 0.719 | 3.2e-81 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.641 | 0.526 | 0.693 | 2e-79 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.648 | 0.539 | 0.677 | 1.3e-77 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.648 | 0.492 | 0.693 | 3.4e-77 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.746 | 0.568 | 0.612 | 7.1e-77 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.635 | 0.532 | 0.671 | 6.3e-76 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.635 | 0.5 | 0.682 | 1.2e-74 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
Identities = 209/281 (74%), Positives = 222/281 (79%)
Query: 41 TGCWVKLRFF-G-----XXXXXXXXXXXXXXXXXTHYESKSTNDTSRDQPAAAVIXXXXX 94
+GCWVK RF G T ESKS N+ S DQP V
Sbjct: 46 SGCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTT 105
Query: 95 XXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 154
+ EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENG
Sbjct: 106 SNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENG 165
Query: 155 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214
TAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVY
Sbjct: 166 TAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVY 225
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDA
Sbjct: 226 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA 285
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
DYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMT
Sbjct: 286 DYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMT 326
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 3.2e-104, P = 3.2e-104
Identities = 197/274 (71%), Positives = 214/274 (78%)
Query: 42 GCWVKLRFFGXXXXXXXXXXXXXXXXXTHYESKSTNDTSRDQPAAAVIXXXXXXXXXXXX 101
GCWVK R+ + S+S S DQP V
Sbjct: 47 GCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSL 106
Query: 102 XXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 161
+ EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPG
Sbjct: 107 STPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 166
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGS
Sbjct: 167 TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 226
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
LENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKLS
Sbjct: 227 LENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLS 286
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
DFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMT
Sbjct: 287 DFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMT 320
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
Identities = 184/207 (88%), Positives = 198/207 (95%)
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
ELK +S+LR F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV
Sbjct: 81 ELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 140
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
KTLN DGLQGHKEWLAE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFR
Sbjct: 141 KTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFR 200
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
R+LPLPWS+RMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKD
Sbjct: 201 RTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 260
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT 315
P+ K+HVSTRVMGTYGYAAPEYVMT
Sbjct: 261 APDEKKSHVSTRVMGTYGYAAPEYVMT 287
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 3.2e-81, P = 3.2e-81
Identities = 154/214 (71%), Positives = 177/214 (82%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+
Sbjct: 54 RTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGV 113
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 114 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 173
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
HLFRR PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLS
Sbjct: 174 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
DFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ T
Sbjct: 233 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLAT 266
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 147/212 (69%), Positives = 176/212 (83%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
K E E+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL
Sbjct: 41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLEN
Sbjct: 101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
HLFRR PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLS
Sbjct: 161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLS 219
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
DFGLA+DGP GD ++VSTRVMGTYGYAAPEY+
Sbjct: 220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYM 251
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 1.3e-77, P = 1.3e-77
Identities = 145/214 (67%), Positives = 177/214 (82%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+
Sbjct: 42 RTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGI 101
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLEN
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
HLFRR PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLS
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
DFGLA+DGP GD +HVSTRVMGT GYAAPEY+ T
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLAT 254
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
Identities = 147/212 (69%), Positives = 173/212 (81%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
VAVK L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 225 HLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283
HLFRR PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDF
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
GLAK GP GDKTHVST+VMGT+GYAAPEYV T
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVAT 267
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 7.1e-77, P = 7.1e-77
Identities = 150/245 (61%), Positives = 180/245 (73%)
Query: 73 SKSTNDTSRDQ-PAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNF 131
SK ++ TSR P+ + E E+ + L+ FTFN+LK AT+NF
Sbjct: 27 SKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATKNF 86
Query: 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 191
R ++LLGEGGFGCVFKGWI++ +PG+G+ VAVK L +G QGHKEWL EVN+LG
Sbjct: 87 RQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQ 146
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLA 250
L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR PL W+IRMK+A+GAAKGL
Sbjct: 147 LSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKGLT 206
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
FLHE A+ VIYRDFK +NILLDAD+NAKLSDFGLAK GP GD THVST+V+GT+GYAAP
Sbjct: 207 FLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAP 265
Query: 311 EYVMT 315
EYV T
Sbjct: 266 EYVAT 270
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
Identities = 141/210 (67%), Positives = 170/210 (80%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E EL + L+ FTFN+LK ATRNF+P S++GEGGFGCV+KGWI E +P KPG+G+ V
Sbjct: 60 EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVV 119
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVK L +G QGHKEWL EV++LG L H+NLVKLIGYC+E ++RLLVYE+MP+GSLENHL
Sbjct: 120 AVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHL 179
Query: 227 FRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
FRR P+PW RMK+A AA+GL+FLHE VIYRDFK SNILLD D+NAKLSDFGL
Sbjct: 180 FRRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGL 236
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
AK GP GD+THV+T+V+GT GYAAPEY+ T
Sbjct: 237 AKAGPTGDRTHVTTQVIGTQGYAAPEYIAT 266
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 144/211 (68%), Positives = 174/211 (82%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E EL + L+ FTFN+LK ATRNFRP+S++GEGGFG V+KGWI+E +P KPG+G+ V
Sbjct: 59 EGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVV 118
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENH 225
AVK L +G QGH++WLAEV+ LG L H+NLVKLIGYC + D RLLVYE+MP+GSLENH
Sbjct: 119 AVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENH 178
Query: 226 LFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
LFRR P+PW R+K+A+GAA+GLAFLHE A+ VIYRDFK SNILLD+++NAKLSDFG
Sbjct: 179 LFRRGAEPIPWRTRIKVAIGAARGLAFLHE-AQ--VIYRDFKASNILLDSEFNAKLSDFG 235
Query: 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
LAK GP GD+THVST+VMGT GYAAPEYV T
Sbjct: 236 LAKVGPTGDRTHVSTQVMGTQGYAAPEYVAT 266
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7393 | 0.9660 | 0.6348 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 324 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.002 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.004 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.004 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.004 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 8e-45
Identities = 60/177 (33%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
LGEGGFG V+ ++ G VA+K + + E L E+ L L H
Sbjct: 1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+VKL G +++ LV E+ GSL++ L L ++I L +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 256 AERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+I+RD K NILLD+D KL+DFGL+K ++GT Y APE
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 5e-40
Identities = 58/179 (32%), Positives = 87/179 (48%), Gaps = 10/179 (5%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
LGEG FG V+KG ++ + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VKL+G C E++ +V E+M G L ++L + L S + AL A+G+ +L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ I+RD N L+ + K+SDFGL++D + D + APE
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPE 173
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 59/167 (35%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
LGEG FG V+KG ++ G + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 251
H N+VKL+G C E++ ++V E+MP G L ++L R L S + AL A+G+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
L + I+RD N L+ + K+SDFGL++D + D V
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-39
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V+KG ++ GT VAVKTL + +E+L E + + L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+L+G C + + +V E+MP G L + L + L +++AL AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ ++RD N L+ + K+SDFGL++D E D
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-39
Identities = 64/183 (34%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 188
+ LG G FG V+K GTG VAVK L + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L L H N+V+LI + D LV E+ G L R PL KIAL +G
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRG 110
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L +LH +I+RD K NILLD + K++DFGLAK + ++T V GT Y
Sbjct: 111 LEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYM 165
Query: 309 APE 311
APE
Sbjct: 166 APE 168
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 18/173 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 195
LGEG FG V+KG K G VAVKTL D + K++L E + L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALGAAK 247
N+V+L+G C E++ LV E+M G L ++L + L + A+ AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
G+ +L + ++RD N L+ D K+SDFGL++D + D T
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 60/183 (32%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ LGEG FG V+ TG VA+K + ++ +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKG 248
L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L +LH + +++RD K NILLD D + KL+DFGLA+ G+K T V GT Y
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163
Query: 309 APE 311
APE
Sbjct: 164 APE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 15/181 (8%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F +G+GGFG V+K K TG VA+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR--------HKR-TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H N+VK G ++ D+ +V EF GSL++ L + L S + KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH +I+RD K +NILL +D KL DFGL+ + + ++GT + AP
Sbjct: 113 YLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAP 166
Query: 311 E 311
E
Sbjct: 167 E 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 56/160 (35%), Positives = 81/160 (50%), Gaps = 11/160 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 195
LGEG FG V + G TG VAVK+LNH G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C + R L+ E++P GSL ++L R + + + KG+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+ I+RD NIL++++ K+SDFGLAK PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 63/179 (35%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 193
L+G G FG V+KG E TG VA+K L + K + E++ L +L
Sbjct: 7 LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VK IG IE L ++ E+ GSL + ++ P P S+ +GLA+L
Sbjct: 58 HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
HE+ VI+RD K +NIL D KL+DFG+A + K V+GT + APE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 58/181 (32%), Positives = 95/181 (52%), Gaps = 19/181 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 193
LLG G FG V+ ++++ TG +AVK+ L+ D + + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKD--------TGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 194 HLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALGAAKGLA 250
H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR K +GLA
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQILEGLA 115
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH +++RD K +NIL+D+D KL+DFG AK + + + V GT + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 311 E 311
E
Sbjct: 173 E 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-23
Identities = 63/167 (37%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 187
R + +LGEG FG V + P GTG VAVKTL + Q + W E+N
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C E + L+ E++P GSL ++L + L L + + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQI 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG
Sbjct: 117 CEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 2e-21
Identities = 65/186 (34%), Positives = 88/186 (47%), Gaps = 28/186 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDL 192
LG+G FG V V K TG A+K L + KE L E N L +
Sbjct: 1 LGKGSFGKVLL----------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM--KIALGAAKG 248
H +VKL Y + +++L LV E+ P G L +HL + + +I L
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA---- 105
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L +LH +IYRD K NILLDAD + KL+DFGLAK+ + +T GT Y
Sbjct: 106 LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYL 160
Query: 309 APEYVM 314
APE ++
Sbjct: 161 APEVLL 166
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.9 bits (229), Expect = 3e-21
Identities = 65/195 (33%), Positives = 87/195 (44%), Gaps = 26/195 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
++R LGEG FG V+ + VA+K L KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 187 NFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 243
L L H N+VKL + ++ LV E++ GSLE+ L R PL S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAK----DGPEGDKTHVS 298
L +LH + +I+RD K NILLD D KL DFGLAK G +
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 299 TRVMGTYGYAAPEYV 313
+ +GT GY APE +
Sbjct: 166 STSVGTPGYMAPEVL 180
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-21
Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 16/155 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
+ +G+G FG V G G VAVK L D +LAE + + L H
Sbjct: 12 ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLH 253
NLV+L+G ++ + +V E+M +GSL ++L R + + ++ AL +G+ +L
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
E+ ++RD N+L+ D AK+SDFGLAK+
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-21
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
N +G+G FG VF+ G P +P T VAVK L + ++ E
Sbjct: 6 NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------ 230
+ + H N+VKL+G C L++E+M G L L RS
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 231 ---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
LPL + ++ IA A G+A+L +ER ++RD T N L+ + K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 288 D 288
+
Sbjct: 179 N 179
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 20/179 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGDL 192
+GEG G VFK E TG TVA+K + G+ + L E+ L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H +VKL+ +LV E+MP L L PLP + KG+A++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H +++RD K +N+L+ AD K++DFGLA+ E + S +V T Y APE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 14/167 (8%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV 193
LG+G FG V +G W G + VAVK L D L ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFL 252
H NL++L G + ++V E P GSL + L + +L S A+ A G+ +L
Sbjct: 55 HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ I+RD NILL +D K+ DFGL + P+ + +V
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 31/189 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
LLG G FG V++G ++G VK V++ G + K+ E+ L L H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---KIALGAAKGLA 250
N+V+ +G E+D + E +P GSL L ++ P IR+ +I LG L
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLG----LE 116
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-----GTY 305
+LH+ R ++RD K +NIL+D + KL+DFG+AK V G+
Sbjct: 117 YLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165
Query: 306 GYAAPEYVM 314
+ APE +
Sbjct: 166 YWMAPEVIA 174
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 56/152 (36%), Positives = 80/152 (52%), Gaps = 12/152 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V KG K G + VAVKTL G KE+L E + + L H
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V+LIG C + +LV E P G L +L +R +P S ++A A G+A+L E
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYL--E 112
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
++ V +RD N+LL + AK+SDFG+++
Sbjct: 113 SKHFV-HRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 58/193 (30%), Positives = 83/193 (43%), Gaps = 23/193 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGDLVH 194
LGEG FG VF G ++P VAVKTL K++ E L + H
Sbjct: 13 LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 241
N+VK G C E D ++V+E+M G L L L S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A+ A G+ +L A + ++RD T N L+ D K+ DFG+++D D V
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 302 MGTYGYAAPEYVM 314
M + PE +M
Sbjct: 185 MLPIRWMPPESIM 197
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-19
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 25/179 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LGEG FG V +G + ++ + +K VAVKT+ D +E+L+E + D
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 194 HLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 242
H N++KLIG C E +++ FM G L + L L LP +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVS 298
+ A G+ +L + R I+RD N +L D ++DFGL+K GD + ++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-19
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVH 194
LGEG FG V+KG E G T +VA+KTL N + + +E+ E + DL H
Sbjct: 13 LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRM 239
N+V L+G C ++ +++E++ G L L R S L S +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
IA+ A G+ +L + ++RD N L+ K+SDFGL++D D V +
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 300 RVMGTYGYAAPEYVM 314
+ + + PE ++
Sbjct: 185 KSLLPVRWMPPEAIL 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 1e-18
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+ LGEG +G V+K ++ G VA+K + +G+ L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+GLA+ H +++RD K NIL++ D KL+DFGLA+
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 56/155 (36%), Positives = 78/155 (50%), Gaps = 21/155 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NGT V AVKTL G + +L E + L H
Sbjct: 14 LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L C E++ +V E+M +GSL + L + L LP + M A A+G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
R I+RD NIL+ + K++DFGLA+
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+G+G FG V+KG ++ VAVKT K +L E L H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ I+RD N L+ + K+SDFG++++
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 24/159 (15%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
LG G FG V+KG WI E VK + VA+K L + + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 248
++V+L+G C+ Q L+ + MP G L +++ L W +++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+++L E + +++RD N+L+ + K++DFGLAK
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 14/183 (7%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVH 194
+LG+G +G V+ G + VK V + T N + E L EV+ L L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K G+A+LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRVMGTYGYAAP 310
V++RD K +N++L + KL DFG A+ G G +++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 311 EYV 313
E +
Sbjct: 178 EVI 180
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 131 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
F E LG G FG V++G W + VA+K L D L +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGA 245
L H +L+ L C + ++ E M +GSL R + LP+ I M A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
A+G+A+L E+ I+RD NIL+ D K++DFGLA+
Sbjct: 114 AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 59/189 (31%), Positives = 86/189 (45%), Gaps = 31/189 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K + TG VA+K + L+ E L E+ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H N++KL+ L LV+EFM L + R LP S+ +GLA
Sbjct: 55 LNHPNIIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGY 307
F H +++RD K N+L++ + KL+DFGLA+ P TH V TR Y
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WY 164
Query: 308 AAPEYVMTA 316
APE ++
Sbjct: 165 RAPELLLGD 173
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGD 191
E ++G G FG V +G ++ G + VA+KTL G + L E + +G
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+++L G + +++ E+M GSL+ L + + G A G+ +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
L +E ++RD NIL++++ K+SDFGL++
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 60/194 (30%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K + VAVK L L K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 240
+VK G C + D ++V+E+M G L N R P L S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 301 VMGTYGYAAPEYVM 314
M + PE +M
Sbjct: 185 TMLPIRWMPPESIM 198
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 59/183 (32%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 193
LG+GGFG V A TG A K L+ L +G + L E L + V
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKV 50
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAF 251
+ + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
LH+ R ++YRD K N+LLD N ++SD GLA + G K GT GY APE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164
Query: 312 YVM 314
+
Sbjct: 165 VLQ 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV 193
+LG+G G V+K TG A+K ++ DG + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAP 310
+R +I+RD K SN+L+++ K++DFG++K + + T V GT Y +P
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSP 169
Query: 311 E 311
E
Sbjct: 170 E 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 57/184 (30%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG G G V K +P TG +AVKT+ + K+ L E++ L
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 307
+I+RD K SNIL+++ KL DFG VS +++ GT Y
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 308 AAPE 311
APE
Sbjct: 166 MAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LG+G FG V++G VK VA+KT+N + + E+L E + + +
Sbjct: 14 LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 246
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+A+L A + ++RD N ++ D K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 307 YAAPEYVM 314
+ APE +
Sbjct: 187 WMAPESLK 194
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 57/182 (31%), Positives = 86/182 (47%), Gaps = 27/182 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + LG+G FG V E P++ TG VAVK L H + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 189 LGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHL--------FRRSLPLPWSIR 238
L L H N+VK G C +R LV E++P GSL ++L R+ L I
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI- 117
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
KG+ +L + ++RD T NIL++++ K+ DFGL K P+ DK +
Sbjct: 118 -------CKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYK 166
Query: 299 TR 300
R
Sbjct: 167 VR 168
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 187
+ +G+G FG V+ + +G +K L++ + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVK 51
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP----WSIRM 239
L L H N++K E+ +L V E+ G L + ++ P P +
Sbjct: 52 ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++ L L +LH R +++RD K NI L ++ KL DFG++K T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 300 RVMGTYGYAAPE 311
V GT Y +PE
Sbjct: 163 VV-GTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 25/182 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+G+G FG VFK V+ A+K ++ + +E + E L L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRMKIALGAAKGL 249
+++ ++ + +V E+ G L L +R PLP W ++I LG L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
A LH + +++RD K+ N+ LDA N K+ D G+AK D T+ + ++GT Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLS 169
Query: 310 PE 311
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 55/155 (35%), Positives = 78/155 (50%), Gaps = 21/155 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G W N T PV AVKTL + K++LAE + L H
Sbjct: 14 LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
L++L C ++ +V E M GSL +L R+L LP I M A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+ I+RD N+L+ + K++DFGLA+
Sbjct: 120 E---AQNYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 19/179 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVH 194
+GEG G V+K TG VA+K + L+ + L E+ + D H
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V + D+ +V E+M GSL + + + + + + +GL +LH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ VI+RD K+ NILL D + KL+DFG A + S V+GT + APE +
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVI 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 59/191 (30%), Positives = 85/191 (44%), Gaps = 21/191 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E P + + VAVKTL K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 243
+VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A G+ +L A + ++RD T N L+ + K+ DFG+++D D V M
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 304 TYGYAAPEYVM 314
+ PE +M
Sbjct: 185 PIRWMPPESIM 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 53/180 (29%), Positives = 76/180 (42%), Gaps = 18/180 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDL 192
++GEG +G V K + TG VA+K + D K L EV L L
Sbjct: 7 GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+V L + LV+E++ R LE LP P ++R + +A+
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H +I+RD K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 116 CHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 49/171 (28%), Positives = 72/171 (42%), Gaps = 21/171 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
+F+ ++GEG F V + T A+K L+ L + K E
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52
Query: 187 NFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIAL 243
L L H ++KL Y +D++ L V E+ P G L ++ SL R A
Sbjct: 53 EVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
L +LH + +I+RD K NILLD D + K++DFG AK
Sbjct: 111 -ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 57/169 (33%), Positives = 83/169 (49%), Gaps = 26/169 (15%)
Query: 136 LLGEGGFGCVFKGW---IEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD 191
LG G FG V++G I G+ P++ VAVKTL Q KE+L E + + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIR------VAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALG 244
H N+VKL+G C+ ++ + ++ E M G L ++L F L L + I L
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLD 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKD 288
AKG +L + I+RD N L+ DAD K+ DFGLA+D
Sbjct: 115 VAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 183
L R LLG G FG V KG WI E + + VA+KT+ + G Q +E
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
+ +G L H +V+L+G C LV + P GSL +H+ + L + +
Sbjct: 58 DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L E +++R+ NILL +D +++DFG+A DK + +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 304 TYGYAAPEYVM 314
+ A E ++
Sbjct: 174 PIKWMALESIL 184
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 18/154 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G +G V++G W + + LTVAVKTL D ++ E+L E + ++ H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G C + ++ EFM G+L ++L R + + + +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
++ I+RD N L+ ++ K++DFGL++
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 23/192 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 184
N+R LLG+G FG V+ TG +AVK + D KE A
Sbjct: 3 NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 301
+G+ +LH +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 302 MGTYGYAAPEYV 313
GT + +PE +
Sbjct: 168 TGTPYWMSPEVI 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 56/163 (34%), Positives = 76/163 (46%), Gaps = 19/163 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 195
LG G FG V++G V+ L VAVKTL Q ++L E + H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALGAAKG 248
N+V+LIG E R ++ E M G L++ L R + P P S+ MK A AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 249 LAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKD 288
+L E I+RD N LL AK++DFG+A+D
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 55/184 (29%), Positives = 80/184 (43%), Gaps = 24/184 (13%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
S LGEG G V K + TG+ A+KT+ D K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 194 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKG 248
+VK G +++ + E+ GSL++ + +R + + KIA KG
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGY 307
L++LH R +I+RD K SNILL KL DFG++ + T GT Y
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169
Query: 308 AAPE 311
APE
Sbjct: 170 MAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 54/158 (34%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 194
LLG+G FG VFKG +++ VAVKT D Q K ++L+E L H
Sbjct: 2 LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VKLIG C + +V E +P G + L ++ L +K AL AA G+A+L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+ I+RD N L+ + K+SDFG+++ +G
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 12/154 (7%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +LV+L+G C+ +L V + MP G L +++ + + + + AKG+ +L
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
E R +++RD N+L+ + + K++DFGLA+
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 4e-15
Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 43/190 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
LG+G FG V+ +E G VA+K + + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53
Query: 192 L-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALGA 245
L H N+VKL E+D+ V+E+M E +L+ R+ P S+ I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRV 301
+GLA +H+ +RD K N+L+ K++DFGLA++ P D +VSTR
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR- 162
Query: 302 MGTYGYAAPE 311
Y APE
Sbjct: 163 ----WYRAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 61/195 (31%), Positives = 90/195 (46%), Gaps = 36/195 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 182
+ LGEG + V+K +E G VA+K L DG+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--M 239
L E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM 108
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH- 296
+ L +GL +LH +++RD K +N+L+ +D KL+DFGLA+ P TH
Sbjct: 109 LMTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
Query: 297 VSTRVMGTYGYAAPE 311
V TR Y APE
Sbjct: 163 VVTRW-----YRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 16/184 (8%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F LGEG +G V+K +E G VA+K + + +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+VK G ++ +V E+ GS+ + + + L I KGL
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH I+RD K NILL+ + AKL+DFG++ G D V+GT + AP
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAP 168
Query: 311 EYVM 314
E +
Sbjct: 169 EVIQ 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-15
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 17/158 (10%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGDLV 193
++G+G FGCV+ G I+ +G + AVK+LN L+ +++L E + D
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQK-------IHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 194 HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLA 250
H N++ L+G C+ + L+V +M G L N F RS +++ I G AKG+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+L A + ++RD N +LD + K++DFGLA+D
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARD 147
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 7e-15
Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 34/187 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K N TG VA+K + ++ KE + E+ L
Sbjct: 7 IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54
Query: 192 LVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALG 244
L H N+V+L + +V+E+M G L++ + + I+ MK L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GL +LH +++RD K SNIL++ D KL+DFGLA+ + T + T
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVIT 164
Query: 305 YGYAAPE 311
Y PE
Sbjct: 165 LWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 137 LGEGGFG----CVFKGWIEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 190
LGEG FG C +G E G AP G + VAVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 241
L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 242 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+ A G+ +L A ++RD T N L+ Y K++DFG++++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 300 RVM 302
R +
Sbjct: 190 RAV 192
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVHL 195
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C ED L+ EF+P GSL+ +L R + ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
R ++RD N+L+++++ K+ DFGL K
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 59/185 (31%), Positives = 86/185 (46%), Gaps = 22/185 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ N T VAVK +++ G Q +++W + EV FL L
Sbjct: 29 IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G +++ LV E+ GS + L PL I GA +GLA+LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+I+RD K NILL KL+DFG A K+ + +GT + APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVI 189
Query: 314 MTALE 318
+ E
Sbjct: 190 LAMDE 194
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 15/159 (9%)
Query: 165 TVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223
VA+K ++ + Q E EV + H N+VK + D+ LV ++ GSL
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 224 NHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
+ + S P L +I + KGL +LH + I+RD K NILL D + K+
Sbjct: 88 -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKI 143
Query: 281 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+DFG LA G V +GT + APE VM
Sbjct: 144 ADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPE-VME 179
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 11/153 (7%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+GEG FG V++G + VAVKT + +E +L E + H
Sbjct: 13 CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+ ++RD N+L+ + KL DFGL++
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 60/181 (33%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E TG VA+K + D K L E+ L L H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV LI ++L LV+E+ ++ N L + +P + KI + + F H
Sbjct: 60 PNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 310
+ I+RD K NIL+ KL DFG A+ GP D T +V+TR Y AP
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 311 E 311
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG FG V +G TG VAVK + D + +L E + L H N
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALGAAKGLAFLHEE 255
LV+L+G I + +V E M +G+L N L R L I++ + +L A+G+ +L
Sbjct: 61 LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+ +++RD NIL+ D AK+SDFGLA+ G G
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-14
Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 29/190 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
LGEG FG V + P V+ G L VAVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 233
L L N+++L+G C+++D ++ E+M G L L L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 234 P---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
P +S + +AL A G+ +L + ++RD T N L+ + K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 291 EGDKTHVSTR 300
GD + R
Sbjct: 190 AGDYYRIQGR 199
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 38/196 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGDLV 193
+G+G FG V K V+ G + K +++ + K+ L +EVN L +L
Sbjct: 8 IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 194 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP----WSIRMKIAL 243
H N+V+ I+ + L V E+ G L L ++ + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 244 GAAKGLAFLH--EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVS 298
L H + V++RD K +NI LDA+ N KL DFGLAK KT+V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 299 TRVMGTYGYAAPEYVM 314
GT Y +PE +
Sbjct: 172 ----GTPYYMSPEQLN 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 56/180 (31%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGDLVH 194
+G G FG V+ V TG +AVK + D KE E+ L L H
Sbjct: 8 IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLVK G + ++ + E+ G+LE L L + L +GLA+LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV---MGTYGYAAPE 311
+++RD K +NI LD + KL DFG A T + V GT Y APE
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + +L ++RD N+L+ D AK+SDFGL K+
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V+ G W+E+ VA+KT+ +G ++++ E + L H
Sbjct: 12 IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C E LV+EFM G L ++L + + + L +G+A+L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
VI+RD N L+ + K+SDFG+ +
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 21/191 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 186
+F ++G+G FG V +++ T A+K +N + L E
Sbjct: 1 HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EI 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILLD + ++DF +A T T GT
Sbjct: 110 VLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163
Query: 306 GYAAPEYVMTA 316
GY APE +
Sbjct: 164 GYMAPEVLCRQ 174
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 55/193 (28%), Positives = 79/193 (40%), Gaps = 23/193 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKI 241
+V+ G C E L+V+E+M G L N R P L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 302 MGTYGYAAPEYVM 314
M + PE ++
Sbjct: 185 MLPIRWMPPESIL 197
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 42/212 (19%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 184
R++ LGEG FG V+K + TG VA+K L H+ G L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56
Query: 185 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 233
E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115
Query: 234 PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 287
I+ M L +G+ +LHE +++RD K +NIL+D K++DFGLA+
Sbjct: 116 --QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 288 -----DGPEGDKTHVSTRVMGTYGYAAPEYVM 314
G G T T ++ T Y PE ++
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 63/195 (32%), Positives = 86/195 (44%), Gaps = 39/195 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE---WLA 184
+F LG G FG V V+ G+G A+K L+ + K+ L
Sbjct: 1 DDFEFIKTLGTGSFGRVML----------VRHKGSGKYYALKILSKAKIVKLKQVEHVLN 50
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM--- 239
E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 51 EKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA 108
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++ L L +LH ++YRD K N+LLD+D K++DFG AK V
Sbjct: 109 QVVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKG 153
Query: 300 RVM---GTYGYAAPE 311
R GT Y APE
Sbjct: 154 RTYTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 23/190 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 185
L+G+G +G V+ + N T TG +AVK + HD Q K +E
Sbjct: 8 LIGKGTYGRVY---LALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+GLA+LH + +++RD K N+L+DAD K+SDFG++K + + + G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 306 GYAAPEYVMT 315
+ APE + +
Sbjct: 175 FWMAPEVIHS 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 49/184 (26%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
+ ++G G FG VF+G ++ G V VA+KTL + + ++L+E + +G
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + +++ E+M G+L+ +L + + G A G+ +L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAA 309
++ ++RD NIL++++ K+SDFGL++ D PEG T ++ + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 310 PEYV 313
PE +
Sbjct: 179 PEAI 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 55/179 (30%), Positives = 77/179 (43%), Gaps = 42/179 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 193
LGEG FG V K E G P TVAVK L D + K+ L DLV
Sbjct: 19 PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATE--KD-------LSDLVSE 65
Query: 194 ---------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSI 237
H N++ L+G C ++ +V E+ G+L + L R S P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 238 RMKI--------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ A A+G+ FL A + I+RD N+L+ D+ K++DFGLA+D
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 21/184 (11%)
Query: 137 LGEGGFGCV-------FKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
LGEG FG V + + E+ + VAVK L D +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIR 238
L L N+ +L+G C D ++ E+M G L L + S L +S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ +A A G+ +L ++RD T N L+ +Y K++DFG++++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 299 TRVM 302
R
Sbjct: 190 GRAP 193
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 137 LGEGGFG----CVFKG---WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
LGEG FG C +G +++++ + V + VAVK L D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 238
+ L N+++L+ CI D ++ E+M G L L R +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ +A A G+ +L + ++RD T N L+ +Y K++DFG++++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 299 TR 300
R
Sbjct: 190 GR 191
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 52/155 (33%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL-VH 194
LG G FG V +E K + VAVK L +E L +E+ + L H
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLH 253
N+V L+G C L++ E+ G L N L R R L + + AKG+AFL
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A + I+RD N+LL K+ DFGLA+D
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 23/188 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F+ LG+G +G V+K + A+K ++ G KE VN +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDL-GSMSQKEREDAVNEI 50
Query: 190 GDLVHLNLVKLIGY--CIEDDQRL-LVYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 243
L +N +I Y D +L +V E+ P G L + +R +P +I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+GL LHE + +++RD K++NILL A+ K+ D G++K K +++ +G
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163
Query: 304 TYGYAAPE 311
T Y APE
Sbjct: 164 TPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 16/152 (10%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W + + VA+K + +G +++ E + L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
NLV+L G C + +V E+M G L N+L R L + + + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
I+RD N L+ D K+SDFGLA+
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 62/190 (32%), Positives = 82/190 (43%), Gaps = 39/190 (20%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 186
+LG+G FG V A +K GT AVK L D K LA
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIA 242
L L+ C + RL V E++ G L H+ R P + +I
Sbjct: 53 GKHPFLTQLHS------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 301
LG L FLHE R +IYRD K N+LLD++ + K++DFG+ K+G G T +
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156
Query: 302 MGTYGYAAPE 311
GT Y APE
Sbjct: 157 CGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 189
F +G+G FG V+K + T VA+K ++ + + E + E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ K G ++ + ++ E+ GS + L + L + I GL
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGL 111
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYG 306
+LHEE I+RD K +NILL + + KL+DFG++ G T ++ +GT
Sbjct: 112 EYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163
Query: 307 YAAPEYVM---------------TALELF 320
+ APE + TA+EL
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 56/189 (29%), Positives = 83/189 (43%), Gaps = 33/189 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 187
N LGEG FG V K +K G T VAVK L + ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLP 232
L + H +++KL G C +D LL+ E+ GSL + L R S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 L------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
L ++ I A ++G+ +L AE +++RD N+L+ K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 285 LAKDGPEGD 293
L++D E D
Sbjct: 173 LSRDVYEED 181
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K TGL A K + + + ++++ E++ L + H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V L +++ ++ EF G+L++ + L + + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K NILL D + KL+DFG+ AK+ K +GT + APE V
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 63/200 (31%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLV 193
LG+GGFG E VK TG A K L+ L+ G K L E L +
Sbjct: 1 LGKGGFG--------EVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGL 249
+V L Y E L LV M G L+ H++ R L + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
LH ++YRD K N+LLD N +LSD GLA + +G T+ GT GY A
Sbjct: 109 LHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMA 162
Query: 310 PEYVM-----TALELFCLKC 324
PE + ++ F + C
Sbjct: 163 PEILKEEPYSYPVDWFAMGC 182
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 188
NF+ LGEG + V+KG N T TG VA+K ++ D +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGA 245
+ +L H N+V+L +++ +LV+E+M + ++ H R +L L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
KG+AF HE V++RD K N+L++ KL+DFGLA+
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG+ A K ++ + ++++ E++ L H N
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+VKL+ ++ ++ EF G+++ + PL + + L +LHE
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+I+RD K NIL D + KL+DFG++ + S +GT + APE VM
Sbjct: 124 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 21/169 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G + G +P T VA+KT+N ++ E+L E + + +
Sbjct: 14 LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 24/182 (13%)
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLN 196
G +G VF K TG A+K + + + L E + L
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+VKL Y + + L LV E++P G L L L + L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS------TRVMGTYGYAA 309
+I+RD K NIL+D++ + KL+DFGL+K G + +++ R++GT Y A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 310 PE 311
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 46/115 (40%), Positives = 62/115 (53%), Gaps = 19/115 (16%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 257
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPE 311
R +IYRD K N+LLDA+ + KL+D+G+ K+G GD T + GT Y APE
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 18/180 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 254
+VKL+G D + ++ EF P G+++ + R L P I++ I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+I+RD K N+LL D + KL+DFG++ + + S +GT + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K G VA+K + + + E++ L + H N
Sbjct: 11 IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---GAAKGLAF 251
+V G + D+ +V E+ GSL++ + R L +IA KGLA+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
LHE I+RD K +NILL D + KL+DFG++
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 64/182 (35%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGDL 192
+G+G FG V + G AVK L + KE +AE N L ++
Sbjct: 3 IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGL 249
H LV L Y + +L V +++ G L HL R RS P P R + A A L
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH +IYRD K NILLD+ + L+DFGL K+G E KT ++ GT Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164
Query: 310 PE 311
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 62/218 (28%), Positives = 86/218 (39%), Gaps = 55/218 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
+F ++G G FG V+ TG A+K L + + AE
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MK 240
+ L D +VKL Y +D++ L LV E+MP G L N L R+ + + R +
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----- 295
+AL + L F+H RD K NIL+DAD + KL+DFGL K +
Sbjct: 112 LALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 296 -----------------HVSTRVM-----GTYGYAAPE 311
H RV GT Y APE
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 64/193 (33%), Positives = 92/193 (47%), Gaps = 34/193 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 188
+LG+GG+G VF+ + + A TG A+K L + H + AE N
Sbjct: 2 KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSIRMKIA 242
L + H +V LI Y + +L L+ E++ G L HL R + + + + +A
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 301
L LH++ +IYRD K NILLDA + KL+DFGL K+ EG TH
Sbjct: 113 LE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160
Query: 302 MGTYGYAAPEYVM 314
GT Y APE +M
Sbjct: 161 CGTIEYMAPEILM 173
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 28/196 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 184
NF+ E +G+G F V+K +G VA+K + + K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 237
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+++ L +H + +++RD K +N+ + A KL D GL + KT
Sbjct: 112 FVQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 298 STRVMGTYGYAAPEYV 313
+ ++GT Y +PE +
Sbjct: 163 AHSLVGTPYYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 57/196 (29%), Positives = 80/196 (40%), Gaps = 39/196 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
++GEG +G V+K + TG VA+K ++ +E E N L H
Sbjct: 13 VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 195 LNLVKLIG------YCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 243
N+ G DDQ LV E GS+ + + L W IA
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117
Query: 244 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 298
+GLA+LHE VI+RD K NILL + KL DFG++ D G + +
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTF 173
Query: 299 TRVMGTYGYAAPEYVM 314
GT + APE +
Sbjct: 174 I---GTPYWMAPEVIA 186
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
LKL + LG G FG V+ G+ + VA+K+L G +
Sbjct: 6 ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 238
+LAE N + L H LV+L + + ++ E+M GSL + L L + I
Sbjct: 48 FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
M A A+G+AF+ + I+RD + +NIL+ K++DFGLA+
Sbjct: 107 M--AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 194
LGEG FG V + E G +P +TVAVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIRM 239
N++ L+G C ++ ++ E+ +G+L L R P P + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A A+G+ +L R I+RD N+L+ D K++DFGLA+
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 45/169 (26%), Positives = 86/169 (50%), Gaps = 12/169 (7%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
E ++G G FG V +G ++ G + VA+KTL + +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++ L G + +++ EFM G+L++ L + + + G A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVST 299
+E ++RD NIL++++ K+SDFGL++ + D T+ S+
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K + TG VA+K + D G+ + E
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 242
++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+GLAF H + R V++RD K N+L++ + KL+DFGLA+ G T +
Sbjct: 107 FQLLQGLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 161
Query: 303 GTYGYAAPE------YVMTALELFCLKC 324
T Y APE Y TA++++ L C
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGC 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 42/204 (20%)
Query: 124 LKLATRNFRPESLL------GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
L+L P S L GEG G V TG VAVK ++ Q
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ EV + D H N+V++ + D+ +V EF+ G+L + +
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--------IVTHT 110
Query: 238 RMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAK 287
RM + L K L+FLH + VI+RD K+ +ILL +D KLSDFG ++K
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPE 311
+ P ++GT + APE
Sbjct: 168 EVPR------RKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 49/153 (32%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ VA+K +++ G Q +++W + EV FL L
Sbjct: 23 IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G + + LV E+ GS + L PL I GA +GLA+LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
I+RD K NILL KL+DFG A
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 26/171 (15%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI P + VA+K L + +KE L
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWS 236
E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWC 115
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+++ AKG+ +L E R +++RD N+L+ + K++DFGLAK
Sbjct: 116 VQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 161 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214
TG +AVK + N Q + E+ + L H ++++++G ED L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
E+M GS+ +HL + ++ + +GL++LH E +I+RD K +N+L+D+
Sbjct: 83 EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDS 138
Query: 275 D-YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+++DFG LA G + +++GT + APE
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 45/237 (18%)
Query: 84 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 143
P+++ SS+++S + S S +K EL+ R+ + +G G G
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELE---RVNR------------------IGSGAGG 88
Query: 144 CVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 201
V+K + TG A+K + NH+ ++ E+ L D+ H N+VK
Sbjct: 89 TVYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCH 138
Query: 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
+ + ++ EFM GSLE L +A G+A+LH R ++
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHIV 190
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTAL 317
+RD K SN+L+++ N K++DFG+++ + D + S +GT Y +PE + T L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDL 244
|
Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 66/209 (31%), Positives = 89/209 (42%), Gaps = 34/209 (16%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
L + + NDL+ +G G G V+K ++ G +AVK
Sbjct: 3 LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46
Query: 170 TLNHDGLQGHKEWLAEVNFLGDL-VHL------NLVKLIGYCIEDDQRLLVYEFMPRGSL 222
+ G +KE + L DL V L +VK GY I D + E M L
Sbjct: 47 QMRRTG---NKEENKRI--LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CL 100
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
+ L R P+P I K+ + K L +L E+ VI+RD K SNILLDA N KL D
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCD 158
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
FG++ + K TR G Y APE
Sbjct: 159 FGISGRLVD-SKAK--TRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 63/190 (33%), Positives = 85/190 (44%), Gaps = 25/190 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAA 109
Query: 247 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ GL LH E +YRD K NILLD + ++SD GLA PEG+ + RV G
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-G 163
Query: 304 TYGYAAPEYV 313
T GY APE +
Sbjct: 164 TVGYMAPEVL 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 61/185 (32%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 193
LG+GGFG V A TG A K LN L +G++ + E L V
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK-V 50
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GL 249
H + + Y + L LV M G L H++ P + A+ GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYG 306
LH+ R +IYRD K N+LLD D N ++SD GLA KDG K + GT G
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPG 162
Query: 307 YAAPE 311
+ APE
Sbjct: 163 FMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 300 RVMGTYGYAAPE 311
+ APE
Sbjct: 195 NGRLPVKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 48/156 (30%), Positives = 69/156 (44%), Gaps = 17/156 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
+G G FG V G G + + V VK L +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 250
N+++ +G CIE LLV EF P G L+N+L + + ++A A GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+LH+ I+ D N L AD + K+ D+GLA
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 117 RKFTFNDLKLATRNFR--PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
R + D ++A F+ PE L +G G FG V+ + + T V VA+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV-------VAI 55
Query: 169 KTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
K +++ G Q +++W + EV FL + H N ++ G + + LV E+ GS +
Sbjct: 56 KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDL 114
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L PL I GA +GLA+LH +I+RD K NILL KL+DFG
Sbjct: 115 LEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTALE 318
A + +GT + APE ++ E
Sbjct: 172 ASIASPANS------FVGTPYWMAPEVILAMDE 198
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVH 194
LGEG FG V +G + ++ + L VAVKT+ +++L+E + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 195 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 243
N+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A G+ +L + + I+RD N +L+ + N ++DFGL+K GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 22/171 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LG+G FG V + ++ G+ VAVK L D +E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 194 HLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 242
H N++KLIG + RL ++ FM G L L + LP ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+ A G+ +L + + I+RD N +L+ + ++DFGL+K GD
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K + VA+K +N +G ++++ E + L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + +V EFM G L N+L +R L + + + +G+ +L +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
I+RD N L+ + K+SDFG+ +
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 245
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 246 --AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 185
+L+G G FG V+ G + +G +AVK +++ + L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQI 115
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR----- 300
KGL +LH R +I+RD K +NIL+D K+SDFG++K E + T
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPS 171
Query: 301 VMGTYGYAAPEYV 313
+ G+ + APE V
Sbjct: 172 LQGSVFWMAPEVV 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 31/192 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 187
+ ++G G FG V + V +K + + + + A E
Sbjct: 1 KYEKIRVVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQ 51
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSIRMK 240
L L H N+++ +ED ++V E+ P G+L N L L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVST 299
+A LH + +++RD KT NILLD K+ DFG++K K+ T
Sbjct: 112 LA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT 160
Query: 300 RVMGTYGYAAPE 311
V+GT Y +PE
Sbjct: 161 -VVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 45/110 (40%), Positives = 58/110 (52%), Gaps = 9/110 (8%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPE 311
RD K N+LLDAD + KL+D+G+ K+G GD T + GT Y APE
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 16/168 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 188
N + + LG G FG VF + G V VK L E+ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIA 242
L H N+V+L+G C E + ++ E+ G L+ L + P P S + K+A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 243 LGA--AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
L A G+ L + ++RD N L+ + K+S L+KD
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-11
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 35/196 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 185
LG G FGCV+K + NG +A+K +N K+ ++E
Sbjct: 7 HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 186 VNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 237
V + + L H N+V+ +E+D+ +V + + P G N L + W+I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+++ L L +LH+E + +++RD +NI+L D ++DFGLAK K
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170
Query: 298 STRVMGTYGYAAPEYV 313
T V+GT Y+ PE V
Sbjct: 171 -TSVVGTILYSCPEIV 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 181
+L L+ F E LGE FG ++KG + G + VA+KTL + + Q E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 230
+ E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 231 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L + IA+ A G+ +L + +++D NIL+ + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+++ D V + + + PE +M
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIM 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 58/195 (29%), Positives = 84/195 (43%), Gaps = 28/195 (14%)
Query: 133 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 183
PE L +G G FG V+ N VA+K +++ G Q +++W +
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
GA +GLA+LH +I+RD K NILL KL DFG A + +G
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVG 173
Query: 304 TYGYAAPEYVMTALE 318
T + APE ++ E
Sbjct: 174 TPYWMAPEVILAMDE 188
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 184
+ E ++G G FG V G ++ G + VA+KTL G+ E +L+
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLK----AGYTEKQRRDFLS 54
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E + +G H N++ L G + ++V E+M GSL+ L + + + G
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKT 295
A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 58/184 (31%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 193
L+GEG +G V K +E TG VA+K + D K + E+ L L
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H NLV LI + LV+EF+ L + L + L S K +G+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 310
+I+RD K NIL+ KL DFG A+ P T +V+TR Y AP
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAP 169
Query: 311 EYVM 314
E ++
Sbjct: 170 ELLV 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 29/187 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
+GEG +G V+KG TG VA+K + L+ +E + E++ L +
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-GAAK 247
L H N+V L +++ + L++EF+ L+ +L SLP + +K L +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ F H R V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 113 GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 308 AAPEYVM 314
APE ++
Sbjct: 168 RAPEVLL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 64/188 (34%), Positives = 78/188 (41%), Gaps = 39/188 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHD-----GLQGH----KEWLAEV 186
LG GGFG V VK T A+K + G Q H KE L E
Sbjct: 1 LGVGGFGRVEL----------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC 50
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
N H +VKL Y D++ +Y E+ G L L R L ++ R IA
Sbjct: 51 N------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA- 100
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+LH R +IYRD K N+LLD++ KL DFG AK G KT G
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCG 154
Query: 304 TYGYAAPE 311
T Y APE
Sbjct: 155 TPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 31/63 (49%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L FLH VIYRD K NILLDA+ + KL+DFG+ K+G T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 309 APE 311
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 63/190 (33%), Positives = 85/190 (44%), Gaps = 25/190 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109
Query: 247 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ GL L E ++YRD K NILLD + ++SD GLA PEG+ V RV G
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-G 163
Query: 304 TYGYAAPEYV 313
T GY APE +
Sbjct: 164 TVGYMAPEVI 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 62/188 (32%), Positives = 81/188 (43%), Gaps = 21/188 (11%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 245
L + V+ V + Y E D LV M G L+ H++ + A
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 165
Query: 306 GYAAPEYV 313
GY APE V
Sbjct: 166 GYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 20/165 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 184
N+R LLG+G FG V+ + + TG +AVK + + + + KE A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+G+++LH +++RD K +NIL D+ N KL DFG +K
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 61/193 (31%), Positives = 80/193 (41%), Gaps = 34/193 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 181
FR ++LG G FG V A K TG A+K L + L K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
N H LV L C + + + V E+ G L H+ P R
Sbjct: 52 IFETAN---SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAV 104
Query: 241 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVS 298
A GL +LHE ++YRD K N+LLD + K++DFGL K+G GD+T S
Sbjct: 105 FYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 299 TRVMGTYGYAAPE 311
T GT + APE
Sbjct: 160 T-FCGTPEFLAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 26/171 (15%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 183
L + +LG G FG V+KG WI P + VA+K L + + +KE L
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWS 236
E + + + +L+G C+ +L V + MP G L ++ + + L L W
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWC 115
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+++ AKG+++L E +++RD N+L+ + + K++DFGLA+
Sbjct: 116 VQI------AKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM-------------- 239
N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A+G+ +L A + I+RD N+L+ + K++DFGLA+D
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 54/208 (25%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
+ +G G +G V V TG VA+K +++ D L K L E+
Sbjct: 2 YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N++ L+ + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSPQP 99
Query: 243 LGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPE 291
L +GL +LH VI+RD K SNIL++++ + K+ DFGLA+ P+
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 292 GDKT-----HVSTRVMGTYGYAAPEYVM 314
D+ +V TR Y APE ++
Sbjct: 157 EDEKGFLTEYVVTRW-----YRAPELLL 179
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 192
+ ++GEG FG V K I+ K G + A+K + + H+++ E+ L L
Sbjct: 12 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGA 245
H N++ L+G C L E+ P G+L + L R+S L IA L +
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 246 AKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+ L F + A ++ I+RD NIL+ +Y AK++DFGL++
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 34/188 (18%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 192
E ++GEG FG V + I+ K G + A+K L + H+++ E+ L L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 238
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
++ A A G+ +L +E+ I+RD N+L+ + +K++DFGL++ G++
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 296 HVSTRVMG 303
+V + MG
Sbjct: 172 YVK-KTMG 178
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 24/168 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
++ + R + LG+G FG V+ G W NGT VA+KTL G + +L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 50 QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107
Query: 241 IALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAK 287
A A G+A++ ER I+RD + +NIL+ + K++DFGLA+
Sbjct: 108 -AAQIADGMAYI----ERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 54/156 (34%), Positives = 79/156 (50%), Gaps = 24/156 (15%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NG VAVKTL G + +L E + L H
Sbjct: 14 LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 253 HEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAK 287
ER I+RD +++NIL+ K++DFGLA+
Sbjct: 119 ----ERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
N+R LLG+G FG V+ + V G L + + + KE A E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55
Query: 187 NFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+ K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTR 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+G+++LH +++RD K +NIL D+ N KL DFG +K
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 58/185 (31%), Positives = 86/185 (46%), Gaps = 24/185 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVK----PGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFL 189
+LG+G FG VF V+ P G A+K L L+ E + L
Sbjct: 3 VLGQGSFGKVFL----------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL 52
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A A
Sbjct: 53 AEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 309 APEYV 313
APE V
Sbjct: 166 APEVV 170
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 8e-10
Identities = 61/189 (32%), Positives = 90/189 (47%), Gaps = 35/189 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
LG+G +G V+K + T VA+K + D + + A E+ FL +
Sbjct: 15 LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62
Query: 192 LV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
L H N+VKL+ E+D+ + LV+E+M E L R ++ R I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVM 302
K L ++H VI+RD K SNILL++D KL+DFGLA+ + E + V T +
Sbjct: 117 LKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 303 GTYGYAAPE 311
T Y APE
Sbjct: 174 ATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 31/69 (44%), Positives = 42/69 (60%), Gaps = 7/69 (10%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 304
A GL FLH + +IYRD K N++LDA+ + K++DFG+ K+ G KT TR GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164
Query: 305 YGYAAPEYV 313
Y APE +
Sbjct: 165 PDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 38/114 (33%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYV 313
YRD K NILLD++ + L+DFGL+K+ E ++ + GT Y APE +
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVI 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 64/189 (33%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
FR +LG+GGFG V A TG A K L ++ K +N
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 191 DLVHLN--LVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +N V + Y E D LV M G L+ H++ ++ P + AA+
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAE 110
Query: 248 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
GL LH E ++YRD K NILLD + ++SD GLA + PEG+ + RV GT
Sbjct: 111 ITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GT 164
Query: 305 YGYAAPEYV 313
GY APE V
Sbjct: 165 VGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 22/166 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 184
N+R LLG G FG V+ + + TG +AVK + + D + KE A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 241
E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+G+++LH +++RD K +NIL D+ N KL DFG +K
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 15/181 (8%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGD 191
E +LG G FG + +G ++ P K L VA+ TL G + +LAE LG
Sbjct: 10 ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+V+L G + ++V E+M G+L++ L + L M + G A G+ +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHVSTRVMGTYGYAAP 310
L +E +++ +L+++D K+S F L +D E T +S + +AAP
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAP 177
Query: 311 E 311
E
Sbjct: 178 E 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 161 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFM 217
GTG A+K L + K+ E + L +L H +V ++ ++++ + EF+
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
G L HL R++ P + +LH + +IYRD K N+LLD +
Sbjct: 101 VGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGH 156
Query: 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
K++DFG AK P+ T + GT Y APE +
Sbjct: 157 VKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVI 187
|
Length = 329 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 24/163 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 111
Query: 246 AKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAK 287
A G+A++ ER ++RD + +NIL+ + K++DFGLA+
Sbjct: 112 ASGMAYV----ERMNYVHRDLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 60/181 (33%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 191
++G+G FG V + +G+ AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H LV L Y + ++L V +++ G L HL R L R A A +
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH +IYRD K NILLD+ + L+DFGL K+G E ++T ++ GT Y AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
Query: 311 E 311
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 26/190 (13%)
Query: 130 NFRPESL-----LGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQG-HKEW 182
+ R E L LG G G V K VK TG +A K ++ K+
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQI 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L E+ + + +V G + ++ + EFM GSL+ ++++ P+P I KIA
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIA 109
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRV 301
+ +GL +L+ +++RD K SNIL+++ KL DFG++ G+ + ++
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 302 MGTYGYAAPE 311
+GT Y +PE
Sbjct: 163 VGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 253
LV+L +++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+ I+RD + +N+L+ K++DFGLA+
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 43/115 (37%), Positives = 62/115 (53%), Gaps = 19/115 (16%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 257
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPE 311
R +IYRD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 180
++ L+T F E LGE FG V+KG + GTAP + VA+KTL D +G +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 230
E+ E L H N+V L+G ++ +++ + L L RS
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 231 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L + + I A G+ FL + V+++D T N+L+ N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++ D + + + +PE +M
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIM 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 23/170 (13%)
Query: 131 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 188
LL EG FG +F G I+E KPG V VKT+ +H L E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 189 LGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 240
L L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119
Query: 241 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+A+ A G+++LH+ R VI++D N ++D + K++D L++D
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD 166
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 63/184 (34%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 191
++G+G FG V + +G AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGL 249
+ H LV L Y + ++L V +F+ G L HL R RS P P + R A A L
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH ++YRD K NILLD+ + L+DFGL K+G T +T GT Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164
Query: 310 PEYV 313
PE +
Sbjct: 165 PEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 34/186 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVH 194
++GEG FG V K I+ K G + A+K + + H+++ E+ L L H
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 195 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 238
N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 298 STRVMG 303
+ MG
Sbjct: 167 K-KTMG 171
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 20/187 (10%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 187
+ + +G+G G V+ TA + TG VA+K +N Q KE + E+
Sbjct: 19 KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + H N+V + + D+ +V E++ GSL + + + + +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQ 126
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 306
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 127 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 180
Query: 307 YAAPEYV 313
+ APE V
Sbjct: 181 WMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHL 195
LG G FGCV KG + + VA+K L ++ + E + E + L +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V++IG C E + +LV E G L L + + S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPE 311
+ ++RD N+LL + AK+SDFGL+K D ++ R G + + APE
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 57/185 (30%), Positives = 84/185 (45%), Gaps = 21/185 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G + +G P + V VK L +Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKG 248
NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L LH+ I+ D N LL AD K+ D+GL+ + + D ++ +
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 309 APEYV 313
APE V
Sbjct: 170 APELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 58/186 (31%), Positives = 85/186 (45%), Gaps = 31/186 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 194
++G GGFG V+ K TG A+K L+ ++ + E LA L + +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIM 47
Query: 195 LNLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L+LV + Y +L + + M G L HL + + +R A
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEI 106
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTH 159
Query: 306 GYAAPE 311
GY APE
Sbjct: 160 GYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 56/201 (27%), Positives = 82/201 (40%), Gaps = 49/201 (24%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 185
F + +GEG +G V++ +G VA+K + DG+ L E
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56
Query: 186 VNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
+ L +L H N+V+L + YC +D LL + MP
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
P S + L +GL +LHE +I+RD K SN+LL K++DFGLA+
Sbjct: 104 -PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--T 157
Query: 291 EGDKTHVSTRVMGTYGYAAPE 311
G T + T Y APE
Sbjct: 158 YGLPAKPMTPKVVTLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 8/119 (6%)
Query: 194 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H+ + +IYRD K N+LLD + + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 55/193 (28%), Positives = 80/193 (41%), Gaps = 30/193 (15%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 189
++ L+G G +G V++G TG VA+K +N D + EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 190 GDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----I 241
L N+ K G RL ++ E+ GS+ R+L I K I
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVI 106
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L ++H+ VI+RD K +NIL+ N KL DFG+A + ST V
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV 162
Query: 302 MGTYGYAAPEYVM 314
GT + APE +
Sbjct: 163 -GTPYWMAPEVIT 174
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 162 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEF 216
TG VA+K L D + + + E L H N+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---D 273
+P +L L LP ++ L LA H + +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 274 ADYNAKLSDFGLAKDGP---EGDKTHVS--TRVMGTYGYAAPE 311
+AK+ DFG+ P + D ++ T V+GT Y APE
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 35/204 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G GGFG V+ K TG A+K L+ ++ + E L + + L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIML 48
Query: 196 NLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+LV + Y +L + + M G L HL + + +R A
Sbjct: 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEII 107
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+G
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHG 160
Query: 307 YAAPEYVM------TALELFCLKC 324
Y APE + ++ + F L C
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGC 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 42/167 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K + TG VA+K + L+ E + E++ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA---- 246
L H N+V+L+ + + +L LV+EF+ L+ + S P L
Sbjct: 55 LNHPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLDPPLIKS 103
Query: 247 ------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+G+A+ H V++RD K N+L+D + KL+DFGLA+
Sbjct: 104 YLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TG VAVK ++ Q + EV + D H N+V + + D+ +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 222 LENHLFRRSLPLPWSIRMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
L + + RM + L + L++LH + VI+RD K+ +ILL +D
Sbjct: 106 LTD--------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSD 154
Query: 276 YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
KLSDFG ++K+ P+ ++GT + APE +
Sbjct: 155 GRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVI 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 25/135 (18%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 237
E L ++ H +++L + E DQR L + E++P G L ++L F S L ++
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ AL +LH + ++YRD K NILLD + + KL+DFG AK K
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRD 153
Query: 298 STRVM-GTYGYAAPE 311
T + GT Y APE
Sbjct: 154 RTWTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 56/195 (28%), Positives = 78/195 (40%), Gaps = 51/195 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 189
+G+GG+G VF K TG VA+K + L L EV L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 238
LVKL+ Y +DD+ L L E++P G L R +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
M A+ A L ++H RD K N L+DA + KL+DFGL+K +
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155
Query: 299 TRVMGTYGYAAPEYV 313
V+G+ Y APE +
Sbjct: 156 NSVVGSPDYMAPEVL 170
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G G V+K + T +AVK + D ++ K+ ++E+ L
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++ G +++ + EFM GSL+ ++R+ +P + +IA+ KGL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+++RD K SN+L++ KL DFG++ ++ +GT Y APE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERI 165
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 35/163 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALG 244
N+V+L D + LV+E+ G ++ + + +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
KGLAF H V++RD K N+L++ + KL+DFGLA+
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G FG V KG + + TVAVK L +D E L E N + L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+V++IG C E + +LV E G L L + +I ++ + G+ +L E
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
++RD N+LL + AK+SDFGL+K
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 27/64 (42%), Positives = 39/64 (60%), Gaps = 5/64 (7%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GL FLH+ + +IYRD K N+LLD D + K++DFG+ K+ G+ ++ GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 308 AAPE 311
APE
Sbjct: 163 IAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 17/178 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 3 IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE-- 111
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPE 311
+ I+RD N L+ K+SDFG++++ E D + ST M + APE
Sbjct: 112 -SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPE 166
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 47/197 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G FG VF A +K GT A+K L D V + D V
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKD-----------VVLMDDDVEC 41
Query: 196 NLV--KLIG-----------YCI--EDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSI 237
+V +++ YC + V E++ G L H+ + LP
Sbjct: 42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY 101
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+I G L FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 102 AAEIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152
Query: 298 STRVMGTYGYAAPEYVM 314
+ GT Y APE ++
Sbjct: 153 TCTFCGTPDYIAPEILL 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 20/190 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
NFR E +G G F V++ +G VA+K + L + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 243
+ L L H N++K IED++ +V E G L H ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
L +H R V++RD K +N+ + A KL D GL + KT + ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 304 TYGYAAPEYV 313
T Y +PE +
Sbjct: 169 TPYYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 33/191 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K T T+A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 246
+ H N+V+L + + LV+E++ L+ H+ F ++ L + +I
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----L 112
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+G+A+ H V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 306 GYAAPEYVMTA 316
Y APE ++ +
Sbjct: 168 WYRAPEILLGS 178
|
Length = 294 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 36/170 (21%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 190
+ +GEG +G V+K TG VA+K L+ +G+ L E+ L
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53
Query: 191 DLV---HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR- 238
L H N+V+L+ C D+ L LV+E + + L + LP P +I+
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKD 111
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
M+ L +G+ FLH +++RD K NIL+ +D K++DFGLA+
Sbjct: 112 LMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 59/193 (30%), Positives = 84/193 (43%), Gaps = 37/193 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+G+G FG VFK A K T VA+K + ++ KE L E+ L
Sbjct: 20 IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 192 LVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV+EF G L N + +L + MK
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 298
+ L GL ++H +++RD K +NIL+ D KL+DFGLA+ + K +
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 299 TRVMGTYGYAAPE 311
T + T Y PE
Sbjct: 181 TNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 14/151 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + L H
Sbjct: 12 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + +V E+M G L N+L S +++ +G+A+L
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--- 117
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+ I+RD N L+D K+SDFGL++
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 60/182 (32%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V ++E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + +S GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT Y A
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164
Query: 310 PE 311
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 21/159 (13%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
+G VAVK ++ Q + EV + D H N+V++ + ++ ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 222 LENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
L + + + L +IA + L +LH + VI+RD K+ +ILL D
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156
Query: 279 KLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
KLSDFG ++KD P+ ++GT + APE +
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVI 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 38/198 (19%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 189
+GEG +G V+K TG VA+K + L KE + E+ L
Sbjct: 13 GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60
Query: 190 GDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWS 236
L H N+V L + L LV+E+M G LE+ L S S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
MK L +GL + H+ + ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 121 F-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 297 VSTRVMGTYGYAAPEYVM 314
+ +V+ T Y PE ++
Sbjct: 174 YTNKVI-TLWYRPPELLL 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 21/95 (22%)
Query: 225 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ + KL DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 285 --------LAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+AK G K Y APE
Sbjct: 150 ISGYLVDSVAKTIDAGCKP-----------YMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 36/187 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V A VK +G VAVK ++ Q + EV + D H N
Sbjct: 28 IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPY 181
Query: 307 YAAPEYV 313
+ APE +
Sbjct: 182 WMAPELI 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 52/157 (33%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193
E LG G FG V+ ++ VAVKT+ G + +LAE N + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLA 250
H LVKL + + ++ EFM +GSL + L PLP I + A+G+A
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
F+ + R I+RD + +NIL+ A K++DFGLA+
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDG 175
+ T ND+ + + E+++ G G +KG +NG V VK +N +
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ +E+ +G L H N+VKLIG C + L++E++ +L L L W
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSW 779
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
R KIA+G AK L FLH V+ + I++D L
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 55/194 (28%), Positives = 85/194 (43%), Gaps = 31/194 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
+F +LG+G FG V A K GT A+K L D + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMK 240
L + + C + RL V E++ G L H+ F+ + ++ +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ GL FLH R +IYRD K N++LD++ + K++DFG+ K E V+TR
Sbjct: 112 V------GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTR 159
Query: 301 VM-GTYGYAAPEYV 313
GT Y APE +
Sbjct: 160 TFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 59/182 (32%), Positives = 78/182 (42%), Gaps = 24/182 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E T G A+K L + + E + E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH R V+YRD K N++LD D + K++DFGL K+G T + GT Y A
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 310 PE 311
PE
Sbjct: 164 PE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 15/118 (12%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
RD K N+LLD + KL+DFG T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 64/205 (31%), Positives = 88/205 (42%), Gaps = 40/205 (19%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGL 176
FT DLK +G G FG V K + +GT +AVK D
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEK 44
Query: 177 QGHKEWLAEVNFLGDLVH-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-----HL 226
+ K L ++ D+V +VK G + + E M SL+ +
Sbjct: 45 E-QKRLLMDL----DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYE 98
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+S+ +P I KIA+ K L +L EE + +I+RD K SNILLD + N KL DFG++
Sbjct: 99 VLKSV-IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPE 311
G D TR G Y APE
Sbjct: 156 --GQLVDSI-AKTRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G +G V+ A T + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGLAFLH 253
N+V+ +G E+ + E +P GSL L + PL + + I +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 254 EEAERPVIYRDFKTSNILLDADYNA--KLSDFG----LAKDGPEGDKTHVSTRVMGTYGY 307
+ +++RD K N+L++ Y+ K+SDFG LA P + GT Y
Sbjct: 126 DNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175
Query: 308 AAPEYV 313
APE +
Sbjct: 176 MAPEVI 181
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 17/188 (9%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 183
+L +F S LG G G V K KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL+ + + + +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+GLA+L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 304 TYGYAAPE 311
T Y +PE
Sbjct: 165 TRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267
D LV E++ G + L + LP + G+ LH+ R +I+RD K
Sbjct: 70 DYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKP 125
Query: 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
N+L+D + KL+DFGL+++G + + +GT Y APE ++
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL 166
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 17/188 (9%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 183
+L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
KGL +L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 304 TYGYAAPE 311
T Y +PE
Sbjct: 165 TRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 33/97 (34%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
KL DFG++ G D ++ +GT Y +PE
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 239
L E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ +A ++++H+ +++RD KT NI L KL DFG++K G + ++
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAE 159
Query: 300 RVMGTYGYAAPE 311
V+GT Y +PE
Sbjct: 160 TVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 183
+ + + +GEG +G VFK +NG G VA+K + +Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 184 ---AEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 234
A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSF 162
Query: 295 THVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324
T V+ T Y APE ++ T ++L+ + C
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 192
LG+G F ++KG ++ V PG ++V +K L H++ LA + + L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A L +L
Sbjct: 59 SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 253 HEEAERPVIYRDFKTSNILL-DADYN------AKLSDFGLA 286
++ +++ + NIL+ N KLSD G+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 162 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMP 218
TG VA+K + K E+ L L H N++ L I + + V E +
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
+ H S PL +GL ++H V++RD K SNIL++ + +
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
K+ DFGLA+ +VSTR Y APE ++T
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLT 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 33/198 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+ P + +G G +G V+K P +G VA+K++ N DGL + EV
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50
Query: 187 NFLGDLVHL---NLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSI 237
L L N+V+L+ C D+ LV+E + + L +L + P LP
Sbjct: 51 ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162
Query: 298 S-TRVMGTYGYAAPEYVM 314
+ T V+ T Y APE ++
Sbjct: 163 ALTPVVVTLWYRAPEVLL 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 59/183 (32%), Positives = 77/183 (42%), Gaps = 26/183 (14%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYA 308
+LH V+YRD K N++LD D + K++DFGL K+G +G GT Y
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYL 162
Query: 309 APE 311
APE
Sbjct: 163 APE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 36/95 (37%), Positives = 45/95 (47%), Gaps = 5/95 (5%)
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
RS PLP + I + LA+LH R +I+RD KT NI LD NA L DFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTALELFCLK 323
T GT +PE + AL+ +C K
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPE--LLALDPYCAK 267
|
Length = 392 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 5/64 (7%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GL FLH + +IYRD K N++LD D + K++DFG+ K+ GD ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 308 AAPE 311
APE
Sbjct: 163 IAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 137 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + VFKG + EN VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFL 252
H N+V L D LV+E++ + L+ ++ + +KI L +GLA+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKIFLYQILRGLAYC 120
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+
Sbjct: 121 HR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175
Query: 313 VMTALE 318
++ + E
Sbjct: 176 LLGSSE 181
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 50/149 (33%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 167 AVKTLNHDGLQGHKE---WLAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 222
AVK L + KE ++E N L ++ H LV L D+ V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
HL R L R A A L +LH ++YRD K NILLD+ + L+D
Sbjct: 84 FYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTD 139
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
FGL K+ E + T ++ GT Y APE
Sbjct: 140 FGLCKENIEHNGT--TSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-07
Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 120
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 44/188 (23%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
NF+ E +G G F V++ + + +K V+ + ++ + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGA 245
L L H N++K + IED++ +V E G L + ++ +P K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +H R V++RD K +N+ + A KL D GL + KT + ++GT
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170
Query: 306 GYAAPEYV 313
Y +PE +
Sbjct: 171 YYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG NG VA+K ++ +G + E + L L H
Sbjct: 13 LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
N+V L + V+E+M L ++ + L P+++R+ +GLA++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +++RD K N+L+ KL+DFGLA+ +T+ S V T Y P+ ++
Sbjct: 122 ---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 315 TALE 318
A +
Sbjct: 177 GATD 180
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G VF + TG VA+K +N + + E+ + +L + N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLH 253
+V + + D+ +V E++ GSL + + + +IA + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLH 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEY 312
VI+RD K+ N+LL D + KL+DFG A+ PE K + ++GT + APE
Sbjct: 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 313 V 313
V
Sbjct: 187 V 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 4/70 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 306 GYAAPEYVMT 315
Y APE ++
Sbjct: 174 WYRAPEIMLN 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 61/195 (31%), Positives = 89/195 (45%), Gaps = 31/195 (15%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F L+G G +G V+KG VK TG A+K ++ G + +E E+N L
Sbjct: 8 FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL+ LH+ VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 168
Query: 301 --VMGTYGYAAPEYV 313
+GT + APE +
Sbjct: 169 NTFIGTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
YRD K NILLD++ + L+DFGL+K+ E D+ + GT Y AP+ V
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIV 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 45/190 (23%)
Query: 139 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGDLV 193
EG +G V++ TG VA+K L + KE L E+N L L
Sbjct: 15 EGTYGVVYRA---------RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 194 HLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR-----MKI 241
H N+V + +G + D+ +V E++ + +E P+ M
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSEVKCLMLQ 114
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G T++
Sbjct: 115 LL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQL 166
Query: 302 MGTYGYAAPE 311
+ T Y APE
Sbjct: 167 VVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 26/194 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWL 183
NF +LG G +G VF + + TG A+K L L H
Sbjct: 1 NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM--- 239
E N L + + + Y + + +L L+ +++ G + HL++R +R
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+I L L LH+ ++YRD K NILLD++ + L+DFGL+K+ +K +
Sbjct: 113 EIILA----LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 300 RVMGTYGYAAPEYV 313
GT Y APE +
Sbjct: 166 -FCGTIEYMAPEII 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K TG A+K + + + E+ + D H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V G + D+ + EF GSL++ ++ + PL S ++ +GL +LH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+ ++RD K +NILL + + KL+DFG++
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
+G+G FG V+KG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 16/115 (13%)
Query: 203 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 256
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
RD K N+LLD + KL+DFG E T V GT Y +PE
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 133 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 185
PE L +G+G FG VFKG +N T V VA+K ++ + + E + E
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L + K G ++ + ++ E++ GS + L R+ P +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEI 110
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +GT
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 306 GYAAPEYV 313
+ APE +
Sbjct: 166 FWMAPEVI 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 15/114 (13%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
RD K N+LLD + KL+DFG + T V GT Y +PE
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 60/192 (31%), Positives = 84/192 (43%), Gaps = 36/192 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLV-H 194
+G+G +G V+K +++G+ AVK L D + E + AE N L L H
Sbjct: 30 IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78
Query: 195 LNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGAA 246
N+VK G + D Q LV E GS L L L ++ I GA
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 301
GL LH +I+RD K +NILL + KL DFG++ STR+
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTS 188
Query: 302 MGTYGYAAPEYV 313
+GT + APE +
Sbjct: 189 VGTPFWMAPEVI 200
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 61/211 (28%)
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVH 194
G G +G V+K G A+K D Q + E+ L +L H
Sbjct: 9 GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 195 LNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 236
N+V L+ +E + L++++ E+ L+ R S+P L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGP 290
I G+ +LH V++RD K +NIL+ + K+ D GLA+ + P
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 291 -----EGDKTHVSTRVMGTYGYAAPEYVMTA 316
+ D V+ T Y APE ++ A
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA+K +N + + E+ + + + N
Sbjct: 27 IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + VFKG + T VA+K + + +G + EV+ L +L H
Sbjct: 13 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V L + LV+E++ L+ +L + +GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R +++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177
Query: 316 ALE 318
+ E
Sbjct: 178 STE 180
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 27/66 (40%), Positives = 36/66 (54%), Gaps = 5/66 (7%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L LH+ ++YRD K NILLDA + L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 309 APEYVM 314
APE ++
Sbjct: 164 APEVLL 169
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 51/193 (26%), Positives = 79/193 (40%), Gaps = 27/193 (13%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ P +G G +G V + T VA+K + + D K L E
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENH-LFRRSLPLPWSIR 238
+ L L H N++ + + R +VYE M + H + R S L
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+GL ++H V++RD K SN+LL+A+ + K+ DFGLA+ +K
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFM 165
Query: 299 TRVMGTYGYAAPE 311
T + T Y APE
Sbjct: 166 TEYVVTRWYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 62/194 (31%), Positives = 83/194 (42%), Gaps = 28/194 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLV- 193
+G+G +G VFK ++NG+ AVK L+ HD +E AE N L L
Sbjct: 26 IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73
Query: 194 HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGA 245
H N+VK G Y +D DQ LV E GS L +R + I I A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL LH I+RD K +NILL + KL DFG++ +GT
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTP 188
Query: 306 GYAAPEYVMTALEL 319
+ APE + +L
Sbjct: 189 FWMAPEVIACEQQL 202
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 50/209 (23%), Positives = 78/209 (37%), Gaps = 60/209 (28%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 187
++P +G G +G V + +G VA+K + H D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 229
L H N++ I D R +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-- 287
L + + +GL ++H VI+RD K SN+L++ D ++ DFG+A+
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 288 -DGPEGDKT----HVSTRVMGTYGYAAPE 311
P K +V+TR Y APE
Sbjct: 158 SSSPTEHKYFMTEYVATR-----WYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 32/161 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + V+KG + G VA+K L H+ +G + E + L DL
Sbjct: 13 LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-GAA 246
H N+V L LV+E++ +++ + M ++ L
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQLL 113
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+GLA+ H+ R V++RD K N+L+ KL+DFGLA+
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 30/167 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F ++G+G FG V K TG A+KTL + K+ LA V
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51
Query: 190 GDLVHLN----LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 242
D++ + +V L Y +D Q L L+ EF+P G L L + R +A
Sbjct: 52 RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110
Query: 243 ---LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+ A L F+H RD K NIL+D + KLSDFGL+
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 19/117 (16%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 257
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYV 313
+IYRD K N++LD++ + K++DFG+ K E V+T+ GT Y APE +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 188
F ++GEG +G V K +E T VA+K + + + KE L E+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGA 245
L L N+V+L + LV+E++ + LE +P P +R I
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
K + + H+ +++RD K N+L+ + KL DFG A++ EG + T + T
Sbjct: 110 IKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATR 165
Query: 306 GYAAPEYVMTA 316
Y +PE ++ A
Sbjct: 166 WYRSPELLLGA 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
LR+ +D +L R +G G +G V+K TG AVK + +
Sbjct: 3 LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
E+ + + H N+V G + ++ + E+ GSL++ ++ + PL
Sbjct: 47 GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSE 105
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+ +GLA+LH + + ++RD K +NILL + + KL+DFG+A
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 40/135 (29%), Positives = 62/135 (45%), Gaps = 19/135 (14%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 237
EV L + H N+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTH 296
+I+LG L +H+ R +++RD K+ NI L + AKL DFG+A+ D
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 297 VSTRVMGTYGYAAPE 311
++ +GT Y +PE
Sbjct: 158 LAYTCVGTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 47/184 (25%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG + NG VA+K + +G + E + L L H
Sbjct: 13 LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
N+V L + LV+E++ L ++ + L P ++++ + +GL+++H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
R +++RD K N+L+ KL+DFGLA+ + +H + + T Y P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 315 TALE 318
+ E
Sbjct: 177 GSTE 180
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 56/180 (31%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E + G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H L L Y + RL V E++ G L HL R + R A L +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
LH ++YRD K N++LD D + K++DFGL K+G T + GT Y APE
Sbjct: 111 LHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 60/195 (30%), Positives = 87/195 (44%), Gaps = 31/195 (15%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F ++G G +G V+KG VK TG A+K ++ + +E E+N L
Sbjct: 18 FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AY 125
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GLA LH VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 126 ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 178
Query: 301 --VMGTYGYAAPEYV 313
+GT + APE +
Sbjct: 179 NTFIGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 32/169 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEV-- 186
+F ++G G FG V K TG A+K L + L+ KE +A V
Sbjct: 2 DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 187 --NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 241
+ L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 242 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
A+ + L ++H RD K N+LLDA + KLSDFGL
Sbjct: 110 TILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 32/130 (24%), Positives = 61/130 (46%), Gaps = 12/130 (9%)
Query: 166 VAVKTLNHDGLQGHKEWLA----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFM 217
V ++T +GHK + E+ L + N++K+ G+ I+ L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
RG L L + L + ++ +A+ KGL L++ +P Y++ + + L+ +Y
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161
Query: 278 AKLSDFGLAK 287
K+ GL K
Sbjct: 162 LKIICHGLEK 171
|
Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 55/196 (28%), Positives = 77/196 (39%), Gaps = 26/196 (13%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LG G FG V A K VA+K + K+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG--- 133
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR- 300
AA+ + ++YRD K N+LLD D K++DFG AK V TR
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRT 185
Query: 301 --VMGTYGYAAPEYVM 314
+ GT Y APE ++
Sbjct: 186 YTLCGTPEYIAPEILL 201
|
Length = 340 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 137 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + V+KG + +N VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N+V L + LV+E++ + L+ +L + +GL + H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 314 MTALE 318
+ + +
Sbjct: 177 LGSTD 181
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 2/129 (1%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 242
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
L + + L E R +++RD K++NI L KL DFG +K + V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 303 GTYGYAAPE 311
GT Y APE
Sbjct: 233 GTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 6/116 (5%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTAL 317
+RD K N+L+D + KL+DFG A +K S +GT Y APE V+T +
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPE-VLTTM 178
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 22/185 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
+G G FG V I TG+ V VK L + + E+L + + L H
Sbjct: 3 IGNGWFGKVLLSEI--------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 248
N+++ +G C+E LLV+E+ G L+++L R S L + ++A A G
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAG 111
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+ +H+ ++ D N L +D K+ D+G+ + D +
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 309 APEYV 313
APE V
Sbjct: 169 APELV 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 9/68 (13%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SNI ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 307 YAAPEYVM 314
Y APE +M
Sbjct: 181 YRAPE-IM 187
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 37/131 (28%), Positives = 61/131 (46%), Gaps = 14/131 (10%)
Query: 159 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
KPG V +K G +G L E L ++ H +++++ + +V +P
Sbjct: 87 KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137
Query: 219 --RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVD 194
Query: 277 NAKLSDFGLAK 287
+ D G A+
Sbjct: 195 QVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 24/181 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVH 194
LG+G +G V+K +P TG+T+A+K + + L K + + E++ L V
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF 251
+V G + + E+M GSL+ L+ + +P + +I KGL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 310
L EE +I+RD K +N+L++ + KL DFG++ + KT++ G Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170
Query: 311 E 311
E
Sbjct: 171 E 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 35/127 (27%), Positives = 51/127 (40%), Gaps = 10/127 (7%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
T VAVK +N D ++ E+ L H N++ + I D + +V M
Sbjct: 24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 219 RGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
GS E+ L + P LP I L ++H + I+R K S+ILL D
Sbjct: 83 YGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDG 138
Query: 277 NAKLSDF 283
LS
Sbjct: 139 KVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 23/70 (32%), Positives = 41/70 (58%), Gaps = 4/70 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL +LH +++RD K N+L++++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 307 YAAPEYVMTA 316
Y APE +M +
Sbjct: 170 YRAPEILMGS 179
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 58/230 (25%), Positives = 86/230 (37%), Gaps = 39/230 (16%)
Query: 78 DTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLL 137
++ D P+ A S + + + + L A K +D LA +FR L
Sbjct: 103 ASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQA----KLKHDDEFLA--HFRVIDDL 156
Query: 138 GEGGFG----CVFKGWIEE-------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 186
G FG C + EE N T KP +A + E E+
Sbjct: 157 PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--NEI 214
Query: 187 NFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
LG L H N++K+ Y I +Y FM + + + PL R
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQTR 270
Query: 239 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
MK L A + ++H+ + +I+RD K NI L+ D L DFG A
Sbjct: 271 AIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 22/59 (37%), Positives = 32/59 (54%), Gaps = 3/59 (5%)
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S PL ++ + A+G+ FL A + I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 14/101 (13%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 251
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 252 LHEEAERPVIYRDFKTSNILL-----DADYNA--KLSDFGL 285
L ++ +++ + T NILL D + KLSD G+
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 38/104 (36%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 272 LDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVM 314
LD + L DFGL K + + DKT+ GT Y APE ++
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLL 166
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 52/209 (24%), Positives = 78/209 (37%), Gaps = 49/209 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGD 191
L+G+GG G V+ + P VA+K + D L K +L E D
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 238
L+H +V + Y I D VY MP G L + SL + +
Sbjct: 59 LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTH 296
+ I + ++H + V++RD K NILL + D+G A K E D
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 297 VST--------------RVMGTYGYAAPE 311
+ +++GT Y APE
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 255
LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFL 116
Query: 256 AERPVIYRDFKTSNILLDADYNA--------KLSDFGLA 286
++ + + + N+LL + + KLSD G++
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 11/105 (10%)
Query: 56 SRSKVDSSVSGTSTHYESKSTNDTSRDQPA-AAVISSTTTSNAESNSSTSKLEEELKVAS 114
SRS + SG+ E+ ++ D+ R + A + T+ +N + ++ KV
Sbjct: 45 SRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTY 104
Query: 115 RLRKFTFN----------DLKLATRNFRPESLLGEGGFGCVFKGW 149
L + D+ ++T+ F+ SLLGEG FG V + W
Sbjct: 105 ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW 149
|
Length = 467 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 30/166 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F ++G G FG V K TG A+K L + KE +A +
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAE 51
Query: 190 GD-LVHLN---LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI--- 241
D LV + +VK+ Y +D + L L+ EF+P G + L ++ + + I
Sbjct: 52 RDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 242 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
A+ A L F+H RD K N+LLDA + KLSDFGL
Sbjct: 111 VLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 47/192 (24%), Positives = 81/192 (42%), Gaps = 28/192 (14%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
++ + ++G+G +G V + + TG VA+K +N + + L E+
Sbjct: 2 YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L L H ++V++ + +R +V+E M S + + + + L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVST 299
+ L ++H V +RD K NIL +AD K+ DFGLA+ D P T
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWT 164
Query: 300 RVMGTYGYAAPE 311
+ T Y APE
Sbjct: 165 DYVATRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 7/67 (10%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 304
GL ++H V++RD K N+L++AD K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 305 YGYAAPE 311
Y APE
Sbjct: 173 RWYRAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 23/68 (33%), Positives = 38/68 (55%), Gaps = 8/68 (11%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 307 YAAPEYVM 314
Y APE ++
Sbjct: 183 YRAPEIML 190
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 308 AAPEYVM 314
APE ++
Sbjct: 184 RAPEVIL 190
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 50/167 (29%), Positives = 72/167 (43%), Gaps = 32/167 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ----GHKEWLA 184
+F ++G G FG V K TG A+K L D L+ GH A
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA- 242
E + L + L +VK+ Y +D L L+ EF+P G + L ++ + IA
Sbjct: 51 ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 243 ----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ + L F+H RD K N+LLD+ + KLSDFGL
Sbjct: 110 TVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E K +TVAVK L +E L +++LG+
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
H+N+V L+G C L++ E+ G L N L R+
Sbjct: 98 -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 22/68 (32%), Positives = 38/68 (55%), Gaps = 8/68 (11%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 307 YAAPEYVM 314
Y APE ++
Sbjct: 181 YRAPEIML 188
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 58/220 (26%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
DL + RP LG G G VF + V VAVK + Q K
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49
Query: 183 LAEVNFLGDLVHLNLVKL--------------IGYCIEDDQRLLVYEFMP--------RG 220
L E+ + L H N+VK+ +G E + +V E+M +G
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 221 SL-ENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DY 276
L E H LF L +GL ++H V++RD K +N+ ++ D
Sbjct: 110 PLSEEHARLFMYQL--------------LRGLKYIHSAN---VLHRDLKPANVFINTEDL 152
Query: 277 NAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVM 314
K+ DFGLA+ D K ++S ++ + Y +P ++
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLL 191
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 26/132 (19%)
Query: 198 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 250
+ + Y +D+ L LV ++ G L L + LP + M IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
++H RD K NIL+D + + +L+DFG L +DG T S+ +GT
Sbjct: 123 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168
Query: 307 YAAPEYVMTALE 318
Y +PE ++ A+E
Sbjct: 169 YISPE-ILQAME 179
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 46/176 (26%), Positives = 67/176 (38%), Gaps = 26/176 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 185
++F+ LLG+G G VF + GT + A+K L+ + + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 242
L L H L L + LV ++ P G L + P L +
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEV---AR 106
Query: 243 LGAAK---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
AA+ L +LH ++YRD K NILL + LSDF L+K
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
AKG++FL A + I+RD NILL K+ DFGLA+D
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD 263
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 36/95 (37%), Positives = 46/95 (48%), Gaps = 11/95 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-- 194
LG G FG V IE + K T TVAVK L H E A ++ L L+H
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIG 68
Query: 195 --LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL 226
LN+V L+G C + L+V EF G+L N+L
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 35/123 (28%), Positives = 52/123 (42%), Gaps = 23/123 (18%)
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 249
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYA 308
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 309 APE 311
APE
Sbjct: 150 APE 152
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 38/198 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGDL 192
+GEG +G V+K TG VA+K ++ +G+ L E++ L L
Sbjct: 9 IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 193 VHLN-LVKLIGYCIEDDQR-------LLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 241
+V+L+ +E + LV+E++ + ++++ PLP
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG--PEGDKTHVS 298
KG+A H+ V++RD K N+L+D K++D GL + P TH
Sbjct: 116 MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170
Query: 299 TRVMGTYGYAAPEYVMTA 316
+ T Y APE ++ +
Sbjct: 171 --EIVTLWYRAPEVLLGS 186
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+H + +I+RD K++NILL ++ KL DFG +K V GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
|
Length = 496 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 22/197 (11%)
Query: 137 LGEGGFGCVFKGWIEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGD 191
LGEG +G V K + G VK K G+ G H L E+ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
+ H N++ L+ +E D LV + M L+ + R + L S I L GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DGPEGDKTHVSTRVMG 303
LH+ ++RD +NI +++ K++DFGLA+ D D+T M
Sbjct: 135 LHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 304 ----TYGYAAPEYVMTA 316
T Y APE +M A
Sbjct: 192 SKVVTLWYRAPELLMGA 208
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 41/199 (20%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
++ +GEG F V K + G A+K + H + L +VN L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46
Query: 191 DLV-------HLNLVKLIGYCIEDDQ--RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
++ H N+++LI + D + RL LV+E M +L + R PLP
Sbjct: 47 EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTH 296
K L +H + +RD K NIL+ D KL+DFG + P + +
Sbjct: 105 YMYQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--Y 158
Query: 297 VSTRVMGTYGYAAPEYVMT 315
+STR Y APE ++T
Sbjct: 159 ISTR-----WYRAPECLLT 172
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 21/43 (48%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
AKG+ FL A R I+RD NILL + K+ DFGLA+D
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 228
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A+G+ FL A R I+RD NILL + K+ DFGLA+D
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A+G+ FL A R I+RD NILL + K+ DFGLA+D
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 223
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 308 AAPEYVM 314
APE ++
Sbjct: 185 RAPEVIL 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 28/158 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLV 193
LG G FG V K T A+KTL + + AE + L +
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAK 247
+ +VKL Y +D L V +++P G + + L R L + + +A+ +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ F+H RD K NIL+D D + KL+DFGL
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVM 314
APE ++
Sbjct: 192 RAPEVIL 198
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 27/160 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+GEG FG +E+G V +K +N + +E EV L ++ H
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 247
N+V+ E+ +V ++ G L LF L W +++ +AL
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+H+ R +++RD K+ NI L D KL DFG+A+
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 8/69 (11%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
GL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 307 YAAPEYVMT 315
Y APE ++
Sbjct: 180 YRAPEVILN 188
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-V 193
+LG G FG V +E + K + TVAVK L HK ++E+ L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 194 HLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL 226
HLN+V L+G C + + L+V EF G+L N L
Sbjct: 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 16/95 (16%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 250
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
F+H RD K NIL+D D + KL+DFGL
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 36/162 (22%), Positives = 70/162 (43%), Gaps = 14/162 (8%)
Query: 134 ESLLGEGGFGCVFK------GWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ L+G GGFGCV++ I A ++ T+ ++TL ++ + + +A
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY-DIDKIALWK 75
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL---ENHLFRRSLPLPWSIRMKIALG 244
+ ++ HL + K G C + + Y F+ L +F+R + I
Sbjct: 76 NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
L ++HE + + D K NI++D + + D+G+A
Sbjct: 135 MLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 23/69 (33%), Positives = 35/69 (50%), Gaps = 8/69 (11%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 307 YAAPEYVMT 315
Y APE ++
Sbjct: 181 YRAPEVILN 189
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 36/127 (28%), Positives = 60/127 (47%), Gaps = 26/127 (20%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 255
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 311
RD K N+LLD + + +L+DFG + +DG T S+ +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPE 173
Query: 312 YVMTALE 318
++ A+E
Sbjct: 174 -ILQAME 179
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 35/129 (27%), Positives = 62/129 (48%), Gaps = 7/129 (5%)
Query: 185 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 242
E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A L +LHE+ +++RD KT N+ L K+ D G+A+ ++ +++ ++
Sbjct: 109 VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163
Query: 303 GTYGYAAPE 311
GT Y +PE
Sbjct: 164 GTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 23/67 (34%), Positives = 35/67 (52%), Gaps = 6/67 (8%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 308 AAPEYVM 314
APE ++
Sbjct: 189 RAPEVIL 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 37/128 (28%), Positives = 59/128 (46%), Gaps = 21/128 (16%)
Query: 203 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAERP 259
+C + +R L V E++ G L + LP + RM A L +LH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYG 306
+++RD K N+L+ + + KL+DFGL+K G EG + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 307 YAAPEYVM 314
Y APE ++
Sbjct: 182 YIAPEVIL 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 324 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.64 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.61 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.5 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.46 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.33 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.21 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.07 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.03 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.78 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.54 | |
| PLN02236 | 344 | choline kinase | 97.42 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.31 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 97.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.96 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.93 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.54 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.16 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.13 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.94 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.8 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.18 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.82 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.39 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=344.79 Aligned_cols=180 Identities=31% Similarity=0.486 Sum_probs=160.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.+|.+.+.||.|+||+||+|+++. ++..||||.+.+.. ....+.+..|+.+|+.|+|||||++++++..
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred ccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence 578888999999999999999887 56799999998764 3334567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC------CcEEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------YNAKL 280 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~------~~~kl 280 (324)
++.+|||||||.||+|.++|+++ ..+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEe
Confidence 99999999999999999999655 47999999999999999999999999 9999999999999764 56899
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+|+.+.... ...+.||++.|||||+++ .++|+||+||
T Consensus 157 ADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~ 202 (429)
T KOG0595|consen 157 ADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGT 202 (429)
T ss_pred cccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHH
Confidence 9999999987543 355689999999999996 4689999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=333.84 Aligned_cols=182 Identities=29% Similarity=0.473 Sum_probs=159.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------hHHHHHHHHHHcCCCCCCcce
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~ 199 (324)
..+.|.+.+.||+|+||.|-+|..+. ||+.||||++++..... ...+.+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 44678899999999999999997665 89999999998754322 234679999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC---C
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---Y 276 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~ 276 (324)
++++|..++..||||||+.||+|.+.+-. ...+.+.....++.|++.||.|||++| |+||||||+|||+..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 99999999999999999999999999954 456888888999999999999999999 9999999999999765 7
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCccccccccc--------cceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
.+||+|||+|+...... ...+.||||.|.|||++.. ++|+|||||
T Consensus 317 llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGc 369 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGC 369 (475)
T ss_pred EEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccc
Confidence 89999999999986433 3556899999999999982 579999999
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.91 Aligned_cols=181 Identities=29% Similarity=0.483 Sum_probs=163.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..|...++||+|||+.||++++.. +|..||+|++.+... ...+++.+||++.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 469999999999999999999865 788999999987532 23467899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+++|||+|+|..++|..++. +..++++.+++.++.||+.||.|||+.+ |||||||..|+||+.+.+|||+||||
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 9999999999999999999985 6678999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|..+...... ..+.||||.|+|||++.. .+||||+||
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGc 206 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGC 206 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhh
Confidence 9988754322 345799999999999984 489999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=326.11 Aligned_cols=182 Identities=31% Similarity=0.452 Sum_probs=161.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|+++++||+|+||+||.++.++ |++.+|+|++++..... .+...+|..+|.+++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3589999999999999999998775 88899999998765432 34578899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
++...+|||+||+.||.|..+|. +...+++..+..++.+|+.||.|||+++ ||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 99999999999999999999995 4567999999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|++....... ...++|||+.|||||+++ .++|+||||+
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGi 213 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGI 213 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHH
Confidence 9996443322 133479999999999998 4689999995
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=331.26 Aligned_cols=198 Identities=58% Similarity=0.989 Sum_probs=173.5
Q ss_pred cccccCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC
Q 020561 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194 (324)
Q Consensus 115 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H 194 (324)
....|++.++..++++|...+.||+|+||.||+|...+ +..||||++.........+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 34569999999999999999999999999999999875 46899998876544314569999999999999
Q ss_pred CCcceEEEEEEeCC-eEEEEEEecCCCChHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 195 pnIv~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
||+|+|+|||.+.+ ..+||+||+++|+|.++|+.... +++|..+++|+.++|.||+|||....++||||||||+||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 99999999999998 59999999999999999987665 89999999999999999999999887799999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
|.++++||+|||+|+..+.. .....+...||.+|+|||++. .++||||||
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFG 265 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFG 265 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccch
Confidence 99999999999999776542 111122117999999999986 379999999
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=318.25 Aligned_cols=185 Identities=26% Similarity=0.402 Sum_probs=159.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEE-EEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG-YCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~-~~~ 205 (324)
.+|++++.||+|+||.||++.+.. +|..||.|.++..... ...++..|+.+|++|+|||||++++ .+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 478888999999999999998876 6779999999865433 2356899999999999999999998 565
Q ss_pred eCCe-EEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCcEEEcCCCcEEE
Q 020561 206 EDDQ-RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 206 ~~~~-~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl 280 (324)
+++. ++||||||..|+|.+.|.. ....+++..+++++.|++.||..+|++-++ .|+||||||.||+|+.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 6655 8999999999999999853 456799999999999999999999994422 3999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||||++.+.... ....+.+|||.||+||.+. .++|||||||
T Consensus 170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGC 216 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGC 216 (375)
T ss_pred ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHH
Confidence 9999999986543 2355689999999999998 3689999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=314.33 Aligned_cols=178 Identities=28% Similarity=0.403 Sum_probs=158.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+.+.++.||+|..|+||+++++. |++.+|+|++..+. ....+++.+|++++..++||+||.+||+|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 355667899999999999999876 78899999996543 33457899999999999999999999999999
Q ss_pred C-eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 D-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 ~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+ ...|+||||++|+|+.++.+ .+.+++.....|+.+|++||.|||+ .+ ||||||||+|||++..|+|||||||.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 9 49999999999999999844 3679999999999999999999996 55 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEec
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLK 323 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlG 323 (324)
++.+.+. ...+++||..|||||-+.+ .+||||||
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLG 264 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLG 264 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceeccc
Confidence 9987654 3456789999999999984 58999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=320.17 Aligned_cols=184 Identities=29% Similarity=0.385 Sum_probs=161.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..+.|+.++.||+|.||.||+|++.. ||+.||+|.+..+.. ....-..|||.||++|+||||++|.+..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 44678899999999999999999876 788999999987653 2234568999999999999999999998
Q ss_pred EeC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 205 IED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 205 ~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
.+. ..+|||+|||+ .+|.-++......|++.++..++.||+.||+|||+++ |+|||||.+|||||.+|.+||+|
T Consensus 186 t~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred EecCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecc
Confidence 887 68999999996 5899999877889999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||||+......... .+..+-|.+|.|||+|++ ++|+||+||
T Consensus 262 FGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GC 308 (560)
T KOG0600|consen 262 FGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGC 308 (560)
T ss_pred ccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhH
Confidence 99999765543322 445567999999999994 589999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=305.72 Aligned_cols=180 Identities=29% Similarity=0.410 Sum_probs=158.2
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.|+.+..+|+|+||.||+|++++ ||+.||||.+..... ...+-.+||+++|++|+|||+|.++++|...
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK 73 (396)
T ss_pred HHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence 57788899999999999999876 899999999965432 2234578999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||+|||+. ++.+-|.+....++......++.|++.|+.|+|+++ +|||||||+||||+.++.+||||||+|+
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 999999999965 666667777788999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
.+.... ...+..+.|.+|.|||.+.+ .+||||+||
T Consensus 150 ~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGC 190 (396)
T KOG0593|consen 150 TLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGC 190 (396)
T ss_pred hhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhH
Confidence 887422 23566788999999999984 589999999
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=320.90 Aligned_cols=185 Identities=29% Similarity=0.400 Sum_probs=161.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCC-CCCCcceEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLIG 202 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~ 202 (324)
...+|.+++.||+|+|++||+|+... |++.||||++.+..... .+.+.+|-.+|.+| .||.|++|+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~ 141 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF 141 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE
Confidence 44689999999999999999998775 78899999997764322 24577899999999 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
.|+++..+|+|+||+++|+|.++|.+. +.|++..+..++.||+.||+|||++| ||||||||+|||||.+|++||+|
T Consensus 142 TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITD 217 (604)
T KOG0592|consen 142 TFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITD 217 (604)
T ss_pred EeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEee
Confidence 999999999999999999999999654 67999999999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCCcc-----------ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKT-----------HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~-----------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||.|+.+...... .....++||..|.+||+|. .++|||+|||
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGC 275 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGC 275 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHH
Confidence 9999987543211 1114589999999999998 4689999999
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=298.14 Aligned_cols=179 Identities=30% Similarity=0.398 Sum_probs=161.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch---HHHHHHHHHHcCCCCCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..++|+.++.||.|+||.|.+++.+. +|..+|+|++++...-.. +...+|..+|+.+.||+++++++.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t 112 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT 112 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence 44689999999999999999999876 677999999987654333 346789999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
|.+.+.+||||||++||.|..+|+ +..++++..+..++.||+.||+|||+.+ ||+|||||+|||||.+|.+||+||
T Consensus 113 ~~d~~~lymvmeyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 113 FKDNSNLYMVMEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eccCCeEEEEEeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999999994 5568999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
|+|+..... ..+.||||.|+|||+++ .++|+||||
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalG 228 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALG 228 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHH
Confidence 999987654 23479999999999998 568999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.67 Aligned_cols=184 Identities=32% Similarity=0.508 Sum_probs=157.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|...+.||+|+||.||++.+.+ +|..+|||.+........+.+.+|+.+|.+|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 357778899999999999998876 57799999997764333466899999999999999999999744444
Q ss_pred --eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEEeecc
Q 020561 209 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 285 (324)
Q Consensus 209 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGl 285 (324)
.++|+|||+++|+|.+++.+.+.++++..+..+..||++||.|||+++ ||||||||+|||++. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 688999999999999999776558999999999999999999999988 999999999999999 79999999999
Q ss_pred cccCCC-CCccceeeccccccCcccccccc----c--cceEEEecC
Q 020561 286 AKDGPE-GDKTHVSTRVMGTYGYAAPEYVM----T--ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~-~~~~~~~~~~~Gt~~y~aPE~l~----~--~~DiwSlGc 324 (324)
++.... ...........||+.|||||++. . ++|||||||
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGC 210 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGC 210 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCC
Confidence 987653 11111123468999999999998 2 689999999
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=289.56 Aligned_cols=181 Identities=31% Similarity=0.490 Sum_probs=160.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.+|..++.||+|.||.||+|++.. ||+.||||.++.....+ ....+||+..|+.++||||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 367788999999999999999876 78899999998764332 2457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+.+-||+||++ .+|+..|+.....++..++..++.+++.||+|||++. |+||||||.|+|++.+|.+||+|||+|
T Consensus 73 ~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccch
Confidence 999999999995 5999999888889999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+......... +..+-|.+|.|||.+. .++|+||.||
T Consensus 149 r~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGC 190 (318)
T KOG0659|consen 149 RFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGC 190 (318)
T ss_pred hccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHH
Confidence 9987655432 2235699999999998 4589999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=312.65 Aligned_cols=185 Identities=26% Similarity=0.371 Sum_probs=159.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch---HHHHHHHHHHcCCCCCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..++|+++.+||+|+||.||+|+-+. ||..+|+|++++...... +.++.|-.+|....+|+||++|..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred CcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 45799999999999999999997655 899999999988754433 457789999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
|++.+++||||||++||++..+|.+ ...|++..+..++.+++.|++-||..| +|||||||+|+|||..|++||+||
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccc
Confidence 9999999999999999999999955 457999999999999999999999998 999999999999999999999999
Q ss_pred cccccCCC----------------------CCcc------ce-----------------eeccccccCccccccccc---
Q 020561 284 GLAKDGPE----------------------GDKT------HV-----------------STRVMGTYGYAAPEYVMT--- 315 (324)
Q Consensus 284 Gla~~~~~----------------------~~~~------~~-----------------~~~~~Gt~~y~aPE~l~~--- 315 (324)
||++.+.. .+.. .. ....+|||-|||||+|++
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99954211 0000 00 013579999999999994
Q ss_pred --cceEEEecC
Q 020561 316 --ALELFCLKC 324 (324)
Q Consensus 316 --~~DiwSlGc 324 (324)
.+|+|||||
T Consensus 366 ~~~cDwWSLG~ 376 (550)
T KOG0605|consen 366 GKECDWWSLGC 376 (550)
T ss_pred CccccHHHHHH
Confidence 489999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=297.44 Aligned_cols=182 Identities=28% Similarity=0.394 Sum_probs=159.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|+.++.|++|+||.||+|+++. |++.||+|+++..... -.-.-+|||.+|.+++|||||.+..+.+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3578889999999999999998875 7889999999865421 1124589999999999999999999887
Q ss_pred eC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 206 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 206 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
.. +.+|||||||+ .+|..++.....++...+...+..|++.||+|||.+. |+||||||+|+|+...|.+||+||
T Consensus 146 G~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 64 57999999995 5999999888889999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||+.+...... .+..+-|.+|.|||.|+ +++|+||+||
T Consensus 222 GLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGC 266 (419)
T KOG0663|consen 222 GLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGC 266 (419)
T ss_pred chhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHH
Confidence 999998775433 45566799999999998 5689999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=310.08 Aligned_cols=182 Identities=27% Similarity=0.371 Sum_probs=160.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC----Cc-cchHHHHHHHHHHcCCC-CCCcceE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GL-QGHKEWLAEVNFLGDLV-HLNLVKL 200 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~~ 200 (324)
....|.+.+.||+|+||+|++|++.. ++..||||++... .. ...+.+.+|+.+++.++ ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 34689999999999999999998876 6789999987664 11 22356778999999999 9999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-CcEE
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAK 279 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~k 279 (324)
++++.....+|+|||||.||+|.+++.+ ..++.+..+..+|+|++.||+|||+++ |+||||||+|||++.+ +++|
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999999999999976 678999999999999999999999988 9999999999999999 9999
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc-------cceEEEec
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLK 323 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlG 323 (324)
|+|||++..... ......+.+||+.|+|||++.. ++||||||
T Consensus 162 l~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~G 210 (370)
T KOG0583|consen 162 LSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLG 210 (370)
T ss_pred EeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhH
Confidence 999999998741 1122456799999999999983 47999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=308.38 Aligned_cols=178 Identities=36% Similarity=0.622 Sum_probs=153.9
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcE-EEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.+.+.||+|+||+||+|.+. |.. ||||++....... .++|.+|+.+|.+|+|||||+++|+|..+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 344456999999999999987 345 9999998654332 45899999999999999999999999988
Q ss_pred C-eEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEeec
Q 020561 208 D-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 284 (324)
Q Consensus 208 ~-~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFG 284 (324)
. .++|||||+++|+|.+++++ ....+++..++.|+.||+.||.|||++++ ||||||||+|||++.++ ++||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence 7 79999999999999999987 47789999999999999999999999774 99999999999999997 99999999
Q ss_pred ccccCCCCCccceeeccccccCccccccccc-------cceEEEec
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLK 323 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlG 323 (324)
+++...... ...+...||+.|||||++.+ ++||||||
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFg 233 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFG 233 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHH
Confidence 998765421 12333689999999999983 48999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.26 Aligned_cols=181 Identities=30% Similarity=0.425 Sum_probs=161.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHH--HHHHHHHHcCCC-CCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDLV-HLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~~~~~ 203 (324)
..++|.+++.||.|.||.||+|.... ++..||||.++..... .++ =+||+..|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 34578899999999999999998776 6779999999876433 233 368999999999 9999999999
Q ss_pred EEeCC-eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+.+.+ .+|+||||| ..+|.+++..+...|++..+..|+.||++||+|+|.+| +.||||||+|||+.....+||+|
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence 99988 999999999 56999999888899999999999999999999999999 99999999999999899999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||||+.+..... .+..+.|.+|.|||+|+. .+||||+||
T Consensus 154 FGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~Gc 198 (538)
T KOG0661|consen 154 FGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGC 198 (538)
T ss_pred cccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHH
Confidence 999998866554 455788999999999983 579999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=313.81 Aligned_cols=180 Identities=33% Similarity=0.453 Sum_probs=161.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|.+.+.||+|+||+||+|+.+. |.+.||+|.+.+..... .+.+.+|+++++.|+|||||.++++|++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 468888999999999999997654 78899999998765432 3568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
...+|+|.|||.| +|..+| .....++++.+..|+.+++.||.|||+++ |+|||+||.|||++..+.+|+||||+|
T Consensus 73 ~~~~~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence 9999999999966 999999 45668999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+.+.. .....+.+.|||.|||||++.+ .+|+|||||
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGc 188 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGC 188 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHH
Confidence 98765 3445777899999999999985 479999999
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=289.07 Aligned_cols=181 Identities=29% Similarity=0.437 Sum_probs=155.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCC-cceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN-LVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~ 205 (324)
..|+.++.||+|+||+||+|+... +|..||+|.+...... ......+|+.+|+.|+|+| ||.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 356667789999999999998876 6789999999766432 2345789999999999999 999999999
Q ss_pred eCC------eEEEEEEecCCCChHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 EDD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
+.+ .+++|+||+ .-+|..++.... ..++...+..++.||+.||+|||+++ |+||||||.||||+..|
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSG 157 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCC
Confidence 887 889999999 569999997654 46888899999999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
.+||+|||+|+...-.... .+..++|.+|.|||++++ .+||||+||
T Consensus 158 ~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~Gc 209 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGC 209 (323)
T ss_pred cEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHH
Confidence 9999999999976533322 445678999999999984 589999999
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=301.64 Aligned_cols=179 Identities=28% Similarity=0.416 Sum_probs=161.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
..|.....||+|+.|.||.|+... ++..||||++........+-+++|+.+|+.++|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 467778899999999999997665 67799999999887766677899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.+|+||||++||+|.+.+.. ..+++.++..|+++++.||+|||.++ |||||||.+|||++.+|.+||+|||+|..
T Consensus 344 eLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred eeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 99999999999999999843 45899999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
+..... .+.+.+|||+|||||++. .++||||||
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLG 456 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLG 456 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhh
Confidence 765433 366789999999999998 468999999
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=289.56 Aligned_cols=185 Identities=25% Similarity=0.342 Sum_probs=162.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch-HHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.++||.|..++||+|+... ++..||||+++.+..... ..+.+|+..|+.++||||++++..|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 34689999999999999999999876 677999999988765544 67899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+..+|+||.||.+|++.+++.. ....+++..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+|||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence 99999999999999999999964 2346999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCC-cccee-eccccccCcccccccc-------ccceEEEec
Q 020561 285 LAKDGPEGD-KTHVS-TRVMGTYGYAAPEYVM-------TALELFCLK 323 (324)
Q Consensus 285 la~~~~~~~-~~~~~-~~~~Gt~~y~aPE~l~-------~~~DiwSlG 323 (324)
.+..+.... ..... ..++||++|||||+++ -++||||||
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfG 219 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFG 219 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhh
Confidence 877654422 22222 5578999999999966 368999999
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=300.28 Aligned_cols=182 Identities=28% Similarity=0.431 Sum_probs=162.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch--HHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|..+++||+|+||.++..+++.+ +..|++|.+........ ....+|+.+++++.|||||.+++.|..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 5789999999999999999988764 44899999987654333 357899999999999999999999999
Q ss_pred CCe-EEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 207 DDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 207 ~~~-~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
++. ++|||+||+||+|.+.|.+.. ..++++.+..|+.||+.||.|||++. |+|||||+.|||++.++.|||+|||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence 988 999999999999999997644 77999999999999999999999888 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|+.+..... ...+++||+.||+||++. .++|||||||
T Consensus 152 laK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC 194 (426)
T KOG0589|consen 152 LAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGC 194 (426)
T ss_pred hhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcc
Confidence 9999876542 245578999999999998 4699999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=306.94 Aligned_cols=183 Identities=29% Similarity=0.443 Sum_probs=159.2
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCC-CCCcceE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKL 200 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~ 200 (324)
.+..++|.++++||+|+||+|+++..+. +++.+|||++++...-. .+....|.+|+.... ||+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 3456799999999999999999998876 67799999999876432 345677888887775 9999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
+.+|++.+++|+||||+.||++..+. +...+++..+..++..|+.||+|||+++ |||||||.+|||||.+|.+||
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEe
Confidence 99999999999999999999965544 4467999999999999999999999999 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
+|||+++....... ...++||||.|||||++. .++|+||||
T Consensus 510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lG 555 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLG 555 (694)
T ss_pred cccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHH
Confidence 99999997653222 245689999999999998 468999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=297.45 Aligned_cols=188 Identities=30% Similarity=0.445 Sum_probs=160.0
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEE
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
+.+.+..+.+.+++.||+|.||.||.|+++. ...||+|.++.... ..+.|++|+.+|++|+|+|||+++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEE
Confidence 3444455566677899999999999999985 23799999976532 346789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
++|..+..+|||||||+.|+|.++|+. ....+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEE
Confidence 999998899999999999999999975 5677999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||||+...+ +.........-...|.|||.+. .++||||||.
T Consensus 345 sDFGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGV 392 (468)
T KOG0197|consen 345 SDFGLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGV 392 (468)
T ss_pred cccccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhh
Confidence 99999995444 3333333334467899999998 5799999993
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.85 Aligned_cols=191 Identities=25% Similarity=0.420 Sum_probs=166.7
Q ss_pred ccCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCC
Q 020561 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHL 195 (324)
Q Consensus 118 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~Hp 195 (324)
.....+|.+..+++.+...||+|.||+||+|+|.. .||||+++...... .+.|.+|+.+|++-+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~ 448 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE 448 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchh
Confidence 44557777788888999999999999999999976 79999998876543 35799999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
||+-+.|+|..+.. .||+.+|+|-+|+.+|+....+|.....+.|++||++|+.|||.++ |||||||..||||.++
T Consensus 449 NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~ 524 (678)
T KOG0193|consen 449 NILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHED 524 (678)
T ss_pred hheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccC
Confidence 99999999988776 9999999999999999987788999999999999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+.|||+||||+................|...|||||+++ ..+|||||||
T Consensus 525 ~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGi 581 (678)
T KOG0193|consen 525 LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGI 581 (678)
T ss_pred CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhH
Confidence 999999999997644332222233456889999999998 4689999997
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=302.61 Aligned_cols=176 Identities=32% Similarity=0.439 Sum_probs=157.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch---HHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
-|..++.||.|+||.||-|++.. +...||||.+.....+.. .+++.||.+|.+|+|||+|.|.|||..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 35667789999999999999876 577999999988766554 467899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+...||||||| -|+-.++|.-...++.+..+..|+.+.+.||.|||+.+ .||||||..||||.+.|.|||+|||.|
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence 99999999999 67888988777788999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
..... ...++|||+|||||+|+ +++||||||.
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccc
Confidence 87644 33478999999999998 5799999993
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=288.75 Aligned_cols=185 Identities=30% Similarity=0.418 Sum_probs=154.1
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------------cchHHHHHHHHHHcC
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------------QGHKEWLAEVNFLGD 191 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~ 191 (324)
...+.|++++.||+|.||+|-+|++.. +++.||||++.+... ...+++.+||.+|++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 345789999999999999999999876 577999999975321 112578999999999
Q ss_pred CCCCCcceEEEEEEeC--CeEEEEEEecCCCChHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 192 LVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 192 l~HpnIv~~~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
|+|||||+|+++..+. +.+|||+|||..|.+.. . ....+ +++.+++.|+++++.||+|||.++ ||||||||+
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs 239 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-C-PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS 239 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCcccc-C-CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence 9999999999998764 67999999999888753 2 23344 899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCC---ccceeeccccccCccccccccc---------cceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMT---------ALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~---~~~~~~~~~Gt~~y~aPE~l~~---------~~DiwSlGc 324 (324)
|+||+.+|++||+|||.+....... ........+|||.|||||.+.+ +.||||||.
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 9999999999999999998763321 1122334689999999999874 579999993
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=296.14 Aligned_cols=183 Identities=27% Similarity=0.358 Sum_probs=155.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|.... +++.||||++..... .....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 478999999999999999998765 677999999975422 12245788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+.+|||||||++|+|.+++.+ ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 99999999999999999999954 457899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc---------------------------------ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ ......+||+.|||||++. .++|||||||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv 224 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence 9764321100 0012357999999999986 3589999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.31 Aligned_cols=183 Identities=26% Similarity=0.355 Sum_probs=155.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|++.. ++..||||++..... .....+.+|+.+|..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 378999999999999999998875 577999999975421 22345778999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999999999999999543 46899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc------------------------------------eeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTH------------------------------------VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~------------------------------------~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.+....... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87643211000 011246999999999986 3589999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=295.06 Aligned_cols=183 Identities=26% Similarity=0.330 Sum_probs=153.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||.||++.... +++.||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 378899999999999999998775 577999999865321 22346788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|||||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999954 457899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc---------------------------------------------ceeeccccccCcccccccc-----c
Q 020561 286 AKDGPEGDKT---------------------------------------------HVSTRVMGTYGYAAPEYVM-----T 315 (324)
Q Consensus 286 a~~~~~~~~~---------------------------------------------~~~~~~~Gt~~y~aPE~l~-----~ 315 (324)
++........ ......+||+.|||||++. .
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9632210000 0001246999999999986 4
Q ss_pred cceEEEecC
Q 020561 316 ALELFCLKC 324 (324)
Q Consensus 316 ~~DiwSlGc 324 (324)
++|||||||
T Consensus 228 ~~DiwSlGv 236 (377)
T cd05629 228 ECDWWSLGA 236 (377)
T ss_pred ceeeEecch
Confidence 589999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.81 Aligned_cols=180 Identities=24% Similarity=0.386 Sum_probs=161.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch---HHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.+|++.+.||+|.||+|-+|.... .|+.||||.++++...+. -.+.+|++||+.|+||||+.+|.+|+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 478888999999999999997654 688999999988765544 35789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+.+.|||||..+|.|.+++.++ ..+++..+..+|+||+.|+.|+|.++ +||||||.+|||||.++++||+||||
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence 999999999999999999999544 57999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+..+.... ..+++||+|.|.+||++.+ .+|-||||.
T Consensus 200 SNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGv 241 (668)
T KOG0611|consen 200 SNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGV 241 (668)
T ss_pred hhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHH
Confidence 98765433 3567899999999999983 489999993
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=295.06 Aligned_cols=182 Identities=26% Similarity=0.324 Sum_probs=153.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|++++.||+|+||+||+|++.. ++..||||++..... .....+.+|+.++..++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999998765 677999999975432 223467899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+.+|+|||||++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 9999999999999999999854 346899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCc---------------------------------------------cceeeccccccCcccccccc-----cc
Q 020561 287 KDGPEGDK---------------------------------------------THVSTRVMGTYGYAAPEYVM-----TA 316 (324)
Q Consensus 287 ~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~aPE~l~-----~~ 316 (324)
+....... .......+||+.|||||++. .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 64311000 00012357999999999986 35
Q ss_pred ceEEEecC
Q 020561 317 LELFCLKC 324 (324)
Q Consensus 317 ~DiwSlGc 324 (324)
+|||||||
T Consensus 229 ~DiwSlG~ 236 (381)
T cd05626 229 CDWWSVGV 236 (381)
T ss_pred cceeehhh
Confidence 89999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=283.55 Aligned_cols=182 Identities=29% Similarity=0.424 Sum_probs=157.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEec--CCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..|..++.||+|+||.|..|.+.. ||..||||.+. .......++..||+.+|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred ceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 456668899999999999998876 77899999997 3344456788999999999999999999999876
Q ss_pred -----CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 -----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 -----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
-+.+|+|+|+| +-+|.+.| +.+..++...+..++.||+.||+|+|+.+ |+||||||.|+|++.+..+|||
T Consensus 93 ~~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred ccccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence 24689999999 67899988 44456999999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||+|+...........+..+-|.+|.|||++. +++||||+||
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGC 216 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGC 216 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhH
Confidence 999999875432333346678899999999998 5689999999
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=293.78 Aligned_cols=183 Identities=25% Similarity=0.299 Sum_probs=153.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|+.++||||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 368999999999999999998775 577999999865322 12345788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++.+|||||||++|+|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999999999954 356889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCC-----------------------------------------ccceeeccccccCcccccccc-----ccceE
Q 020561 286 AKDGPEGD-----------------------------------------KTHVSTRVMGTYGYAAPEYVM-----TALEL 319 (324)
Q Consensus 286 a~~~~~~~-----------------------------------------~~~~~~~~~Gt~~y~aPE~l~-----~~~Di 319 (324)
|....... ........+||+.|||||++. .++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 85321000 000012357999999999986 35899
Q ss_pred EEecC
Q 020561 320 FCLKC 324 (324)
Q Consensus 320 wSlGc 324 (324)
|||||
T Consensus 228 wSlGv 232 (376)
T cd05598 228 WSVGV 232 (376)
T ss_pred eeccc
Confidence 99998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.00 Aligned_cols=178 Identities=28% Similarity=0.431 Sum_probs=156.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.+|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.++.+++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 578999999999999999998875 577999999975422 22356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++..|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999954 457899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++...... ....||+.|+|||++. .++|||||||
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 203 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHH
Confidence 98764422 2357999999999986 4589999997
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=293.54 Aligned_cols=182 Identities=25% Similarity=0.317 Sum_probs=153.2
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|++++.||+|+||+||+|+... ++..||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58889999999999999998765 577999999975432 123467889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence 99999999999999999999543 46899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCc---------------------------------------------cceeeccccccCcccccccc-----cc
Q 020561 287 KDGPEGDK---------------------------------------------THVSTRVMGTYGYAAPEYVM-----TA 316 (324)
Q Consensus 287 ~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~aPE~l~-----~~ 316 (324)
........ .......+||+.|||||++. .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 53211000 00012347999999999987 35
Q ss_pred ceEEEecC
Q 020561 317 LELFCLKC 324 (324)
Q Consensus 317 ~DiwSlGc 324 (324)
+|||||||
T Consensus 229 ~DiwSlGv 236 (382)
T cd05625 229 CDWWSVGV 236 (382)
T ss_pred eeEEechH
Confidence 89999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=286.12 Aligned_cols=175 Identities=30% Similarity=0.378 Sum_probs=150.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 211 (324)
++||+|+||.||+|.+.. +|+.||||++..... ....++.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 469999999999998765 577999999975422 22346788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
|||||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 99999999999999854 457899999999999999999999988 99999999999999999999999999986432
Q ss_pred CCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 292 GDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 292 ~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 183 (323)
T cd05571 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183 (323)
T ss_pred CCC--cccceecCccccChhhhcCCCCCccccCcccch
Confidence 211 123357999999999986 3589999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=292.27 Aligned_cols=185 Identities=22% Similarity=0.292 Sum_probs=157.7
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
....++|++.+.||+|+||.||++++.. +++.||+|++..... .....+.+|+.+++.++||||++++
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3455789999999999999999998875 577999999864321 2234577899999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+++.+++..|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 110 CAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999854 35889999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
|||++......... .....+||+.|||||++. .++|||||||
T Consensus 185 DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ 235 (370)
T cd05621 185 DFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (370)
T ss_pred ecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehH
Confidence 99999876432211 123457999999999875 3589999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=269.51 Aligned_cols=181 Identities=28% Similarity=0.436 Sum_probs=161.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..++|++++.||+|-||.||+|+.+. ++..||+|++.+... ....++.+|+++-+.|+||||+++|++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred chhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34689999999999999999999876 577999999976542 234678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
|.+....||++||.+.|+|...|+. ...++++.....++.|++.||.|+|.++ ||||||||+|+|++..+.+||+|
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccC
Confidence 9999999999999999999999963 3456999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc-----cceEEEec
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLK 323 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlG 323 (324)
||.+...+... +.+.|||.-|.+||++.+ .+|+||||
T Consensus 168 fGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lg 209 (281)
T KOG0580|consen 168 FGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLG 209 (281)
T ss_pred CCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHH
Confidence 99998765332 566899999999999984 58999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=287.11 Aligned_cols=178 Identities=30% Similarity=0.400 Sum_probs=156.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|++.. ++..||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368899999999999999998875 577999999975422 22356789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..||||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence 99999999999999999999954 456899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...... .....||+.|+|||++. .++|||||||
T Consensus 148 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 186 (333)
T cd05600 148 SKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGC 186 (333)
T ss_pred Ccccccc-----cCCcccCccccChhHhcCCCCCCccceecchH
Confidence 9865431 23457999999999986 4589999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=282.59 Aligned_cols=175 Identities=28% Similarity=0.455 Sum_probs=146.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC-
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD- 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 208 (324)
.|+..+++|.|+||.||+|.... ++..||||.+-.+. +--.+|+.+|+.+.|||||++..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 46677899999999999999886 56799999885443 22347999999999999999998886532
Q ss_pred ----eEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-CcEEE
Q 020561 209 ----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKL 280 (324)
Q Consensus 209 ----~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl 280 (324)
.+.+||||+|. +|.+.++. .+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence 34589999974 89998863 3567888888889999999999999988 9999999999999976 99999
Q ss_pred EeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||||.|+.+..+... ....-|..|.|||.|.+ +.||||.||
T Consensus 168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGC 214 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGC 214 (364)
T ss_pred ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhH
Confidence 999999998766543 23456899999999984 579999999
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=285.33 Aligned_cols=183 Identities=25% Similarity=0.272 Sum_probs=158.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+++... ++..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 368899999999999999998775 577999999975432 22345788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence 999999999999999999999766568999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlGc 324 (324)
+......... ......||+.|+|||++. .++|||||||
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 197 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV 197 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccc
Confidence 9876543222 223357999999999986 4589999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=285.22 Aligned_cols=178 Identities=26% Similarity=0.343 Sum_probs=155.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368899999999999999998775 577999999965432 22346788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 99999999999999999999954 457899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++...... ....||+.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 186 (291)
T cd05612 148 AKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGI 186 (291)
T ss_pred chhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHH
Confidence 98764321 2356999999999987 3589999997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.45 Aligned_cols=183 Identities=27% Similarity=0.351 Sum_probs=154.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||++.... ++..||||++.... ......+.+|+.++..++||||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368889999999999999998875 57799999996432 122346788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+.+|||||||++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999954 356899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc---------------------------------ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ ......+||+.|||||++. .++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 224 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccc
Confidence 8754321100 0011357999999999986 4589999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=278.64 Aligned_cols=180 Identities=32% Similarity=0.448 Sum_probs=154.6
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|+..+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.++..++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 37778999999999999998875 5779999998754322 22457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999888543 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .....||+.|||||++. .++|||||||
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGv 189 (285)
T cd05631 149 AVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGC 189 (285)
T ss_pred cEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHH
Confidence 987643321 23357999999999986 4589999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=284.23 Aligned_cols=183 Identities=22% Similarity=0.264 Sum_probs=156.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||++++.. ++..||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999998875 567999999964221 12345788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++..|+||||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+......... ......||+.|||||++. .++|||||||
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 196 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGV 196 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhh
Confidence 8765432221 122246999999999985 2589999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.89 Aligned_cols=180 Identities=27% Similarity=0.384 Sum_probs=159.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.-|++++.||.|+-|.|-+|++.. ||+.+|||++.+... .....+.+|+-+|+-|.||||+++|++|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 357889999999999999998876 899999999987621 12246889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+..++|+|+||+++|.|+++|.+ .+++++..+.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 99999999999999999999954 458999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|.....+. ...+.||+|.|.|||++++ ++||||.|.
T Consensus 159 AsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGV 200 (786)
T KOG0588|consen 159 ASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGV 200 (786)
T ss_pred eecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHH
Confidence 98754433 2455799999999999993 589999983
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=288.20 Aligned_cols=192 Identities=29% Similarity=0.424 Sum_probs=154.1
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+.... +..++..||||.+..... .....+.+|+.++..+ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 45578999999999999999999864211 112467899999975432 2235688999999999 89999999998
Q ss_pred EEeC-CeEEEEEEecCCCChHHHHhccC----------------------------------------------------
Q 020561 204 CIED-DQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 230 (324)
Q Consensus 204 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------- 230 (324)
+... +.+++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 45889999999999999986421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeecc
Q 020561 231 ---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301 (324)
Q Consensus 231 ---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 301 (324)
.++++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++..............
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 24778888999999999999999988 999999999999999999999999999865433222122234
Q ss_pred ccccCcccccccc-----ccceEEEecC
Q 020561 302 MGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 302 ~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.+++.|||||++. .++|||||||
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~ 264 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGV 264 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHH
Confidence 5678899999886 4689999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.66 Aligned_cols=180 Identities=27% Similarity=0.361 Sum_probs=154.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+... .+..||+|.+..... .....+.+|+.++..++||||+++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 35789999999999999999986542 235899999864321 2235678899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 999999999999999999999954 357899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++...... ....||+.|||||++. .++|||||||
T Consensus 177 ~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 216 (340)
T PTZ00426 177 FAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGI 216 (340)
T ss_pred CCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhh
Confidence 998764321 2357999999999986 3589999998
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=283.13 Aligned_cols=183 Identities=22% Similarity=0.252 Sum_probs=156.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||++++.. +++.||+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478999999999999999998775 567999999865321 12234778999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..||||||+++|+|.+++.+....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence 999999999999999999999765567899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc----------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------~~DiwSlGc 324 (324)
+......... ......||+.|||||++.. ++|||||||
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGv 196 (331)
T cd05624 149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 196 (331)
T ss_pred eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeeh
Confidence 9866443221 1223579999999998752 579999997
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=282.37 Aligned_cols=175 Identities=29% Similarity=0.383 Sum_probs=150.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 211 (324)
+.||+|+||.||+++... ++..||||++..... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 369999999999998765 577999999975432 22356788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
|||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 99999999999998854 457899999999999999999999988 99999999999999999999999999886432
Q ss_pred CCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 292 GDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 292 ~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 183 (328)
T cd05593 148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183 (328)
T ss_pred ccc--ccccccCCcCccChhhhcCCCCCccCCccccch
Confidence 211 123457999999999986 4589999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=288.32 Aligned_cols=188 Identities=23% Similarity=0.296 Sum_probs=159.2
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcc
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLV 198 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv 198 (324)
.++.+..++|++.+.||+|+||.||++++.. +++.||+|++..... .....+.+|+.+++.++||||+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv 106 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 3444566899999999999999999998875 677999999864321 1224577899999999999999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
++++++.+.+..|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred eEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999999854 35888999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
||+|||+++........ .....+||+.|||||++. .++|||||||
T Consensus 182 kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGv 235 (371)
T cd05622 182 KLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (371)
T ss_pred EEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhH
Confidence 99999999876432211 123457999999999975 3689999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=288.50 Aligned_cols=180 Identities=27% Similarity=0.372 Sum_probs=160.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..|+..+.||+|.||.||+|.+.. |++.||+|++......+ .+++.+|+.+|.+++++||.++|+.+...
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 357777899999999999999876 78899999998765443 46789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..+|++||||.||++.+.| +....+.+..+..++++++.||.|||.++ .||||||+.|||+..+|.+||+|||.+.
T Consensus 84 ~~LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 9999999999999999999 44555688888889999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
.+...... ..+++|||.|||||++. .++||||||
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLG 198 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLG 198 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhh
Confidence 87654433 35678999999999998 468999999
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=282.49 Aligned_cols=175 Identities=30% Similarity=0.375 Sum_probs=149.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 211 (324)
+.||+|+||.||+++... +|..||+|.+..... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 469999999999998765 577999999975422 22345778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
|||||+++|+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 99999999999998854 357899999999999999999999988 99999999999999999999999999876433
Q ss_pred CCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 292 GDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 292 ~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... ......||+.|||||++. .++|||||||
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 183 (323)
T cd05595 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183 (323)
T ss_pred CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHH
Confidence 221 123357999999999986 3589999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=280.48 Aligned_cols=175 Identities=30% Similarity=0.379 Sum_probs=148.9
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 211 (324)
+.||+|+||.||++.+.. ++..||+|++..... ....++.+|+.++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999998765 577999999975422 22346778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|||||+++|+|..++.+ ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99999999999998854 3578999999999999999999997 57 9999999999999999999999999987543
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 184 (325)
T cd05594 148 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 184 (325)
T ss_pred CCCc--ccccccCCcccCCHHHHccCCCCCccccccccc
Confidence 2211 123357999999999986 4589999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.32 Aligned_cols=194 Identities=27% Similarity=0.461 Sum_probs=158.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcce
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-------~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
..+|++.+.||+|+||.||+|.+...... .++..++..||+|.+...... ...++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 45788999999999999999987543211 122345668999999765322 2357899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
+++++.+.+..++||||+++|+|.+++.... ..+++...+.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985321 24678889999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 262 HrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||||+|||++.++.+||+|||+++...............++..|||||++. .++|||||||
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 99999999999999999999999998764433222223345688999999876 4689999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.44 Aligned_cols=196 Identities=28% Similarity=0.407 Sum_probs=162.4
Q ss_pred cCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCC
Q 020561 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHL 195 (324)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hp 195 (324)
+.-..|++..++..+.+.||+|+||.||+|.+...+.. ....||||..+... .....++++|+++|++|+||
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence 44455666677788889999999999999998863220 11238999998532 33446799999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
|||++||++....+++||||+|.||+|.++|.+....++..+.+.++.+++.||+|||+++ +|||||..+|+|+..+
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKK 298 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCC
Confidence 9999999999999999999999999999999877667999999999999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.+||+||||++........ .....-...|+|||.+. .++||||+|+
T Consensus 299 ~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV 350 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGV 350 (474)
T ss_pred CeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheee
Confidence 99999999999875421111 10112467999999997 5689999996
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=288.55 Aligned_cols=184 Identities=22% Similarity=0.288 Sum_probs=156.5
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
+..++|++.+.||+|+||.||++++.. ++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345689999999999999999998875 577999999964321 22245778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++.+.+..|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999999999999854 35788899999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
||++......... .....+||+.|||||++. .++|||||||
T Consensus 186 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGv 235 (370)
T cd05596 186 FGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (370)
T ss_pred ccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhH
Confidence 9999875432211 123457999999999875 3589999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=280.17 Aligned_cols=173 Identities=31% Similarity=0.353 Sum_probs=149.0
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||+|+||.||+|++.. ++..||+|.+.... ......+.+|+.++.+++||||+++++++...+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999998875 57799999996532 22235678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 72 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 999999999999954 457899999999999999999999988 9999999999999999999999999998643322
Q ss_pred ccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 294 KTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 294 ~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
. .....+||+.|||||++. .++|||||||
T Consensus 148 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv 181 (312)
T cd05585 148 D--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGV 181 (312)
T ss_pred C--ccccccCCcccCCHHHHcCCCCCCccceechhH
Confidence 1 123457999999999986 4589999997
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=284.82 Aligned_cols=180 Identities=29% Similarity=0.411 Sum_probs=159.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCC-CCCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~~~~ 203 (324)
...|++.+.||+|.||.||++..+. ||..+|+|.+.+..... ...+.+|+.+|++|. |||||.+++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~ 104 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA 104 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4578899999999999999998765 78899999998765543 357899999999999 9999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC----CCcEE
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DYNAK 279 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~~k 279 (324)
|++.+.+++|||+|.||.|.+.|... .+++..+..++.||+.++.|||+.+ ||||||||+|+|+.. ++.+|
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEE
Confidence 99999999999999999999999765 3999999999999999999999988 999999999999953 35799
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++|||++....... .....+||+.|+|||++. ..+||||+|+
T Consensus 180 ~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gv 226 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGV 226 (382)
T ss_pred EeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHH
Confidence 99999999876622 245679999999999998 4689999995
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=281.07 Aligned_cols=184 Identities=28% Similarity=0.362 Sum_probs=154.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCCC-CCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 204 (324)
+|++.+.||+|+||.||+++...+ ..++..||+|++..... ...+.+.+|+.++..+. ||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG------HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 588899999999999999986532 22678999999865321 22345788999999994 99999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...+..++||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCc
Confidence 999999999999999999999854 346899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+++......... .....||+.|||||++. .++|||||||
T Consensus 151 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 195 (332)
T cd05614 151 LSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195 (332)
T ss_pred CCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchh
Confidence 998654322211 22357999999999986 2589999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=284.85 Aligned_cols=183 Identities=30% Similarity=0.394 Sum_probs=157.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 368899999999999999998875 577999999975422 22356788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999999999999999654 67899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCC---------------------------ccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~---------------------------~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .........||+.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 218 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecch
Confidence 98654432 001122357999999999987 3689999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=278.92 Aligned_cols=182 Identities=24% Similarity=0.371 Sum_probs=155.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|++.. ++..||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 3579999999999999999998865 5779999999754322 23467889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
....++||||++ ++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 999999999995 6888888766667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+....... ......||+.|+|||++.+ ++|||||||
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 192 (303)
T cd07869 151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGC 192 (303)
T ss_pred eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHH
Confidence 76433221 1233568999999998752 479999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=280.30 Aligned_cols=183 Identities=22% Similarity=0.255 Sum_probs=156.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||++++.. ++..||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 378899999999999999998875 567999999864321 11234778999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|+||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+........ ......+||+.|||||++. .++|||||||
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGv 196 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHH
Confidence 976543221 1123357999999999875 3589999997
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=277.51 Aligned_cols=181 Identities=25% Similarity=0.389 Sum_probs=154.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||.|+||.||+|+... ++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 479999999999999999998765 577999999975432 2234678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++ ++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 99999999996 5999998766667899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
........ .....|++.|+|||++.+ ++|||||||
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 192 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGC 192 (288)
T ss_pred eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHH
Confidence 65432221 223468999999998852 489999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.91 Aligned_cols=178 Identities=33% Similarity=0.448 Sum_probs=149.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
+.||+|+||.||+++..... .+++.||||++..... .....+.+|+.+|+.++||||+++++++..++..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 68999999999999865321 2578999999975321 2224567899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++++|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 76 YLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999999999999854 456888899999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......||+.|+|||++. .++|||||||
T Consensus 152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 188 (323)
T cd05584 152 HEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGA 188 (323)
T ss_pred cCCC--cccccCCCccccChhhccCCCCCCcceecccHH
Confidence 2221 123357999999999986 3589999997
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.82 Aligned_cols=180 Identities=28% Similarity=0.386 Sum_probs=152.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCC-CcceEEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHL-NLVKLIGYCI 205 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hp-nIv~~~~~~~ 205 (324)
+|++++.||+|+||.||+|.+.. +++.||||++..... ...+.+..|+.++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 58889999999999999998765 577999999975421 2235678899999999765 5888999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence 99999999999999999999854 356899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .....+||+.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 189 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHH
Confidence 875432221 123457999999999987 3579999997
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.87 Aligned_cols=180 Identities=26% Similarity=0.351 Sum_probs=152.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCC-CCCCcceEEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 205 (324)
+|++.+.||+|+||.||+|++.. ++..||||++..... .....+..|..++..+ +||+|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 57889999999999999998765 577999999975432 1223567788888777 5899999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence 99999999999999999999854 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 189 (323)
T cd05616 148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189 (323)
T ss_pred ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhH
Confidence 986432221 123457999999999987 4589999997
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=271.88 Aligned_cols=151 Identities=30% Similarity=0.357 Sum_probs=135.7
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch---HHHHHHHHHHcCCCCCCcceEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
+..++|++++.||.|.-|+||++++.. ++..+|+|++.+.....+ .+...|-+||+.++||.++.||+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 344678888999999999999999876 567999999988765443 45677999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
.++.+...|+|||||+||+|..+++++ ...+++..+..++.+|+.||+|||-.| ||+|||||+||||.++|+|.|+
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEee
Confidence 999999999999999999999988754 467999999999999999999999988 9999999999999999999999
Q ss_pred eeccccc
Q 020561 282 DFGLAKD 288 (324)
Q Consensus 282 DFGla~~ 288 (324)
||.|+..
T Consensus 222 DFDLS~~ 228 (459)
T KOG0610|consen 222 DFDLSLR 228 (459)
T ss_pred ecccccc
Confidence 9999853
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=275.82 Aligned_cols=178 Identities=30% Similarity=0.427 Sum_probs=160.0
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
|.+++.||+|+||.||+|.+++ +|..+|||.+..+ .+.+++..|+.+|.++..|++|+|||.+.....+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 5566789999999999998776 7889999998754 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|||||||..|++.+.++.+..++++..+..+++..+.||+|||... -||||||..||||+.+|..||+|||.|..+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999999999999888899999999999999999999999977 8999999999999999999999999998775
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+... .+.+++|||.|||||++. +.+||||||.
T Consensus 181 DTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGI 217 (502)
T KOG0574|consen 181 DTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGI 217 (502)
T ss_pred hhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcc
Confidence 4322 245689999999999998 5789999993
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=276.92 Aligned_cols=175 Identities=26% Similarity=0.400 Sum_probs=148.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|++.. ++..||+|++..... .....+.+|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 479999999999998875 577999999976432 2234577888888776 799999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 999999999999988854 457899999999999999999999988 9999999999999999999999999997543
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......||+.|+|||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 184 (329)
T cd05618 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184 (329)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCccceecccH
Confidence 2211 123457999999999987 3689999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=277.73 Aligned_cols=175 Identities=27% Similarity=0.407 Sum_probs=149.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|++.. ++..||||+++.... .....+.+|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 469999999999998875 577999999976432 2234578899999888 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|||||||++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 999999999999998854 457999999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|+|||++. .++|+|||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 184 (329)
T cd05588 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184 (329)
T ss_pred cCCC--ccccccCCccccCHHHHcCCCCCCccceechHH
Confidence 2111 123467999999999987 3589999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=275.42 Aligned_cols=178 Identities=30% Similarity=0.405 Sum_probs=151.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 212 (324)
+.||+|+||.||+++.... +.+|..||+|++...... ...++.+|+.+|++++||||+++++++.+.+..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITG------PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEecc------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 5799999999999976532 226889999999754322 23457789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 76 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999999999854 456899999999999999999999988 999999999999999999999999999865433
Q ss_pred CccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.. ......||+.|||||++. .++|||||||
T Consensus 152 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 186 (318)
T cd05582 152 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 186 (318)
T ss_pred CC--ceecccCChhhcCHHHHcCCCCCCccceeccce
Confidence 21 123457999999999986 3689999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=275.90 Aligned_cols=175 Identities=34% Similarity=0.494 Sum_probs=146.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHH-HHcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||+||+|++.. ++..||||++..... ....++..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 469999999999998875 577999999975422 12234555554 56789999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 999999999999999854 457899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 184 (323)
T cd05575 148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGA 184 (323)
T ss_pred cCCC--ccccccCChhhcChhhhcCCCCCccccccccch
Confidence 3221 123457999999999987 3589999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.21 Aligned_cols=193 Identities=29% Similarity=0.447 Sum_probs=166.6
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+...+.+..+.||+|+||+||+|+....... .....||||.++..... .+.+|.||+++|+.|+|||||+|+|+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~----~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPG----QDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCC----ccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34556677788999999999999987653211 24568999999877654 66889999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc---------C----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcE
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRR---------S----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~---------~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NI 270 (324)
|..++.++||+|||..|||.++|..+ . .+++..+.+.|+.|||.||+||-++. +|||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhc
Confidence 99999999999999999999999632 1 23888999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 271 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||.++..|||+||||++.....+.+.......-..+|||||.|+ +.+||||+|.
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV 693 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV 693 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence 99999999999999999988877776654445578999999998 6799999993
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=277.75 Aligned_cols=178 Identities=29% Similarity=0.434 Sum_probs=149.2
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHH---cCCCCCCcceEEEEE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFL---GDLVHLNLVKLIGYC 204 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~HpnIv~~~~~~ 204 (324)
|++.+.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6678899999999999998765 577999999975421 2224566666554 677899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...+..|+||||+++++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence 999999999999999999988843 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++....... .....+||+.|||||++. .++|||||||
T Consensus 147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 189 (324)
T cd05589 147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGV 189 (324)
T ss_pred CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHH
Confidence 9875432221 123467999999999986 3589999997
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.55 Aligned_cols=184 Identities=22% Similarity=0.262 Sum_probs=156.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
.|.+.+.||+|+||.||+|....+ .+..||+|.+..........+.+|+.+|+.++|||||++++++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 488889999999999999986542 256789998765544444567889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 210 RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.||||||+++|+|.++|.. ...++++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 9999999999999998853 2456899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+..............+||+.|||||++. .++|||||||
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 259 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHH
Confidence 8765433222234467999999999986 3589999997
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=275.96 Aligned_cols=175 Identities=33% Similarity=0.473 Sum_probs=146.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHH-HHcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
+.||+|+||+||+|++.. +|..||||++..... ....++..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 469999999999998765 577999999965421 22234556655 46789999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 999999999999998854 457899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 184 (325)
T cd05604 148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGA 184 (325)
T ss_pred CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccc
Confidence 2221 123457999999999987 3589999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=275.98 Aligned_cols=175 Identities=31% Similarity=0.421 Sum_probs=148.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|++.. ++..||||++..... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 369999999999998765 577999999975422 2234567888888866 799999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999998854 456899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......||+.|+|||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 184 (321)
T cd05591 148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184 (321)
T ss_pred cCCc--cccccccCccccCHHHHcCCCCCCccceechhH
Confidence 3221 123457999999999986 3689999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=275.85 Aligned_cols=175 Identities=29% Similarity=0.420 Sum_probs=146.8
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcC-CCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|.+.. ++..||||+++.... .....+..|..++.. ++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 369999999999998865 577999999975421 222445667777765 4799999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999999999999999854 457899999999999999999999988 9999999999999999999999999998653
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 184 (316)
T cd05592 148 NGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGV 184 (316)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHH
Confidence 3221 133457999999999986 3589999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.01 Aligned_cols=187 Identities=28% Similarity=0.372 Sum_probs=155.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEE-EE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGY-CI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~-~~ 205 (324)
..++++.++|.+|||+.||+|.+.. .|..||+|++-..+....+.+.+||.+|++|. |+|||.|++. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 3467788999999999999999876 23699999997777666778999999999998 9999999993 22
Q ss_pred e---C---CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 206 E---D---DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 206 ~---~---~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
. . -.++|.||||.||.|-+++..+ ...|++.++++|+.|+++||.+||... .||||||||-+||||..+++.
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCE
Confidence 1 1 2468999999999999999743 456999999999999999999999987 889999999999999999999
Q ss_pred EEEeecccccCCCCCcc-cee------eccccccCcccccccc--------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKT-HVS------TRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~-~~~------~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
||||||.|......... ... -...-|+.|.|||+|. .++|||+|||
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGC 246 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHH
Confidence 99999998754322211 000 0124699999999997 6799999999
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=286.06 Aligned_cols=176 Identities=28% Similarity=0.416 Sum_probs=152.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-C-----CCcceEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H-----LNLVKLIGY 203 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~~~~~ 203 (324)
+|++.++||+|+||+|.+|++.. |++.||||+++... ....+...|+.+|..|+ | -|||+++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 67889999999999999998876 88999999997653 33356678999999997 4 489999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC--CCcEEE
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKL 280 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl 280 (324)
|...+++|||+|++ ..+|.++|... ...++...+..++.||+.||.+||+.+ |||+||||+||||.. ...|||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeE
Confidence 99999999999999 67999999753 357999999999999999999999988 999999999999953 347999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||.|........ ..+-+..|.|||+|+ ++.|||||||
T Consensus 333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhh
Confidence 99999998654322 356789999999999 5789999999
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=276.00 Aligned_cols=175 Identities=29% Similarity=0.384 Sum_probs=152.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 212 (324)
++||.|.||+||-|+++. ||+.||||++.+..... ..++.+|+.||.+++||.||.+...|++.+..|+
T Consensus 570 evLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred hhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 789999999999998876 78899999998765433 3568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEEeecccccC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDG 289 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla~~~ 289 (324)
|||-+.|.-|+-+|.....++++.....++.||+.||.|||.++ |||.||||+||||. .-.++||||||+|+++
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 99999655555555566678999999999999999999999988 99999999999994 4567999999999998
Q ss_pred CCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+... .+..++|||.|+|||+|+. ..|+||+|.
T Consensus 718 gEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGV 754 (888)
T KOG4236|consen 718 GEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGV 754 (888)
T ss_pred chhh---hhhhhcCCccccCHHHHhhccccccccceeeeE
Confidence 7643 3566899999999999983 479999983
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=274.67 Aligned_cols=175 Identities=31% Similarity=0.462 Sum_probs=146.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHH-HHcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|++.. ++..||+|++..... ....++.+|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 469999999999998875 567999999865422 12234555654 57889999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+|||||++++|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 999999999999988854 456889999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|+|||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 184 (321)
T cd05603 148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGA 184 (321)
T ss_pred CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccch
Confidence 2221 123457999999999986 3689999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=275.89 Aligned_cols=175 Identities=31% Similarity=0.447 Sum_probs=148.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|++.. ++..||||++.... ......+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999998775 56799999997542 12234567888888876 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 999999999999998854 357899999999999999999999988 9999999999999999999999999988643
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 184 (320)
T cd05590 148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184 (320)
T ss_pred cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHH
Confidence 2221 123457999999999987 3589999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.58 Aligned_cols=192 Identities=28% Similarity=0.410 Sum_probs=156.4
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+...+. ..++..||||.+...... ....+.+|+.+++.+ +||||++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 445689999999999999999998754221 124568999999754322 235688999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC-----------------------------------------------------
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 230 (324)
|...+..++|||||++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCc
Q 020561 231 ----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294 (324)
Q Consensus 231 ----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 294 (324)
.++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 24788889999999999999999988 99999999999999999999999999987644322
Q ss_pred cceeeccccccCcccccccc-----ccceEEEecC
Q 020561 295 THVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 295 ~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........+++.|||||++. .++|||||||
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGv 302 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHH
Confidence 22222234567899999886 4689999997
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.74 Aligned_cols=191 Identities=28% Similarity=0.401 Sum_probs=155.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+... ....++..||||+++.... ...+.+.+|+.+|..+ +||||++++++|
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345789999999999999999975321 1123567899999975432 2335688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC------------------------------------------------------
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 230 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 230 (324)
.+.+..++|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999985421
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 231 --------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 231 --------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 24788889999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
............++..|||||++. .++|||||||
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~ 304 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 304 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHH
Confidence 433221122234567899999986 4689999997
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=275.97 Aligned_cols=181 Identities=27% Similarity=0.375 Sum_probs=156.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||++.+.. ++..||+|.+..... ....++.+|+.+|++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4689999999999999999998775 677999999976532 223578999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 9999999999999999999954 346899999999999999999999842 2999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... .....||+.|+|||++. .++|||||||
T Consensus 152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 190 (331)
T cd06649 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190 (331)
T ss_pred ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHH
Confidence 8664322 23357999999999987 3589999997
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.71 Aligned_cols=176 Identities=20% Similarity=0.228 Sum_probs=151.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
...|++++.||+|+||.||+|.+.. +++.||+|.... ..+.+|+.+|++|+||||+++++++...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 3579999999999999999998875 677999997542 4568899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...++|||++ .++|..++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 9999999999 4789888854 346899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ ......||+.|+|||++. .++|||||||
T Consensus 231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 271 (391)
T PHA03212 231 FPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGI 271 (391)
T ss_pred cccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHH
Confidence 54322111 123457999999999986 3589999997
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=273.83 Aligned_cols=175 Identities=30% Similarity=0.437 Sum_probs=145.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHH-HHcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
+.||+|+||+||+|++.. ++..||+|++..... ....++..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 369999999999998775 567899999975321 11234444544 56789999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999999999999854 446888888999999999999999988 9999999999999999999999999997643
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 184 (325)
T cd05602 148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 184 (325)
T ss_pred cCCC--CcccccCCccccCHHHHcCCCCCCccccccccH
Confidence 2221 123457999999999986 3689999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=275.16 Aligned_cols=180 Identities=26% Similarity=0.354 Sum_probs=151.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCC-CCCcceEEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 205 (324)
+|+..+.||+|+||.||+|.+.. ++..||||++..... ...+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47778999999999999998765 577999999975421 22345778899998886 577888999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|+||||+++|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence 99999999999999999999854 356999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... ......||+.|||||++. .++|||||||
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 189 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHH
Confidence 986433221 123356999999999987 3589999997
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=275.62 Aligned_cols=177 Identities=26% Similarity=0.369 Sum_probs=149.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|+.++.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 356677899999999999998765 567999999965432 2235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+.+++||||+++++|.... ..++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999986532 3567788899999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
....... ......||..|+|||++. .++|||||||
T Consensus 217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGv 261 (353)
T PLN00034 217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261 (353)
T ss_pred ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHH
Confidence 7643221 123357999999999874 2589999997
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=273.31 Aligned_cols=175 Identities=29% Similarity=0.411 Sum_probs=147.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||.||+|++.. ++..||+|.++.... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999998875 677999999975421 2234567788888754 899999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 999999999999999854 456899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|+|||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 184 (316)
T cd05620 148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184 (316)
T ss_pred cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHH
Confidence 2221 133467999999999987 3589999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=269.60 Aligned_cols=182 Identities=26% Similarity=0.399 Sum_probs=154.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 368899999999999999998875 577999999875432 223567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++..|+||||++++.|..+. +....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999887666544 44557899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... ......||+.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGv 189 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGC 189 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHH
Confidence 876443221 123357899999999986 3589999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=276.94 Aligned_cols=181 Identities=26% Similarity=0.397 Sum_probs=150.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|.+.. ++..||||.+.... .....++.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 47888999999999999998765 57799999986432 22335688999999999999999999988654
Q ss_pred C-----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 208 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+ ..|+||||| +++|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEcc
Confidence 2 479999999 4789998854 446899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCcc-ceeeccccccCcccccccc-------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
||+++........ .......||+.|+|||++. .++|||||||
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGv 196 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 196 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHH
Confidence 9999865332211 1123457999999999875 2589999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=272.84 Aligned_cols=175 Identities=27% Similarity=0.399 Sum_probs=149.0
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
++||+|+||+||+|++.. ++..||+|++...... ....+.+|+.++.++ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 479999999999998876 5679999999764322 234577899999888 599999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 999999999999998854 357999999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|+|||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 184 (327)
T cd05617 148 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184 (327)
T ss_pred CCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHH
Confidence 2211 123467999999999987 3589999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=272.46 Aligned_cols=175 Identities=30% Similarity=0.447 Sum_probs=147.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcC-CCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~ 210 (324)
+.||+|+||+||+|.+.. ++..||||++..... .....+..|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999998875 577999999975421 223456678888876 4899999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 999999999999999854 356899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 184 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHH
Confidence 2221 123457999999999986 3589999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=275.18 Aligned_cols=180 Identities=27% Similarity=0.391 Sum_probs=155.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+..... ....++.+|+++++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 4689999999999999999998765 577899999876532 223568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
++..++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCc
Confidence 9999999999999999999954 34689999999999999999999974 5 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+....... .....||+.|+|||++.. ++|+|||||
T Consensus 151 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 190 (333)
T cd06650 151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190 (333)
T ss_pred chhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHH
Confidence 97653321 223568999999999863 489999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=266.55 Aligned_cols=187 Identities=24% Similarity=0.391 Sum_probs=156.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|.+..... .+..||+|.++..... ....+.+|+.++.+++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSK------RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCC------ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 3578899999999999999998764322 4678999999765322 23568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++|+|.+++......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++|+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999765667899999999999999999999988 999999999999999999999999987
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... ......++..|+|||++. .++|||||||
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 196 (266)
T cd05064 155 QEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGI 196 (266)
T ss_pred ccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHH
Confidence 654322111 111234567899999886 3689999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.93 Aligned_cols=180 Identities=33% Similarity=0.458 Sum_probs=154.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
+|++.+.||+|+||+||++.+.. ++..||||.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47888999999999999998765 5779999999754322 22457789999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999888643 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .....|++.|||||++. .++|||||||
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~ 189 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGC 189 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHH
Confidence 987543221 22347899999999986 3589999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.64 Aligned_cols=182 Identities=26% Similarity=0.409 Sum_probs=160.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+.|+++..||.|+||+||+|..++ |+...|.|++........++++-||+||+.+.||+||+|++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 457788899999999999997765 67788899998776666788999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.+||+.|||.||-....+..-+..+.+.++..+++|++.||.|||+++ |||||||..|||+.-+|.++|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999999988777889999999999999999999999998 99999999999999999999999998765
Q ss_pred CCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
.... ...+..++|||+|||||+++ ..+||||||.
T Consensus 180 n~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGI 223 (1187)
T KOG0579|consen 180 NKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGI 223 (1187)
T ss_pred chhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhh
Confidence 3321 11245689999999999998 3579999993
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=271.61 Aligned_cols=173 Identities=28% Similarity=0.365 Sum_probs=144.4
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCC---CCCCcceEEEEEEeCCeE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~~~ 210 (324)
||+|+||+||+|++.. ++..||||++...... ....+..|..++..+ .||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999998775 5779999999653221 123455677777655 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999999999999999854 457899999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.... .....+||+.|||||++. .++|||||||
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 185 (330)
T cd05586 148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185 (330)
T ss_pred CCCC--CccCccCCccccCHHHHcCCCCCCCccceecccc
Confidence 3221 123457999999999875 3489999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=266.81 Aligned_cols=174 Identities=32% Similarity=0.466 Sum_probs=148.7
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||+|+||+||++.+.. +++.||+|.+...... ..+.+..|+.+++.++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999998765 5779999998754322 224567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 214 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999988743 3356899999999999999999999988 9999999999999999999999999998664
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
..... .....||+.|+|||++. .++|+|||||
T Consensus 149 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~ 185 (280)
T cd05608 149 DGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGV 185 (280)
T ss_pred CCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHH
Confidence 43221 23357899999999987 3689999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=284.97 Aligned_cols=179 Identities=33% Similarity=0.499 Sum_probs=153.7
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC-
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD- 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 208 (324)
+...+.||+|+||.||+|+++. ||+.||||.++... ....+.+.+|+++|++|+|||||+++++=++..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4556789999999999998776 89999999997643 344577899999999999999999998765543
Q ss_pred -----eEEEEEEecCCCChHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc--CCC--c
Q 020561 209 -----QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADY--N 277 (324)
Q Consensus 209 -----~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~--~ 277 (324)
...+|||||.+|+|...|.+. ...+++.+.+.++..++.||.|||+++ ||||||||.||++- .+| .
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence 467999999999999999754 357999999999999999999999988 99999999999983 223 3
Q ss_pred EEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
-||+|||.|+.+.++. ..+.++||+.|.+||+... -+|.|||||
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 6999999999987655 4667899999999999883 279999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.83 Aligned_cols=192 Identities=24% Similarity=0.373 Sum_probs=156.2
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCC-CCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~ 203 (324)
...+.|+++++||+|+||.||+|.+.... ...++..||||++...... ..+.+.+|+.+|+++. ||||++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 34568999999999999999999875321 1123567999999754332 2356899999999996 9999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC-----------------------------------------------------
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 230 (324)
|.+.+..|||||||++|+|.++|.+..
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999885421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 231 ------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 231 ------------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 24777888999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++.++.+||+|||+++...............+++.|||||++. .++|||||||
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGv 327 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHH
Confidence 9999999999999999998754432222222345778999999886 4589999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=280.69 Aligned_cols=174 Identities=28% Similarity=0.477 Sum_probs=151.6
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
+..+....++.||.|+-|.||+|++. ++.||||.++... ..+|.-|++|+||||+.|.|+|.
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 33344455678999999999999986 4589999886322 35788899999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
....+|||||||+.|.|...| +...++.......|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||.
T Consensus 183 qsPcyCIiMEfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CCceeEEeeeccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccc
Confidence 999999999999999999999 55668899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++...... ....++||..|||||+|. .++||||||.
T Consensus 259 S~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGV 299 (904)
T KOG4721|consen 259 SKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGV 299 (904)
T ss_pred hHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHH
Confidence 99875542 244579999999999998 4689999993
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=274.37 Aligned_cols=181 Identities=25% Similarity=0.354 Sum_probs=162.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch--HHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.=|.+.+.||+|.|+.|-+|++.- ||..||||++.+...... ..+.+|++-|+.++|||||++|++..+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 357788999999999999998765 899999999987655433 468899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE-cCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl-~~~~~~kl~DFGl 285 (324)
...+|||+|+=++|+|.++|.+....+.+..+.++|.||+.|+.|+|..+ +|||||||+||++ ..-|-|||+|||+
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccc
Confidence 99999999999999999999998889999999999999999999999988 9999999999986 5779999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+..+..+.. .++.||+..|-|||+|+ .++||||||.
T Consensus 166 SNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGV 207 (864)
T KOG4717|consen 166 SNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGV 207 (864)
T ss_pred cccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHH
Confidence 987766544 45679999999999998 5789999993
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=270.11 Aligned_cols=188 Identities=24% Similarity=0.400 Sum_probs=155.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|.+...+.. ....||||.+..... ...+++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 35799999999999999999987653321 234699999875432 334678899999999999999999999876
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
. ..++|+||+++|+|.+++......+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccc
Confidence 4 578999999999999999766667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...............++..|||||++. .++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv 199 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHH
Confidence 8765433222222234567899999986 3589999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.62 Aligned_cols=178 Identities=25% Similarity=0.281 Sum_probs=153.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
...|.+.+.||+|+||.||+|.+.. ++..||||.... ..+.+|+.+|++|+|||||++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999998775 567999996432 3467899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..+||||++ .++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999999 57999988665567999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...............||+.|||||++. .++|||||||
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGv 350 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGL 350 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHH
Confidence 754332222223457999999999987 3579999997
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=258.95 Aligned_cols=181 Identities=29% Similarity=0.447 Sum_probs=157.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----c----chHHHHHHHHHHcCCC-CCCc
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----Q----GHKEWLAEVNFLGDLV-HLNL 197 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l~-HpnI 197 (324)
.-..|...+.||.|..+.|-++.++. ||..+|+|++..... . ..+.-.+|+.||+++. ||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 34578888999999999998886554 888999999864321 1 1234568999999996 9999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
+.+.++++.+..+|+|+|.|+.|.|.++|. ..-.+++.....|++|+..|+.|||..+ ||||||||+|||++++.+
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN 161 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence 999999999999999999999999999994 4567999999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----------ccceEEEec
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TALELFCLK 323 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlG 323 (324)
+||+|||+|+.+..+.. ....||||+|+|||.+. ..+|+||+|
T Consensus 162 i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~G 215 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACG 215 (411)
T ss_pred eEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHH
Confidence 99999999999887665 44579999999999997 247999998
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=277.65 Aligned_cols=180 Identities=27% Similarity=0.270 Sum_probs=153.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|++++.||+|+||.||+|..... .++..||+|.+... ....+|+.+|++|+||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 45799999999999999999976532 24678999988643 3456899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...|+|||++. ++|.+++ .....+++..++.++.||+.||.|||+++ ||||||||+|||++.++.++|+|||++.
T Consensus 159 ~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred CEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 99999999994 7899988 44567999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...............||+.|+|||++. .++|||||||
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv 275 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGL 275 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHH
Confidence 765433322233467999999999987 3589999997
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=274.42 Aligned_cols=176 Identities=23% Similarity=0.273 Sum_probs=152.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
...+|++++.||+|+||.||+|++.. ++..||+|+.... ....|+.++++++||||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34579999999999999999998765 5668999975432 23579999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+ .++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccc
Confidence 99999999999 56899998776678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .....||+.|+|||++. .++|||||||
T Consensus 205 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 244 (357)
T PHA03209 205 QFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244 (357)
T ss_pred cccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHH
Confidence 75432211 23356999999999986 4689999997
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.59 Aligned_cols=180 Identities=26% Similarity=0.345 Sum_probs=160.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
...|.+...||+|.|++|.+|++.. |+..||||.+.+..... ...+.+|+++|..|+|||||+++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 4578999999999999999998876 78899999998765432 345889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
....+|+||||+.+|.++++|.+.+ .+.+..+..++.|++.|++|||+++ |||||||++||||+.+.++||+|||+
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence 9999999999999999999996654 4556889999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc------cceEEEec
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLK 323 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlG 323 (324)
+..+.... ...+.+|++.|.|||++.+ .+|+||||
T Consensus 202 S~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslg 242 (596)
T KOG0586|consen 202 STFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLG 242 (596)
T ss_pred ceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhh
Confidence 99876433 3556899999999999983 58999998
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=280.96 Aligned_cols=175 Identities=27% Similarity=0.415 Sum_probs=154.2
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 215 (324)
+||+|.||+||-|++.. |...+|||-+........+-+..|+.+.++|+|.|||+++|.+-.++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999999876 677999999987665555668899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcEEEEeecccccCCCC
Q 020561 216 FMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 216 ~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~~~ 292 (324)
-++||+|..+|+..=+++ .+.+.-.+..||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+..-
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 999999999997655566 78888899999999999999998 99999999999995 6899999999999876443
Q ss_pred CccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 293 DKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 293 ~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
.. ...++.||..|||||+|. .++|||||||
T Consensus 730 nP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GC 766 (1226)
T KOG4279|consen 730 NP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGC 766 (1226)
T ss_pred Cc--cccccccchhhhChHhhccCCcCCCchhhhhhccc
Confidence 22 234578999999999998 3689999999
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=269.61 Aligned_cols=175 Identities=32% Similarity=0.449 Sum_probs=148.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 210 (324)
+.||+|+||+||+|.+.. ++..||||++..... .....+.+|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999998765 567999999975421 2234567888999888 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 999999999999998854 347999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+||+.|||||++. .++|+|||||
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGv 184 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGV 184 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHH
Confidence 2221 122356999999999987 3589999997
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=267.75 Aligned_cols=181 Identities=28% Similarity=0.404 Sum_probs=153.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|.+.+.||+|+||.||+|++.. ++..||+|.+...... ....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 478999999999999999998765 5678999998754322 234678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++ ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 99999999996 5898888666667899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ .....+|+.|+|||++. .++|||||||
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (309)
T cd07872 153 AKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGC 193 (309)
T ss_pred ecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHH
Confidence 65332211 22346899999999875 3589999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.95 Aligned_cols=186 Identities=25% Similarity=0.304 Sum_probs=155.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||+||+|++.. ++..||||++...... ....+.+|+.++..++|+||++++..+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 34689999999999999999998765 5779999999765432 235678899999999999999998877
Q ss_pred EeCC--------eEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 205 IEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 205 ~~~~--------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
...+ .+++||||+++|+|.++|... ...+++..+..++.|++.||.|||+.+ ||||||||+|||++
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~ 177 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC 177 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence 5432 368999999999999998642 356899999999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++.+||+|||+++..............+||+.|||||++. .++|||||||
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGv 233 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGV 233 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHH
Confidence 99999999999998764432222234467999999999987 3589999997
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=279.98 Aligned_cols=177 Identities=27% Similarity=0.478 Sum_probs=145.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|++++.||+|+||.||+|.+.. +++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4579999999999999999998765 57799999886432 2345799999999999999999887542
Q ss_pred --------CeEEEEEEecCCCChHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 208 --------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 208 --------~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
..+++||||++ ++|.+++. .....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence 24679999996 57777664 23467899999999999999999999988 99999999999998664
Q ss_pred -cEEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 277 -NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 277 -~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
.+||+|||+|+....... .....||+.|||||++.+ ++|||||||
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 259 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence 699999999987644322 223578999999998753 479999998
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=261.93 Aligned_cols=181 Identities=31% Similarity=0.432 Sum_probs=147.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCC---CCCCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~~~~~ 203 (324)
++|++.+.||+|+||.||+|++... ++..||||.+...... ....+.+|+.+++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 3688999999999999999987532 3568999998654322 223566777776655 69999999998
Q ss_pred EEe-----CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 204 CIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 204 ~~~-----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
+.. ...+++||||++ ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence 852 456899999995 6999998643 345899999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...... ......||+.|+|||++. .++|||||||
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 197 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHH
Confidence 9999999998754332 123457899999999986 4689999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=274.06 Aligned_cols=180 Identities=26% Similarity=0.397 Sum_probs=151.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++++.||+|+||.||++.+.. ++..||||.+.... ....+++.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 57889999999999999998765 57799999986532 22345788999999999999999999999877
Q ss_pred C-----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 208 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+ ..|+||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999995 68888874 3457899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||+++........ ......+|+.|+|||++.+ ++|||||||
T Consensus 147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (372)
T cd07853 147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGC 193 (372)
T ss_pred ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHH
Confidence 9999865432211 1233468999999998763 479999997
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=271.05 Aligned_cols=182 Identities=32% Similarity=0.459 Sum_probs=160.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.+.|+.-++||+|+||.||-+..+. ||+.+|.|.+.+..... ..-.++|-.+|.+++.++||.+--+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 4568888999999999999987765 89999999987654322 23467899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
++.+.+++||..|.||+|.-+|.+.+ ..+++..++.++.+|+.||++||... ||.|||||+|||||+.|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999987654 46999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|||..++..... ...+||.+|||||++.+ ++|+|||||
T Consensus 332 GLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGC 374 (591)
T KOG0986|consen 332 GLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGC 374 (591)
T ss_pred ceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHh
Confidence 999998776542 33489999999999984 579999999
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.70 Aligned_cols=187 Identities=25% Similarity=0.437 Sum_probs=157.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||.||+|.+...+. +...||||.+...... ...++.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 578899999999999999998865321 3458999998754332 235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999999999999766667999999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...............+++.|+|||.+. .++|||||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~ 196 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 196 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHH
Confidence 875322221112234567899999886 3589999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=259.49 Aligned_cols=181 Identities=27% Similarity=0.402 Sum_probs=156.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++-++||+|.|+.||++.+.. ||+.+|+|+++.... .+.+++.+|++|.+.|+|||||++.+..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 34678888999999999999986554 899999999876543 3457889999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~ 281 (324)
......|||+|++.|++|..-|-.+ ..+++..+-.+++||+.+|.|+|.++ |||||+||+|+||. ...-+||+
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 9999999999999999998777544 46788899999999999999999998 99999999999994 44569999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
|||+|..+..+. .....+|||.|||||++. ..+|||+.|
T Consensus 156 ~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cG 199 (355)
T KOG0033|consen 156 DFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 199 (355)
T ss_pred ccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhh
Confidence 999999887332 345578999999999998 458999987
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=239.65 Aligned_cols=180 Identities=29% Similarity=0.402 Sum_probs=157.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|...+.||+|.||+||+|+..+ |++.||+|++..+.. ......++|+.+|+.|.|.|||++++....+
T Consensus 3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45566789999999999998876 788999999976542 2234678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..+-+|+||| ..+|..++..-.+.++.+.+..++.|++.||.|+|+++ ++||||||.|.||+.+|.+||+|||+++
T Consensus 74 kkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 9999999999 56899998777788999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.+.-... ..+..+-|.+|.+|.++. ++.|+||-||
T Consensus 150 afgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagc 190 (292)
T KOG0662|consen 150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190 (292)
T ss_pred hcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcch
Confidence 8765432 233345699999999997 4689999999
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.31 Aligned_cols=190 Identities=25% Similarity=0.277 Sum_probs=165.5
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCc
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI 197 (324)
..++.+..++|+++++||+|+||.|..++++. |++.||+|++++... ....-|..|-.+|..-+.+-|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi 137 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI 137 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence 34555667899999999999999999998875 788999999987432 222457889999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
++++-.|.++.++|+||||++||+|..+|.+.. ++|+..+..++..|+.||+-||+.| +|||||||+|||||..|+
T Consensus 138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 999999999999999999999999999997766 8999999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+||+|||.|-.+..... ......+|||-|++||+|. ..+|+||||.
T Consensus 214 ikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV 269 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGV 269 (1317)
T ss_pred EeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHH
Confidence 99999999987764332 2344568999999999998 2489999993
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=281.89 Aligned_cols=182 Identities=23% Similarity=0.413 Sum_probs=145.2
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC------CCC
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV------HLN 196 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------Hpn 196 (324)
++.....+|++++.||+|+||+||+|.+.. ++..||||+++.... ....+..|+.++..+. |++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~ 192 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFP 192 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcc
Confidence 334456789999999999999999998765 567999999964321 1234556666666654 456
Q ss_pred cceEEEEEEeC-CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcC
Q 020561 197 LVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 197 Iv~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~ 274 (324)
|+++++++... ...|||||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+ .+ ||||||||+|||++.
T Consensus 193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMET 267 (467)
T ss_pred eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEec
Confidence 88999888765 5788999998 78999988544 579999999999999999999998 47 999999999999986
Q ss_pred CC----------------cEEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 275 DY----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 275 ~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++ .+||+|||++...... ....+||+.|||||++.+ ++|||||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 333 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHH
Confidence 65 4999999988653221 234679999999999873 579999998
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=270.68 Aligned_cols=192 Identities=27% Similarity=0.398 Sum_probs=154.6
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+...+ ...+++.||+|++...... ..+.+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 44568999999999999999999764321 1235789999998754322 234678899999999 79999999998
Q ss_pred EEeC-CeEEEEEEecCCCChHHHHhccC----------------------------------------------------
Q 020561 204 CIED-DQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 230 (324)
Q Consensus 204 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------- 230 (324)
|... ..++++|||+++++|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 8654 56889999999999999985321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccc
Q 020561 231 --------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302 (324)
Q Consensus 231 --------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 302 (324)
.++++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+.............
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 26789999999999999999999988 9999999999999999999999999998764432222222345
Q ss_pred cccCcccccccc-----ccceEEEecC
Q 020561 303 GTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 303 Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++..|||||++. .++|||||||
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv 263 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGV 263 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHH
Confidence 678899999886 4589999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=279.37 Aligned_cols=177 Identities=25% Similarity=0.413 Sum_probs=151.5
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+...+||+|+|-+||+|.+.. +|..||.-.++... ....++|..|+.+|+.|+|||||++|.+|.+.
T Consensus 43 k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 334689999999999999876 67788876665432 22346899999999999999999999999987
Q ss_pred Ce--EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcEEEEeec
Q 020561 208 DQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFG 284 (324)
Q Consensus 208 ~~--~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFG 284 (324)
.. +.+|+|++..|+|..|+.+ -..+.......|++||+.||.|||++. +||||||||.+||+|+ ..|.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchh
Confidence 66 7789999999999999954 456888999999999999999999987 8999999999999996 56999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc----ccceEEEec
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLK 323 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlG 323 (324)
||+...... ...++|||.|||||+.. ..+||||||
T Consensus 192 LAtl~r~s~----aksvIGTPEFMAPEmYEE~YnE~VDVYaFG 230 (632)
T KOG0584|consen 192 LATLLRKSH----AKSVIGTPEFMAPEMYEENYNELVDVYAFG 230 (632)
T ss_pred HHHHhhccc----cceeccCccccChHHHhhhcchhhhhhhhh
Confidence 999875433 33378999999999987 468999999
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=271.80 Aligned_cols=185 Identities=31% Similarity=0.515 Sum_probs=163.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
++.+...+.+.||+|-||.|.+|.... +..||||.++...... +.+|.+|+++|.+|+|||||+++++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 344567788999999999999998763 5699999998775443 47899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
..++.+++|+||+++|+|.++|.+...+ +.......|+.||+.||+||.+.+ +|||||.++|+|++.++++||+||
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 9999999999999999999999766433 356677889999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
|+++.+...+........+-.++|||||.|+ +++|+|++|
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafg 726 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFG 726 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhH
Confidence 9999988888777666677789999999987 789999998
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=259.29 Aligned_cols=181 Identities=25% Similarity=0.362 Sum_probs=155.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||.||+|.+.. ++..||+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 467778899999999999998765 56799999997654444456788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++++|.+++.. ...+++.+.+.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999999999999854 447899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
...... ......|++.|+|||++. .++|+|||||
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~ 197 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197 (267)
T ss_pred ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHH
Confidence 543211 123357899999999874 3589999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=290.36 Aligned_cols=184 Identities=22% Similarity=0.360 Sum_probs=153.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+++.+|+.++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 478999999999999999998765 5779999999754322 2357899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
+.+..|+||||++|++|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d 149 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF 149 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence 999999999999999999998531 123566778899999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCc----------------cceeeccccccCccccccccc-----cceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~----------------~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+.+||+|||+++....... .......+||+.|||||++.+ ++|||||||
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV 219 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence 9999999999986521110 001123579999999999873 579999997
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=257.29 Aligned_cols=182 Identities=24% Similarity=0.341 Sum_probs=156.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|++.+.||+|+||.||+|.+.. ++..||+|++..........+.+|+.++.+++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3579999999999999999998765 5679999999755444445678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++.+ ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999999854 357899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
....... ......|++.|+|||++. .++|+|||||
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~ 197 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHH
Confidence 6543211 122346899999999874 3589999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=257.90 Aligned_cols=173 Identities=32% Similarity=0.486 Sum_probs=147.4
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||+|+||.||+++... +|..||+|.+...... ....+..|+.++++++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999998775 5779999999653321 123456799999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 214 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
|||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999888543 346889999999999999999999988 999999999999999999999999999876443
Q ss_pred CccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.. .....|++.|+|||++. .++|+|||||
T Consensus 149 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv 182 (277)
T cd05607 149 KT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGC 182 (277)
T ss_pred ce---eeccCCCCCccCHHHHccCCCCCchhHHHHHH
Confidence 21 23356899999999986 4589999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=261.51 Aligned_cols=191 Identities=25% Similarity=0.419 Sum_probs=155.5
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+... ....++..||||.+..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456899999999999999999987531 1123467899999865332 22356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
.....++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCC
Confidence 9999999999999999999986422 23577888999999999999999988 99999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++|+|||+++...............+++.|||||++. .++|||||||
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHH
Confidence 99999999998654433222222235678899999986 3579999997
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.10 Aligned_cols=180 Identities=33% Similarity=0.457 Sum_probs=153.6
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|+..+.||+|+||.||++.+.. +++.||||.+....... ...+.+|+.++++++|+||+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 36778899999999999998875 67799999986543222 2356789999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999988543 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .....|++.|||||++. .++|||||||
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 189 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 189 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHH
Confidence 976543221 12347999999999987 3589999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=269.26 Aligned_cols=178 Identities=26% Similarity=0.380 Sum_probs=148.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||++.+.. ++..||||.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT 90 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 4689999999999999999998765 57799999996542 223456889999999999999999999986
Q ss_pred eCC------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
... ..|+||||++ ++|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 91 PQKSLEEFQDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred cCCCccccceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 543 4799999996 46777663 24788899999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||+++...... ......||+.|+|||++. .++|||||||
T Consensus 164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 210 (359)
T cd07876 164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 210 (359)
T ss_pred EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHH
Confidence 99999997643321 123357899999999987 3589999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=259.90 Aligned_cols=189 Identities=29% Similarity=0.489 Sum_probs=156.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++.+.||+|+||.||+|.+...+. ..+...||+|.+...... ...++.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 478889999999999999998765321 124568999998754322 235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
...+++|||+++++|.+++.... ..+++...+.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 99999999999999999996431 45788899999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+++...............+++.|||||++. .++|||||||
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 999999999999998764433222233346788999999876 4589999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=259.38 Aligned_cols=188 Identities=26% Similarity=0.435 Sum_probs=154.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++.+.||+|+||.||+|.+...+. .++..||+|.+..... ....++.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 468888999999999999998643221 2467899999975432 2235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
+..|+||||+++++|.+++... ...+++...+.++.|++.||.|||+++ |+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 9999999999999999998532 124788899999999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.++.+||+|||+++...............++..|+|||++. .++|+|||||
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGV 214 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHH
Confidence 9999999999999998764433222223345677899999985 4589999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=259.12 Aligned_cols=183 Identities=27% Similarity=0.414 Sum_probs=158.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+.|++++.||.|+||.||+|.+.. ++..|++|.+..........+.+|+.+++.++||||+++++++..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 3579999999999999999998875 5679999999766555556788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|..++.+....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999888665667999999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
....... ......+++.|+|||++. .++|+|||||
T Consensus 159 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ 203 (292)
T cd06644 159 KNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 203 (292)
T ss_pred ecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHH
Confidence 6433211 122346889999999984 2589999997
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=258.73 Aligned_cols=179 Identities=33% Similarity=0.451 Sum_probs=153.1
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
|+..+.||+|+||+||+|.+.. +++.||+|.+...... ....+.+|+.+++.++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 6677899999999999998875 5779999998654322 223577899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999999888643 346999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .....|++.|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~ 189 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGC 189 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHH
Confidence 76543221 22357899999999986 3579999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=259.22 Aligned_cols=170 Identities=19% Similarity=0.281 Sum_probs=145.7
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEEe----C
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE----D 207 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~ 207 (324)
..||+|++|.||+|.+. |..||||.+....... .+.+.+|+.+|.+++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 67999999999999873 6699999997654332 3567799999999999999999999877 3
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
...++||||+++|+|.+++.+ ...+++...+.++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence 578999999999999999954 35789999999999999999999984 6 889999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
+...... ....|++.|+|||++.. ++|||||||
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 8654322 22468999999999853 689999997
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=254.76 Aligned_cols=178 Identities=25% Similarity=0.394 Sum_probs=148.2
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 369999999999998865 466899998864432 2235689999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++.+....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999999765567899999999999999999999988 9999999999999999999999999988654322
Q ss_pred ccceeeccccccCccccccccc-----cceEEEecC
Q 020561 294 KTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 294 ~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
.........++..|+|||.+.. ++|+|||||
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 184 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHH
Confidence 1111111123467999999863 479999997
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=257.11 Aligned_cols=180 Identities=27% Similarity=0.447 Sum_probs=155.9
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
|++.+.||+|+||.||+|.+.. ++..+++|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 6777899999999999998765 5678999999765544456788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
++||||+++++|..++.+...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999999988665667999999999999999999999988 9999999999999999999999999987653
Q ss_pred CCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
.... ......|++.|+|||++. .++|+|||||
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 196 (282)
T cd06643 155 RTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 196 (282)
T ss_pred cccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHH
Confidence 3211 123356899999999984 2589999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=259.02 Aligned_cols=194 Identities=26% Similarity=0.394 Sum_probs=160.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcce
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-------~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
..+|++.+.||+|+||.||+|.+...+... .....+..||+|.+..... .....+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876533211 1223456899999876543 23457889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
+++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996533 26899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++.++.++|+|||+++...............+++.|||||++. .++|||||||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH
Confidence 999999999999999998765433322233445788999999876 3689999997
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=258.31 Aligned_cols=181 Identities=29% Similarity=0.374 Sum_probs=158.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHH---HHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|..+++||+|.||+|.+++-+. |++.+|||++++.......+ -+.|-++|...+||++..+.-.|+
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 578888999999999999997654 88999999998876554444 467999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+++|+||||..||.|.-+|.+ ...+++.....+..+|+.||.|||+++ ||.||||.+|+|||.+|++||+||||
T Consensus 239 t~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred cCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence 99999999999999999999954 457899989999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... ...++||||.|+|||+|. .++|+|.+|.
T Consensus 315 CKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GV 356 (516)
T KOG0690|consen 315 CKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGV 356 (516)
T ss_pred chhcccccc--eeccccCChhhcCchhhccccccceeehhhhhH
Confidence 986543222 245689999999999998 5789999983
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=258.09 Aligned_cols=187 Identities=27% Similarity=0.387 Sum_probs=152.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++.+.||+|+||+||+|.+...+.. ....|++|.+..... ....++..|+.+++.+.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 4788899999999999999988653221 122588888864322 223567788889999999999999998764
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...++++||+++|+|.+++......+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 5578999999999999999766678999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...............++..|+|||++. .++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~ 199 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGV 199 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHH
Confidence 764433222233355778999999986 3579999997
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=260.06 Aligned_cols=190 Identities=30% Similarity=0.455 Sum_probs=157.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|.+.+.||+|+||+||++...... ...++..+|+|.+..........+.+|+.++.+++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 357889999999999999999764311 1124567999998765544456789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999999986322 24899999999999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.+||+|||+++...............+++.|+|||++. .++|+|||||
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 210 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHH
Confidence 999999999998664432222222344678899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=256.91 Aligned_cols=175 Identities=26% Similarity=0.390 Sum_probs=151.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.++||+|+||.||+|.+.. ++..||+|.+..... ....++.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 368888999999999999998765 577999999875532 2235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999999999997553 4688889999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...... .....||..|+|||++. .++|+|||||
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 181 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGI 181 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHH
Confidence 654332 23357899999999986 3589999997
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.90 Aligned_cols=190 Identities=30% Similarity=0.456 Sum_probs=157.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|.+.+.||+|+||.||+|.+.... ...++..||||.+...... ....+.+|++++..+.||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 356888899999999999999875421 0124678999999765433 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
....++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEc
Confidence 999999999999999999996432 34788899999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++.+||+|||++................+++.|+|||++. .++|||||||
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence 99999999999998654332222223345678999999986 4589999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=259.26 Aligned_cols=193 Identities=27% Similarity=0.413 Sum_probs=157.4
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~ 202 (324)
.+..++|++.+.||+|+||.||++.+..... ......+|+|.+..... ....++.+|+.++.++ +||||+++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3455678999999999999999998764221 12356899999875432 2234688999999999 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp 267 (324)
++...+..+++|||+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp 160 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA 160 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence 999999999999999999999998532 346889999999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 268 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||++.++.+||+|||+++...............++..|+|||++. .++|||||||
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 222 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 222 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhh
Confidence 99999999999999999998765433222122234567899999876 3589999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=254.51 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=153.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||.||++.+.. +..+|+|.+.... ....++.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468888999999999999998753 3479999886443 23467889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||+++|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999999999999755557899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~ 189 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHH
Confidence 5432221 112234567899999986 3689999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=261.53 Aligned_cols=178 Identities=24% Similarity=0.400 Sum_probs=143.3
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe--CCeEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRL 211 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~ 211 (324)
...||+|+||.||+|++... .++..||+|.+..... ...+.+|+.+|++++||||+++++++.. ....|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 46899999999999987532 1467899999875432 2457899999999999999999998864 45688
Q ss_pred EEEEecCCCChHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE----cCCCcEE
Q 020561 212 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 279 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~k 279 (324)
+||||+. ++|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+|||+ +..+.+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 9999994 6888887421 235889999999999999999999988 9999999999999 4567899
Q ss_pred EEeecccccCCCCCcc-ceeeccccccCccccccccc------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|+|||+++........ .......||+.|||||++.+ ++|||||||
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 204 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence 9999999876432211 11234578999999998863 479999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=255.63 Aligned_cols=188 Identities=29% Similarity=0.438 Sum_probs=155.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.|++++.||+|+||.||++++... ...++..||+|.+.... ......+.+|+.+++.+.||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccC-----CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 4578899999999999999986532 12367899999987543 22235788999999999999999999998875
Q ss_pred --CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
...++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcc
Confidence 5689999999999999999665557899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ .......|+..|+|||++. .++|||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 200 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhh
Confidence 9876543221 1122345777899999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=255.32 Aligned_cols=180 Identities=29% Similarity=0.383 Sum_probs=147.8
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+||.||+|.+.... ++..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY-------TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCCC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 36899999999999875422 456899999875542 2234688899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 214 YEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
|||+++|+|.+++... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999999999642 234567788899999999999999988 999999999999999999999999999765
Q ss_pred CCCCccceeeccccccCcccccccc------------ccceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM------------TALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~------------~~~DiwSlGc 324 (324)
.............|++.|+|||++. .++|+|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 197 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHH
Confidence 4332222223356788999999874 3689999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=291.09 Aligned_cols=189 Identities=25% Similarity=0.366 Sum_probs=155.2
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
......+|++++.||+|+||+||+|++.. ++..||+|.+...... ....+..|+.+|..|+|||||+++
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~ 78 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 34455789999999999999999998875 5779999998754322 235688999999999999999999
Q ss_pred EEEEeC--CeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeCCCCCCcEEE
Q 020561 202 GYCIED--DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE----RPVIYRDFKTSNILL 272 (324)
Q Consensus 202 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~----~~ivHrDLkp~NILl 272 (324)
++|... ..+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||
T Consensus 79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 988653 5689999999999999998642 3579999999999999999999998532 349999999999999
Q ss_pred cC-----------------CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 273 DA-----------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 273 ~~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
+. .+.+||+|||++........ .....||+.|||||++. .++|||||||
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ 231 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHH
Confidence 54 33589999999987643321 23357999999999984 3579999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=289.31 Aligned_cols=190 Identities=28% Similarity=0.441 Sum_probs=161.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+.++.+.||+|.||.||.|......... ....||||.+.+.. .+...+|++|..+|++++|||||+++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 345677889999999999999987643210 13469999997764 3445689999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
....+|++|||++|+|..+|++. ...++....+.++.|||.|+.||++++ +|||||..+|+||+....+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence 99999999999999999999865 567889999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+|+.+...+.+.......-...|||||.+. +++||||||.
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGV 892 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGV 892 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHH
Confidence 9999999776655544333323457899999988 6799999993
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=257.49 Aligned_cols=187 Identities=24% Similarity=0.358 Sum_probs=152.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..|+.+..||+|.||.||+|.-.+.+. .....+|||.++.... .......+|+.+++.|+||||+.+..++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~-----kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTND-----KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCc-----ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 368899999999999999995443110 0134799999975522 112457899999999999999999998887
Q ss_pred -CCeEEEEEEecCCCChHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC----Cc
Q 020561 207 -DDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YN 277 (324)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~ 277 (324)
+..++|++||.+ -+|.+.|+- ....++......|+.||+.|+.|||++- |+||||||+|||+..+ |.
T Consensus 99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 788999999996 489888852 2356899999999999999999999999 9999999999999777 99
Q ss_pred EEEEeecccccCCCCCccc-eeeccccccCccccccccc------cceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|||+|||+++.+.+.-... ....++-|.+|.|||.|++ ++||||+||
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC 228 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC 228 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence 9999999999876543322 2334567999999999984 589999999
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=266.68 Aligned_cols=177 Identities=24% Similarity=0.401 Sum_probs=150.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++++.||+|+||.||+|.+.. ++..||||.+..... ....++.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 3679999999999999999998765 577999999975432 22356778999999999999999999875
Q ss_pred eC------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
.. ...|++||++ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEE
Confidence 43 3478999998 789988874 346899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|+|||+++..... .....||+.|+|||++.. ++|||||||
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 204 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 204 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHH
Confidence 9999999875432 223578999999999863 589999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=254.30 Aligned_cols=185 Identities=29% Similarity=0.472 Sum_probs=151.4
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
|++.+.||+|+||.||+|.+..++. ++..||||.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678899999999999998865332 4568999999754322 2357889999999999999999999887655
Q ss_pred e------EEEEEEecCCCChHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 209 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 209 ~------~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
. .++||||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence 4 79999999999999988432 246899999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...............++..|+|||++. .++|||||||
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~ 203 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 203 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHH
Confidence 9999999998765433221122234567899999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=255.80 Aligned_cols=179 Identities=30% Similarity=0.381 Sum_probs=144.4
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 214 (324)
.||+|+||.||+|..... .....+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 589999999999975432 1345789998764432 22346789999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 215 EFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 215 E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
||+++|+|.+++.... ...++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999996532 23467888899999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccccCcccccccc------------ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM------------TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~------------~~~DiwSlGc 324 (324)
............+++.|+|||++. .++|||||||
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 197 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGV 197 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHH
Confidence 322211122335677899999863 3689999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=257.60 Aligned_cols=188 Identities=23% Similarity=0.374 Sum_probs=153.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||+||+|.+..++.. ....||+|.+...... ...++.+|+.++..+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 45788999999999999999987654321 1235899998754332 24568899999999999999999999875
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
...+++|||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 4578999999999999999765667999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...............+++.|||||++. .++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 199 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHH
Confidence 8765432221112223567899999986 3579999997
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=254.62 Aligned_cols=187 Identities=25% Similarity=0.430 Sum_probs=154.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++.+.||+|+||.||+|.+...+. ++..||||.+.... .....+|..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 357888999999999999999876432 24479999987542 22345789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...++||||+++++|.+++......+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999999999766667899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccc---cccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVM---GTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~---Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
............... .+..|+|||++. .++|||||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~ 199 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGI 199 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHH
Confidence 654322211111111 245799999986 3589999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=295.32 Aligned_cols=183 Identities=30% Similarity=0.406 Sum_probs=156.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
-+++-...||.|.||.||.|...+ ||...|+|-+..... ...+.+.+|..+|..|+|||||++||+=..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 467778899999999999997665 788999998865432 334568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..+|.||||.+|+|.+.+ +.+.-.++.....+..|++.||.|||+++ ||||||||+||||+.+|.+|++|||.|
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 99999999999999999999 44555777777888899999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--ceeeccccccCcccccccc--------ccceEEEecC
Q 020561 287 KDGPEGDKT--HVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
..+...... ......+||+.|||||++. ++.|||||||
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 876553211 1223568999999999998 4689999999
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=256.15 Aligned_cols=188 Identities=29% Similarity=0.420 Sum_probs=154.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe--
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 206 (324)
.+|++.+.||+|+||.||++.... ....++..||||.+........+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478889999999999999997642 1123677999999976654445678999999999999999999998754
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
....++||||+++++|.+++.+....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence 34689999999999999999765567899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccce-eeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHV-STRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
........... .....++..|+|||++.. ++|||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 199 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGV 199 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHH
Confidence 87654332111 111234556999999863 489999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=260.29 Aligned_cols=194 Identities=27% Similarity=0.455 Sum_probs=155.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCc-----cccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTA-----PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-----~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
.++|++.+.||+|+||.||++++...+.. .....+...||+|.+...... ....+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 45799999999999999999987532110 001123346999999765322 235688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NI 270 (324)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985432 23688899999999999999999988 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 271 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|++.++.+||+|||++................++..|+|||++. .++|+|||||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 219 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHH
Confidence 99999999999999998764433222222334577899999876 4689999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=259.70 Aligned_cols=179 Identities=27% Similarity=0.375 Sum_probs=154.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||.||++.+.. ++..+|+|.+...... ...++.+|++++.+++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368899999999999999998765 5778999998754322 235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999999544 578999999999999999999997 46 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
....... .....|++.|+|||++.+ ++|+|||||
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 186 (308)
T cd06615 148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186 (308)
T ss_pred ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHH
Confidence 7654322 223578999999998763 489999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=256.66 Aligned_cols=179 Identities=30% Similarity=0.452 Sum_probs=146.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCC---CCCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~~~~~~ 204 (324)
+|++.+.||+|+||.||+|++.. ++..||+|.+...... ....+.+|+.++..+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 47888999999999999998875 6779999998754322 123456777777665 699999999988
Q ss_pred Ee-----CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 205 IE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 205 ~~-----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
.. ....++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 65 245799999996 5898888653 345899999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 148 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 195 (288)
T cd07863 148 KLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 195 (288)
T ss_pred EECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHH
Confidence 9999999987643221 22356899999999986 4589999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=257.91 Aligned_cols=183 Identities=27% Similarity=0.410 Sum_probs=158.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||.|+||.||++.+.. ++..||+|.+........+.+.+|+.++++++||||+++++.+..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 3568889999999999999998765 4679999999766544456788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..|+||||+++++|.+++.+....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence 9999999999999999999766667999999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
........ .....|++.|+|||++. .++|+|||||
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~ 196 (280)
T cd06611 152 KNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGI 196 (280)
T ss_pred hhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHH
Confidence 65432211 23356899999999874 2589999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.94 Aligned_cols=189 Identities=30% Similarity=0.455 Sum_probs=157.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|.+.+.||+|+||.||+|.+..... ..++..+++|.+........+.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 468888999999999999997653211 1245679999987665554567899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 9999999999999999996422 34789999999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++.++|+|||++................|+..|+|||++. .++|||||||
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 213 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHH
Confidence 99999999999998664433222223345788999999886 4589999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=246.93 Aligned_cols=188 Identities=28% Similarity=0.357 Sum_probs=157.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|||+.||++.... ++..||+|++.-...++.+..++|++..++++||||++++++...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 34689999999999999999997543 678999999987776777889999999999999999999887654
Q ss_pred C-----CeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 207 D-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
+ ...||+++|...|+|.+.+.+ .+..+++.+.+.|+.+|+.||++||+.. .+++||||||.|||+.+++.+
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCce
Confidence 3 358999999999999999864 3457999999999999999999999987 689999999999999999999
Q ss_pred EEEeecccccCCCCCccc-e------eeccccccCcccccccc--------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTH-V------STRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~-~------~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+|.|||.++...-.-... . -..-.-|..|.|||.+. .++|||||||
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC 229 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC 229 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence 999999998653211110 0 01123588999999886 5789999999
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=259.14 Aligned_cols=181 Identities=26% Similarity=0.393 Sum_probs=154.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||.||+|++.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 578999999999999999998765 5779999998754322 234678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++ ++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 6999998766667899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
........ .....+++.|+|||++.+ ++|||||||
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 193 (301)
T cd07873 153 AKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC 193 (301)
T ss_pred ccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHH
Confidence 65432211 223457899999998753 579999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=255.92 Aligned_cols=191 Identities=25% Similarity=0.395 Sum_probs=157.1
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+..... ..++..||+|.+..... .....+.+|+.++..++||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34678899999999999999998764221 12457899999875532 22346889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
.....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 9999999999999999999996421 24678899999999999999999988 99999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.+||+|||+++...............++..|+|||++. .++|||||||
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHH
Confidence 99999999998664433222223345788999999876 4589999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=256.49 Aligned_cols=180 Identities=22% Similarity=0.362 Sum_probs=146.2
Q ss_pred eecCCCceEEEEEEEccCCCcc---------------ccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~---------------~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~ 200 (324)
.||+|+||.||+|.+...+... ........|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999865322110 1122345799999876544334568889999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---- 276 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---- 276 (324)
++++...+..++||||+++|+|..++.+....+++..++.++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999766667899999999999999999999987 99999999999997543
Q ss_pred ---cEEEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 277 ---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 277 ---~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.+||+|||++....... ...++..|+|||.+. .++|||||||
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGT 209 (274)
T ss_pred ccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHH
Confidence 48999999986543221 235788899999885 2589999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=253.61 Aligned_cols=187 Identities=25% Similarity=0.420 Sum_probs=155.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++.+.||+|+||.||+|.+...+. .+..+|+|.+...... ....+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578889999999999999998764321 2447999998754322 235788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..|+||||+++++|.+++.+....+++...+.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence 9999999999999999999766667899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccce-eeccccccCccccccccc-----cceEEEecC
Q 020561 288 DGPEGDKTHV-STRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
.......... .....++..|+|||++.. ++|+|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~ 197 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGI 197 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHH
Confidence 7654322111 111234568999999873 589999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=251.14 Aligned_cols=182 Identities=28% Similarity=0.379 Sum_probs=158.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||.|+||.||+|.+.. ++..+++|.+........+.+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 578899999999999999998765 46689999998665555577899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.+|++|||+++++|.+++......+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999999999998665568999999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCccceeeccccccCccccccccc--------cceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
...... ......++..|+|||++.. ++|+|||||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~ 192 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHH
Confidence 543211 1233568999999999864 379999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=250.51 Aligned_cols=183 Identities=29% Similarity=0.444 Sum_probs=154.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
++|++.+.||+|+||.||+|.... ++..||+|.+...... ....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 478999999999999999998765 5779999998654221 12467889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 9999999999999999999999854 346889999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccce-eeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHV-STRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++.......... .....|+..|+|||++. .++|||||||
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC 195 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHH
Confidence 99986543221111 12346889999999987 3589999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=250.39 Aligned_cols=181 Identities=25% Similarity=0.393 Sum_probs=156.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788999999999999998875 567999999865432 2345788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999999999654 467899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .....|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 189 (256)
T cd08529 149 KLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189 (256)
T ss_pred eeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHH
Confidence 876543221 23356899999999987 3589999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=266.73 Aligned_cols=179 Identities=24% Similarity=0.339 Sum_probs=149.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||.+..... ....++.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 34689999999999999999998764 577999999975432 2235678999999999999999999988
Q ss_pred EeC------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 205 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
... ...|+||||++ ++|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 654 35799999996 467777642 4788999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 159 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 206 (355)
T cd07874 159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_pred EEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHH
Confidence 9999999986543221 23357899999999986 3589999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=254.94 Aligned_cols=190 Identities=27% Similarity=0.424 Sum_probs=156.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|...+.||+|+||.||++..... ....++..+|+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35778889999999999999975421 11235668999998765545456799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 99999999999999999986432 24789999999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++.+||+|||++................+++.|+|||++. .++|||||||
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 99999999999998654332221122234578899999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=256.84 Aligned_cols=194 Identities=26% Similarity=0.433 Sum_probs=155.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcce
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-------~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
.++|++.+.||+|+||.||++.+....... ....++..||+|.+..... ....++.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998654311100 1223456799999975432 23457889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
+++++...+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986432 23677889999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.++|+|||+++...............+++.|+|||++. .++|+|||||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~ 220 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHH
Confidence 999999999999999998654432221122234567899999765 4689999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=260.67 Aligned_cols=193 Identities=26% Similarity=0.387 Sum_probs=155.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|.+.+.||+|+||.||++++....+. .+.+...+|+|.+.... .....++.+|+.++..+ +||||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 346799999999999999999987532210 11234579999997543 22335688899999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
...+..|+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 99999999999999999999996432 24888999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.+||+|||+++...............+++.|||||++. .++|+|||||
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 230 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHH
Confidence 999999999999999998664322211112223457899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=268.90 Aligned_cols=192 Identities=24% Similarity=0.394 Sum_probs=154.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCC-CCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV-HLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-HpnIv~~~~~ 203 (324)
+..++|.+.+.||+|+||.||+|++.... ...++..||||+++...... ...+.+|+.+|.++. ||||++++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 34457888899999999999999876321 12246689999997653322 346889999999997 9999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC-----------------------------------------------------
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 230 (324)
|...+..++|||||++|+|.+++++..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996421
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 020561 231 --------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (324)
Q Consensus 231 --------------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLk 266 (324)
..+++...+.++.||+.||.|||+.+ |+|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence 13567778899999999999999987 9999999
Q ss_pred CCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 267 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 267 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||++.++.+||+|||+++...............+++.|||||++. .++|||||||
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv 329 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHH
Confidence 999999999999999999998653322211122345788999999886 3579999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=265.46 Aligned_cols=178 Identities=24% Similarity=0.338 Sum_probs=149.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 4689999999999999999998765 56789999997543 223356789999999999999999999875
Q ss_pred eC------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
.. ...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred ccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 43 35799999995 578777742 4788999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||+++...... ......||+.|+|||++. .++|||||||
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 213 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHH
Confidence 99999998654322 123357899999999986 4689999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=259.15 Aligned_cols=194 Identities=25% Similarity=0.396 Sum_probs=156.2
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+...+|.+.+.||+|+||.||+|++..... .....+..||+|.+.... .....++.+|+.++..+ .||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 345678899999999999999998642111 011245689999987543 22345688999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
+......++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 999999999999999999999996531 34788889999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++.++.+||+|||+++...............+++.|+|||++. .++|||||||
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 227 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHH
Confidence 9999999999999999998765433222122234677899999886 3589999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=263.59 Aligned_cols=192 Identities=28% Similarity=0.393 Sum_probs=152.1
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+...+ ...+++.||||.+...... ....+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 34568999999999999999999864311 1225779999999754322 234688999999999 68999999998
Q ss_pred EEeC-CeEEEEEEecCCCChHHHHhccC----------------------------------------------------
Q 020561 204 CIED-DQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 230 (324)
Q Consensus 204 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------- 230 (324)
+... ...++|||||++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 8654 46789999999999999985321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccc
Q 020561 231 --------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296 (324)
Q Consensus 231 --------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 296 (324)
..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence 23677888999999999999999988 9999999999999999999999999998654322211
Q ss_pred eeeccccccCcccccccc-----ccceEEEecC
Q 020561 297 VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 297 ~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......+++.|+|||++. .++|||||||
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 269 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 269 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHH
Confidence 112234567899999875 3579999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=255.82 Aligned_cols=178 Identities=31% Similarity=0.458 Sum_probs=155.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368899999999999999998875 467999999865432 22356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.+||+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999999999544 57899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...... .....|++.|+|||.+. .++|+|||||
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 186 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGI 186 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHH
Confidence 9876543 22346899999999886 3589999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=257.41 Aligned_cols=191 Identities=25% Similarity=0.403 Sum_probs=153.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+.... ....+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4568999999999999999999765311 111355899999865432 22346788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
..+..++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~ 156 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDF 156 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCC
Confidence 9999999999999999999996421 23566788899999999999999988 99999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++|+|||+++...............++..|+|||++. .++|+|||||
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~ 209 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 209 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH
Confidence 99999999998654432222222234577899999986 3579999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=248.08 Aligned_cols=181 Identities=23% Similarity=0.326 Sum_probs=155.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+|++.+.||+|+||.||++.+.. ++..||+|.+.... ....+++.+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 57888999999999999998765 57799999986543 223456888999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
.+|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999999998854 3456889999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 188 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGC 188 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhch
Confidence 6644222 123356899999999986 3589999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=289.03 Aligned_cols=185 Identities=29% Similarity=0.433 Sum_probs=150.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
...+|+.+++||+||||.||+++.+-+ |+.||||++.... .....++.+|+..|++|+|||||+|+..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlD---------Gr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLD---------GREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeeccc---------chhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 346788899999999999999999874 6699999998764 122356899999999999999999998885
Q ss_pred eCC-----------------------------------------------------------------------------
Q 020561 206 EDD----------------------------------------------------------------------------- 208 (324)
Q Consensus 206 ~~~----------------------------------------------------------------------------- 208 (324)
+..
T Consensus 548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg 627 (1351)
T KOG1035|consen 548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG 627 (1351)
T ss_pred ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence 432
Q ss_pred ------------------------------------------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHH
Q 020561 209 ------------------------------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246 (324)
Q Consensus 209 ------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~ 246 (324)
.+||.||||+.-+|.+++++....-.....+++++||+
T Consensus 628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREIL 707 (1351)
T ss_pred cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHH
Confidence 13899999998777777754322225788899999999
Q ss_pred HHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC----------------CCCccceeeccccccCcccc
Q 020561 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP----------------EGDKTHVSTRVMGTYGYAAP 310 (324)
Q Consensus 247 ~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~Gt~~y~aP 310 (324)
.||.|+|+++ ||||||||.||+|+.++.|||+|||+|+... ........+..+||.-|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999988 9999999999999999999999999998721 01111124567899999999
Q ss_pred cccc--------ccceEEEec
Q 020561 311 EYVM--------TALELFCLK 323 (324)
Q Consensus 311 E~l~--------~~~DiwSlG 323 (324)
|++. .++|+||||
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLG 805 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLG 805 (1351)
T ss_pred HHhcccccccccchhhhHHHH
Confidence 9987 357999999
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.88 Aligned_cols=188 Identities=25% Similarity=0.410 Sum_probs=155.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|.+...+.. ....||+|.+...... ...++.+|+.++..++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 35788899999999999999987654321 2347999988765432 33578899999999999999999999987
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
...++||||+++|+|.+++.+....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccc
Confidence 7889999999999999999776667999999999999999999999987 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...............++..|+|||.+. .++|+|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 199 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV 199 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHH
Confidence 8765433221112223467899999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=251.74 Aligned_cols=179 Identities=23% Similarity=0.348 Sum_probs=145.0
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 214 (324)
.||+|+||.||+|...... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 5999999999999765322 233577887765432 33467899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 215 EFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 215 E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
||+++|+|.+++.+.. ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999996532 34567778899999999999999988 99999999999999999999999999865432
Q ss_pred CCccceeeccccccCcccccccc------------ccceEEEecC
Q 020561 292 GDKTHVSTRVMGTYGYAAPEYVM------------TALELFCLKC 324 (324)
Q Consensus 292 ~~~~~~~~~~~Gt~~y~aPE~l~------------~~~DiwSlGc 324 (324)
...........|+..|+|||++. .++|||||||
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 196 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGV 196 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHH
Confidence 22111223456889999999874 3589999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=252.05 Aligned_cols=181 Identities=23% Similarity=0.330 Sum_probs=147.9
Q ss_pred ceecCCCceEEEEEEEccCCCc---cccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~---~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 211 (324)
+.||+|+||.||+|.+...... .........|++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986532110 0111234578999887654444456888999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc-------EEEEeec
Q 020561 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-------AKLSDFG 284 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-------~kl~DFG 284 (324)
+||||+++++|..++.+....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998766667999999999999999999999988 999999999999987664 8999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++...... ....|+..|||||++. .++|||||||
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 197 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGT 197 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHH
Confidence 98765332 1245788999999875 2479999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=256.93 Aligned_cols=188 Identities=24% Similarity=0.351 Sum_probs=153.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+|++.+.||+|+||.||+|.+..... ...+..||||++...... ....+.+|+.++..++||||+++++++...+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 56777899999999999998754211 113568999999755432 2356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 209 QRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
..++++||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 999999999999999998421 235788889999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++.+||+|||+++...............+++.|+|||++. .++|||||||
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHH
Confidence 99999999999998764433222223345678999999986 3589999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=251.74 Aligned_cols=181 Identities=25% Similarity=0.400 Sum_probs=153.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||.||+|.+.. +..+|||.+..... ....+.+|+.++.+++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468888999999999999997653 33699999875432 3467899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999999765557899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~ 189 (256)
T cd05113 150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGV 189 (256)
T ss_pred cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHH
Confidence 5443211 112234567899999986 3589999996
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=251.79 Aligned_cols=183 Identities=27% Similarity=0.394 Sum_probs=153.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+++.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 34678999999999999999998643 45799999876442 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence 999999999999999999996533 46899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ .......+..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 192 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHH
Confidence 9876532211 111122345799999886 3689999996
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=252.20 Aligned_cols=183 Identities=25% Similarity=0.413 Sum_probs=154.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34678999999999999999998653 45799998865432 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCcc
Confidence 99999999999999999999643 456888999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... ......++..|+|||++. .++|||||||
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 192 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 192 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHH
Confidence 9876543211 122234677899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=252.98 Aligned_cols=182 Identities=26% Similarity=0.401 Sum_probs=154.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....++.+|+.+++.++||||+++++++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 467888999999999999998875 46689999987543 33467889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccc
Confidence 999999999999999998643 346899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... .....+++.|+|||++. .++|||||||
T Consensus 153 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 193 (263)
T cd05052 153 LMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 193 (263)
T ss_pred ccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHH
Confidence 765432211 11223467899999876 3689999997
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=254.90 Aligned_cols=180 Identities=26% Similarity=0.413 Sum_probs=153.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++++.||+|+||.||++.+.. ++..||+|.+..... ....++.+|+.++.+++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368889999999999999998865 567999998865422 2235788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
+..++||||+++++|..++... ...+++..+..++.||+.||.|||+ .+ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence 9999999999999999988653 2378999999999999999999997 36 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlGc 324 (324)
++....... .....|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 195 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence 997654322 22346889999999873 3589999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=252.21 Aligned_cols=176 Identities=28% Similarity=0.379 Sum_probs=151.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+|+.|--+.... ||..||||++.+..-..+.++.+|++++.+++ |+||++++++|+++..+|||
T Consensus 84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 589999999999887665 78899999998876666788999999999997 99999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC---cEEEEeecccccCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGP 290 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~DFGla~~~~ 290 (324)
||-|.||+|..+|.++ ..+++.++.++..+|+.||+|||.++ |.||||||+|||-.... -||||||.|...+.
T Consensus 155 fEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999999654 57999999999999999999999988 99999999999996544 37999998876543
Q ss_pred CCCc-----cceeeccccccCcccccccc----------ccceEEEec
Q 020561 291 EGDK-----THVSTRVMGTYGYAAPEYVM----------TALELFCLK 323 (324)
Q Consensus 291 ~~~~-----~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlG 323 (324)
.... +....+.+|+..|||||++. ..+|+||||
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 2211 12233568999999999986 468999998
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=256.74 Aligned_cols=184 Identities=27% Similarity=0.449 Sum_probs=149.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+..++. ...+|+|.+..... .....+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCc-------eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 3578889999999999999998865321 23568887764322 2235688899999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcE
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NI 270 (324)
..+..|+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Ni 155 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 155 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheE
Confidence 9999999999999999999996432 25789999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 271 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|++.++.+||+|||++........ .....++..|+|||++. .++|||||||
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 211 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 211 (303)
T ss_pred EecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhh
Confidence 999999999999999874322111 11123467899999875 4689999997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=253.43 Aligned_cols=180 Identities=27% Similarity=0.414 Sum_probs=151.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.++..++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 57888999999999999998765 567999999865432 2235678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+..|+||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 6898888543 256899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+........ ......+++.|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 190 (285)
T cd07861 148 ARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGT 190 (285)
T ss_pred eeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHH
Confidence 976543221 122345789999999875 2479999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=250.38 Aligned_cols=181 Identities=26% Similarity=0.391 Sum_probs=152.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ...++.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 368888999999999999998753 34799999865432 2356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence 999999999999999999765567899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~ 189 (256)
T cd05059 150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGV 189 (256)
T ss_pred ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHH
Confidence 5432211 111122456799999886 3589999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.68 Aligned_cols=182 Identities=24% Similarity=0.383 Sum_probs=154.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|++.. ++..||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 478999999999999999998775 567999998864322 22346789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+.+..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999988853 2345889999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
||++......... .....|++.|+|||++.+ ++|+|||||
T Consensus 150 ~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 194 (267)
T cd08228 150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 194 (267)
T ss_pred cccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHH
Confidence 9998876443211 223468899999999863 479999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=243.55 Aligned_cols=182 Identities=31% Similarity=0.423 Sum_probs=154.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCC-CCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 205 (324)
.++.+.+..||.|+.|.|++++++. +|...|||.+..... ...++++..+.++.+.+ .|+||+.+|+|.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3456667889999999999999876 778999999976643 33467888888877765 899999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+...+|.||.| ...++.++.+-..++++..+-++...++.||.||..++ +|||||+||+|||+|..|++||||||+
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence 999999999998 45677777666778999999999999999999999865 499999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc--------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
+-.+.+... .+...|.+.|||||-|.. .+||||||.
T Consensus 239 sGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGI 282 (391)
T KOG0983|consen 239 SGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGI 282 (391)
T ss_pred cceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhcc
Confidence 987755432 344679999999999983 479999993
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=257.46 Aligned_cols=191 Identities=27% Similarity=0.372 Sum_probs=156.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|.+.+.||+|+||.||+|.+.... ...++..||||.+..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLS----KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCC----CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 4457899999999999999999764211 122566899999875432 2235688999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
...+..++||||+++|+|.+++.... ..+++.+...++.||+.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999996533 34899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++...............+++.|+|||++. .++|||||||
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGv 231 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHH
Confidence 9998765432221122234678899999886 3579999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=253.33 Aligned_cols=182 Identities=31% Similarity=0.459 Sum_probs=157.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|++.+.||.|+||.||+|.+.. +..+|+|.+.........++.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 4578899999999999999998864 458999999876655567789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccch
Confidence 9999999999999999999653 356899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... .....++..|+|||++. .++|||||||
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~ 192 (261)
T cd05148 152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGI 192 (261)
T ss_pred hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHH
Confidence 876443211 12234677899999876 3589999996
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=254.13 Aligned_cols=184 Identities=34% Similarity=0.541 Sum_probs=150.3
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEE
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 211 (324)
+.+.||.|.||.||+|.+... ....+..|+||.++.... ...+++.+|+..+++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 346899999999999999831 112467899999965432 23578999999999999999999999999888899
Q ss_pred EEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 212 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
+|||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ |+|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999999766 578999999999999999999999988 9999999999999999999999999998874
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
............+...|+|||.+. .++||||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~ 193 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGM 193 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccc
Confidence 333222223345778999999986 4689999995
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=263.65 Aligned_cols=184 Identities=23% Similarity=0.285 Sum_probs=156.4
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CccchHHHHHHHHHHcCCC-CCCcceEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLV-HLNLVKLIG 202 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~~~~ 202 (324)
+..+.|++++.||.||.+.||++...+ ...||+|.+... +.+...-|.+|+.+|.+|+ |.+||+||+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 345679999999999999999997664 236777776543 2333456899999999997 999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
|-..++.+||||||= ..+|..+|.+...-++...+..+..|++.|+.++|.++ |||.||||+|+|+ -.|.+||+|
T Consensus 428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLID 502 (677)
T KOG0596|consen 428 YEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLID 502 (677)
T ss_pred eeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeee
Confidence 999999999999975 57999999776655554477788899999999999999 9999999999999 567899999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc----------------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------------~~~DiwSlGc 324 (324)
||+|..+...........-+||+.||+||.+. ..+|||||||
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC 560 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC 560 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence 99999988877776677789999999999987 2479999999
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.27 Aligned_cols=181 Identities=31% Similarity=0.433 Sum_probs=156.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 47888999999999999998765 467999999976542 2235788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 99999999766677999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ ......|+..|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 189 (286)
T cd07832 148 LFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC 189 (286)
T ss_pred cccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHH
Confidence 76543321 122346899999999875 3589999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=255.43 Aligned_cols=180 Identities=24% Similarity=0.382 Sum_probs=156.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.+.||||+++++.+....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 589999999999999999998764 56799999998766555567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++++|.+++.. ..+++.+...++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 99999999999999999853 35889999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... .....|++.|+|||++. .++|+|||||
T Consensus 166 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gv 204 (296)
T cd06654 166 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (296)
T ss_pred ccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHH
Confidence 5432211 22346899999999876 3589999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=254.06 Aligned_cols=188 Identities=28% Similarity=0.381 Sum_probs=152.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+|++.+.||+|+||.||+|....... ......+++|.+...... ...++.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47888999999999999998753211 113457999988754322 2356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhcc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 209 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999998532 135788999999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+++++.+||+|||+++...............++..|+|||++. .++|||||||
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 217 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHH
Confidence 9999999999999999999998654332221122335677899999875 4589999996
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=247.25 Aligned_cols=181 Identities=32% Similarity=0.506 Sum_probs=154.9
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+||.||+|.+.... .++..|++|.+....... ...+.+|+.++..++|+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999887531 136689999997664433 46788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 214 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
|||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999999765 467999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+................+++.|+|||.+. .++|||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 98776543222233356789999999886 3589999997
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=254.32 Aligned_cols=183 Identities=26% Similarity=0.439 Sum_probs=149.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
++|++.++||+|+||.||+|.+...+. ...+++|.++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL-------KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC-------cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 478899999999999999998865321 2357888886432 22345688999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 999999999999999999996422 25888999999999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.++.+||+|||++........ ......+..|+|||++. .++|||||||
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 206 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGV 206 (297)
T ss_pred ECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHH
Confidence 99999999999999874322111 11122356799999876 4689999997
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=253.02 Aligned_cols=181 Identities=28% Similarity=0.421 Sum_probs=152.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 578999999999999999998765 4679999998754322 224567899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++ ++|.+++.+....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 99999999997 5999998766567899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ .....++..|+|||++. .++|||||||
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~ 192 (291)
T cd07844 152 AKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGC 192 (291)
T ss_pred ccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHH
Confidence 64322111 22235788999999875 2479999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=253.46 Aligned_cols=179 Identities=33% Similarity=0.523 Sum_probs=153.7
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchH--HHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
|++++.||+|+||+||+++... ++..||+|++......... ...+|+.++++++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 5678899999999999998876 5679999999876543322 3456999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999996 3457899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.... ........++..|+|||++. .++|+|||||
T Consensus 148 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 187 (260)
T PF00069_consen 148 LSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGI 187 (260)
T ss_dssp STST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHH
T ss_pred cccc--cccccccccccccccccccccccccccccccccccc
Confidence 4211 11234467899999999986 3479999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=255.53 Aligned_cols=180 Identities=28% Similarity=0.399 Sum_probs=152.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|++.. +|..||+|.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 47888999999999999998875 5779999998654321 224577899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...++|+||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999996 5888888665667999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ .....+++.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 188 (284)
T cd07839 148 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 188 (284)
T ss_pred ccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHH
Confidence 65432211 22346789999999875 3579999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=249.40 Aligned_cols=183 Identities=28% Similarity=0.426 Sum_probs=151.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+|++.+.||+|+||.||+|.+.. ++..||||.+..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 478899999999999999998765 577999998864321 112467889999999999999999998
Q ss_pred EEeC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 204 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+.+. ..+++||||+++++|.+++.+. ..+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 8764 4688999999999999998543 45888999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++......... .......|+..|+|||++. .++|+|||||
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 197 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGC 197 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHH
Confidence 99999865322111 1122346899999999986 3589999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=247.26 Aligned_cols=181 Identities=24% Similarity=0.369 Sum_probs=156.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|+..++||.|+||.||.++... ++..+++|.+.... .....++.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58889999999999999998775 56789999986543 23345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..+++|||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999999654 456899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ ......|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGC 189 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHH
Confidence 87644331 123456899999999886 3589999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=249.18 Aligned_cols=184 Identities=25% Similarity=0.364 Sum_probs=154.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++++.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 44556566789999999999998765 466899999877655555678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DF 283 (324)
.+..++||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 999999999999999999997544445 78888999999999999999988 999999999999976 679999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
|++......... .....|++.|+|||++. .++|+|||||
T Consensus 154 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGv 199 (268)
T cd06624 154 GTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGC 199 (268)
T ss_pred hhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHH
Confidence 998765432211 22345899999999874 3579999995
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=248.87 Aligned_cols=179 Identities=24% Similarity=0.409 Sum_probs=147.1
Q ss_pred ceecCCCceEEEEEEEccCCCccc-cCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~-~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+||.||+|.+...+.... .+.....+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999876331100 1112346888887654332 5678899999999999999999999988 778999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-------cEEEEeeccc
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-------NAKLSDFGLA 286 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-------~~kl~DFGla 286 (324)
|||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999765557899999999999999999999988 99999999999999887 7999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
...... ....++..|+|||++.. ++|||||||
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 875441 12356788999999864 389999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.40 Aligned_cols=194 Identities=27% Similarity=0.407 Sum_probs=155.0
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+...+|++++.||+|+||.||+|.+...++ ........||+|.+..... ....++.+|+.++.++ .||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 344578999999999999999998653221 0112345799998875432 2235788999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
+...+..+++|||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999996421 24788899999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++.++.+||+|||+++...............++..|||||++. .++|||||||
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 224 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 224 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHH
Confidence 9999999999999999998764432221122233467899999986 3589999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=248.15 Aligned_cols=180 Identities=30% Similarity=0.485 Sum_probs=151.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
++||+|+||.||+|.+...+ .+...||||.+..... ...+++.+|+.++++++||||+++++.+.+ ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 46899999999999886521 1344799999987665 445678999999999999999999999988 889999
Q ss_pred EEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 214 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
|||+++++|.+++.+.. ..+++...+.++.|++.||.|||+++ ++||||+|+||+++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999996654 57899999999999999999999988 999999999999999999999999999876543
Q ss_pred Ccc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... .......++..|+|||++. .++|||||||
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~ 188 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGV 188 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHH
Confidence 221 1112245788999999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.27 Aligned_cols=194 Identities=24% Similarity=0.400 Sum_probs=154.4
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+...+|.+.+.||+|+||.||+|....... ........||+|.+..... ....++.+|+.++..+ .||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345678899999999999999997643111 1112356799999875432 2235688999999999 59999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
+...+..++||||+++|+|.+++.... ..+++.....++.||+.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce
Confidence 999999999999999999999996421 35888999999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++.++.+||+|||+++...............+++.|||||++. .++|||||||
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 9999999999999999998764432211111223456899999876 3589999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=255.13 Aligned_cols=177 Identities=24% Similarity=0.410 Sum_probs=142.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe--CCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~l 212 (324)
..||+|+||.||+|...... ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-------~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-------DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-------ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 57999999999999875422 467899999875432 2467899999999999999999998854 567899
Q ss_pred EEEecCCCChHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE----cCCCcEEE
Q 020561 213 VYEFMPRGSLENHLFR--------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKL 280 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~--------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~kl 280 (324)
||||+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 999995 578877742 1235889999999999999999999988 9999999999999 56779999
Q ss_pred EeecccccCCCCCcc-ceeeccccccCccccccccc------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+|||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 204 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHH
Confidence 999999876443211 11233578999999998853 479999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=254.47 Aligned_cols=180 Identities=25% Similarity=0.380 Sum_probs=156.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||.||+|.... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 589999999999999999998765 56799999997665555567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999999999999854 45789999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... .....|++.|+|||++. .++|+|||||
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGv 203 (297)
T cd06656 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203 (297)
T ss_pred ccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHH
Confidence 5433211 22346899999999886 3489999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=253.02 Aligned_cols=189 Identities=30% Similarity=0.363 Sum_probs=155.7
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcce
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 199 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 199 (324)
++.+....++|++.+.||+|+||.||++.+.. ++..+|+|++.... ....++.+|+.++..+ +||||++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence 34445567899999999999999999998765 56799999886432 2235678899999999 6999999
Q ss_pred EEEEEE-----eCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 200 LIGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 200 ~~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
+++++. ..+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil 156 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL 156 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence 999874 34578999999999999998752 3356889999999999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
++.++.+||+|||+++....... ......|++.|+|||++. .++|||||||
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 99999999999999987643221 122346899999999874 3689999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=249.30 Aligned_cols=184 Identities=35% Similarity=0.483 Sum_probs=150.1
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC--
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-- 207 (324)
|++.+.||+|+||+||++..... ...++..||+|.+..... .....+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 48889999999999998765421 123577999999976532 2345688999999999999999999988654
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 468899999999999999954 35899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccc-eeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTH-VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~-~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... ......++..|+|||++. .++|||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~ 198 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGV 198 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHH
Confidence 765432211 112234567899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=252.35 Aligned_cols=190 Identities=28% Similarity=0.403 Sum_probs=153.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+..... ..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4578999999999999999998864110 114668999988654322 23468899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC---c
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 277 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~ 277 (324)
.+..++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 999999999999999999996532 25889999999999999999999988 99999999999998654 5
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...............++..|||||++. .++|||||||
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 9999999998763322211111223456899999976 4689999997
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=249.67 Aligned_cols=183 Identities=30% Similarity=0.413 Sum_probs=153.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 205 (324)
+...|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 34568888999999999999998765 57799999986543 3345788999999998 6999999999987
Q ss_pred eC------CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 206 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
.. ...|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence 53 4689999999999999998653 356899999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+|+|||++........ ......|++.|+|||++. ..+|+|||||
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 204 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 204 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHH
Confidence 9999999986543221 123457899999999885 2589999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=246.89 Aligned_cols=178 Identities=26% Similarity=0.399 Sum_probs=145.9
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 214 (324)
.||+|+||.||+|.+.... ++..||+|++...... ..+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 3899999999999876321 3557999998765322 2356889999999999999999999875 45789999
Q ss_pred EecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCc
Q 020561 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294 (324)
Q Consensus 215 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 294 (324)
||+++++|.+++......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 999999999999766667999999999999999999999988 99999999999999999999999999986544322
Q ss_pred cce-eeccccccCcccccccc-----ccceEEEecC
Q 020561 295 THV-STRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 295 ~~~-~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... .....+++.|+|||++. .++|||||||
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 186 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGI 186 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHH
Confidence 111 11123357899999876 3689999997
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=249.49 Aligned_cols=188 Identities=23% Similarity=0.438 Sum_probs=155.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|+..+.||+|+||.||+|.+...+. ....+|+|.+..... ....++..|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 3478888999999999999998865322 234799999875532 234568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999766667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcccee-eccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVS-TRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~-~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
............ .....++.|+|||++. .++|||||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 198 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 198 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHH
Confidence 866443221111 1122345799999886 3579999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=249.70 Aligned_cols=184 Identities=27% Similarity=0.439 Sum_probs=147.3
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC-
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 207 (324)
|.+.+.||+|+||.||+|.+...+. ...||+|.++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~-------~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDS-------ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCC-------eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 3467899999999999998865321 2369999887543 22235688999999999999999999987532
Q ss_pred -----CeEEEEEEecCCCChHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 208 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 208 -----~~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
...+++|||+++|+|.+++.. ....+++.....++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN 150 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence 246899999999999998742 2245889999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...............+++.|+|||++. .++|||||||
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~ 202 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGV 202 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHH
Confidence 9999999998765433221122234677899999986 4589999997
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=253.43 Aligned_cols=180 Identities=26% Similarity=0.407 Sum_probs=156.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||.|+||.||+|.+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468999999999999999998765 57799999997665555567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++++|..++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999999999998854 35899999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... .....|++.|+|||.+. .++|+|||||
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv 203 (296)
T cd06655 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203 (296)
T ss_pred ccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHH
Confidence 5443221 22346899999999876 3589999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=251.38 Aligned_cols=182 Identities=26% Similarity=0.387 Sum_probs=152.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
+.+|.+.+.||+|+||.||+|.... ++..||+|.+....... ...+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4679999999999999999998765 46699999987553322 2467889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..|+||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence 999999999995 7888877655566888889999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+........ .....+++.|+|||++.+ ++|+|||||
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 192 (291)
T cd07870 151 RAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGC 192 (291)
T ss_pred cccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHH
Confidence 865332211 223457899999999863 469999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=246.93 Aligned_cols=182 Identities=27% Similarity=0.468 Sum_probs=153.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------hHHHHHHHHHHcCCCCCCcceE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLVHLNLVKL 200 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~ 200 (324)
+|.+...||.|+||.||+|.+.. ++..||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 47788899999999999998765 46689999886543221 1457889999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
++++...+..++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEe
Confidence 9999999999999999999999999954 356889999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCcc----ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKT----HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~----~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+++........ .......|+..|+|||++. .++|+|||||
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~ 200 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGC 200 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHH
Confidence 999999876532111 1112346889999999886 3589999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=255.09 Aligned_cols=188 Identities=24% Similarity=0.415 Sum_probs=152.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|+..+.||+|+||.||+|.+...+.. ....||+|.+....... ..++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 45788889999999999999988653321 12368999887543322 2468899999999999999999999875
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
. ..++++||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccc
Confidence 4 467999999999999999766667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+...............++..|+|||++.. ++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~ 199 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGV 199 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHH
Confidence 87644322211222345778999998863 489999996
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=251.33 Aligned_cols=179 Identities=23% Similarity=0.341 Sum_probs=148.0
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 214 (324)
+.||.|+||.||+|.....+.. .......||+|.+........+.+..|+.+++.+.||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 3699999999999987643210 01123468899886554444467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--------EEEEeeccc
Q 020561 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLA 286 (324)
Q Consensus 215 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------~kl~DFGla 286 (324)
||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999766667899999999999999999999988 999999999999987665 699999998
Q ss_pred ccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
...... ....+++.|+|||++.. ++|||||||
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGT 193 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHH
Confidence 765332 22468899999998863 479999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=255.90 Aligned_cols=180 Identities=19% Similarity=0.213 Sum_probs=147.9
Q ss_pred CCceecCC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 133 PESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 133 ~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++++||+| +|++||++.... +|..||||.+...... ....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 789999998875 6789999999765322 2245778999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.++++||+.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999999643 345899999999999999999999988 9999999999999999999999998755
Q ss_pred cCCCCCcc-----ceeeccccccCcccccccc-------ccceEEEecC
Q 020561 288 DGPEGDKT-----HVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
........ .......++..|||||++. .++|||||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 43221110 0011235678899999986 3579999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=271.30 Aligned_cols=185 Identities=26% Similarity=0.464 Sum_probs=160.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
...+.++||.|.||.|++|+++..++ ....||||.++...... +.+|+.|+.||.+++||||++|.|+.....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred heEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 34677899999999999999997665 35689999998765433 457999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.++||.|||++|+|+.+|+++...|++.+...+++.|+.|++||-+.+ +|||||..+|||++.+-.+|++||||++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999988888999999999999999999999988 99999999999999999999999999998
Q ss_pred CCCCCccceeecccc--ccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMG--TYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~G--t~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++... ..++.-| ..+|.|||.|. .++||||+|.
T Consensus 781 ledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGI 822 (996)
T KOG0196|consen 781 LEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGI 822 (996)
T ss_pred cccCCCc-cccccCCccceeecChhHhhhcccCchhhccccce
Confidence 7554422 1222222 46999999997 5789999983
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=252.95 Aligned_cols=180 Identities=29% Similarity=0.447 Sum_probs=153.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
+|++.+.||+|+||.||+|.+.. ++..||||.+...... ....+..|+.+++.++||||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47788999999999999998765 5679999999765432 224567899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..++||||+ +++|.+++......+++..+..++.||+.||.|||+++ |+|+||+|+|||++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 89999999654447999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++......... .....+++.|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 191 (298)
T cd07841 148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC 191 (298)
T ss_pred eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHH
Confidence 99876543221 22235688999999874 3489999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=252.67 Aligned_cols=183 Identities=23% Similarity=0.349 Sum_probs=153.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368889999999999999998765 577999999876532 22346788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999999999999999543 56899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCc-------------cceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDK-------------THVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~-------------~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... ........|+..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI 204 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHH
Confidence 874211100 00111245788999999876 3589999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=245.24 Aligned_cols=181 Identities=25% Similarity=0.340 Sum_probs=152.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
.|++.+.||+|+||.||++.+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48889999999999999998765 466899999965432 223467889999999999999999998764
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+..+|+||||+++++|.+++... ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence 44689999999999999999653 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ ......|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHH
Confidence 987643221 123456899999999987 3589999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=246.03 Aligned_cols=182 Identities=25% Similarity=0.416 Sum_probs=155.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.+.. ++..||+|.++.... ....++.+|+.++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 578999999999999999998875 577999998864322 22457889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
..+..++||||+++++|..++.. ....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence 99999999999999999998853 2356899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
||++......... .....|++.|+|||++.. ++|+|||||
T Consensus 150 ~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 194 (267)
T cd08224 150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 194 (267)
T ss_pred cceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHH
Confidence 9998865443211 223468999999998763 579999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=247.14 Aligned_cols=188 Identities=32% Similarity=0.447 Sum_probs=156.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
+.|++.+.||+|+||.||+|.+...+ ..++..||||.+...... ....+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 46788899999999999999876431 125779999999765443 34678999999999999999999999877
Q ss_pred -CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
....++||||+++++|.+++......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence 55789999999999999999766557999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc-eeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.......... ......++..|+|||++. .++|+|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~ 200 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGV 200 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhh
Confidence 98775332211 111234566799999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=259.24 Aligned_cols=179 Identities=32% Similarity=0.521 Sum_probs=148.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcC--CCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~ 206 (324)
...++.++||+|.||.||+|.+. ++.||||++.... ...|..|-+|.+. +.|+||++|+++-..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 45667789999999999999875 4699999997543 3567777777654 579999999987665
Q ss_pred CC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeCCCCCCcEEEcCCC
Q 020561 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 207 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------~~~ivHrDLkp~NILl~~~~ 276 (324)
.. .++||+||.+.|+|.++|.. ..++|....+|+.-+++||+|||+.. +++|+|||||..||||..|+
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 54 78999999999999999954 57899999999999999999999753 45799999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCccccccccc-----------cceEEEec
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------ALELFCLK 323 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~DiwSlG 323 (324)
++.|+|||||..+.........-.-+||.+|||||+|.+ +.||||+|
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 999999999988765433322333689999999999984 36999987
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=248.54 Aligned_cols=182 Identities=26% Similarity=0.415 Sum_probs=154.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.+.. ++..||||.+..... ....++.+|+.+++.+.||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468888999999999999998765 467999998865332 22356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
..+..+++|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999998853 2356899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
||++......... .....|+..|+|||++.. ++|+|||||
T Consensus 150 fg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 194 (267)
T cd08229 150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 194 (267)
T ss_pred chhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHH
Confidence 9998876443221 223468999999999863 579999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=248.73 Aligned_cols=188 Identities=24% Similarity=0.366 Sum_probs=155.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++...||.|+||.||+|+...... ..+...|++|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 578899999999999999999764321 224568999988654433 345789999999999999999999999998
Q ss_pred CeEEEEEEecCCCChHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 99999999999999999996433 15899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||++......... ......+++.|+|||.+. .++|||||||
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 206 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGV 206 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHH
Confidence 9999998765332211 122335678899999876 3479999996
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=246.28 Aligned_cols=181 Identities=27% Similarity=0.482 Sum_probs=145.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEE-eCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-EDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~~l 212 (324)
+.||+|+||.||+|.+.... .....||||.+.... ......+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 36899999999999875422 134589999985432 223457889999999999999999999776 4556889
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
||||+.+++|.+++.+....+++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999999765556778888999999999999999988 999999999999999999999999999865432
Q ss_pred Cccc--eeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKTH--VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~~--~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......++..|+|||++. .++|||||||
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 190 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 190 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHH
Confidence 1110 111234677899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=247.70 Aligned_cols=186 Identities=24% Similarity=0.354 Sum_probs=152.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|.+.+.||+|+||.||+|.+.... .+...||||...... ....+.+.+|+.+++++.||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 346888899999999999999876421 124479999887654 2334578999999999999999999998875
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence 5678999999999999999765557899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ ..+...++..|+|||++. .++|||||||
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 196 (270)
T cd05056 155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 196 (270)
T ss_pred eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHH
Confidence 876543221 122233557899999876 3589999996
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=248.33 Aligned_cols=181 Identities=30% Similarity=0.405 Sum_probs=153.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++...||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 368889999999999999998875 567999999864432 223557899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
....++||||++++.|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999999988887764 4456899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
......... .....++..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 189 (286)
T cd07847 148 RILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGC 189 (286)
T ss_pred eecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHH
Confidence 876543311 22345788999999875 2589999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=252.62 Aligned_cols=184 Identities=30% Similarity=0.393 Sum_probs=155.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.... ++..||+|.+...... ....+..|+.++..++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368888999999999999998765 5679999999765433 2356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.....|+||||+.+++|.+++.+. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence 999999999999999999998643 357899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCcc---------------------------ceeeccccccCccccccccc-----cceEEEecC
Q 020561 285 LAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~---------------------------~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++......... .......||..|+|||++.+ ++|||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ 220 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGI 220 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHH
Confidence 98764322110 00113468999999999863 589999996
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=245.01 Aligned_cols=183 Identities=29% Similarity=0.430 Sum_probs=151.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+|+..+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 378999999999999999998765 577999999864422 112457889999999999999999998
Q ss_pred EEeC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 204 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+.+. ...+++|||+++++|.+++.+. ..+++...+.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 8763 6788999999999999999543 46899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++......... .......++..|+|||++. .++|+|||||
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 197 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGC 197 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHH
Confidence 99999765332111 1112345889999999986 3589999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=248.23 Aligned_cols=181 Identities=27% Similarity=0.400 Sum_probs=150.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|++.+.||+|+||.||+|.+.. ...||+|.+..... ..+++.+|+.+++.++||||+++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 3579999999999999999998754 23699999975432 3467899999999999999999999874 4
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++|+|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence 5689999999999999999653 345889999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~ 191 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHH
Confidence 866443221 112234677899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.14 Aligned_cols=182 Identities=29% Similarity=0.447 Sum_probs=152.6
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcC--CCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~ 203 (324)
...+...+.+.||+|.||.||+|+|+ |+.||||++.... ...|.+|.+|.+. |+|+||+.|++.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 34567888999999999999999996 6799999997543 3567888888765 689999999987
Q ss_pred EEeCC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCcEEEcC
Q 020561 204 CIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-----EAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 204 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-----~~~~~ivHrDLkp~NILl~~ 274 (324)
-..+. .+|||.+|.+.|+|.++|.+ ..++....++++.-++.||++||- ++++.|.|||||..|||+..
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 65543 68999999999999999955 679999999999999999999995 46677999999999999999
Q ss_pred CCcEEEEeecccccCCCCCcc--ceeeccccccCcccccccc-----------ccceEEEec
Q 020561 275 DYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVM-----------TALELFCLK 323 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlG 323 (324)
++.+.|+|||||......... ......+||-+|||||+|. ..+||||||
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG 413 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence 999999999999865443211 1123468999999999997 358999998
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=272.34 Aligned_cols=192 Identities=19% Similarity=0.237 Sum_probs=143.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCcccc-C-----CCCcEE----EEEEecCCCccchHHHHHHHHHHcCCCCCC
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK-P-----GTGLTV----AVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~-~-----~t~~~v----avK~~~~~~~~~~~~~~~E~~~l~~l~Hpn 196 (324)
...+|++++.||+|+||+||+|.++........ + ..+... +.|.+.. ......++.+|+.+|++|+|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 356899999999999999999976542110000 0 000111 1111111 1112346789999999999999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCChHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 197 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
||++++++...+..|+|||++ .++|..++.... .......+..|+.||+.||.|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 567877774321 22345667789999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+++........ ......||+.|+|||++. .++|||||||
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 356 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHH
Confidence 99999999999999876543221 122357999999999987 3589999997
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=246.92 Aligned_cols=182 Identities=24% Similarity=0.408 Sum_probs=152.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+|+..+.||+|+||.||++.... ++..||+|.+...... ..+.+.+|+.++++++||||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999998765 5779999998754311 23568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~D 282 (324)
+.+.+..++||||+++++|.+++.+ ..++++.....++.||+.||.|||+++ ++|+||+|+||+++.++ .+||+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence 9999999999999999999999954 347899999999999999999999988 99999999999998775 599999
Q ss_pred ecccccCCCCCcc--ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++......... .......|+..|+|||++. .++|+|||||
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 196 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGC 196 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHH
Confidence 9999876442111 1122346889999999876 4589999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=247.11 Aligned_cols=180 Identities=28% Similarity=0.374 Sum_probs=148.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHH-HcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||++.+.. +|..||||.+..... ....++..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 378889999999999999998775 577999999976532 223456667665 566789999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 207 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++..|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence 999999999995 688887753 335689999999999999999999986 6 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
||++........ .+...|+..|+|||++. .++|+|||||
T Consensus 148 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 195 (283)
T cd06617 148 FGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195 (283)
T ss_pred cccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHH
Confidence 999986543211 22346899999999874 3579999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=248.87 Aligned_cols=190 Identities=25% Similarity=0.384 Sum_probs=155.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+...+ +.++..|++|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3568899999999999999999887522 12467899999875432 22356889999999999999999999877
Q ss_pred e-CCeEEEEEEecCCCChHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 206 E-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 206 ~-~~~~~lv~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
. ....++++||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQ 155 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCc
Confidence 6 467899999999999999986432 45899999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++.+.............++..|+|||++. .++|||||||
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 207 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGV 207 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHH
Confidence 9999999998664433221222345677899999886 3589999997
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=246.50 Aligned_cols=179 Identities=27% Similarity=0.375 Sum_probs=156.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
+|++.+.||.|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 47888999999999999998765 577999999975432 224678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+.+++|.+++... .++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence 99999999999999999999554 57899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .....|+..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 187 (258)
T cd05578 148 TKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGV 187 (258)
T ss_pred cccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHH
Confidence 87654321 22356889999999986 4689999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=245.24 Aligned_cols=177 Identities=31% Similarity=0.521 Sum_probs=153.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||.|+||.||+|... ++.||||.+..... ..+++.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 457899999999999999999763 56899999976543 456789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999999996543 36899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+....... ...++..|+|||++.. ++|+|||||
T Consensus 150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~ 187 (256)
T cd05039 150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGI 187 (256)
T ss_pred cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHH
Confidence 87633221 2335678999998863 579999996
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=242.72 Aligned_cols=176 Identities=32% Similarity=0.477 Sum_probs=147.2
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
++||+|+||.||+|.... +..||+|.+....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~----------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD----------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEecC----------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 368999999999997542 5589999987654322 34688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999999765567899999999999999999999988 9999999999999999999999999987643322
Q ss_pred ccceeeccccccCccccccccc-----cceEEEecC
Q 020561 294 KTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 294 ~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
.. ......+++.|+|||++.. ++|||||||
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 182 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGI 182 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHH
Confidence 11 1111234678999999873 589999996
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=246.72 Aligned_cols=179 Identities=26% Similarity=0.358 Sum_probs=155.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+|++.+.||.|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence 68888999999999999998765 57799999987653 223356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+|+||+++++|.+++... ++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 999999999999999999543 7899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...... ......|++.|+|||++. .++|+|||||
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~ 186 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186 (274)
T ss_pred eccccc--ccccccCCccccChhhhccCCCCchhhHHHHHH
Confidence 654321 123356889999999986 3689999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=245.33 Aligned_cols=176 Identities=30% Similarity=0.462 Sum_probs=148.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE-e
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-E 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~ 206 (324)
..+|++.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 357889999999999999999653 5589999986543 2357889999999999999999999765 4
Q ss_pred CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCcc
Confidence 567899999999999999996543 35889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... ....++..|+|||++. .++|||||||
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 187 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGI 187 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHH
Confidence 88654322 1234567899999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=249.31 Aligned_cols=181 Identities=29% Similarity=0.421 Sum_probs=153.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||.|+||.||+|.+.. ++..+|+|.++..... ....+.+|+.++.+++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 478888999999999999998865 5678999999754322 12356789999999999999999999988
Q ss_pred C--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 207 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 207 ~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
. +..|+||||++ ++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 7 88999999996 5999998765557999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++......... .....+++.|+|||++. .++|+|||||
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 195 (293)
T cd07843 152 LAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGC 195 (293)
T ss_pred ceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHH
Confidence 99876543211 22345789999999875 3589999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=243.73 Aligned_cols=180 Identities=29% Similarity=0.402 Sum_probs=158.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ..++.+|+.+++.++||||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578999999999999999998875 466899999875532 567899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+++||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999999999999999766678999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...... ......|+..|+|||++. .++|||||||
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~ 187 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHH
Confidence 654321 122345889999999876 3589999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=245.75 Aligned_cols=183 Identities=28% Similarity=0.417 Sum_probs=154.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+.. +..||||.+..... ...++.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 45689999999999999999998653 35799999875443 34678999999999999999999999998
Q ss_pred CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccc
Confidence 899999999999999999996543 56899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+......... ......++..|+|||.+.+ ++|+|||||
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 192 (261)
T cd05034 150 ARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGI 192 (261)
T ss_pred ceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHH
Confidence 9876532211 1112235678999998863 589999996
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.87 Aligned_cols=185 Identities=31% Similarity=0.470 Sum_probs=155.2
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
|++.+.||.|+||.||++.+...+. .++..||+|.+...... ....+..|+.++..++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 4567899999999999998876321 13478999999765433 45678999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.+++|||+++++|.+++...... +++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999999999654433 899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.......... ...+++.|+|||.+. .++|+|||||
T Consensus 153 ~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~ 192 (258)
T smart00219 153 LYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGV 192 (258)
T ss_pred cccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHH
Confidence 6554222111 223678999999885 3589999997
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=250.06 Aligned_cols=190 Identities=28% Similarity=0.435 Sum_probs=154.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+... ....++..||+|.+..... ....++.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 45799999999999999999986521 1112567899999875432 223568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999999996321 24778889999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||++.++.++|+|||++................+++.|+|||++. .++|||||||
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGV 220 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHH
Confidence 9999999999999999999988654332211122234567899999876 3589999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=250.87 Aligned_cols=181 Identities=31% Similarity=0.426 Sum_probs=153.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999998865 5679999998654322 23567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++..++||||+++++|..+.. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999999999998888764 3345899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ ......++..|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 189 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHH
Confidence 87544321 123356889999999875 3589999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=250.03 Aligned_cols=180 Identities=27% Similarity=0.384 Sum_probs=154.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||+||++.+.. ++..||+|++..... ...+++.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 3578888999999999999998765 567999998865432 334678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++++|.+++.+ ...+++..+..++.+++.||.|||+ .+ |+||||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999999998854 3568999999999999999999997 45 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .....|+..|+|||++. .++|+|||||
T Consensus 151 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 190 (284)
T cd06620 151 SGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGI 190 (284)
T ss_pred ccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHH
Confidence 87543321 12356899999999986 3589999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=244.09 Aligned_cols=181 Identities=30% Similarity=0.511 Sum_probs=151.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+|++.+.||.|+||.||+|... ++..+|||.+...... ....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788899999999999999753 4678999998654211 12457889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+.+.+..++||||+++++|.+++.+. .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccc
Confidence 99999999999999999999999543 46889999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCC----ccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|++....... .........|+..|+|||++. .++|+|||||
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 196 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGC 196 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHH
Confidence 9987643211 111122356899999999986 4589999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=244.88 Aligned_cols=181 Identities=27% Similarity=0.396 Sum_probs=150.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 4578899999999999999997653 45799999876443 3467899999999999999999999875 5
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceee
Confidence 5689999999999999999653 345899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 191 (260)
T cd05070 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191 (260)
T ss_pred eeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHH
Confidence 875443211 112234567899999876 3689999996
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=264.87 Aligned_cols=190 Identities=29% Similarity=0.373 Sum_probs=160.8
Q ss_pred CHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcc
Q 020561 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLV 198 (324)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 198 (324)
.++.+...+.-|++.++||.|.+|+||+++... +++.+|||++...... .+++..|.++|+.+ +|||++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~ 79 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVA 79 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcc
Confidence 344444566789999999999999999998876 5678999988766433 36678899999888 599999
Q ss_pred eEEEEEEe-----CCeEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 199 KLIGYCIE-----DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 199 ~~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
.+|++|.- ++.+|||||||.+|+.-+++.. .+..+.|..+..|++.++.||.+||.+. +||||||-.|||+
T Consensus 80 ~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLL 156 (953)
T KOG0587|consen 80 TFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLL 156 (953)
T ss_pred eEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEE
Confidence 99999864 4789999999999999999864 3578999999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+.++.|||+|||++..+..... -+.+.+|||.|||||++. -.+|+||||.
T Consensus 157 T~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGI 216 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGI 216 (953)
T ss_pred eccCcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccc
Confidence 9999999999999988754322 244578999999999997 2489999993
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=252.27 Aligned_cols=178 Identities=28% Similarity=0.398 Sum_probs=151.8
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
|.....||+|+||.||++.... ++..||||.+........+.+.+|+.+++.++||||+++++.+...+..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 4444679999999999998765 5679999998765544456788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999999999998843 35889999999999999999999988 9999999999999999999999999987653
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ......|++.|+|||++. .++|+|||||
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv 206 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206 (292)
T ss_pred cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHH
Confidence 3221 122346899999999875 4689999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=242.98 Aligned_cols=177 Identities=28% Similarity=0.390 Sum_probs=145.2
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
.||+|+||.||+|.+... .++..+|+|++..... ...+++.+|+.+++.+.||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 589999999999976532 2567899999865432 22357889999999999999999999875 4567899
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||.|||++.++.+||+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 74 MELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 999999999999954 346899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccce-eeccccccCcccccccc-----ccceEEEecC
Q 020561 294 KTHV-STRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 294 ~~~~-~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....+++.|+|||.+. .++|+|||||
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 186 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGV 186 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHH
Confidence 2111 11223467899999876 3689999997
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=244.48 Aligned_cols=182 Identities=27% Similarity=0.449 Sum_probs=152.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------chHHHHHHHHHHcCCCCCCcce
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
+|.+.+.||.|+||.||+|.... ++..||+|.+...... ..+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 47788999999999999998765 5679999988542110 1135778999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
+++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence 999999999999999999999999999554 57899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
|+|||++................|+..|+|||++. .++|+|||||
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~ 200 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGC 200 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHH
Confidence 99999998654322211223356899999999865 3479999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=251.83 Aligned_cols=178 Identities=26% Similarity=0.380 Sum_probs=152.1
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
|.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.++..+.||||+++++++...+..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3444579999999999998765 4679999999765544456788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++++|..++.. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999999999998743 46899999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
..... .....|++.|+|||++. .++|+|||||
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 205 (297)
T cd06659 169 KDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGI 205 (297)
T ss_pred ccccc--ccceecCccccCHHHHccCCCCchhhHHHHHH
Confidence 32211 22356899999999986 3589999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=241.62 Aligned_cols=177 Identities=29% Similarity=0.451 Sum_probs=148.8
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
++||+|+||.||++.+.. +..||+|.+...... ....+.+|+.++++++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 469999999999998754 458999998765443 345789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++......+++..++.++.+++.||.|||+++ ++||||+|+|||++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 9999999999999765567899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 294 KTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 294 ~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.........++..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 183 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGI 183 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHH
Confidence 111111123466799999876 3579999996
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=247.25 Aligned_cols=188 Identities=30% Similarity=0.358 Sum_probs=155.7
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceE
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKL 200 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~ 200 (324)
..+....++|++.+.||+|+||.||++.... ++..+|+|++.... .....+.+|+.++.++ +||||+++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~ 84 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF 84 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 3344456789999999999999999998765 57799999986542 2235678899999999 79999999
Q ss_pred EEEEEeC-----CeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 201 IGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 201 ~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
++++... +..|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili 161 (291)
T cd06639 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILL 161 (291)
T ss_pred EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence 9998754 358999999999999998853 3457899999999999999999999987 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+.++.+||+|||++......... .....|+..|+|||++. .++|||||||
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGv 221 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI 221 (291)
T ss_pred cCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHH
Confidence 99999999999999875432211 12346899999999863 4689999997
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=241.64 Aligned_cols=184 Identities=25% Similarity=0.361 Sum_probs=157.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||.|+||+||+|.... ++..+|+|++..... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 478999999999999999998765 466899999975432 2346788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999999999999653 246899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc--eeeccccccCccccccccc------cceEEEecC
Q 020561 286 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+.......... ......|+..|+|||++.. ++|+|||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~ 195 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI 195 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhH
Confidence 98765433221 2233568999999998763 489999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=244.45 Aligned_cols=177 Identities=28% Similarity=0.465 Sum_probs=143.7
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~l 212 (324)
++||+|+||.||+|.+..++. ...+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC-------eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 368999999999998875321 2357888887433 22335788999999999 79999999999999999999
Q ss_pred EEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 213 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence 999999999999986432 24789999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||++........ ......+..|+|||++. .++|+|||||
T Consensus 151 ~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 199 (270)
T cd05047 151 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 199 (270)
T ss_pred EEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHH
Confidence 99999999864321111 11123456799999876 3689999997
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=243.01 Aligned_cols=183 Identities=28% Similarity=0.424 Sum_probs=151.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----ccchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 478899999999999999998765 57799999885421 1223468899999999999999999999
Q ss_pred EEeC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 204 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+.+. ..+++||||+++++|.+++... ..+++.....++.||+.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 8764 4688999999999999998543 45889999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+++........ .......|+..|+|||++. .++|+|||||
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 197 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVAC 197 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHH
Confidence 99999865331111 1122356899999999986 3579999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=251.61 Aligned_cols=193 Identities=27% Similarity=0.341 Sum_probs=157.9
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------hHHHHHHHHHHcCCC
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLV 193 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~ 193 (324)
|.+-....++|-++.+||+|||+.||+|++.. ..+.||||+-..+.... .+...+|.+|.+.|.
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD 525 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD 525 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC
Confidence 33334445678889999999999999998875 35589999875543221 134678999999999
Q ss_pred CCCcceEEEEEEe-CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 194 HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 194 HpnIv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
||.||++|++|.- .+.+|-|+|||+|.+|.-+|. ....+++..+..|+.||+.||.||.... .||||=||||.||||
T Consensus 526 HpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 526 HPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILL 603 (775)
T ss_pred cceeeeeeeeeeeccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEE
Confidence 9999999999864 467889999999999999984 4457899999999999999999999876 889999999999999
Q ss_pred c---CCCcEEEEeecccccCCCCCccc-----eeeccccccCcccccccc---------ccceEEEecC
Q 020561 273 D---ADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 273 ~---~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
. ..|.+||+||||++++......+ ......||.+|++||.+. .++||||+|.
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV 672 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence 4 56889999999999886644332 233468999999999886 4689999984
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=245.69 Aligned_cols=180 Identities=29% Similarity=0.458 Sum_probs=152.6
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+|++.+.||.|+||.||+|.+.. ++..||||.+...... ....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 58888999999999999998865 5779999999765432 2356778999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
..+|||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999997 58988886433 46899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ ......+++.|++||++. .++|+|||||
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGC 189 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHH
Confidence 76543221 122345789999999875 3579999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=242.83 Aligned_cols=182 Identities=26% Similarity=0.442 Sum_probs=152.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++++.||+|+||.||+|... .+..||+|.+..... ...++.+|+.++++++||||+++++++ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 71 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-T 71 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-c
Confidence 4467999999999999999999864 356899999875543 346789999999999999999999976 4
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..+++|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcc
Confidence 56789999999999999998643 356899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... ......++..|+|||++. .++|||||||
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~ 191 (260)
T cd05067 149 ARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 191 (260)
T ss_pred eeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHH
Confidence 9876532211 122234678899999885 3589999996
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=245.39 Aligned_cols=188 Identities=29% Similarity=0.393 Sum_probs=154.5
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceE
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKL 200 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~ 200 (324)
.++......|++.+.||.|+||.||+|.+.. ++..||+|++.... ....++..|+.++.++ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~ 78 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY 78 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence 3333455789999999999999999998875 56799999986543 2235678899999998 69999999
Q ss_pred EEEEEe------CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 201 IGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 201 ~~~~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
++++.. .+..|++|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++
T Consensus 79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~ 155 (282)
T cd06636 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLT 155 (282)
T ss_pred eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 999853 45789999999999999998643 356888889999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
.++.++|+|||++........ ......|++.|+|||++. .++|+|||||
T Consensus 156 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~ 214 (282)
T cd06636 156 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214 (282)
T ss_pred CCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHH
Confidence 999999999999876532211 122356899999999875 2589999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=240.82 Aligned_cols=179 Identities=32% Similarity=0.494 Sum_probs=146.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+||.||+|.+.... .++..||+|.+...... ..+++.+|+.+++.+.||||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999876432 13468999999766542 3457889999999999999999999876 4567999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||..+ ++||||||+|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999996543 7899999999999999999999988 9999999999999999999999999998764432
Q ss_pred ccce-eeccccccCcccccccc-----ccceEEEecC
Q 020561 294 KTHV-STRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 294 ~~~~-~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .....++..|+|||.+. .++|||||||
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 186 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHH
Confidence 2111 11122456899999876 3689999997
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=249.02 Aligned_cols=182 Identities=31% Similarity=0.451 Sum_probs=152.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+....... ...+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 3589999999999999999998765 67799999986543221 235678999999999999999999987
Q ss_pred eC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 206 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 206 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+. +..++||||+. ++|.+++......+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 65 56899999995 5899988765567999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|++......... .....+++.|+|||++. .++|||||||
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~ 197 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGC 197 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHH
Confidence 999876543211 22234688899999875 3589999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=243.44 Aligned_cols=185 Identities=26% Similarity=0.434 Sum_probs=149.2
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
|++.++||+|+||.||+|.+..+. .++..||||++..... ...+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999876532 2578999999975432 23456889999999999999999999886542
Q ss_pred ------eEEEEEEecCCCChHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 209 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 209 ------~~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
..++++||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~ 151 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT 151 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence 247899999999999887421 235788999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...............+++.|++||.+. .++|||||||
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~ 203 (273)
T cd05074 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGV 203 (273)
T ss_pred EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHH
Confidence 9999999998764433221222334567899999876 4589999997
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=245.68 Aligned_cols=184 Identities=28% Similarity=0.356 Sum_probs=153.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
+|++.+.||+|+||.||+++.... ..+|..||+|++..... ...+.+.+|+.++.++ +||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~------~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSG------HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccC------CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 478889999999999999987532 12578999999975422 2235678899999999 599999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
..+...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999999543 56889999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
++......... ......|+..|+|||++. .++|||||||
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~ 196 (290)
T cd05613 151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196 (290)
T ss_pred cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHH
Confidence 99875432211 122356899999999885 3589999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=240.82 Aligned_cols=179 Identities=31% Similarity=0.480 Sum_probs=153.2
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
+|+..+.||+|+||+||+|.... ++..|++|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 46778899999999999998765 466999999865432 1235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
......++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999999543 46889999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++....... ......|++.|+|||.+. .++|+|||||
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~ 190 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHH
Confidence 988764432 123356899999999875 2479999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=242.03 Aligned_cols=183 Identities=28% Similarity=0.420 Sum_probs=151.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
+..++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 345689999999999999999997653 3469999887543 22457889999999999999999999987
Q ss_pred eCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
. ...+++|||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCc
Confidence 7 7789999999999999999653 456788899999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++......... ......++..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 191 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 191 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHH
Confidence 99866433221 122234567899999986 3589999997
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=245.39 Aligned_cols=181 Identities=28% Similarity=0.384 Sum_probs=153.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|.+.. ++..||||.++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK 72 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence 68889999999999999998875 56799999986542 22346788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++++.|..++ +....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 73 ~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 73 GRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred CEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 9999999999886666555 44456899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
........ ......++..|+|||++.. ++|+|||||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~ 190 (288)
T cd07833 149 ALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGC 190 (288)
T ss_pred ccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHH
Confidence 76554321 1233568899999998863 479999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=247.99 Aligned_cols=179 Identities=26% Similarity=0.382 Sum_probs=152.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 35566789999999999998765 567999999875432 22356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999999999998843 46899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
....... .....|+..|+|||++.. ++|+|||||
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 189 (277)
T cd06642 151 LTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189 (277)
T ss_pred ccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHH
Confidence 6442211 223468899999999863 589999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=244.20 Aligned_cols=180 Identities=26% Similarity=0.370 Sum_probs=154.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..|+..+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.+.||||+++++++.+.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 357778899999999999998765 567999999875432 2345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++.. .++++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccce
Confidence 999999999999999999853 46889999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~ 189 (277)
T cd06640 150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189 (277)
T ss_pred eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHH
Confidence 7644321 122346889999999976 3589999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=242.72 Aligned_cols=183 Identities=30% Similarity=0.376 Sum_probs=154.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+.. ++..+++|++..... ...++.+|+.+++++ .||||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 35789999999999999999998765 466899999876543 235788999999999 6999999999997
Q ss_pred eCC------eEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 EDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
... ..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA 150 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence 654 489999999999999988642 367899999999999999999999988 99999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
.++|+|||++........ ......|++.|+|||++. .++|||||||
T Consensus 151 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ 206 (275)
T cd06608 151 EVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206 (275)
T ss_pred eEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHH
Confidence 999999999876543221 123356899999999875 2489999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=240.11 Aligned_cols=181 Identities=24% Similarity=0.372 Sum_probs=154.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||++.... ++..||+|.+..... ....++.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 47888999999999999998775 466899999865422 2235788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++... ...+++.+.+.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999999998653 346889999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... .....|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08218 149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGC 189 (256)
T ss_pred eecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHH
Confidence 866443211 12346889999999986 3579999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=244.60 Aligned_cols=172 Identities=29% Similarity=0.397 Sum_probs=140.9
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHH---HcCCCCCCcceEEEEEEeCCe
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF---LGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~---l~~l~HpnIv~~~~~~~~~~~ 209 (324)
+||+|+||.||++.+.. ++..||+|.+....... ...+.+|..+ +...+||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999998765 57799999986543221 1223444433 344579999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 9999999999999998854 346999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.... .....|++.|+|||++. .++|+|||||
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 184 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHH
Confidence 4322 12246899999999875 2479999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=239.37 Aligned_cols=180 Identities=26% Similarity=0.400 Sum_probs=153.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||++.... ++..+|||.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 57888999999999999998765 567999999875432 2235788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-CcEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGl 285 (324)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||+|+||+++.+ +.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999999999654 345899999999999999999999988 9999999999999754 4689999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .....|+..|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHH
Confidence 987654322 22346899999999986 3589999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=243.61 Aligned_cols=179 Identities=27% Similarity=0.402 Sum_probs=153.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCC---CCCcceEEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV---HLNLVKLIGYCI 205 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~ 205 (324)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... ....++.+|+.+++.+. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47788899999999999998765 567999999875432 23356888999999986 999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.....++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence 99999999999999999999854 37899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+......... .....|+..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 190 (277)
T cd06917 148 AALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190 (277)
T ss_pred eeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHH
Confidence 9876543321 23346899999999875 3589999996
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=246.11 Aligned_cols=180 Identities=26% Similarity=0.387 Sum_probs=155.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||.||++.... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 588999999999999999998654 46689999987654444567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999999999999854 35788999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...... ......|++.|+|||++. .++|+|||||
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 203 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHH
Confidence 544322 123346899999999876 3589999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=244.49 Aligned_cols=179 Identities=31% Similarity=0.387 Sum_probs=155.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+|+..+.||.|+||.||++.+.. ++..||+|.+..... ....++.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 57788899999999999998875 567999999876543 33457889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||||+++++|.+++......+++.....++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999997655688999999999999999999999 77 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ....|+..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 187 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence 6533211 1156899999999876 3589999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=258.78 Aligned_cols=184 Identities=24% Similarity=0.301 Sum_probs=154.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchH---HHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..-|..++.||-|+||+|-+++-.+ |...||+|.+.+.+.-.+. .+..|..||+....+.||+||-.|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 3457888999999999999997554 6779999999876544333 356799999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+++.+|+||+|++||++..+|.+.+ -|++..+..++.++..|+++.|..| +|||||||+|||||.+|+|||+|||
T Consensus 699 QDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 699 QDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred ccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecc
Confidence 99999999999999999999996654 6899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCC---CCcc----c---------------------------------eeeccccccCcccccccc-----ccceE
Q 020561 285 LAKDGPE---GDKT----H---------------------------------VSTRVMGTYGYAAPEYVM-----TALEL 319 (324)
Q Consensus 285 la~~~~~---~~~~----~---------------------------------~~~~~~Gt~~y~aPE~l~-----~~~Di 319 (324)
||+-+.. ...+ + ..-.++||+.|+|||+|. ..+|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 9964311 0000 0 001357999999999998 35899
Q ss_pred EEecC
Q 020561 320 FCLKC 324 (324)
Q Consensus 320 wSlGc 324 (324)
||.|.
T Consensus 855 ws~gv 859 (1034)
T KOG0608|consen 855 WSVGV 859 (1034)
T ss_pred hHhhH
Confidence 99983
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=242.38 Aligned_cols=172 Identities=29% Similarity=0.411 Sum_probs=141.8
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHH---HHHHcCCCCCCcceEEEEEEeCCe
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAE---VNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E---~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
+||+|+||.||+|++.. +++.||+|.+....... ...+..| +.+++...||||+.+++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999998765 57799999987543221 1123333 344555689999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 9999999999999998854 457999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.... .....|+..|+|||++. .++|||||||
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~ 184 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 184 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHH
Confidence 4322 12346899999999986 3479999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=245.80 Aligned_cols=177 Identities=32% Similarity=0.440 Sum_probs=152.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..|++.+.||+|+||.||+|.+.. ++..||+|.+...... ...++.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 468888999999999999998765 4679999998654322 2246889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..|+||||++ |+|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence 9999999999996 6788877655567999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+...... ....|++.|+|||++. .++|||||||
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~ 202 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHH
Confidence 8765432 2246889999999874 3589999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=242.16 Aligned_cols=179 Identities=28% Similarity=0.385 Sum_probs=152.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
-|++.+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.++.+++||||+++++++...+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 47778899999999999998765 466999999865432 22356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999999999999853 46899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
...... ......|+..|+|||++.. ++|+|||||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 189 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 189 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHH
Confidence 544221 1223468899999998863 589999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=240.37 Aligned_cols=181 Identities=27% Similarity=0.438 Sum_probs=152.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ...++.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 467888999999999999998753 44799998875433 2457889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 999999999999999999765567899999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......++..|+|||++. .++|+|||||
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~ 189 (256)
T cd05112 150 VLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV 189 (256)
T ss_pred cccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHH
Confidence 5432211 111233567899999886 3589999996
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=246.55 Aligned_cols=183 Identities=28% Similarity=0.411 Sum_probs=150.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 579999999999999999998765 5779999998654322 22356789999999999999999999876
Q ss_pred CC--------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 207 DD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 207 ~~--------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
.. ..++||||+. ++|.+++......+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL 158 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence 54 3599999995 5898888666567899999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCcc--ceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||++......... .......++..|+|||++. .++|+|||||
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence 99999999865432211 1122346788999999874 3589999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=244.07 Aligned_cols=184 Identities=29% Similarity=0.449 Sum_probs=148.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
+.||+|+||.||+|.+..... ....+..+|||.+..... ....++.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998764221 011346899998865432 2345788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-----cEEEEe
Q 020561 214 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-----NAKLSD 282 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-----~~kl~D 282 (324)
|||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999999642 234788999999999999999999988 99999999999999877 899999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++................++..|+|||++. .++|||||||
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 201 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGV 201 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHH
Confidence 99998654432222222234678899999887 3589999997
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=239.72 Aligned_cols=181 Identities=29% Similarity=0.416 Sum_probs=157.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||.||+|.+.. ++..|+||.+..... .....+.+|+..+.+++||||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 368889999999999999998875 577999999976644 3346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+++++|.+++... ..+++...+.++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999544 678999999999999999999999 88 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
......... .....++..|+|||.+.. ++|+|||||
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~ 188 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGL 188 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHH
Confidence 876543322 123468899999999873 489999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=244.54 Aligned_cols=180 Identities=32% Similarity=0.486 Sum_probs=151.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|+.++.||.|+||.||+|++.. ++..||||.+..... .....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 58889999999999999998765 577999999875432 2235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||+. ++|..++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999995 6899888543 356899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
......... .....+++.|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07860 148 RAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189 (284)
T ss_pred hhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence 865432211 22235788999999875 2489999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=239.48 Aligned_cols=181 Identities=27% Similarity=0.400 Sum_probs=152.6
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
+|++.+.||.|+||.||++.+.. ++..||+|.+..... ...+++..|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 47888999999999999998765 567999999875433 223568889999999999999999998764
Q ss_pred -CCeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 207 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH-----EEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH-----~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
....+++|||+++++|.+++... ..++++..++.++.||+.||.||| +.+ |+|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence 45689999999999999998643 467899999999999999999999 666 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+||+|||++......... .....|++.|+|||++.. ++|+|||||
T Consensus 149 ~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 149 VKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred EEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 999999999876543321 223468999999999863 479999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=256.64 Aligned_cols=193 Identities=28% Similarity=0.445 Sum_probs=164.5
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcce
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
.....+..+...+.+.||.|-||.||+|.+.... ++....||||.-+.+. ....+.|+.|..+|++++|||||+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhh
Confidence 3344445556667789999999999999887632 3345679999998754 344578999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
++|+|.+ ...|||||+++.|.|..+|..+...++......++.||+.||.|||+.. +|||||..+|||+.....||
T Consensus 456 LIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 456 LIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceee
Confidence 9999975 5689999999999999999988889999999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
|+||||++.+.+...+... ...-..-|||||.+. +++|||=||
T Consensus 532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFg 579 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFG 579 (974)
T ss_pred ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHH
Confidence 9999999998876655433 344577899999986 789999887
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=247.02 Aligned_cols=184 Identities=25% Similarity=0.377 Sum_probs=150.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|++.+.||+|+||.||+|.+... .++..||+|.+.... ......+.+|+.++..++||||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 377888999999999999987652 146799999997633 2223567889999999999999999999998
Q ss_pred C--CeEEEEEEecCCCChHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC----CC
Q 020561 207 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DY 276 (324)
Q Consensus 207 ~--~~~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~ 276 (324)
. ...++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence 8 88999999996 4777766421 236889999999999999999999988 999999999999999 99
Q ss_pred cEEEEeecccccCCCCCc-cceeeccccccCccccccccc------cceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
.+||+|||++........ ........+++.|+|||++.+ ++|||||||
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 999999999987644322 111223468899999998753 479999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=241.66 Aligned_cols=177 Identities=27% Similarity=0.385 Sum_probs=148.2
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCC-CCCcceEEEEEEeC-
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIED- 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~- 207 (324)
|++.+.||+|+||.||+|.... ++..||+|.+...... ......+|+.++.++. ||||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 5678899999999999998765 4669999998754321 2234567999999986 99999999999987
Q ss_pred -CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccc
Confidence 88999999996 5888888665567899999999999999999999988 999999999999999 99999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ .....++..|+|||++. .++|+|||||
T Consensus 147 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv 187 (282)
T cd07831 147 RGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGC 187 (282)
T ss_pred cccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHH
Confidence 87644322 12346889999999764 3589999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=240.82 Aligned_cols=180 Identities=27% Similarity=0.386 Sum_probs=148.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.+.||||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 468888999999999999998753 3368999886543 23467889999999999999999998875 56
Q ss_pred eEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence 689999999999999999653 345889999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
........ ......++..|+|||++.. ++|+|||||
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~ 191 (260)
T cd05069 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191 (260)
T ss_pred EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHH
Confidence 65433211 1122346778999998763 589999996
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=238.01 Aligned_cols=182 Identities=31% Similarity=0.422 Sum_probs=155.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||+|.... ++..|++|.+...... ....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 47888999999999999998765 4679999999766543 446788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999999999999543 45889999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccce--eeccccccCccccccccc--------cceEEEecC
Q 020561 288 DGPEGDKTHV--STRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~--~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
.......... .....+++.|+|||++.. .+|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 7654332111 112467899999998763 469999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=250.95 Aligned_cols=178 Identities=25% Similarity=0.363 Sum_probs=149.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|+..+.||+|+||.||+|.+.. ++..||||.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT 85 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeec
Confidence 4679999999999999999998775 57799999986432 223356788999999999999999999886
Q ss_pred eC------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
.. ...|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 86 PQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred cCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 44 35799999995 5888887432 888999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||+++....... .....|++.|+|||++. .++|||||||
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 205 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHH
Confidence 999999987644221 22346889999999886 4589999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=241.69 Aligned_cols=179 Identities=29% Similarity=0.398 Sum_probs=153.2
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
.|...+.||+|+||.||++.... ++..+++|.+........+.+.+|+.+++.+.||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 34555799999999999998765 466899999876544445668899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++|+||+++++|.+++.. .++++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 9999999999999999855 46899999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
..... ......|++.|+|||++. .++|+|||||
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv 203 (285)
T cd06648 166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 203 (285)
T ss_pred ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHH
Confidence 43221 122356899999999986 3589999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=242.84 Aligned_cols=181 Identities=27% Similarity=0.399 Sum_probs=149.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCC-CCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368889999999999999998875 5779999998654321 2356888999999995 699999999998
Q ss_pred eCCe-----EEEEEEecCCCChHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-C
Q 020561 206 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-D 275 (324)
Q Consensus 206 ~~~~-----~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~ 275 (324)
..+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||+|+||+++. +
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~ 147 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK 147 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence 7665 8999999975 898888542 245899999999999999999999988 999999999999998 8
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+.+||+|||++......... .....+++.|+|||++. .++|+|||||
T Consensus 148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 99999999999865332111 12235788999999875 3589999996
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=249.52 Aligned_cols=182 Identities=31% Similarity=0.454 Sum_probs=150.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||.+.... ......+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~ 76 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVI 76 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeee
Confidence 4578889999999999999998764 56799999885432 22234577899999999 999999999988
Q ss_pred EeC--CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 205 IED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 205 ~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
... ...|+||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 77 KAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 654 36899999996 5999988543 7889999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCcc---ceeeccccccCcccccccc------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~---~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||++......... .......||+.|+|||++. .++|+|||||
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 201 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGC 201 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHH
Confidence 9999876443221 1223456899999999875 3589999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=234.19 Aligned_cols=180 Identities=31% Similarity=0.469 Sum_probs=158.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
+|+..+.||+|+||.||++.+.. ++..+++|++..........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47788999999999999998875 466899999977654445678999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++++||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999999999665467999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
..... .....|+..|+|||++. .+.|+|||||
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 185 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGI 185 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHH
Confidence 55432 22356899999999986 4589999996
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=238.67 Aligned_cols=174 Identities=31% Similarity=0.498 Sum_probs=146.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||.||++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5688999999999999999853 35689999986543 235788999999999999999999988654
Q ss_pred eEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 5799999999999999996543 45889999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
...... .....+..|+|||++.. ..|+|||||
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~ 185 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGV 185 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHH
Confidence 643321 12234678999998863 579999997
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-33 Score=241.00 Aligned_cols=185 Identities=26% Similarity=0.386 Sum_probs=158.9
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCC-CCCCcce
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVK 199 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~ 199 (324)
+.+...+|.++++||+|+|++|.++++.. |.+.+|+|++++..... ..-++.|-.++.+. +||++|.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence 34556799999999999999999998875 78899999998754332 33456777777666 6999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
++.+|+++..+|+|.||++||+|.-++. +..+++++.+..+..+|+.||.|||+.+ ||.||||..|||+|..|++|
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence 9999999999999999999999988884 4568999999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEec
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLK 323 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlG 323 (324)
|+|+|+++....... ..++++|||.|+|||++.+ ++|+|+||
T Consensus 392 ltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalg 438 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALG 438 (593)
T ss_pred ecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHH
Confidence 999999986433222 2456899999999999984 58999998
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=244.35 Aligned_cols=176 Identities=31% Similarity=0.448 Sum_probs=150.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|...+.||+|+||.||++.+.. ++..||+|.+...... ...++.+|+.+++.++||||+++++++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 46778899999999999998765 5679999998754322 23468889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++..++||||++ |+|.+++.....++++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 999999999996 5888887666667999999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
...... ....|++.|+|||++. .++|+|||||
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGv 212 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHH
Confidence 765432 2246899999999873 3579999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=237.27 Aligned_cols=172 Identities=28% Similarity=0.374 Sum_probs=148.9
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||.|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+.++...++|
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 6999999999998865 5679999999754322 235688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 9999999999999543 46899999999999999999999988 9999999999999999999999999998775432
Q ss_pred ccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 294 KTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 294 ~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
. .....|++.|+|||++. .++|+|||||
T Consensus 148 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~ 180 (262)
T cd05572 148 K---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180 (262)
T ss_pred c---cccccCCcCccChhHhcCCCCCChhhhhhhHH
Confidence 1 22346899999999976 3479999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=249.37 Aligned_cols=182 Identities=28% Similarity=0.391 Sum_probs=154.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch---HHHHHHHHHHcCC-CCCCcceEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDL-VHLNLVKLIG 202 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~HpnIv~~~~ 202 (324)
...+|..+.+||+|+||+|.+|..+ +|.+.+|||+++++..... +--+.|-++|+.. +-|.+++++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk---------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeeeccc---------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 3457888999999999999999654 4788999999988754322 2235677777766 4789999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+|++-+++|+||||+.||+|.-+|++ -.++.+..+..++.+|+.||-|||+++ ||.||||.+||+||.+|++||+|
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 99999999999999999999999854 457888999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
||+++.-.....+ ..+++|||.|+|||++. .++|+||+|
T Consensus 494 FGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~G 537 (683)
T KOG0696|consen 494 FGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 537 (683)
T ss_pred cccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHH
Confidence 9999865443332 34589999999999998 468999998
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=243.62 Aligned_cols=184 Identities=28% Similarity=0.379 Sum_probs=152.7
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 45689999999999999999998875 567999999975432 2234577899999999999999999998
Q ss_pred EeCC----------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 205 IEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 205 ~~~~----------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
.+.. ..++||||+++ +|...+......+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~ 151 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNN 151 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 7655 78999999975 787777655567999999999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++.+||+|||++......... ......++..|+|||++. .++|||||||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 206 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206 (302)
T ss_pred CCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence 999999999999876543221 112234688899999875 3589999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=240.26 Aligned_cols=183 Identities=27% Similarity=0.398 Sum_probs=157.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+.|+..+.||+|+||.||+|.+.. ++..|++|++..... ....+.+|+.+++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 34578888999999999999998875 466899999976544 45678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..|+|+||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999999765457999999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ ......+++.|+|||++. .++|+|||||
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGv 204 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGI 204 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHH
Confidence 76543221 122345889999999876 4589999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=249.69 Aligned_cols=182 Identities=25% Similarity=0.398 Sum_probs=149.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||.+.... .....++.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999998765 57799999986432 2233567889999999999999999988765
Q ss_pred C-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
. ...|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 4 35799999995 588887743 46899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCcc-ceeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||++......... .......||+.|||||++. .++|||||||
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 198 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence 99999865432211 1122356899999999865 2479999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=240.11 Aligned_cols=173 Identities=34% Similarity=0.494 Sum_probs=147.0
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||+|+||+||+|.+.. +++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6899999999998765 577999999865432 1234567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 214 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
|||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999999986543 46899999999999999999999988 999999999999999999999999998765432
Q ss_pred CccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.. .....++..|+|||++. .++|+|||||
T Consensus 149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 182 (277)
T cd05577 149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGC 182 (277)
T ss_pred Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHH
Confidence 11 22345788999999976 3589999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=248.52 Aligned_cols=182 Identities=25% Similarity=0.414 Sum_probs=151.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||+|.... ++..||+|++..... .....+.+|+.+|..++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 689999999999999999998775 577999999875432 234567889999999999999999988763
Q ss_pred ----CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 207 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
....++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 356899999995 689998854 456999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCcc--ceeeccccccCcccccccc------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||++......... .......|+..|+|||++. .++|||||||
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 200 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGC 200 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHH
Confidence 9999765432211 1123357899999999874 3589999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=252.74 Aligned_cols=179 Identities=26% Similarity=0.338 Sum_probs=154.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------hHHHHHHHHHHcCCC---CCCc
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLV---HLNL 197 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---HpnI 197 (324)
.+|..++.+|.|+||.|++|.++.+ ...|+||.+.+...-. .-.+-.|+.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 5799999999999999999998874 4489999997653211 112456999999998 9999
Q ss_pred ceEEEEEEeCCeEEEEEEec-CCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 198 VKLIGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
++++++|++++++||+||-- ++.+|.++|. ....+++.++..|+.||+.|+++||+++ |||||||-+||+++.+|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence 99999999999999999975 5679999994 4557999999999999999999999999 99999999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
.+||+|||.|.....+. ...++||..|.|||++.+ ..|||+||.
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgi 757 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGI 757 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhh
Confidence 99999999998876654 345689999999999984 369999993
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=241.35 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=148.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 468889999999999999998765 567999999865432 223567889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEEeec
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFG 284 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFG 284 (324)
.+..|+||||++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||+|+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999995 5888887543 234678888899999999999999988 999999999999985 5679999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++........ ......+++.|+|||++. .++|||||||
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 192 (294)
T PLN00009 149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGC 192 (294)
T ss_pred cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHH
Confidence 9976543211 122345789999999875 3589999996
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=239.84 Aligned_cols=180 Identities=27% Similarity=0.407 Sum_probs=152.5
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC-
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 207 (324)
|++.+.||.|+||.||+|.+.. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 5678899999999999998875 46799999997653 22235688999999999999999999999988
Q ss_pred -CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++||||++ ++|.+++......+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccce
Confidence 88999999996 5899988665567999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
......... ..+...++..|+|||.+. .++|||||||
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 190 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGC 190 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHH
Confidence 876543211 122345788999999765 3589999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=240.12 Aligned_cols=179 Identities=30% Similarity=0.374 Sum_probs=151.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC-
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 207 (324)
+|+..+.||.|+||.||++.+.. ++..||+|.+..... ....++.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 57788999999999999999865 567999999875433 2345789999999999999999999988654
Q ss_pred -CeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 208 -DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+.+++||||+++++|.+++.. ....+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeec
Confidence 468999999999999988743 3456889999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|++........ ....++..|+|||.+.. ++|+|||||
T Consensus 150 g~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~ 191 (287)
T cd06621 150 GVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGL 191 (287)
T ss_pred ccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHH
Confidence 99876543221 23457889999998863 589999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=236.30 Aligned_cols=174 Identities=22% Similarity=0.208 Sum_probs=143.3
Q ss_pred HhcCCCCCcee--cCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 127 ATRNFRPESLL--GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
..++|++.+.+ |+|+||.||++.... ++..+|+|.+........ |+.....+ +||||+++++.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEE
Confidence 34567777776 999999999998765 577999999875432211 22222222 69999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~D 282 (324)
+...+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999999554 48999999999999999999999988 99999999999999988 999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
||++....... ...|+..|+|||++.. ++|+|||||
T Consensus 154 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 194 (267)
T PHA03390 154 YGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGV 194 (267)
T ss_pred CccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHH
Confidence 99988654321 2458999999999863 479999996
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=239.35 Aligned_cols=179 Identities=28% Similarity=0.439 Sum_probs=150.5
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
|++.+.||.|++|.||+|.+.. +|..||+|++...... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6778899999999999998765 5679999998755322 2356788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..|++|||++ ++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999994 68999986433 46899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ .....+++.|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 188 (283)
T cd07835 148 AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGC 188 (283)
T ss_pred ccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHH
Confidence 65432211 12235688999999875 2489999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=237.42 Aligned_cols=175 Identities=29% Similarity=0.448 Sum_probs=149.1
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||.|+||.||++.+.. ++..|++|.+..... .....+.+|+.++.+++||||+++++.+......|+|
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999998765 577999999976543 2345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999996543 7899999999999999999999988 9999999999999999999999999988654331
Q ss_pred c------cceeeccccccCccccccccc-----cceEEEecC
Q 020561 294 K------THVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 294 ~------~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
. ........++..|+|||++.. ++|+|||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 189 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHH
Confidence 1 111233568899999998863 589999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=224.37 Aligned_cols=183 Identities=26% Similarity=0.339 Sum_probs=150.7
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++...+..||+|+||.|=+-++.. +|...|+|.+..... +..++.++|+.+..+. ..|++|++||..
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 34455566789999999998887776 677999999975532 3346788999887665 699999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
......||.||.| ..+|..+.. +.+..+++...-+|+.-++.||.|||++- .|||||+||+|||++.+|++|||
T Consensus 115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence 9999999999999 567877653 46778999999999999999999999964 49999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCccccccccc---------cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---------ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---------~~DiwSlGc 324 (324)
|||++-.+.+.-. .+.-.|...|||||.+.. ++||||||-
T Consensus 192 DFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGI 240 (282)
T KOG0984|consen 192 DFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGI 240 (282)
T ss_pred ccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhh
Confidence 9999987655322 222468999999999972 479999993
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=235.86 Aligned_cols=177 Identities=25% Similarity=0.269 Sum_probs=148.0
Q ss_pred HhcCCCCC-ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEE
Q 020561 127 ATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 204 (324)
.+++|.+. ++||-|-.|+|..+..+. |++.+|+|++... .+..+|+++.-..+ |||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 34566655 579999999999997664 8999999988533 45678999876664 99999999987
Q ss_pred Ee----CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCC
Q 020561 205 IE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADY 276 (324)
Q Consensus 205 ~~----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~ 276 (324)
.. ...+.+|||.++||.|...|..+ ...+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .+.
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence 64 35688999999999999999754 467999999999999999999999988 99999999999995 456
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
.+||+|||+|+...... ...+.+-||+|.|||++- ..+|+||||
T Consensus 202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlg 250 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLG 250 (400)
T ss_pred ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchh
Confidence 79999999999865422 234567899999999997 468999998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-33 Score=236.02 Aligned_cols=182 Identities=29% Similarity=0.385 Sum_probs=149.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 205 (324)
..+.+.+..||.|+||+|++-.++. +|+..|||++..... ...++++.|.+...+- +.||||++||++.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 3455566789999999999876654 788999999986654 3456788998876655 5899999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
.++..||.||+| ..+|..+... ....+++...-.|....+.||.||-... .|||||+||+||||+..|.+|||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeee
Confidence 999999999999 5677665531 3456899999999999999999998744 49999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCccccccccc-------cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
|||++..+...- ..+.-.|...|||||-+.. ++|+||||-
T Consensus 211 DFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 211 DFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred cccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 999998764422 2344579999999999983 479999993
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=233.23 Aligned_cols=181 Identities=25% Similarity=0.412 Sum_probs=157.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||.|+||.||++.+.. ++..||+|.+..... .....+.+|+++++.++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 57888999999999999999875 467999999976543 3446788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
+..++||||+++++|.+++.+. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999999999754 367999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... .......|++.|+|||.+. .++|+||||+
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~ 191 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGC 191 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHH
Confidence 998765432 1223356899999999876 4589999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=261.75 Aligned_cols=181 Identities=23% Similarity=0.260 Sum_probs=154.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||.|+||.||+|.+.. +++.||||++....... ..++.+|+.++..++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 578999999999999999998875 57799999997543222 256888999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..||||||+.+++|.+++.. ...+++..++.|+.||+.||+|||.++ ||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 99999999999999999999954 346889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
++........ .....+|+.|++||.... ..++|++|+
T Consensus 151 s~~~~~~~~~--~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~ 193 (669)
T cd05610 151 SKVTLNRELN--MMDILTTPSMAKPKNDYSRTPGQVLSLISSLGF 193 (669)
T ss_pred CccccCCccc--ccccccCccccCccccccCCCCceeeeeeecCc
Confidence 9876543322 234679999999997662 257888874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=232.02 Aligned_cols=180 Identities=36% Similarity=0.561 Sum_probs=156.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||++.+.. ++..|++|.+..... .....+.+|++++.+++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 47888999999999999998765 466899999977654 3346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999999999998544 57899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .....|+..|+|||.+. .++|+|||||
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~ 187 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHH
Confidence 76554321 22356899999999875 4589999995
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=246.88 Aligned_cols=180 Identities=29% Similarity=0.435 Sum_probs=150.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|.+.+.||+|+||+||+|.+.. ++..||||.+.... .....++.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 75 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPP 75 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheec
Confidence 478999999999999999998765 67799999987542 2223567889999999999999999998765
Q ss_pred C-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
. ...|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 76 PHREAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred ccccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 4 34799999995 789988854 457999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||++........ ......++..|+|||++. .++|+|||||
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 197 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGC 197 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHH
Confidence 9999987644321 123346889999999875 3589999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=239.46 Aligned_cols=175 Identities=33% Similarity=0.471 Sum_probs=149.7
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
|...+.||+|+||.||+|.+.. ++..|++|.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6667889999999999998765 5779999998754322 224678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..|+||||+. ++|.+++.....++++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999999995 6888888666667999999999999999999999988 9999999999999999999999999986
Q ss_pred cCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
.... .....|+..|+|||++. .++|+|||||
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGv 208 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHH
Confidence 5432 12356899999999974 2479999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=235.81 Aligned_cols=181 Identities=23% Similarity=0.403 Sum_probs=152.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||++.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 47788999999999999998876 466899999865432 2235678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGl 285 (324)
+..++|+||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++ .+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999999999653 345899999999999999999999988 99999999999998875 469999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ ......|++.|+|||++. .++|+|||||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC 190 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence 987654321 122346899999999876 3589999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=240.16 Aligned_cols=174 Identities=28% Similarity=0.403 Sum_probs=149.8
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 214 (324)
..||+|+||.||++.... ++..||||.+..........+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 26 IKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 579999999999998765 57799999986554444567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCc
Q 020561 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294 (324)
Q Consensus 215 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 294 (324)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 97 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99999999998743 35899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cceeeccccccCcccccccc-----ccceEEEecC
Q 020561 295 THVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 295 ~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......|++.|+|||++. .++|+|||||
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGv 204 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHH
Confidence 123356899999999885 3589999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=239.16 Aligned_cols=179 Identities=30% Similarity=0.381 Sum_probs=147.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCC-CCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~ 207 (324)
+|+..+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+.++.++. ||||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 56667889999999999998765 577999999875432 23356889999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 208 DQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+..+++|||+. ++|.++.. .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence 99999999985 46655432 2235789999999999999999999974 6 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc--------cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
||++........ .....|++.|+|||++.. ++|||||||
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~ 198 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGI 198 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHH
Confidence 999976543221 123468999999998763 489999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=231.60 Aligned_cols=182 Identities=31% Similarity=0.473 Sum_probs=156.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|+..+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47778999999999999998875 567999999876543 2346788999999999999999999999988
Q ss_pred --CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
...++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence 88999999999999999996544 8999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+................++..|+|||.+. .++|+|||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~ 191 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHH
Confidence 98775543211123356899999999986 3589999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.17 Aligned_cols=182 Identities=26% Similarity=0.405 Sum_probs=151.1
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceE
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKL 200 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~ 200 (324)
.+....++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.++.+++||||+++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 344456889999999999999999998765 577999999975422 223567889999999999999999
Q ss_pred EEEEEeC------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 201 IGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 201 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
++++... ...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 9988643 3468888887 7899888743 35899999999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
++.+||+|||++...... .....|++.|+|||++.. ++|||||||
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~ 206 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHH
Confidence 999999999998865332 223468999999998753 589999997
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=239.03 Aligned_cols=186 Identities=20% Similarity=0.231 Sum_probs=138.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch-----------HHHHHHHHHHcCCCCCC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVHLN 196 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~Hpn 196 (324)
.+.|++.+.||+|+||+||+|.+..+.. .+..+|+|.......... .....+...+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 3579999999999999999998765311 144677776543321110 11223445567789999
Q ss_pred cceEEEEEEeCC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 197 LVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 197 Iv~~~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
|+++++++.... ..+++||++ ..++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill 159 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV 159 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999876543 457888887 4467766643 334678889999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCcc-----ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.++|+|||+|+........ .......||+.|+|||++. .++|||||||
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~ 221 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGY 221 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHH
Confidence 99999999999999865332111 1112346999999999876 3589999997
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=242.25 Aligned_cols=184 Identities=31% Similarity=0.418 Sum_probs=150.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999998765 5678999998654322 1245778999999999999999999875
Q ss_pred eCC--------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 206 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 206 ~~~--------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
... .+++||||+. ++|...+......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 443 4699999995 5788877665667999999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCcc---------ceeeccccccCcccccccc------ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKT---------HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~---------~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++|+|||++......... ...+...|++.|+|||++. .++|||||||
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 215 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC 215 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence 999999999865432211 1112346788999999875 3489999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=240.11 Aligned_cols=176 Identities=30% Similarity=0.428 Sum_probs=150.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.|...+.||+|+||.||+|++.. ++..||+|.+..... ....++.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 86 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 46667889999999999998865 467899999864322 223467889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+. |+|.+++.....++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence 999999999996 6888887655567899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
...... ....|++.|+|||++. .++|||||||
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~ 202 (308)
T cd06634 163 SIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202 (308)
T ss_pred eeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHH
Confidence 765432 2246889999999863 3589999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=239.50 Aligned_cols=183 Identities=29% Similarity=0.401 Sum_probs=155.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCC-CCCcceEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 204 (324)
++|++.+.||+|+||.||+|.... ++..||+|++..... .....+.+|+.++.++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 368899999999999999998875 577999999876432 22356788999999999 99999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...+..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999999999999544 47999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCcc------------------ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~------------------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++......... .......|+..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~ 210 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGC 210 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHH
Confidence 99865442211 1122346789999999875 3589999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=232.08 Aligned_cols=171 Identities=27% Similarity=0.376 Sum_probs=142.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHH-HcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF-LGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
+.||+|+||.||+|.+.. ++..||||.+....... ...+..|..+ ...+.||||+++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 579999999999998765 46799999987543221 1234455544 4456899999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.++|+|||++....
T Consensus 73 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999999999999954 346899999999999999999999988 9999999999999999999999999988654
Q ss_pred CCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
. .....|++.|+|||++.. ++|+|||||
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~ 181 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHH
Confidence 3 122468899999999863 579999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=243.22 Aligned_cols=181 Identities=29% Similarity=0.399 Sum_probs=148.2
Q ss_pred CCC-CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------------hHHHHHHHHHHcCCCC
Q 020561 130 NFR-PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGDLVH 194 (324)
Q Consensus 130 ~y~-~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H 194 (324)
+|. +.+.||.|+||+||+|.+.. ++..||||.+....... ...+.+|+.+++.++|
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 79 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC
Confidence 454 45789999999999998765 56799999986543221 1247789999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 195 pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
|||+++++++...+..++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+|||++.
T Consensus 80 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~ 154 (335)
T PTZ00024 80 ENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINS 154 (335)
T ss_pred cceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECC
Confidence 999999999999999999999996 699999853 456899999999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCC------------ccceeeccccccCcccccccc------ccceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGD------------KTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~------------~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++.++|+|||++....... .........+++.|+|||++. .++|+|||||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 222 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHH
Confidence 9999999999997654111 001112235788999999885 3479999997
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=234.19 Aligned_cols=181 Identities=27% Similarity=0.461 Sum_probs=150.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------cchHHHHHHHHHHcC-CCCCCcc
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGD-LVHLNLV 198 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~HpnIv 198 (324)
+|++.+.||+|+||.||+|.+..+ ++..+|+|.+..... ....++.+|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 478889999999999999987652 356899998854321 122457788888865 7999999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcC
Q 020561 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~ 274 (324)
++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ |+|+||+|+|||++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~ 149 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE 149 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence 999999999999999999999999988742 34578999999999999999999996 45 999999999999999
Q ss_pred CCcEEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++.+||+|||++....... ......|+..|+|||++.. .+|+|||||
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 201 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHH
Confidence 9999999999998755432 2234568999999999873 589999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=236.07 Aligned_cols=178 Identities=31% Similarity=0.478 Sum_probs=150.8
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCC-CCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~ 208 (324)
|++.+.||+|+||.||+|.... ++..|+||.+...... ......+|+..+++++ ||||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6678899999999999998865 4678999998654321 2234567999999999 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..++||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 889999886543 57899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
....... .....|+..|+|||++. .++|+|||||
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~ 187 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHH
Confidence 7644322 22346889999999874 3589999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=236.71 Aligned_cols=184 Identities=28% Similarity=0.354 Sum_probs=152.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
+|++.+.||+|+||.||+++...+. .++..||||.+..... .....+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4778899999999999999865322 2567899999875322 2234678899999999 599999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|.||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECc
Confidence 999999999999999999999854 356889999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
++......... ......|+..|+|||.+. .++|+|||||
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~ 196 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHH
Confidence 98875443221 122346899999999875 2579999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=242.38 Aligned_cols=183 Identities=27% Similarity=0.369 Sum_probs=146.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
+|++.+.||+|+||.||++.+.... .+..||||.+..... ...+.+.+|+.++.++ .||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 4778889999999999999876521 166899999864321 2235678899999999 59999999987543
Q ss_pred C----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 207 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 207 ~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
. ...|++|||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCc
Confidence 2 45789999985 68999884 3457899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCcc--ceeeccccccCccccccccc------cceEEEecC
Q 020561 283 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv 198 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHH
Confidence 9999865432211 11223578999999998753 479999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=243.45 Aligned_cols=177 Identities=27% Similarity=0.389 Sum_probs=149.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 4679999999999999999998765 5779999998653221 2346789999999999999999999987
Q ss_pred eCC------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
... ..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred CCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 654 358999999 7899988843 46899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|+|||++....... ....+++.|+|||++.. ++|+|||||
T Consensus 159 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 204 (343)
T cd07880 159 ILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGC 204 (343)
T ss_pred EeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHH
Confidence 99999998654321 22467899999998753 589999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=237.97 Aligned_cols=180 Identities=26% Similarity=0.436 Sum_probs=149.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.+..+.||-|+||.||...+-. .|+.||+|.+..- .....+++.+|+.+|..++|.|++..+++..-.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPR---------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPR---------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEeccCCC---------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 56777899999999999886554 5779999988543 223347899999999999999999999877654
Q ss_pred C-----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 208 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
. .+|+++|++ ..+|..+| -....++.....-++.||+.||+|||+.+ |+||||||.|.|++.+..+||||
T Consensus 125 h~dfFqEiYV~TELm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 125 NPSFFQELYVLTELM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred CchHHHHHHHHHHHH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence 3 357888988 56888777 44567898999999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+++.....+..+ .+..+-|.+|.|||+++ +++||||+||
T Consensus 200 FGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGC 246 (449)
T KOG0664|consen 200 FGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGC 246 (449)
T ss_pred cccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhH
Confidence 99999765544333 33345689999999998 4689999999
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=242.79 Aligned_cols=181 Identities=28% Similarity=0.430 Sum_probs=152.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||.|+||.||+|.... ++..||||.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 47888999999999999998765 57799999987643 23346788999999999999999999998877
Q ss_pred C-----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 208 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+ ..|+||||++ ++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||.|||++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999996 5899988543 48999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCcc-ceeeccccccCccccccccc------cceEEEecC
Q 020561 283 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||++......... .......+++.|+|||++.. ++|+|||||
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 9999876553210 11233468999999999874 489999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=235.92 Aligned_cols=179 Identities=30% Similarity=0.443 Sum_probs=153.1
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
|++.+.||+|++|.||+|.... ++..+++|.+...... ....+.+|+.++++++||||+++++++...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 5677899999999999998765 5678999998765432 3457889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 9999999996 4898888765568999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
...... ......++..|+|||.+.. ++|+|||||
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~ 187 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGC 187 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHH
Confidence 655331 1223468889999998763 479999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=251.16 Aligned_cols=191 Identities=25% Similarity=0.412 Sum_probs=163.8
Q ss_pred CHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcce
Q 020561 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
.+++|++...+......||-|.||.||.|.|+.. ...||||.++.+... .++|+.|..+|+.++|||+|+
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVq 327 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 327 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHH
Confidence 4577777778888889999999999999999863 458999999876543 578999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
|+|+|..+..+|||+|||.+|+|.++|++.. ..++....+.++.||..|++||..++ +|||||..+|+|+..+..|
T Consensus 328 LLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiV 404 (1157)
T KOG4278|consen 328 LLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIV 404 (1157)
T ss_pred HhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceE
Confidence 9999999999999999999999999997543 45777888999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+||||++.+..+..+. .....-.+-|.|||-|. -++|||+||.
T Consensus 405 KvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGV 454 (1157)
T KOG4278|consen 405 KVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGV 454 (1157)
T ss_pred EeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHH
Confidence 999999999876544321 11122356899999987 4689999983
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=239.89 Aligned_cols=178 Identities=20% Similarity=0.242 Sum_probs=143.5
Q ss_pred ceecCC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 135 SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 135 ~~lG~G--~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
..||+| +||+||++++.. +++.||||++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356666 999999998765 5779999998754322 235678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 211 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
++||||+.+++|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999999999999998653 345899999999999999999999988 999999999999999999999999865432
Q ss_pred CCCCcc-----ceeeccccccCccccccccc-------cceEEEecC
Q 020561 290 PEGDKT-----HVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
...... .......++..|||||++.. ++|||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence 211100 00011235677999999863 479999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=243.91 Aligned_cols=181 Identities=26% Similarity=0.347 Sum_probs=148.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC-
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 207 (324)
.+|++.+.||.|+||.||+|.... ++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 578999999999999999998765 6779999999766555556788999999999999999999776543
Q ss_pred -------------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-
Q 020561 208 -------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD- 273 (324)
Q Consensus 208 -------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~- 273 (324)
...|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 35789999996 589888843 46899999999999999999999988 99999999999997
Q ss_pred CCCcEEEEeecccccCCCCCcc-ceeeccccccCcccccccc------ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.++.+||+|||++......... .......|+..|+|||++. .++|||||||
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 207 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHH
Confidence 4567899999999765332111 1112235788999999864 3589999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=235.35 Aligned_cols=182 Identities=32% Similarity=0.454 Sum_probs=150.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCC-CCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||.+...... ...++.+|+.++.++. ||||+++++++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 34678999999999999999998865 5779999999754322 2345677887777775 99999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
.+....|+||||+ .++|.+++......+++..+..++.||+.||.|||+ .+ |+||||+|+||+++.++.+||+||
T Consensus 84 ~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 84 ITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred ecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence 9999999999998 457888776555689999999999999999999997 46 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCccccccccc---------cceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---------ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---------~~DiwSlGc 324 (324)
|++........ .....+++.|+|||++.. ++|+|||||
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 206 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHH
Confidence 99876543221 122357889999999862 479999996
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=231.68 Aligned_cols=178 Identities=30% Similarity=0.436 Sum_probs=146.6
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCC---CCCCcceEEEEEE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDL---VHLNLVKLIGYCI 205 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~HpnIv~~~~~~~ 205 (324)
|++.+.||+|+||.||+|.+.. ++..||+|.+....... ...+.+|+.++.++ +||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 5678899999999999999875 46799999997543221 23466777776555 6999999999999
Q ss_pred eCCe-----EEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~~~-----~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
..+. .+++|||+. ++|.+++.+.. ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence 8876 999999996 58999886533 36899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||++........ .....++..|+|||++. .++|+|||||
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~ 194 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGC 194 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHH
Confidence 999999987644322 12235788999999987 3589999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=230.31 Aligned_cols=179 Identities=26% Similarity=0.425 Sum_probs=153.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|++.+.||+|+||.||++.+.. ++..+|+|.+..... ....++.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 47888999999999999998765 567999999875432 2234678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999999998652 356899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++....... .....|++.|+|||.+.. ++|+|||||
T Consensus 149 ~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~ 189 (256)
T cd08530 149 ISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGC 189 (256)
T ss_pred chhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHH
Confidence 998765531 222468899999999863 589999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=237.13 Aligned_cols=160 Identities=24% Similarity=0.263 Sum_probs=134.0
Q ss_pred CCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHH
Q 020561 162 TGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIR 238 (324)
Q Consensus 162 t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~ 238 (324)
++..||||++.... ......+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.+. ...+++...
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 57799999997652 233457899999999999999999999999999999999999999999999653 356889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCc-----cceeeccccccCccccccc
Q 020561 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYV 313 (324)
Q Consensus 239 ~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~Gt~~y~aPE~l 313 (324)
..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+........ ........++..|+|||++
T Consensus 104 ~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 104 AFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 999999999999999988 99999999999999999999999999875532211 0111234578899999987
Q ss_pred c-------ccceEEEecC
Q 020561 314 M-------TALELFCLKC 324 (324)
Q Consensus 314 ~-------~~~DiwSlGc 324 (324)
. .++|+|||||
T Consensus 181 ~~~~~~~~~~~Diws~G~ 198 (314)
T cd08216 181 QQNLQGYNEKSDIYSVGI 198 (314)
T ss_pred cCCCCCCCcchhHHHHHH
Confidence 5 3589999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=239.30 Aligned_cols=179 Identities=28% Similarity=0.384 Sum_probs=149.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..+++|++.+.||.|+||.||+|.... ++..||||.+..... ...+.+.+|+.++..++||||++++++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 356789999999999999999998765 577999998864322 223567899999999999999999999
Q ss_pred EEe-CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+.. ....++||||+ +++|.+++.. .++++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.++|+|
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 876 45789999999 6789888843 45788888999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||++...... .....+++.|+|||++.+ ++|+|||||
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 194 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC 194 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHH
Confidence 9999864332 122457889999998753 489999997
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=232.94 Aligned_cols=179 Identities=32% Similarity=0.468 Sum_probs=152.3
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
|+..+.||+|+||.||+|.... ++..||+|.+.... ....+.+..|+.+++.++||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5667889999999999998775 57799999997653 222356788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..++||||++ ++|.+++.+....+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999997 5999999765457999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
....... .....++..|+|||++.. ++|+|||||
T Consensus 148 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~ 187 (282)
T cd07829 148 FGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGC 187 (282)
T ss_pred cCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHH
Confidence 6443221 222356788999998753 589999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=250.47 Aligned_cols=181 Identities=27% Similarity=0.331 Sum_probs=158.1
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
...+++.+..||-|+||.|=+...... ...+|+|++++...-+ .+.+..|-.+|..++.|+||++|..
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT 488 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT 488 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence 345777888999999999999877642 2258999998764332 2457789999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
|.+..++|++||-|-||.|...|+. .+.++..++..++..+++|++|||+++ ||+|||||+|++|+.+|.+||.||
T Consensus 489 frd~kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 489 FRDSKYVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hccchhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeeh
Confidence 9999999999999999999999954 457999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCccccccccc-----cceEEEec
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLK 323 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlG 323 (324)
|+|+.+..+..+ .++||||.|.|||++++ ++|.||||
T Consensus 565 GFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLG 606 (732)
T KOG0614|consen 565 GFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALG 606 (732)
T ss_pred hhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHH
Confidence 999998877654 34799999999999994 58999998
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=238.48 Aligned_cols=175 Identities=25% Similarity=0.403 Sum_probs=146.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.+|.+.+.||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 85 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS 85 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence 579999999999999999998764 577999999875422 223467899999999999999999999875
Q ss_pred CC------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 DD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.. ..++||||+. .+|..++ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred cccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 43 4689999995 4777665 236899999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+|||+++..... .....+++.|+|||++.. ++|+|||||
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGv 203 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGC 203 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHH
Confidence 999999865332 123467899999998753 589999997
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=245.45 Aligned_cols=184 Identities=22% Similarity=0.311 Sum_probs=135.7
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCccchHH--------------HHHH
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHKE--------------WLAE 185 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-------~~~~t~~~vavK~~~~~~~~~~~~--------------~~~E 185 (324)
..++|++.++||+|+||.||+|.+...+... .....++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999764322111 112346789999987543322222 3347
Q ss_pred HHHHcCCCCCCc-----ceEEEEEEe--------CCeEEEEEEecCCCChHHHHhccC----------------------
Q 020561 186 VNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS---------------------- 230 (324)
Q Consensus 186 ~~~l~~l~HpnI-----v~~~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~---------------------- 230 (324)
+.++.+++|.++ ++++++|.. .+..||||||+++++|.++|+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777653 356899999999999999986321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccc
Q 020561 231 -LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309 (324)
Q Consensus 231 -~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~a 309 (324)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 12456778899999999999999988 9999999999999999999999999997654322111 112245889999
Q ss_pred ccccc
Q 020561 310 PEYVM 314 (324)
Q Consensus 310 PE~l~ 314 (324)
||++.
T Consensus 379 PE~l~ 383 (507)
T PLN03224 379 PEELV 383 (507)
T ss_pred hhhhc
Confidence 99875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=247.33 Aligned_cols=184 Identities=28% Similarity=0.450 Sum_probs=156.0
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
..+.++||+|.||.|++|.|..... +-..||||.+..+... ...+|++|+.+|.+|+|||+++|||+..+ ..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 3445789999999999999886332 3458999999877554 45789999999999999999999999887 67
Q ss_pred EEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 210 RLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..||||+++.|+|.+.|++ ....|.......++.||+.||.||-+++ +|||||..+|+||.....|||+||||.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence 8899999999999999987 4566888888999999999999999988 99999999999999999999999999999
Q ss_pred CCCCCccceee-ccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVST-RVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~-~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...+...... ...-...|.|||.|. -++|+|++|.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGV 303 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGV 303 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhh
Confidence 87765543332 223356899999998 4689999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=265.00 Aligned_cols=172 Identities=27% Similarity=0.432 Sum_probs=144.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
..|...++||+|+||.||+|.+.. ++..||||.+..... ....|+.++++++|||||+++++|.+.+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 467788899999999999998765 467999999864432 1235688999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|+||||+++|+|.++++ .++|..+..|+.||+.||+|||....++|+||||||+||+++.++.+++. ||....
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999994 38899999999999999999996544569999999999999999888876 776554
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... ....||+.|||||++. .++|||||||
T Consensus 832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred cccC------CCccccccccCcccccCCCCCcccchhhHHH
Confidence 3221 1236899999999987 4689999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-33 Score=232.77 Aligned_cols=183 Identities=29% Similarity=0.437 Sum_probs=150.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..|+....||+|.||.||+|+.++ +|+.||+|.+-... .......++|+.+|..|.|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 356666789999999999998776 67789998764322 1122456899999999999999999988754
Q ss_pred C--------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 207 D--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 207 ~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
. ..+|+||.+|+ .+|.-+|.....+++..++.+++.+++.||.|+|... |+|||+||+|+||+.++.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence 3 34899999995 5899999777788999999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCcc--ceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||+++.+...... .-.+..+-|.+|.+||.++ +..|||.-||
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 99999999876443221 1123345599999999998 4689999999
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=224.76 Aligned_cols=173 Identities=34% Similarity=0.453 Sum_probs=148.6
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
||+|+||.||++.+.. ++..||+|.+...... ....+..|+.+++.++||||+++++.+..++..++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999998765 4669999998765432 234688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~ 293 (324)
|||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 9999999999999543 46899999999999999999999988 9999999999999999999999999998764432
Q ss_pred ccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 294 KTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 294 ~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
. ......|+..|+|||.+. ..+|+|||||
T Consensus 148 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~ 181 (250)
T cd05123 148 S--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181 (250)
T ss_pred C--cccCCcCCccccChHHhCCCCCCchhhHHHHHH
Confidence 1 123356889999999886 3589999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=224.23 Aligned_cols=162 Identities=25% Similarity=0.253 Sum_probs=136.7
Q ss_pred CCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 020561 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219 (324)
Q Consensus 140 G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~ 219 (324)
|.||.||++++.. +++.||+|.+.... .+.+|...+....||||+++++++...+..++||||+++
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8899999998875 67799999997643 233455555666799999999999999999999999999
Q ss_pred CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceee
Q 020561 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299 (324)
Q Consensus 220 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 299 (324)
|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 9999998543 46899999999999999999999988 999999999999999999999999988765432 12
Q ss_pred ccccccCcccccccc-----ccceEEEecC
Q 020561 300 RVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 300 ~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...++..|+|||++. .++|+|||||
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 170 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGA 170 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHH
Confidence 234677899999876 3579999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-31 Score=249.75 Aligned_cols=181 Identities=25% Similarity=0.368 Sum_probs=159.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|+++..+|.|.||.||+|++.. +++..|+|+++...-.+..-+..|+-+++..+|||||.|++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 4689999999999999999999876 6889999999887666666678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+.+||.||||.+|+|.+..+ -..++++.++..++++.+.||+|||+.+ -+|||||-.|||+++.|.+|++|||.+.
T Consensus 85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 99999999999999998764 4568999999999999999999999988 8999999999999999999999999987
Q ss_pred cCCCCCccceeeccccccCcccccccc--------ccceEEEec
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLK 323 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlG 323 (324)
.+...-. .+..++||+.|||||+-. ..+|||++|
T Consensus 161 qitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~g 202 (829)
T KOG0576|consen 161 QITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALG 202 (829)
T ss_pred hhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccc
Confidence 7644221 134578999999999976 348999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=228.74 Aligned_cols=182 Identities=25% Similarity=0.382 Sum_probs=151.9
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC--C----Cc
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--L----NL 197 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--p----nI 197 (324)
......+|.+...+|+|.||+|-.+++.. ++..||||+++.-. ...+..+-|+++|.+|.+ | -+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 33457899999999999999999999886 56799999986422 223456779999999952 3 27
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC--
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-- 274 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-- 274 (324)
|++.++|...++.|||+|.+ |-++.++|... -.+++..++..|+.|++.+++|||+.. ++|-||||+|||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 88889999999999999998 67999999653 367999999999999999999999988 999999999999932
Q ss_pred ------------------CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 275 ------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 275 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+..|||+|||.|+...... +.++.|..|.|||+++ ..+||||+||
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGC 297 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGC 297 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeee
Confidence 3459999999998765433 3467799999999998 5799999999
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=238.63 Aligned_cols=177 Identities=27% Similarity=0.405 Sum_probs=150.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|++.. ++..||||.+.... ......+.+|+.+++.+.||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 4679999999999999999998875 56799999986532 122356788999999999999999998887
Q ss_pred eCCe------EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
..+. .++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEE
Confidence 6654 89999999 6799998854 46899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|+|||++...... .....++..|+|||++. .++|||||||
T Consensus 159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 204 (343)
T cd07851 159 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 204 (343)
T ss_pred Ecccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHH
Confidence 9999999876432 22346889999999875 3589999996
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=227.05 Aligned_cols=180 Identities=22% Similarity=0.309 Sum_probs=146.1
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
+|.+.+.||+|+||.||++.+.. ++..+++|.++... .....++.+|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 47888999999999999998764 23345555554321 12224567899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
.+....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence 999999999999999999998853 3457899999999999999999999988 999999999999975 569999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++........ ......|++.|+|||.+. .++|+|||||
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 193 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGC 193 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHH
Confidence 9999987644322 122356889999999876 3589999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=249.55 Aligned_cols=175 Identities=22% Similarity=0.304 Sum_probs=123.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEE---
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY--- 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~--- 203 (324)
..++|++.+.||+|+||.||+|.+..+.. ..+..||||.+..... .+.+..| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999999876311 1267999998864321 1111111 1222223333332221
Q ss_pred ---EEeCCeEEEEEEecCCCChHHHHhccCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 204 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLPL-------------------PWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 204 ---~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
.......+|||||+++++|.+++......+ ....+..++.||+.||.|||+++ ||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 245667899999999999999986432211 12345679999999999999988 99
Q ss_pred eCCCCCCcEEEcC-CCcEEEEeecccccCCCCCccceeeccccccCcccccccc
Q 020561 262 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314 (324)
Q Consensus 262 HrDLkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~ 314 (324)
||||||+|||++. ++.+||+|||+|+.+...... .....+||+.|||||.+.
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhh
Confidence 9999999999985 689999999999865433221 233467899999999653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=228.82 Aligned_cols=166 Identities=19% Similarity=0.171 Sum_probs=129.1
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----ccchHHHHHHHHHHcCCCCCCcce-
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVK- 199 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~- 199 (324)
.....|.+.+.||+|+||+||+|.+... ++..||||++.... ......+.+|+.+|.+|+|+||+.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 3456899999999999999999987641 35678999875331 112356889999999999999985
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCcEEEcCCCcE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNA 278 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~~ 278 (324)
+++ .+..|||||||+|++|.. + .. .. ...++.|++.||.|||+++ |||||| ||+|||++.++.+
T Consensus 87 l~~----~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 87 LLA----TGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred EEE----cCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 443 245799999999999963 2 11 11 1467889999999999988 999999 9999999999999
Q ss_pred EEEeecccccCCCCCccce------eeccccccCcccccccc
Q 020561 279 KLSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVM 314 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~------~~~~~Gt~~y~aPE~l~ 314 (324)
||+|||+|+.......... .+...+++.|+|||++.
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9999999997644321111 13467899999999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=244.51 Aligned_cols=186 Identities=26% Similarity=0.387 Sum_probs=157.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
..+..++||+|+||+||+|.|...+.. -..+||||++.... .....+++.|+-+|.+|.|||+++++++|....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 345668999999999999988865443 24589999986543 334578999999999999999999999998766
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
+.||++|++.|+|.++++.....+-....+.|..||++||.|||.+. +|||||..+|||+.....+||.|||+++.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 78999999999999999888888999999999999999999999987 99999999999999999999999999998
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.............-.+.|||-|.+. .++||||+|.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGV 888 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGV 888 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhh
Confidence 87655443333233366899999887 4689999983
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=214.76 Aligned_cols=175 Identities=21% Similarity=0.343 Sum_probs=148.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 206 (324)
.++|++.+.+|+|-|+.||.|.... +...++||+++.-. .+.+.+|+.+|..|. ||||+++++...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 4689999999999999999998665 45689999997532 367899999999998 9999999999887
Q ss_pred CC--eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEEee
Q 020561 207 DD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 283 (324)
Q Consensus 207 ~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DF 283 (324)
+. ...||+||+.+.+...+. ..++.-.+..++.+++.||.|+|+.| |+|||+||.|+++|. ...++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeec
Confidence 64 456999999988887766 35777888899999999999999998 999999999999985 567999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||.+......... .+.+..|--||.+. .+.|+|||||
T Consensus 178 GLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGC 221 (338)
T ss_pred chHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHH
Confidence 99998877655433 34678899999986 4689999999
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=242.02 Aligned_cols=195 Identities=27% Similarity=0.443 Sum_probs=158.4
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceE
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKL 200 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~ 200 (324)
.+++..++..+.+.||+|.||.|++|......... ......||||.++..... ..+.+..|+.+|..+ .||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 34455566677789999999999999876432211 112568999999765433 346789999999998 59999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
+|+|...+.+++|+|||..|+|..+|+... ..++....+.++.||+.|++||++.. +|||||
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDL 444 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDL 444 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhh
Confidence 999999999999999999999999997655 34888999999999999999999977 999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCCCCCccceeecccc--ccCcccccccc-----ccceEEEec
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~aPE~l~-----~~~DiwSlG 323 (324)
..+|||+..+..+||+|||+|+............ ..| ...|||||.+. .++||||+|
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfG 508 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFG 508 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHH
Confidence 9999999999999999999999766654432221 122 44699999987 468999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=239.92 Aligned_cols=176 Identities=31% Similarity=0.443 Sum_probs=140.9
Q ss_pred CCCCceecCCCceE-EEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCC
Q 020561 131 FRPESLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDD 208 (324)
Q Consensus 131 y~~~~~lG~G~fg~-Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~ 208 (324)
|...+++|.|+-|+ ||+|.+. |+.||||++-... .....+||..|+.-+ |||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44456789998875 8999885 6699999986443 245678999998885 999999999988899
Q ss_pred eEEEEEEecCCCChHHHHhcc--CCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---C--CcEEE
Q 020561 209 QRLLVYEFMPRGSLENHLFRR--SLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---D--YNAKL 280 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~--~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~--~~~kl 280 (324)
..||..|+| .-+|.+++... ... ......+.+..|++.||++||+.+ ||||||||.||||+. + ..++|
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence 999999999 56999999653 111 111345678899999999999988 999999999999965 2 56899
Q ss_pred EeecccccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+++.+..+... .......||-+|+|||+|. .++|||||||
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGC 702 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGC 702 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCc
Confidence 999999987664332 1134567999999999998 5689999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=206.42 Aligned_cols=181 Identities=33% Similarity=0.427 Sum_probs=154.6
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
|.+.+.||.|++|.||++.... ++..+|+|.+...... ..+.+.+|+..+.+++|+||+++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5667899999999999998875 4668999999876544 45778899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++++||+++++|.+++......+++.....++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999999654333889999999999999999999987 999999999999999999999999999877
Q ss_pred CCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
...... ......++..|++||++. ..+|+|+|||
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~ 188 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGV 188 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHH
Confidence 554211 122346788999999872 3689999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=226.68 Aligned_cols=174 Identities=25% Similarity=0.286 Sum_probs=144.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
...|++...||.|+|+.|-.+.+.. ++...++|++.... .+..+|+.++... +||||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccc---------cccchhheeccccc----cccccccchhhhhcCCCcceeecceecC
Confidence 5678888889999999999987765 67799999997662 2234577665555 69999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE-cCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl-~~~~~~kl~DFGl 285 (324)
....|+|||++.|+-|.+.+.... .....+..|+.+|+.|+.|||+++ ||||||||+|||+ +..++++|+|||.
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEech
Confidence 999999999999998888875432 222677789999999999999988 9999999999999 6999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++..... ..+.+-|..|.|||++. .++||||||.
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGv 501 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGV 501 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHH
Confidence 9987654 22235688999999997 5799999993
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=196.14 Aligned_cols=174 Identities=35% Similarity=0.539 Sum_probs=148.9
Q ss_pred ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEEE
Q 020561 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (324)
Q Consensus 137 lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 215 (324)
||+|.+|.||++.... ++..+++|++...... ....+.+|+..++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999998864 4679999999766432 23578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEEeecccccCCCCCc
Q 020561 216 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDK 294 (324)
Q Consensus 216 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 294 (324)
|+++++|.+++......+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99999999999654356899999999999999999999988 999999999999998 89999999999987654321
Q ss_pred cceeeccccccCccccccccc------cceEEEecC
Q 020561 295 THVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 295 ~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
......+...|++||.+.. +.|+|+|||
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~ 182 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHH
Confidence 1222457889999998764 379999996
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-28 Score=210.53 Aligned_cols=175 Identities=25% Similarity=0.385 Sum_probs=144.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+|.-+..+|.|.- .|--|.+.- ++++||+|.+.... ....++..+|..++..++|+||++++.+|.-.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 5666678888887 666665543 67799999886542 22346778999999999999999999988643
Q ss_pred ------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 208 ------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 208 ------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
...|+||||+ ..+|.+.+. ..++-.....|+.|++.|++|||+.+ |+||||||+||++..+..+||.
T Consensus 88 ~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred ccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence 3579999999 679999885 45778889999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+|+..... ...+..+.|..|.|||++. ..+||||+||
T Consensus 161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGc 205 (369)
T KOG0665|consen 161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205 (369)
T ss_pred cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhh
Confidence 99999865332 2245567899999999998 4589999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=203.31 Aligned_cols=168 Identities=33% Similarity=0.500 Sum_probs=145.8
Q ss_pred CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 020561 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219 (324)
Q Consensus 141 ~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~ 219 (324)
+||.||+|.+.. ++..+|+|++....... .+.+.+|+..+++++|+||+++++++......+++|||+++
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999998875 46799999997665444 57889999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceee
Q 020561 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299 (324)
Q Consensus 220 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 299 (324)
++|.+++.... .+++..+..++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ...
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 99999985433 3899999999999999999999988 9999999999999999999999999998765532 123
Q ss_pred ccccccCcccccccc-----ccceEEEecC
Q 020561 300 RVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 300 ~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...++..|++||.+. .++|+|||||
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~ 174 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGV 174 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHH
Confidence 356889999999875 4689999995
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=199.78 Aligned_cols=175 Identities=22% Similarity=0.352 Sum_probs=143.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEE-EEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGY-CIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~-~~~ 206 (324)
+.|.+.+.||+|.||.+.+++++. +...+++|.+.... ....+|.+|...--.|. |.||+.-|+. |++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 578899999999999999999876 56689999987653 34578999988766664 8999988764 677
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE--cCCCcEEEEeec
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFG 284 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~~~kl~DFG 284 (324)
.+..+++|||+|.|+|..-+.. ..+-+.....++.|++.||.|||+++ +||||||.+|||| .+...|||||||
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 7888899999999999987743 45778888999999999999999998 9999999999999 244579999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc----------ccceEEEec
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLK 323 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlG 323 (324)
+.+.....-. ..--+..|-+||++. ...|+|.||
T Consensus 169 ~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfG 212 (378)
T KOG1345|consen 169 LTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFG 212 (378)
T ss_pred cccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchhee
Confidence 9886543211 123467799999876 357999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=214.61 Aligned_cols=182 Identities=24% Similarity=0.345 Sum_probs=151.3
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC------CCCcc
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV------HLNLV 198 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv 198 (324)
.+....|.+....|+|-|++|.+|.+.. .|..||||+|..+... .+.=++|+++|.+|+ --|++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4455688888899999999999998876 3559999999866432 344578999999996 35799
Q ss_pred eEEEEEEeCCeEEEEEEecCCCChHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-
Q 020561 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD- 275 (324)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~- 275 (324)
+|+..|...+++|||+|-+ ..+|.+.|.+. ...|.......++.|+..||..|-.++ |+|.||||.|||++..
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9999999999999999988 67999999754 345788888999999999999999988 9999999999999765
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
..+||||||.|........ +.+.-+..|.|||+|++ ..|+||+||
T Consensus 574 ~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGC 623 (752)
T ss_pred ceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeece
Confidence 4579999999988765442 22344678999999994 689999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=204.81 Aligned_cols=186 Identities=26% Similarity=0.369 Sum_probs=151.6
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG 202 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~ 202 (324)
+......|..++.||+|.|++||++.+... ....+.||+|.+...... .++.+|+++|..+. +.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchh
Confidence 344556899999999999999999988762 124679999999765433 67899999999996 999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLS 281 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~ 281 (324)
++...+...+||||++.....+++. .++...+..+++.++.||.++|.+| ||||||||.|+|.+. .+.-.|.
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEE
Confidence 9999999999999999999888883 3667888999999999999999999 999999999999974 5667999
Q ss_pred eecccccCC-----------------C--C-----------------------CccceeeccccccCcccccccc-----
Q 020561 282 DFGLAKDGP-----------------E--G-----------------------DKTHVSTRVMGTYGYAAPEYVM----- 314 (324)
Q Consensus 282 DFGla~~~~-----------------~--~-----------------------~~~~~~~~~~Gt~~y~aPE~l~----- 314 (324)
|||||.... . . ......-...||++|.|||++.
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997210 0 0 0000011246999999999998
Q ss_pred -ccceEEEecC
Q 020561 315 -TALELFCLKC 324 (324)
Q Consensus 315 -~~~DiwSlGc 324 (324)
+++||||.|.
T Consensus 256 ttaiDiws~GV 266 (418)
T KOG1167|consen 256 TTAIDIWSAGV 266 (418)
T ss_pred CCccceeeccc
Confidence 6799999983
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=203.19 Aligned_cols=133 Identities=24% Similarity=0.347 Sum_probs=111.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-----C---CCcc
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----H---LNLV 198 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv 198 (324)
...+|.+.+.||=|.|++||+|++.. +.+.||+|+++-.. ...+..+.||.+|++++ | ..||
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred cCceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 34789999999999999999999987 45699999997543 22355678999998874 3 3599
Q ss_pred eEEEEEEeC----CeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 199 KLIGYCIED----DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 199 ~~~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
+|++.|... .++|||+|++ |.+|..+|.... ..++...+..|++||+.||.|||.. .+|||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 999998754 4789999999 889999997543 5689999999999999999999984 469999999999999
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=186.63 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=108.3
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--c-------hH-----------------HHHHHHH
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--G-------HK-----------------EWLAEVN 187 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~ 187 (324)
...||+|+||.||+|.+. +|+.||||+++..... . .. ...+|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999764 4779999999754211 0 01 1234999
Q ss_pred HHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeCCCC
Q 020561 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRDFK 266 (324)
Q Consensus 188 ~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~ivHrDLk 266 (324)
++.+|.++++.....+.. ...+|||||+++++|...+.. ..+++...+..++.|++.+|.|| |+.+ |||||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999998877644433222 223899999998877655322 35788999999999999999999 6877 9999999
Q ss_pred CCcEEEcCCCcEEEEeecccccCC
Q 020561 267 TSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 267 p~NILl~~~~~~kl~DFGla~~~~ 290 (324)
|+|||++ ++.++|+|||+|....
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccCC
Confidence 9999998 5789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=180.37 Aligned_cols=141 Identities=17% Similarity=0.138 Sum_probs=111.2
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------------------------hHHHHHHHH
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------------------HKEWLAEVN 187 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--------------------------~~~~~~E~~ 187 (324)
...||+|+||.||+|.+. +|..||||+++...... ...+.+|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 568999999999999764 46799999997653110 112357899
Q ss_pred HHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCC
Q 020561 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFK 266 (324)
Q Consensus 188 ~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLk 266 (324)
.+.++.|++|.....+.... .||||||++++++...+.. ...++......++.|++.+|.+||+ .+ |+|||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 99999999886554444332 4899999988865443222 3467888899999999999999999 88 9999999
Q ss_pred CCcEEEcCCCcEEEEeecccccCCC
Q 020561 267 TSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 267 p~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
|+|||++ ++.++|+|||+++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999998 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=196.08 Aligned_cols=196 Identities=24% Similarity=0.329 Sum_probs=159.1
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcce
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
..++.+...++++..++-+|.||.||.|.|++.+.. ...+.|-+|.++....+ ....++.|...|..+.|||+..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 455566677888889999999999999988864331 23456778888655332 2356889999999999999999
Q ss_pred EEEEEEeC-CeEEEEEEecCCCChHHHHh-----c--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 200 LIGYCIED-DQRLLVYEFMPRGSLENHLF-----R--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 200 ~~~~~~~~-~~~~lv~E~~~~gsL~~~l~-----~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
+.+++.++ ...++++.++..|+|..+|. + ....++..+...++.|++.|++|||+++ |||.||..+|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 99998765 56789999999999999997 2 1245777888899999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEec
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
||+.-++||+|=.+++.+-..+........--...||+||.+. .++|+||||
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfG 485 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFG 485 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHH
Confidence 9999999999999999876665543333334467899999998 578999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=183.92 Aligned_cols=166 Identities=9% Similarity=0.032 Sum_probs=125.4
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHH---------HHHHHHHHcCCCCCC
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLVHLN 196 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~Hpn 196 (324)
....+|+.+++||.|+||.||++... +..+|||++.......... +.+|+..+.+|.||+
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~-----------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTD-----------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecC-----------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 45679999999999999999986432 3479999997554332222 578999999999999
Q ss_pred cceEEEEEEeC--------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 197 LVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 197 Iv~~~~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
|..+.+++... +..+|||||++|.+|.++. .++. ....+++.+|..||..+ ++|||++|+
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~ 164 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKG 164 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChH
Confidence 99999886644 3578999999999998874 1232 24568999999999988 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccccceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~DiwSlGc 324 (324)
||+++.++ ++|+|||..+.......... ..--..| ..++|+||||+
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a~d~---~vler~y------~~~~di~~lg~ 210 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKAKDR---IDLERHY------GIKNEIKDLGY 210 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhhHHH---HHHHhHh------cccccccceeE
Confidence 99999988 99999998876533221110 0000011 13689999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=177.31 Aligned_cols=138 Identities=20% Similarity=0.229 Sum_probs=107.5
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-----CCCCcceEEEEEEe
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-----VHLNLVKLIGYCIE 206 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~~ 206 (324)
.-.++||+|+||.||. +.. ++.. +||++........+.+.+|+.+++.| .||||+++++++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3457899999999995 332 3334 69988765444557799999999999 57999999999998
Q ss_pred CC---eEE-EEEEe--cCCCChHHHHhccCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCcEEEcC----C
Q 020561 207 DD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AFLHEEAERPVIYRDFKTSNILLDA----D 275 (324)
Q Consensus 207 ~~---~~~-lv~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~~~~ivHrDLkp~NILl~~----~ 275 (324)
+. .++ +|||| +++++|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. +
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESE 145 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCC
Confidence 73 444 78999 5579999999542 35555 35677888777 9999998 999999999999974 3
Q ss_pred CcEEEEee-ccccc
Q 020561 276 YNAKLSDF-GLAKD 288 (324)
Q Consensus 276 ~~~kl~DF-Gla~~ 288 (324)
..++|+|| |....
T Consensus 146 ~~~~LiDg~G~~~~ 159 (210)
T PRK10345 146 VIPVVCDNIGESTF 159 (210)
T ss_pred CcEEEEECCCCcce
Confidence 47999994 54444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=180.76 Aligned_cols=171 Identities=22% Similarity=0.276 Sum_probs=141.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~ 207 (324)
-+|++++.||+|+||.+|.|...- +++.||||.-..... .-++..|.+..+.|. .++|..+|-+..+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccccc---------cCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 379999999999999999998765 577999998765432 246777888888875 69999999888888
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-----CcEEEEe
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNAKLSD 282 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-----~~~kl~D 282 (324)
-+-.||||++ |.+|++++.-.+..|+..+.+.++.|++.-++|+|+++ +|.|||||+|+||... ..|.|+|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence 8889999999 89999999877889999999999999999999999998 9999999999999643 4589999
Q ss_pred ecccccCCCCCcc-----ceeeccccccCcccccccc
Q 020561 283 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVM 314 (324)
Q Consensus 283 FGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~ 314 (324)
||+|+...+.... .......||.+||+=-.-+
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl 209 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL 209 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccc
Confidence 9999987554322 2233467999999855433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=174.29 Aligned_cols=173 Identities=24% Similarity=0.296 Sum_probs=142.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC-CCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~ 205 (324)
....|.+++.||.|+||.+|.|.... .|..||||+-..... ..++..|..+...|+| +.|..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 34689999999999999999998775 578999998765432 2467889999999975 78888888888
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~D 282 (324)
+..+-.+||+++ |.+|++++.=....++..+.+-++-|++.-++|+|.++ +|||||||+|+|.. ....+.|+|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEe
Confidence 899999999999 89999998655667999999999999999999999988 99999999999995 445789999
Q ss_pred ecccccCCCCCc-----cceeeccccccCcccccccc
Q 020561 283 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVM 314 (324)
Q Consensus 283 FGla~~~~~~~~-----~~~~~~~~Gt~~y~aPE~l~ 314 (324)
||||+...+... ........||.+|.+=-...
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~ 194 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHL 194 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhh
Confidence 999987544221 11223467999998765544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=184.06 Aligned_cols=179 Identities=36% Similarity=0.498 Sum_probs=149.8
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCC-CcceEEEEEEe
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHL-NLVKLIGYCIE 206 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~Hp-nIv~~~~~~~~ 206 (324)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.+++.+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667789999999999999876 378999997664432 56789999999999988 79999999987
Q ss_pred CCeEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DF 283 (324)
....+++++|+.+++|.+++.... ..++......++.|++.++.|+|..+ ++||||||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence 777899999999999997775433 26899999999999999999999988 99999999999999888 7999999
Q ss_pred cccccCCCCCccc----eeeccccccCccccccccc--------cceEEEecC
Q 020561 284 GLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~----~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
|+++......... ......||..|+|||.+.. ..|+||+||
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~ 199 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHH
Confidence 9998654433211 2345689999999998764 369999884
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=188.65 Aligned_cols=182 Identities=23% Similarity=0.250 Sum_probs=143.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC----CCcceEEEEE-
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH----LNLVKLIGYC- 204 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~~~~~~- 204 (324)
.|.+.+.||+|+||.||++.....+ ...+|+|............+..|+.++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999876521 34789998876533322367788888888873 6899999998
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-----CcE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNA 278 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-----~~~ 278 (324)
..+...||||+.+ |.+|.++..... ..++..+.+.|+.|++.+|++||+.+ +|||||||+|+++... ..+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence 5778899999998 899999885444 78999999999999999999999988 9999999999999754 469
Q ss_pred EEEeecccccCC--CCCc---cce---eeccccccCcccccccc-----ccceEEEec
Q 020561 279 KLSDFGLAKDGP--EGDK---THV---STRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 279 kl~DFGla~~~~--~~~~---~~~---~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
.|.|||+++... .... ... .....||..|+++.+-. ..-|+||++
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~ 224 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLF 224 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHH
Confidence 999999998322 1111 001 12345999999999776 235999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-24 Score=214.64 Aligned_cols=131 Identities=15% Similarity=0.137 Sum_probs=97.6
Q ss_pred cCCCC-CCcceEEEEE-------EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 190 GDLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 190 ~~l~H-pnIv~~~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
+.++| +||.+++++| .....++++|||+ +++|.++|......+++..++.++.||+.||.|||+++ ||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 34556 5788888877 2334677888987 67999999765667999999999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCC-------------------cEEEEeecccccCCCCCc--------------cceeeccccccCcc
Q 020561 262 YRDFKTSNILLDADY-------------------NAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGYA 308 (324)
Q Consensus 262 HrDLkp~NILl~~~~-------------------~~kl~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~ 308 (324)
||||||+||||+..+ .+||+|||+++....... .......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455566666543211000 00011246899999
Q ss_pred cccccc-----ccceEEEecC
Q 020561 309 APEYVM-----TALELFCLKC 324 (324)
Q Consensus 309 aPE~l~-----~~~DiwSlGc 324 (324)
|||++. .++|||||||
T Consensus 183 APE~~~~~~~~~~sDVwSlGv 203 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGV 203 (793)
T ss_pred ChhhhccCCCCchhhhhhHHH
Confidence 999987 4689999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=164.37 Aligned_cols=136 Identities=18% Similarity=0.252 Sum_probs=113.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
+.||+|++|.||+|.+. |..|+||......... ..++.+|+.++..+.|++|+....++..
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 57999999999999763 4578999865432211 1357789999999999999887777777
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||++|++|.+++.... + ....++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcc
Confidence 888899999999999999985322 2 77889999999999999988 99999999999999 789999999999
Q ss_pred ccCC
Q 020561 287 KDGP 290 (324)
Q Consensus 287 ~~~~ 290 (324)
....
T Consensus 142 ~~~~ 145 (211)
T PRK14879 142 EFSK 145 (211)
T ss_pred cCCC
Confidence 8643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=167.89 Aligned_cols=145 Identities=18% Similarity=0.159 Sum_probs=111.5
Q ss_pred CCCCCceecCCCceEEEEEE-EccCCCccccCCCCcEEEEEEecCCCcc------------------------chHHHHH
Q 020561 130 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWLA 184 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~-~~~~~~~~~~~~t~~~vavK~~~~~~~~------------------------~~~~~~~ 184 (324)
-|.+.+.||+|+||.||+|. +.. +|..||||++...... ....+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 48888999999999999997 332 5789999998754210 0123568
Q ss_pred HHHHHcCCCCC--CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 020561 185 EVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (324)
Q Consensus 185 E~~~l~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivH 262 (324)
|+.++.++.+. .+.++++. ...+|||||+++++|..++.. ...+.......++.||+.+|.|||+.+. |+|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH 172 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGE--LVH 172 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence 99999999753 34444442 235899999999888766522 2345666678999999999999998552 999
Q ss_pred CCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 263 RDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 263 rDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
|||||+||+++ ++.++|+|||++.....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999999 88999999999986544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=158.22 Aligned_cols=133 Identities=20% Similarity=0.142 Sum_probs=105.6
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch----HHHHHHHHHHcCCC-CCCcceEEEEEEeC
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH----KEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-HpnIv~~~~~~~~~ 207 (324)
+...|++|+||+||.+.. .+..++.+.+........ ..+.+|+++|++|. |++|++++++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---- 70 (218)
T ss_pred cceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----
Confidence 457899999999997643 255788777765543211 24789999999995 5889999885
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~~kl~DFGla 286 (324)
+..+++|||+.|.+|.+.+.. . ...++.|++.+|.+||+++ |||||| ||+|||++.++.++|+|||+|
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 447999999999998765411 1 1357789999999999988 999999 799999999999999999999
Q ss_pred ccCCC
Q 020561 287 KDGPE 291 (324)
Q Consensus 287 ~~~~~ 291 (324)
.....
T Consensus 140 ~~~~~ 144 (218)
T PRK12274 140 VRGNP 144 (218)
T ss_pred eecCC
Confidence 86543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=160.35 Aligned_cols=132 Identities=20% Similarity=0.309 Sum_probs=107.1
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+||+|+||.||+|.+. +..|++|........ ...++.+|+.++..+.|+++....-++...
T Consensus 1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 4899999999999843 558999986543211 124577899999999988766655556667
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999998743211 78899999999999988 99999999999999 8899999999988
Q ss_pred cCC
Q 020561 288 DGP 290 (324)
Q Consensus 288 ~~~ 290 (324)
...
T Consensus 138 ~~~ 140 (199)
T TIGR03724 138 YSD 140 (199)
T ss_pred CCC
Confidence 753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=182.11 Aligned_cols=138 Identities=22% Similarity=0.291 Sum_probs=112.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--c------cchHHHHHHHHHHcCCCCCCcceE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--L------QGHKEWLAEVNFLGDLVHLNLVKL 200 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~HpnIv~~ 200 (324)
..|...+.||+|+||.||+|.+... .+++|...... . ...+++.+|+.++..++|++|+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 3456778999999999999987532 33444321111 0 112467899999999999999988
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
+.++......++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 888887778899999999999999884 35678999999999999988 9999999999999 6789999
Q ss_pred EeecccccCC
Q 020561 281 SDFGLAKDGP 290 (324)
Q Consensus 281 ~DFGla~~~~ 290 (324)
+|||+++...
T Consensus 469 iDFGla~~~~ 478 (535)
T PRK09605 469 IDFGLGKYSD 478 (535)
T ss_pred EeCcccccCC
Confidence 9999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=157.97 Aligned_cols=138 Identities=17% Similarity=0.070 Sum_probs=108.5
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------------------chHHHHHHHH
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVN 187 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~----------------------~~~~~~~E~~ 187 (324)
.|.+.+.||+|+||.||++... +|+.||||++...... ....+.+|..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 4788899999999999999764 4779999987643210 0113567889
Q ss_pred HHcCCCCC--CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 188 FLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 188 ~l~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
++..+.|+ .++..++ ....++||||+++++|..+... .....++.+++.++.++|..+ |+||||
T Consensus 86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 99988877 4455544 2456899999999999765421 334678899999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCCC
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
||+||+++.++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-21 Score=187.35 Aligned_cols=178 Identities=22% Similarity=0.252 Sum_probs=137.1
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecC---CCccc---hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~---~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
....++|.|++|.|+......... .++.|.... ..... ...+..|+.+-..|.||||+..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~---------~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLK---------SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCCCc---------cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 456789999999777775543221 233332221 11111 122566888888999999988877776
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+....+-+||||++ +|..++... ..+....+-.++.|++.||+|||+.+ |.||||||+|+++...|.+||+|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence 66666666999999 999998543 46888899999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcc--ceeeccccccCccccccccc------cceEEEec
Q 020561 286 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT------ALELFCLK 323 (324)
Q Consensus 286 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~------~~DiwSlG 323 (324)
+......... ......+|+..|+|||++.. .+||||.|
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ 512 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCG 512 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhcc
Confidence 9866444333 45567899999999999984 47999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=142.87 Aligned_cols=136 Identities=22% Similarity=0.153 Sum_probs=114.2
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC--CCcceEEEEEEeCCeE
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQR 210 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~ 210 (324)
+.+.||.|.++.||++.... ..+++|....... ...+.+|+.++..+.| +++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEecC-----------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 35689999999999998642 4799999865533 4578899999999976 5899999988888889
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
+++|||++++.+..+ +......++.+++.+|.+||.....+++|+||+|+||+++..+.+++.|||++...
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999999988877643 55666778999999999999864455999999999999999899999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-21 Score=180.20 Aligned_cols=172 Identities=28% Similarity=0.355 Sum_probs=140.9
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch--HHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l 212 (324)
++|+|.||.||+++-.. ....|..+|+|++++...... .....|..++..++ ||.+|++.-.++.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhc------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 47999999999874321 123577899999876543221 23456788888887 9999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
+++|..+|.|...+.+. ..+.+.....+...++.+++++|..+ |+|||+|++||+++.+|.+++.|||+++..-..
T Consensus 75 ~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99999999999988544 34666666677778999999999988 999999999999999999999999999976543
Q ss_pred CccceeeccccccCcccccccc---ccceEEEec
Q 020561 293 DKTHVSTRVMGTYGYAAPEYVM---TALELFCLK 323 (324)
Q Consensus 293 ~~~~~~~~~~Gt~~y~aPE~l~---~~~DiwSlG 323 (324)
.. .|||..|||||++. .++|.||+|
T Consensus 151 ~~------~cgt~eymApEI~~gh~~a~D~ws~g 178 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIINGHLSAADWWSFG 178 (612)
T ss_pred hh------cccchhhhhhHhhhccCCcccchhhh
Confidence 32 28999999999998 578999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=144.93 Aligned_cols=137 Identities=21% Similarity=0.148 Sum_probs=97.1
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHH----------------------HHHHHHHH
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL 189 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l 189 (324)
.+.||+|+||.||+|.+. ++..||||++....... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 468999999999999765 36689999986542211 011 13455555
Q ss_pred cCCCCC--CcceEEEEEEeCCeEEEEEEecCCCChHHH-HhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCC
Q 020561 190 GDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENH-LFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDF 265 (324)
Q Consensus 190 ~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDL 265 (324)
..+.+. .+.+.+++ ...++||||++++.+... +.... .. ..+..++.+++.++.++|. .+ |+||||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl 141 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDL 141 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCC
Confidence 555433 24445543 245899999998544321 11111 11 5678899999999999999 77 999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCCC
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
||+||+++ ++.++|+|||.+.....
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccccC
Confidence 99999999 89999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-20 Score=173.16 Aligned_cols=107 Identities=26% Similarity=0.444 Sum_probs=91.0
Q ss_pred EEEEEecCCCChHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 211 LLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
||.|++|...+|.+||.++ ....++...+.++.|++.|++| ++ .+|||+||.||++..+..+||.|||+...
T Consensus 332 yI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheee
Confidence 7999999999999999633 3467888899999999999999 56 99999999999999999999999999987
Q ss_pred CCCCC----ccceeeccccccCcccccccc-----ccceEEEec
Q 020561 289 GPEGD----KTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 289 ~~~~~----~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
..... .....+..+||..||+||.|. .++||||||
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLG 449 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALG 449 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHH
Confidence 76544 111234568999999999998 468999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.7e-18 Score=147.70 Aligned_cols=136 Identities=22% Similarity=0.241 Sum_probs=103.9
Q ss_pred ceec-CCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------cchHHHHHHHHHHcCCCCCCc--c
Q 020561 135 SLLG-EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLVHLNL--V 198 (324)
Q Consensus 135 ~~lG-~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnI--v 198 (324)
..|| .|+.|+||.+... +..++||.+..... ....++.+|+.++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4677 7888888887653 45788887753211 122467889999999998875 6
Q ss_pred eEEEEEEeCC----eEEEEEEecCC-CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 199 KLIGYCIEDD----QRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 199 ~~~~~~~~~~----~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
..+++..... ..+|||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~ 176 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD 176 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence 7777654432 23599999997 699988843 245543 3568999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCC
Q 020561 274 ADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~ 290 (324)
.++.++|+|||.+....
T Consensus 177 ~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 177 PDGKFWLIDFDRGELRT 193 (239)
T ss_pred CCCCEEEEECCCcccCC
Confidence 98999999999988754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.2e-19 Score=175.33 Aligned_cols=180 Identities=20% Similarity=0.204 Sum_probs=139.8
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC---CCCcceEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIG 202 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~ 202 (324)
+....|.+.+.||+|+||+||+|...+ |+.||+|+-+.......- -=.+++.+|+ -+-|..+..
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHH
Confidence 344677888999999999999998764 679999988776543221 1112223333 355677777
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-------CC
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-------AD 275 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-------~~ 275 (324)
++...+.-+||+||.+.|+|.+++. ....+++...+.+..|++.-|+.||..+ |||+||||+|+||. ..
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence 7777888899999999999999995 5567899999999999999999999998 99999999999993 24
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccccc-----ceEEEe
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA-----LELFCL 322 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~DiwSl 322 (324)
.-++|+|||.+..+..-.........++|-.+-++|+..++ +|.|.|
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl 889 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL 889 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence 45999999999876544433445667889999999998865 466554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-18 Score=142.81 Aligned_cols=87 Identities=28% Similarity=0.226 Sum_probs=75.8
Q ss_pred CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceee
Q 020561 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299 (324)
Q Consensus 220 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 299 (324)
|+|.+++..+..++++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 7899999766677999999999999999999999854 999999999999999 99998754321
Q ss_pred ccccccCcccccccc-----ccceEEEecC
Q 020561 300 RVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 300 ~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
..||+.|||||++. .++|||||||
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~ 92 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGI 92 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHH
Confidence 25899999999987 3589999997
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-17 Score=149.02 Aligned_cols=192 Identities=21% Similarity=0.305 Sum_probs=129.1
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCcc-----------ccCC---------------CCcEEEEEEecCCCc-cc
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAP-----------VKPG---------------TGLTVAVKTLNHDGL-QG 178 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-----------~~~~---------------t~~~vavK~~~~~~~-~~ 178 (324)
+..++|++++.||+|.-..||.|....++... ..+. ...+.|||.+-.-.. ..
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 44578999999999999999999877533211 0011 123556666532111 11
Q ss_pred hHHHH----HHH------HH--------HcC--------CCCCCcceEEEEEEeCC------------------------
Q 020561 179 HKEWL----AEV------NF--------LGD--------LVHLNLVKLIGYCIEDD------------------------ 208 (324)
Q Consensus 179 ~~~~~----~E~------~~--------l~~--------l~HpnIv~~~~~~~~~~------------------------ 208 (324)
...++ +|. .. .+. -.|||||++.++|.+.-
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 11111 111 11 111 25999999998885431
Q ss_pred ---eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE--cCCC--cEEEE
Q 020561 209 ---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADY--NAKLS 281 (324)
Q Consensus 209 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~--~~kl~ 281 (324)
.+|+||... ..+|.+++..+ ..+.....-|+.|+++|+.|||.++ |.|||||.+|||+ |+++ .+.|+
T Consensus 314 ~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 314 EPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred CCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEc
Confidence 469999887 46999999653 4567778889999999999999999 9999999999999 3443 47889
Q ss_pred eecccccCCCCC----ccceeeccccccCcccccccc-----------ccceEEEec
Q 020561 282 DFGLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVM-----------TALELFCLK 323 (324)
Q Consensus 282 DFGla~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlG 323 (324)
|||.+-.-.... .....-..-|...-||||+.. .++|.|+.|
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~G 444 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAG 444 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhh
Confidence 999885432210 111112345888999999987 468999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=163.68 Aligned_cols=146 Identities=29% Similarity=0.459 Sum_probs=104.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|..+++|..|+||-||..+++. |.+.+|+| ++++.. +++- ++.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~---------trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc---------cccchhhc-ccccch-----hhhc--cccccCCccee----------
Confidence 478889999999999999998875 67789994 443321 1111 33333344333
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
|+-...+ +...+++... +.+++|||+.+ |+|||+||+|.||..-|++|++|||+.+.
T Consensus 136 -----------gDc~tll-k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhc-ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 5556655 3333444333 67899999988 99999999999999999999999999975
Q ss_pred CCCCCcc-------------ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKT-------------HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~-------------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... .....++|||.|+|||++. ..+|+|+||.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGi 246 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI 246 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHH
Confidence 3221100 0112468999999999998 3489999983
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.6e-18 Score=143.67 Aligned_cols=172 Identities=22% Similarity=0.351 Sum_probs=133.6
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch--HHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
++..|.+...|..|+|++..+ .+++|+++......+ .+|..|.-.|+-+.||||+.+++.|..+..+
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred hhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 345688899999999999753 677788876544332 5788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 211 LLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++..||+.|+|...|+... -..+..++.+++.+|+.|+.|||+..+ -|.---|....+++|++.+.+|.- +-+++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfs 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFS 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceee
Confidence 99999999999999997643 346778999999999999999999762 233346888999999998887751 111110
Q ss_pred CCCCccceeeccccccCcccccccc--------ccceEEEec
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLK 323 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlG 323 (324)
-. .....-.|.||+||.++ .++|+|||.
T Consensus 341 fq------e~gr~y~pawmspealqrkped~n~raadmwsfa 376 (448)
T KOG0195|consen 341 FQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFA 376 (448)
T ss_pred ee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHH
Confidence 00 01123478899999998 358999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-17 Score=163.12 Aligned_cols=184 Identities=24% Similarity=0.293 Sum_probs=148.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCC-CCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 206 (324)
.|.+.+.||+|+|+.|-......+ +...+|+|.+.... ....+....|..+-..+. |+|++++++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 566777899999999988765443 34467777776543 112234455777777787 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHH-hccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCCcEEEcCCC-cEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY-NAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~~ivHrDLkp~NILl~~~~-~~kl~DF 283 (324)
.+..+++++|..++++...+ .......+...+..++.|+..+|.|+| ..+ +.||||||+|.+++..+ .++++||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 99999999999999999988 433335677778889999999999999 777 99999999999999999 9999999
Q ss_pred cccccCCC-CCccceeecccc-ccCccccccccc------cceEEEecC
Q 020561 284 GLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~-~~~~~~~~~~~G-t~~y~aPE~l~~------~~DiwSlGc 324 (324)
|+|..... ..........+| ++.|+|||.... ..|+||+|+
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGI 218 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccc
Confidence 99998766 333334455688 999999999875 479999996
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=145.08 Aligned_cols=141 Identities=20% Similarity=0.142 Sum_probs=96.8
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccch-----------------------------------
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH----------------------------------- 179 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~----------------------------------- 179 (324)
+.||.|++|+||+|++. +|+.||||+.........
T Consensus 123 ~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 192 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK 192 (437)
T ss_pred cceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence 68999999999999876 377999999865421100
Q ss_pred -----HHHHHHHHHHcCC----CCCCcceEEEE-EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHH-H
Q 020561 180 -----KEWLAEVNFLGDL----VHLNLVKLIGY-CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK-G 248 (324)
Q Consensus 180 -----~~~~~E~~~l~~l----~HpnIv~~~~~-~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~-g 248 (324)
-++.+|...+.++ .|.+-+.+-.. +......+|||||++|++|.++........+ ...++.+++. .
T Consensus 193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~ 269 (437)
T TIGR01982 193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSF 269 (437)
T ss_pred HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHH
Confidence 0234455544444 22222222222 2223457899999999999887643222222 2345555555 4
Q ss_pred HHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 249 L~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
+..+|..+ ++|+|++|.||+++.++.++|+|||++..+..
T Consensus 270 l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 67889888 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-17 Score=163.95 Aligned_cols=178 Identities=24% Similarity=0.240 Sum_probs=135.4
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-c---chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-Q---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
+|...+.||.+.|=+|.+|++.+ | .|+||++-+... . ..++-+.|++ ...++|||.+.+.-+-.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 56777899999999999998764 4 489999865542 2 2234455665 56678999999988877
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+...|||=+|+ ..+|.+.|..+ ..+...+..-|+.|++.||.-+|..+ |+|+|||.+||||+..+=+.|+||..
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence 777888999998 56999998543 35677777889999999999999988 99999999999999999999999987
Q ss_pred cccCC--CCCcc---ceeeccccccCcccccccc----------------ccceEEEecC
Q 020561 286 AKDGP--EGDKT---HVSTRVMGTYGYAAPEYVM----------------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~--~~~~~---~~~~~~~Gt~~y~aPE~l~----------------~~~DiwSlGc 324 (324)
-+... .+... ....+..--..|+|||-+- .+-||||+||
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GC 226 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGC 226 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhH
Confidence 66432 21111 1111222334799999775 2459999999
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=134.67 Aligned_cols=177 Identities=21% Similarity=0.244 Sum_probs=111.2
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCC----------CC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVH----------LN 196 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H----------pn 196 (324)
.+...+.||.|+|+.||.+.+.. |++.+|||+....... ..+++.+|.-....+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 34456789999999999999876 8899999988544322 23456666655444332 11
Q ss_pred cceEEEEEE---------eCC--------eEEEEEEecCCCChHHHHh---ccCCC---CCHHHHHHHHHHHHHHHHHHH
Q 020561 197 LVKLIGYCI---------EDD--------QRLLVYEFMPRGSLENHLF---RRSLP---LPWSIRMKIALGAAKGLAFLH 253 (324)
Q Consensus 197 Iv~~~~~~~---------~~~--------~~~lv~E~~~~gsL~~~l~---~~~~~---l~~~~~~~i~~qi~~gL~yLH 253 (324)
++--++... ... ..+++|+-+ .++|.+++. ..... +....++.+..|++..+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 222122211 111 236778877 578888753 22221 333445667789999999999
Q ss_pred hcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc-------------cceEE
Q 020561 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------------ALELF 320 (324)
Q Consensus 254 ~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------------~~Diw 320 (324)
+.+ |||+||+|+|+|++.+|.+.|+||+......... .. ...+..|.+||.... +.|.|
T Consensus 163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW 234 (288)
T PF14531_consen 163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW 234 (288)
T ss_dssp HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence 998 9999999999999999999999998877643311 11 234578999997632 35999
Q ss_pred EecC
Q 020561 321 CLKC 324 (324)
Q Consensus 321 SlGc 324 (324)
+||+
T Consensus 235 ~LG~ 238 (288)
T PF14531_consen 235 QLGI 238 (288)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9985
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-14 Score=118.12 Aligned_cols=132 Identities=19% Similarity=0.065 Sum_probs=96.9
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCc-ceEEEEEEeCCeEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~l 212 (324)
++.|+.|.++.||++... +..|++|....... ....+.+|+.++..+.+.++ .+++.+. ....++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 457899999999998753 45899998765432 12345789999988865554 4455443 334589
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
||||++|.++.... . ....++.+++.+|..||... ...++|+|++|.||+++ ++.++|+|||.+...
T Consensus 69 v~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 69 ITEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred EEEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 99999998876431 1 11245678999999999876 22359999999999998 678999999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-15 Score=138.21 Aligned_cols=133 Identities=27% Similarity=0.419 Sum_probs=110.5
Q ss_pred HcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 189 l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+......+++.....++++|+.||.|||.-. -..|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 46789999999999999999999999999999999999887888999999999999999999999854 1299999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc------------cceEEEec
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------------ALELFCLK 323 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------------~~DiwSlG 323 (324)
|+++|....+||+|||+.................-..-|.|||.+.. ..|+||+|
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ 145 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG 145 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence 99999999999999999887643111111111123456999999873 26999987
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-14 Score=138.99 Aligned_cols=143 Identities=17% Similarity=0.133 Sum_probs=93.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc------------------------------
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------ 178 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~------------------------------ 178 (324)
.+|+. +.||+|++|+||+|++.+ +|+.||||++...-...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45666 789999999999999875 57899999997542100
Q ss_pred ----hH------HHHHHHHHHcCCC----CCCcceEEEEEEe-CCeEEEEEEecCCCChHHHH--hccCC---CCCHHHH
Q 020561 179 ----HK------EWLAEVNFLGDLV----HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSIR 238 (324)
Q Consensus 179 ----~~------~~~~E~~~l~~l~----HpnIv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l--~~~~~---~l~~~~~ 238 (324)
.+ ++.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++- ...+. .+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 01 2334444444432 3333333333322 34568999999999998743 22211 1222333
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----cEEEEeecccccCCC
Q 020561 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAKDGPE 291 (324)
Q Consensus 239 ~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGla~~~~~ 291 (324)
..++.|+ +..+ ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 270 ~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3333443 3456 99999999999999888 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-14 Score=136.74 Aligned_cols=185 Identities=25% Similarity=0.242 Sum_probs=147.4
Q ss_pred hcCCCCCceecC--CCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCC-CCCcceEEE
Q 020561 128 TRNFRPESLLGE--GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIG 202 (324)
Q Consensus 128 ~~~y~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~~~~ 202 (324)
...|.+...+|. |.+|.||.+.... ..++..+|+|.-+... .....+=.+|+....+++ |+|.++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 345667788999 9999999998732 1256689998743322 222334467787777775 999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCCcEEEcCC-Cc
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILLDAD-YN 277 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~ 277 (324)
.|.+.+..|+.+|+| +.+|..+.......++...++.++.+... ||.++|+.+ |+|-|+||+||++..+ ..
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 999999999999999 58898888766666888999999999999 999999988 9999999999999988 89
Q ss_pred EEEEeecccccCCCCCcccee---eccccccCccccccccc----cceEEEec
Q 020561 278 AKLSDFGLAKDGPEGDKTHVS---TRVMGTYGYAAPEYVMT----ALELFCLK 323 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~---~~~~Gt~~y~aPE~l~~----~~DiwSlG 323 (324)
++++|||+...+......... ....|...|++||.+.. ..|+||||
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLG 314 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchh
Confidence 999999999987765422211 22357888999999873 46999987
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.6e-13 Score=111.42 Aligned_cols=145 Identities=14% Similarity=0.090 Sum_probs=100.9
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---------------------cc-hHHH----HHHHH
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------------------QG-HKEW----LAEVN 187 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---------------------~~-~~~~----~~E~~ 187 (324)
...||.|--+.||.|....... ....+..+|||+.+.... .. .+.+ .+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 3579999999999997542100 011246899998753110 00 1112 37999
Q ss_pred HHcCCC--CCCcceEEEEEEeCCeEEEEEEecCCCChHH-HHhccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeC
Q 020561 188 FLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYR 263 (324)
Q Consensus 188 ~l~~l~--HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~ivHr 263 (324)
.|.+|. ..++.+.+++ ...+|||||+.+..+.. .+. ...++......+..+++.+|..| |..+ |||+
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999886 3567777764 45689999997654422 221 12355566677889999999998 8877 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 264 DFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 264 DLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
||++.|||+. ++.+.|+|||.+.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999996 56899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-12 Score=105.81 Aligned_cols=133 Identities=22% Similarity=0.283 Sum_probs=99.8
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.+|++|+-+.+|.+.+. |..+++|.-...... ...+..+|+.+++++.--.|..-+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 46789999999998653 445677754322211 12456789999998875555554545667
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+...|+|||++|-.|.+.+... ...++..+-.-+.-||..+ |||+||.++||++...+ +.++||||+
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcc
Confidence 77889999999999999888543 2456677777788899999 99999999999997665 999999999
Q ss_pred ccCC
Q 020561 287 KDGP 290 (324)
Q Consensus 287 ~~~~ 290 (324)
....
T Consensus 139 ~~s~ 142 (204)
T COG3642 139 EFSD 142 (204)
T ss_pred cccc
Confidence 8643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-12 Score=110.41 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=109.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCC--CCcceEEEEEEeC---C
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVH--LNLVKLIGYCIED---D 208 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~---~ 208 (324)
+.|+.|.++.||++...+ |..+++|....... ....++.+|+.++..+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 578999999999987642 45899998765432 134568899999999875 4567777776654 2
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------- 256 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-------------------------------- 256 (324)
..++||||++|.+|.+.+.. ..++......++.+++.+|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 56899999999888775522 35677777888888888888888531
Q ss_pred ---------------------CCCeEeCCCCCCcEEEcC--CCcEEEEeecccccC
Q 020561 257 ---------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDG 289 (324)
Q Consensus 257 ---------------------~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~~ 289 (324)
...+||+|+.|.|||++. ++.+.|+||+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 234799999999999988 667899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.7e-12 Score=103.92 Aligned_cols=143 Identities=21% Similarity=0.204 Sum_probs=106.5
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.+.+|-+|+-+.|+++.+. |+.++||.-..... -...+..+|+++|.++.--.|.--.-++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 4578999999999999875 66777875432211 1235678899999998755655555556
Q ss_pred EeCCeEEEEEEecCC-CChHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC---cEE
Q 020561 205 IEDDQRLLVYEFMPR-GSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAK 279 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~-gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~k 279 (324)
.+...-.|+|||++| -++.+++..... .........++..|-..+.-||.++ |||+||..+||+|..++ .+.
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence 677777899999976 478888864332 2333333788899999999999999 99999999999996554 358
Q ss_pred EEeecccccC
Q 020561 280 LSDFGLAKDG 289 (324)
Q Consensus 280 l~DFGla~~~ 289 (324)
|+|||++..-
T Consensus 157 lIdfgls~~s 166 (229)
T KOG3087|consen 157 LIDFGLSSVS 166 (229)
T ss_pred EEeecchhcc
Confidence 9999998653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.2e-12 Score=120.60 Aligned_cols=153 Identities=16% Similarity=0.161 Sum_probs=116.2
Q ss_pred CCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHH
Q 020561 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241 (324)
Q Consensus 162 t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i 241 (324)
++.+|.|...+.....-.....+-+..|+.|+||||++|++.++.++.+|||+|-+ ..|..++.+. ........
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----~~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----GKEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----HHHHHHHH
Confidence 57788888887655422344677888899999999999999999999999999998 4677777543 25555667
Q ss_pred HHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccccc---ce
Q 020561 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTA---LE 318 (324)
Q Consensus 242 ~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~D 318 (324)
+.||+.||.|||+.+ +++|++|.-..|+++..|..||++|-++........ ......--..|..|+.+... .|
T Consensus 110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~~s~D 185 (690)
T KOG1243|consen 110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSEWSID 185 (690)
T ss_pred HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccccchh
Confidence 889999999998633 399999999999999999999999988765432211 01111223357778877644 79
Q ss_pred EEEecC
Q 020561 319 LFCLKC 324 (324)
Q Consensus 319 iwSlGc 324 (324)
.|-|||
T Consensus 186 ~~~Lg~ 191 (690)
T KOG1243|consen 186 SWGLGC 191 (690)
T ss_pred hhhHHH
Confidence 999987
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-12 Score=123.03 Aligned_cols=179 Identities=23% Similarity=0.199 Sum_probs=136.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHH--HHHHHHHHcCCC-CCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDLV-HLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~~~~~~ 204 (324)
..+|..+..||.|.|+.||....+. .++..|++|.+.........+ -+.|+.+...+. |.+++.++..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 4578888999999999999876442 145689999887654433322 356777777764 99999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-CcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DF 283 (324)
......||-.|||+++++...+ .-...+++...+++..|++.++.++|+.. ++|+|+||+||++..+ +..++.||
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence 9989999999999999988766 33345778888999999999999999988 9999999999999775 88899999
Q ss_pred cccccCCCCCccceeeccccccCcc-cccccc------ccceEEEec
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYA-APEYVM------TALELFCLK 323 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~-aPE~l~------~~~DiwSlG 323 (324)
|+.+.+.... ....++-+++ .+|+++ ..+|++|||
T Consensus 412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~ 453 (524)
T KOG0601|consen 412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLG 453 (524)
T ss_pred ccccccceec-----ccccccccccccchhhcccccccccccccccc
Confidence 9987532211 1122344455 355555 457999987
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-09 Score=97.05 Aligned_cols=140 Identities=14% Similarity=0.060 Sum_probs=98.1
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----------chHHHHHHHHHHcCCCCC--CcceEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHL--NLVKLI 201 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hp--nIv~~~ 201 (324)
+++-.-....|++..+. |+.|.||........ ....+.+|...+.+|..- ..+..+
T Consensus 28 e~v~~~~~rrvvr~~~~-----------g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pV 96 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-----------GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGV 96 (268)
T ss_pred cEEecCCCceEEEEEEC-----------CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCee
Confidence 44444444456665542 568999977433211 011477898888877432 233444
Q ss_pred EEEEe-----CCeEEEEEEecCCC-ChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 202 GYCIE-----DDQRLLVYEFMPRG-SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 202 ~~~~~-----~~~~~lv~E~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
++... ....+||||++++. +|.+++... ..+.+......++.+++..+.-||..+ |+|+||++.|||++.
T Consensus 97 a~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~ 173 (268)
T PRK15123 97 AFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHL 173 (268)
T ss_pred EEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEec
Confidence 44433 23478999999875 899888431 234566777889999999999999999 999999999999975
Q ss_pred -------CCcEEEEeeccccc
Q 020561 275 -------DYNAKLSDFGLAKD 288 (324)
Q Consensus 275 -------~~~~kl~DFGla~~ 288 (324)
+..+.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cccCCCCCceEEEEECCcccc
Confidence 46899999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-11 Score=107.87 Aligned_cols=136 Identities=23% Similarity=0.317 Sum_probs=101.5
Q ss_pred HHHcCCCCCCcceEEEEEEeC-----CeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 020561 187 NFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 258 (324)
Q Consensus 187 ~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ 258 (324)
.-|-++.|.|||+++.+|.+. ....++.||+..|+|.++|++. ...+......+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 334556799999999999764 3478999999999999999742 345777778899999999999999987 8
Q ss_pred CeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCC--ccceeeccccccCcccccccc-----ccceEEEec
Q 020561 259 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 259 ~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
+|+|++|..+.|++..+|-+||.--........-. .........|-++|.|||+=. +++|||++|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 89999999999999999999986321111110000 000111234678899999754 578999988
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-10 Score=94.55 Aligned_cols=100 Identities=21% Similarity=0.204 Sum_probs=66.5
Q ss_pred HHHHHHHHHcCCCCC--CcceEEEEEEeCCeEEEEEEecC--CCChHHHHhccCCCCCHHHHHHHHHHHHHHHHH-HHhc
Q 020561 181 EWLAEVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 255 (324)
Q Consensus 181 ~~~~E~~~l~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~ 255 (324)
...+|.+.|.++..- ++.+++.+. ..+|||||++ |..|..+.... ++......++.+++..+.. +|..
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc
Confidence 356899999999755 567776542 3479999998 55554433211 1234456677788885555 5787
Q ss_pred CCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 256 ~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
+ |||+||.+.|||++.+ .+.|+|||.+.....
T Consensus 127 g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 127 G---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSSH 158 (188)
T ss_dssp T---EEESS-STTSEEEETT-CEEE--GTTEEETTS
T ss_pred C---ceecCCChhhEEeecc-eEEEEecCcceecCC
Confidence 7 9999999999999877 999999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.1e-09 Score=99.14 Aligned_cols=138 Identities=20% Similarity=0.236 Sum_probs=109.9
Q ss_pred ceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe----CCeEEEEEEec
Q 020561 142 FGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFM 217 (324)
Q Consensus 142 fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~~~~~lv~E~~ 217 (324)
-.+.|+++... +|..|++|+++.+..........-+++++++.|+|||++.+++.+ +..+++|++|.
T Consensus 289 ~~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 35788988776 466899999965544444445567889999999999999998873 45789999998
Q ss_pred CC-CChHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 218 PR-GSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 218 ~~-gsL~~~l~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++ ++|.++.... +...++...+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEec
Confidence 86 6787765421 235778999999999999999999998 88899999999999998999987
Q ss_pred ecccccCCC
Q 020561 283 FGLAKDGPE 291 (324)
Q Consensus 283 FGla~~~~~ 291 (324)
-|+...+..
T Consensus 437 C~i~Dvl~~ 445 (655)
T KOG3741|consen 437 CGIMDVLQE 445 (655)
T ss_pred ccceeeecC
Confidence 776655433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.8e-08 Score=86.15 Aligned_cols=107 Identities=24% Similarity=0.231 Sum_probs=83.9
Q ss_pred HHHHHHHHHHcCCC--CCCcceEEEEEEeC----CeEEEEEEecCC-CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q 020561 180 KEWLAEVNFLGDLV--HLNLVKLIGYCIED----DQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252 (324)
Q Consensus 180 ~~~~~E~~~l~~l~--HpnIv~~~~~~~~~----~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yL 252 (324)
.+..+|...+..|. .-.+.+.+++.... ...+||+|++++ .+|.+++.... .++......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence 46778888877775 33355566665543 245899999987 48999885422 266677888999999999999
Q ss_pred HhcCCCCeEeCCCCCCcEEEcCCC---cEEEEeecccccCC
Q 020561 253 HEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGP 290 (324)
Q Consensus 253 H~~~~~~ivHrDLkp~NILl~~~~---~~kl~DFGla~~~~ 290 (324)
|..+ |+|+||+|.|||++.+. .+.|+||+.++...
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 99999999999998887 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-08 Score=86.60 Aligned_cols=136 Identities=18% Similarity=0.065 Sum_probs=94.5
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------------------cchHHHHHHHHH
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHKEWLAEVNF 188 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----------------------~~~~~~~~E~~~ 188 (324)
..++..||-|--+.||.|.... |.++|||.-..... -.+....+|.++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~----------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK----------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECCC----------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 4567899999999999998753 77999996532210 012235689999
Q ss_pred HcCCCCC--CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 020561 189 LGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (324)
Q Consensus 189 l~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLk 266 (324)
|.+|.-. .+.+.++ -+...+||||++|-.|...- +.....-.++..|+.-+.-+-..| |||+|+.
T Consensus 163 L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9998744 6776665 35678999999886665321 122233334444444444443556 9999999
Q ss_pred CCcEEEcCCCcEEEEeecccccC
Q 020561 267 TSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 267 p~NILl~~~~~~kl~DFGla~~~ 289 (324)
+-|||++.+|.+.++||=-+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999665543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-07 Score=82.37 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=85.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCC--CcceEEEEEEeCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~~~~~~~~~~~~~l 212 (324)
..||+|..+.||+.. +..+++|...... ......+|.+++..+..- .+.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 478999999999841 3357788876433 234578899999888643 35677888777778889
Q ss_pred EEEecCCCC-hHHHH---------------------hccC-CCCCHHHH-HHHHHH----------HHH-HHHHHHhc-C
Q 020561 213 VYEFMPRGS-LENHL---------------------FRRS-LPLPWSIR-MKIALG----------AAK-GLAFLHEE-A 256 (324)
Q Consensus 213 v~E~~~~gs-L~~~l---------------------~~~~-~~l~~~~~-~~i~~q----------i~~-gL~yLH~~-~ 256 (324)
|||+++|.+ +...+ +.-. ........ ..+..+ +.. ...+|... .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 21111 1100 00110000 001000 111 12222211 1
Q ss_pred CCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 257 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
...++|+|+.|.||+++.++ +.|+||+.+...
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 23479999999999999888 999999988754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-08 Score=98.22 Aligned_cols=142 Identities=17% Similarity=0.146 Sum_probs=93.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc------------------------------------
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------------ 178 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~------------------------------------ 178 (324)
+.|+.++-|+||+|.+. +|+.||||+...+-...
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 68999999999999987 48899999886532100
Q ss_pred ----hHHHHHHHHHHcCCC-----CCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHH
Q 020561 179 ----HKEWLAEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249 (324)
Q Consensus 179 ----~~~~~~E~~~l~~l~-----HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL 249 (324)
.-++.+|...+.++. .|+|.--.=+|.......|+|||++|-.+.+........++.........++. +
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--L 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--H
Confidence 012334555544442 34433223334445677899999999988887533334455333332222222 2
Q ss_pred HHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 250 ~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
.-+-..+ +.|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2222245 99999999999999999999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.7e-10 Score=111.92 Aligned_cols=181 Identities=20% Similarity=0.178 Sum_probs=125.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.+.+.+.+-+|.|+.++.+.-. .+|...++|+....... ..+....+-.++-...||.++...-.+..
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa---------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPA---------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred cceecccccCCCCcccccCCcc---------ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence 4566677888999999876433 24555666655433211 11223344444444456777766655566
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
....+||++|+.+++|...|+... ..+.+-+......+..+++|||+.. ++|||++|.|+|...++..++.|||+.
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence 778999999999999999996544 4555566667778899999999976 899999999999999999999999844
Q ss_pred ccCCCC----------------------Ccc-------ceeeccccccCcccccccc-----ccceEEEec
Q 020561 287 KDGPEG----------------------DKT-------HVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 287 ~~~~~~----------------------~~~-------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
...... ... ...-...||+.|.+||.+. .++|+|++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 321100 000 0011357999999999998 358999987
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-07 Score=79.25 Aligned_cols=138 Identities=17% Similarity=0.111 Sum_probs=100.1
Q ss_pred cCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC------ccchHHHHHHHHHHcCCCC--CCcceEEEEEEeC--
Q 020561 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG------LQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIED-- 207 (324)
Q Consensus 138 G~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~-- 207 (324)
|+||.+-|++-.+. |..+=+|.-.... ......|.+|+..|.+|.. ..+.+...+....
T Consensus 27 ~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~ 95 (216)
T PRK09902 27 RRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIE 95 (216)
T ss_pred CCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccC
Confidence 56888889986554 3356677654211 2244679999999988863 2345554222221
Q ss_pred --CeEEEEEEecCC-CChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--EEEE
Q 020561 208 --DQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLS 281 (324)
Q Consensus 208 --~~~~lv~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--~kl~ 281 (324)
-..+||+|-+++ -+|.+++.... .+.+......++.+++..+.-||+.+ +.|+|+-+.|||++.++. ++++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEE
Confidence 236899998754 68999885432 35677778899999999999999988 999999999999986667 9999
Q ss_pred eecccccC
Q 020561 282 DFGLAKDG 289 (324)
Q Consensus 282 DFGla~~~ 289 (324)
||.-++..
T Consensus 173 DlEk~r~~ 180 (216)
T PRK09902 173 DLEKSRRR 180 (216)
T ss_pred Ehhccchh
Confidence 99877643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.7e-10 Score=104.78 Aligned_cols=163 Identities=17% Similarity=0.093 Sum_probs=116.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC-cceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~lv 213 (324)
.-++++++++++|.+... + +....+.+... ....-++++|.+++||| .+.+++-+..++..+++
T Consensus 248 h~fvK~altknpKkRpta---------e-klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTA---------E-KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred HHHHHHHhcCCCccCCCh---------h-hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 446789999999876442 1 12225544332 34456889999999999 88888888888999999
Q ss_pred EEecCCC-ChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 214 YEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 214 ~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
|+++.++ +-..........+..-+...+.+.-+.+|+|||+.. =+||| ||+... +..+..||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999777 222222112223444455667777888999999854 48999 777644 78999999998877654
Q ss_pred CccceeeccccccCcccccccc-----ccceEEEec
Q 020561 293 DKTHVSTRVMGTYGYAAPEYVM-----TALELFCLK 323 (324)
Q Consensus 293 ~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlG 323 (324)
. ......+|+.|+|||++. ...|.|++|
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~ 417 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLA 417 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCC
Confidence 3 234567999999999876 457999886
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.3e-07 Score=76.77 Aligned_cols=140 Identities=11% Similarity=0.082 Sum_probs=90.8
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHH---------HHHHHHHcCCC---
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---------LAEVNFLGDLV--- 193 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~--- 193 (324)
+...+|...+++-......|.+-... |..+++|..........+.| .+++..+.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG 96 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence 45568888888888777777765543 56899998865443222221 22333333332
Q ss_pred CCCcceEEEEE-----EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 194 HLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 194 HpnIv~~~~~~-----~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
-..++.++.+. ......+|+|||++|..|.+... +++ .+...|..++.-||..| +.|+|..|.
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpg 164 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPG 164 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcC
Confidence 22222322222 22244579999999988876541 222 24456778899999998 999999999
Q ss_pred cEEEcCCCcEEEEeecccccC
Q 020561 269 NILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~ 289 (324)
|++++.+ .++++||+..+..
T Consensus 165 NFlv~~~-~i~iID~~~k~~~ 184 (229)
T PF06176_consen 165 NFLVSNN-GIRIIDTQGKRMS 184 (229)
T ss_pred cEEEECC-cEEEEECcccccc
Confidence 9999855 4999999876643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.3e-07 Score=77.72 Aligned_cols=150 Identities=18% Similarity=0.146 Sum_probs=97.5
Q ss_pred HHHHHHhcCCCCCc---eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-------------------ch
Q 020561 122 NDLKLATRNFRPES---LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-------------------GH 179 (324)
Q Consensus 122 ~~~~~~~~~y~~~~---~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-------------------~~ 179 (324)
..+....+...+.. .|.+|--+.||+|... .+..+|||+....... ..
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r 107 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR 107 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence 33333334444444 4567777899998653 3668999988643211 11
Q ss_pred H-----HHHHHHHHHcCCC--CCCcceEEEEEEeCCeEEEEEEecCCCCh-HHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q 020561 180 K-----EWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLPWSIRMKIALGAAKGLAF 251 (324)
Q Consensus 180 ~-----~~~~E~~~l~~l~--HpnIv~~~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~l~~~~~~~i~~qi~~gL~y 251 (324)
. ...+|+.-|.++. +-.+.+-+.+.. -.|||||+....+ .-.| ...++....+..+..++++.+.-
T Consensus 108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHH
Confidence 1 1245777777764 555666665442 3699999954311 1111 11233444677788888888887
Q ss_pred HHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 252 LHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 252 LH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
|-. .+ +||+||+.-|||+. ++.+.|+|||-|.....
T Consensus 182 l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 182 LYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred HHHhcC---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 766 55 99999999999998 88999999999877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.58 E-value=1e-06 Score=77.29 Aligned_cols=140 Identities=20% Similarity=0.130 Sum_probs=84.5
Q ss_pred eecCCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEEE
Q 020561 136 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 136 ~lG~G~f-g~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 213 (324)
.|-.|.+ ..||+.... +..+.||+..... ..++.+|+.++..+. +--+.+++++....+..++|
T Consensus 5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 3445555 789987532 2368888875443 235677888887774 44567788877766778999
Q ss_pred EEecCCCChHHHH-------------------hccC---CCCCHH--HHHHHHH--------------------HHHHHH
Q 020561 214 YEFMPRGSLENHL-------------------FRRS---LPLPWS--IRMKIAL--------------------GAAKGL 249 (324)
Q Consensus 214 ~E~~~~gsL~~~l-------------------~~~~---~~l~~~--~~~~i~~--------------------qi~~gL 249 (324)
||+++|.+|.... +.-. .++... ..+.... .+...+
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (244)
T cd05150 71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY 150 (244)
T ss_pred EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence 9999987776432 1100 011100 0000000 011112
Q ss_pred HHHHh----cCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 250 AFLHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 250 ~yLH~----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..|-. .....++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 22211 11234899999999999998877899999988653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.6e-07 Score=77.28 Aligned_cols=143 Identities=18% Similarity=0.155 Sum_probs=83.7
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCC--CcceEEEEEEe---CC
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE---DD 208 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~~~~~~~~---~~ 208 (324)
++.|+.|..+.||+..... ..+++|..... .....+.+|..++..|... .+.+++..... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 3578999999999987643 38999987654 3345677888888877532 35667764433 34
Q ss_pred eEEEEEEecCCCChHH----------------HH---hcc---CCCCCHHH---------HHHH------------HHHH
Q 020561 209 QRLLVYEFMPRGSLEN----------------HL---FRR---SLPLPWSI---------RMKI------------ALGA 245 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~----------------~l---~~~---~~~l~~~~---------~~~i------------~~qi 245 (324)
..+++|++++|..+.. .+ +.. ...+.... .... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 5789999999987777 11 111 01111111 0000 1112
Q ss_pred HH-HHHHHHhc----CCCCeEeCCCCCCcEEEc-CCCcEEEEeecccccC
Q 020561 246 AK-GLAFLHEE----AERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDG 289 (324)
Q Consensus 246 ~~-gL~yLH~~----~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~ 289 (324)
.. .++.++.. ....++|+|+.|.|||++ .++.+.|+||+.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 22 23333321 234599999999999999 6666789999887653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.5e-07 Score=86.43 Aligned_cols=140 Identities=16% Similarity=0.116 Sum_probs=88.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------------------------------hH---
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------------------------------HK--- 180 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-------------------------------~~--- 180 (324)
+.||.-+.|+||+|+.++ |..||||+-+..-... .+
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 679999999999999875 7799999765431110 01
Q ss_pred ---HHHHHHHHHc----CCCCCC------cceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHH
Q 020561 181 ---EWLAEVNFLG----DLVHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247 (324)
Q Consensus 181 ---~~~~E~~~l~----~l~Hpn------Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~ 247 (324)
+|.+|.+-.. .+.|-+ |.++|-.+ .....|+||||+|..+.+.-.-....++...+..-+.++..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 2333433222 223444 44454322 34578999999998776654323334555544333333322
Q ss_pred HHHHHHhcCCCCeEeCCCCCCcEEEcC----CCcEEEEeecccccCCC
Q 020561 248 GLAFLHEEAERPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 248 gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~~kl~DFGla~~~~~ 291 (324)
-+ |-..| ++|.|=.|.||++.. ++.+.+-|||+...+..
T Consensus 315 ~q--If~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQ--IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HH--HHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22 22234 999999999999983 67899999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.2e-06 Score=70.26 Aligned_cols=128 Identities=17% Similarity=0.222 Sum_probs=89.6
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----------------ccchHHHHHHHHHHcCCC----
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGDLV---- 193 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 193 (324)
..+||+|+.-.||.-- . .....||++.... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~HP--~----------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP--D----------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEECC--C----------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 4589999999999632 1 2256788887655 112345667776665555
Q ss_pred --CCCcceEEEEEEeCCeEEEEEEecCC------CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 194 --HLNLVKLIGYCIEDDQRLLVYEFMPR------GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 194 --HpnIv~~~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
+.+|.+++|+.+++-.+-+|+|.+.+ .+|.+++.+. .++. .... .+-.-.+||-.++ |+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALDEFKRYLLDHH---IVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHHHHHHHHHHcC---CeecCC
Confidence 88999999999999999999998643 3788888432 3554 3233 3334456777777 999999
Q ss_pred CCCcEEEcCC--C--cEEEEe
Q 020561 266 KTSNILLDAD--Y--NAKLSD 282 (324)
Q Consensus 266 kp~NILl~~~--~--~~kl~D 282 (324)
+|.||++... + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999432 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=73.68 Aligned_cols=103 Identities=28% Similarity=0.241 Sum_probs=81.1
Q ss_pred HHHHHHHcCCCC-CCcceEEEEEEeCCeEEEEEEecCCCChHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 020561 183 LAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259 (324)
Q Consensus 183 ~~E~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 259 (324)
..|.-+|..|.+ +++++++|+|- .++|.||...+++..... ..-...+|..+.+|+.+++..+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999993 378999998765532100 01124689999999999999999999855445
Q ss_pred eEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 260 ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
+.-.|++|+|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.7e-06 Score=85.03 Aligned_cols=149 Identities=16% Similarity=0.198 Sum_probs=91.5
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCC-CCCc--ceEEEEEEeC--
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNL--VKLIGYCIED-- 207 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~~~~~~~~~-- 207 (324)
++.|+.|.+..+|+......+ ....+++|+..... ......+.+|+.+|+.|. |++| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 467899999999987654311 11357777765432 223356889999999995 6654 7888877664
Q ss_pred -CeEEEEEEecCCCChHH--------------------H---HhccCC----------CCC--HHHHHHHHH--------
Q 020561 208 -DQRLLVYEFMPRGSLEN--------------------H---LFRRSL----------PLP--WSIRMKIAL-------- 243 (324)
Q Consensus 208 -~~~~lv~E~~~~gsL~~--------------------~---l~~~~~----------~l~--~~~~~~i~~-------- 243 (324)
+..|+||||++|..+.+ . |+.-.. +.. ..+...+..
T Consensus 116 ~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~ 195 (822)
T PLN02876 116 IGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGE 195 (822)
T ss_pred CCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcc
Confidence 46789999998764321 1 111000 000 111211111
Q ss_pred -------HHHHHHHHHHhcCC--------CCeEeCCCCCCcEEEcCC-Cc-EEEEeecccccC
Q 020561 244 -------GAAKGLAFLHEEAE--------RPVIYRDFKTSNILLDAD-YN-AKLSDFGLAKDG 289 (324)
Q Consensus 244 -------qi~~gL~yLH~~~~--------~~ivHrDLkp~NILl~~~-~~-~kl~DFGla~~~ 289 (324)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus 196 ~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 196 GKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12234566654322 249999999999999753 33 579999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.6e-06 Score=74.34 Aligned_cols=74 Identities=18% Similarity=0.196 Sum_probs=46.4
Q ss_pred CceecCCCce-EEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC---CCcceEEEEEEeC--
Q 020561 134 ESLLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIED-- 207 (324)
Q Consensus 134 ~~~lG~G~fg-~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~~~~~~~~~-- 207 (324)
++.|+.|+.. .||+. +..+++|...... ...++.+|..+|..|.. --+.++++.....
T Consensus 2 ~~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~ 65 (235)
T cd05155 2 IEPVDSGGTDNATFRL--------------GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG 65 (235)
T ss_pred ceeccCCCcccceEEc--------------CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC
Confidence 3567877776 58875 1247778655422 23468889999877752 1345555544332
Q ss_pred -CeEEEEEEecCCCChH
Q 020561 208 -DQRLLVYEFMPRGSLE 223 (324)
Q Consensus 208 -~~~~lv~E~~~~gsL~ 223 (324)
...|++|++++|.++.
T Consensus 66 ~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 66 YPWPWSVYRWLEGETAT 82 (235)
T ss_pred CCcceEEEEeecCCCCC
Confidence 2458999999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.33 E-value=7e-06 Score=69.15 Aligned_cols=125 Identities=29% Similarity=0.406 Sum_probs=89.6
Q ss_pred cCCCCCceecCCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecC---CCc-------c-----------chHHHHHHH
Q 020561 129 RNFRPESLLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---DGL-------Q-----------GHKEWLAEV 186 (324)
Q Consensus 129 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~---~~~-------~-----------~~~~~~~E~ 186 (324)
.+++.++.||.|.- |.||+++.. |..||+|++.. ... . ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 68889999999999 999999875 67999999321 110 0 012467899
Q ss_pred HHHcCCC---CCCc--ceEEEEEEeC------------------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHH
Q 020561 187 NFLGDLV---HLNL--VKLIGYCIED------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243 (324)
Q Consensus 187 ~~l~~l~---HpnI--v~~~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~ 243 (324)
++..+|+ +.++ |+.+|+..-. ....||.||++... .+. ..-+.
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~ 171 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIP 171 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHH
Confidence 9888876 4456 8888887432 12357888775533 122 23355
Q ss_pred HHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 244 qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+|..-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 6777888999988 999999999986 4589999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.5e-06 Score=67.82 Aligned_cols=130 Identities=18% Similarity=0.144 Sum_probs=88.0
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcc-eEEEEEEeCCeE
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQR 210 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~ 210 (324)
+..+.|++|.+|.||+|.+. |..+|+|+-..+.. +..+..|+++|..+.-.++. ++|.+.. .
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~ 87 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----D 87 (201)
T ss_pred hhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence 34568999999999999886 45899998766543 36788999999988866654 3444332 3
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC-CCcEEEcCCCcEEEEeecccccC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK-TSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLk-p~NILl~~~~~~kl~DFGla~~~ 289 (324)
++.|||+.|-.|.++-.. .+..+...+ ++.---|-..+ |-|..|. |..++|..++.+.|+||.-|+.-
T Consensus 88 ~i~me~i~G~~L~~~~~~----~~rk~l~~v----lE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG----GDRKHLLRV----LEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhhcCcchhhhhhc----ccHHHHHHH----HHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 566999998888876532 133333333 33322233334 8888776 45555556669999999998854
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.2e-06 Score=84.88 Aligned_cols=80 Identities=25% Similarity=0.421 Sum_probs=60.5
Q ss_pred HHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccce-------eeccccccCcccccccc-
Q 020561 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM- 314 (324)
Q Consensus 243 ~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-------~~~~~Gt~~y~aPE~l~- 314 (324)
.+++.||.|+|.. ..+||++|.|++|.++..+.+||+.|+.+........... ..-..-...|.|||++.
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4556999999984 4599999999999999999999999998865443111100 11123456899999997
Q ss_pred ----ccceEEEecC
Q 020561 315 ----TALELFCLKC 324 (324)
Q Consensus 315 ----~~~DiwSlGc 324 (324)
.++|+|||||
T Consensus 184 ~~~~~~sd~fSlG~ 197 (700)
T KOG2137|consen 184 TTNTPASDVFSLGV 197 (700)
T ss_pred ccccccccceeeee
Confidence 4689999997
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.6e-05 Score=69.67 Aligned_cols=76 Identities=12% Similarity=0.064 Sum_probs=54.5
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC---CCcceEEEEEEe---C
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIE---D 207 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~~~~~~~~---~ 207 (324)
.+.||.|..+.||+....+ + .+.+|..+.. .....+.+|...|+.|.- ..+.++++++.. .
T Consensus 19 ~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ----------G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEcCC----------C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 4679999999999975432 2 4667775431 122568889999888752 467888887754 3
Q ss_pred CeEEEEEEecCCCCh
Q 020561 208 DQRLLVYEFMPRGSL 222 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL 222 (324)
+..+||||++++.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.6e-05 Score=64.90 Aligned_cols=142 Identities=19% Similarity=0.158 Sum_probs=79.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC-CCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~~~~~lv 213 (324)
+.|..|-...+|+.....+ .+..|++|+....... .-...+|+.++..+.. .-.+++++.+. + .+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEE
Confidence 5677888889998864310 1347889976543211 1223468888887753 23445554332 2 489
Q ss_pred EEecCCCChHHH--------------H---hccCCCC----------C-HHHHHHHHH----------------------
Q 020561 214 YEFMPRGSLENH--------------L---FRRSLPL----------P-WSIRMKIAL---------------------- 243 (324)
Q Consensus 214 ~E~~~~gsL~~~--------------l---~~~~~~l----------~-~~~~~~i~~---------------------- 243 (324)
|||++|.++... | +...... . +.....+..
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (235)
T cd05157 71 YEFIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFE 150 (235)
T ss_pred EEeeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHH
Confidence 999998765321 1 1111111 1 112112211
Q ss_pred HHHHHHHH----HHhc-CCCCeEeCCCCCCcEEEcC-CCcEEEEeecccccC
Q 020561 244 GAAKGLAF----LHEE-AERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDG 289 (324)
Q Consensus 244 qi~~gL~y----LH~~-~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~ 289 (324)
.+...+.. +-.. ....++|+|+.+.|||++. ++.+.|+||..|...
T Consensus 151 ~l~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 151 QLRDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 11111111 1111 2234999999999999997 578999999888653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.4e-07 Score=89.54 Aligned_cols=64 Identities=19% Similarity=0.274 Sum_probs=47.8
Q ss_pred EeCCCCCC-cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 261 IYRDFKTS-NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 261 vHrDLkp~-NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.|++..|. |++++....+++.|||.++..............+||+.|||||++. .++|||||||
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~ 568 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGV 568 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHH
Confidence 44566666 6667777778999999988765443333334468999999999987 4589999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00013 Score=68.40 Aligned_cols=77 Identities=19% Similarity=0.131 Sum_probs=53.5
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC------C-ccchHHHHHHHHHHcCCC---CCCcceEEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV---HLNLVKLIGY 203 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---HpnIv~~~~~ 203 (324)
.+.||.|.+..||+..... .++.|+||.-... . ....++...|.+.|..+. ..++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 3579999999999998753 1247999975311 1 123456778888887763 3567888876
Q ss_pred EEeCCeEEEEEEecCCCC
Q 020561 204 CIEDDQRLLVYEFMPRGS 221 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gs 221 (324)
+++..++||||+++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 3455789999997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.2e-05 Score=68.99 Aligned_cols=141 Identities=19% Similarity=0.132 Sum_probs=83.4
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCC--CcceEEEE------EE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY------CI 205 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~~~~~------~~ 205 (324)
++.|..|....+|+.... +..+++|+... ....++..|+.++..|.+. .+.+++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 456777877899987542 23688898764 2234566778777777432 24454432 23
Q ss_pred eCCeEEEEEEecCCCChHH----H----------Hhcc--C--C------CCCHHHHH----------HHHHHHHHHHHH
Q 020561 206 EDDQRLLVYEFMPRGSLEN----H----------LFRR--S--L------PLPWSIRM----------KIALGAAKGLAF 251 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~----~----------l~~~--~--~------~l~~~~~~----------~i~~qi~~gL~y 251 (324)
..+..++|++|++|..+.. . |+.. . . ...|.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999998866522 1 1110 0 0 01111110 011123334444
Q ss_pred HHh----cCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 252 LHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 252 LH~----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
+-. .-+..+||+|+.|.|||++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 443 1224599999999999999887789999988765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.2e-05 Score=66.08 Aligned_cols=138 Identities=17% Similarity=0.131 Sum_probs=76.9
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCc-ceEEEEEEeCCeEEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 214 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~lv~ 214 (324)
.+..|-...+|+... .+..+++|..........-...+|..+++.+....+ .+++... . -++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 345677888998752 245788887654322211134678888888864333 3444433 2 36899
Q ss_pred EecCCCChHHH-----------------Hhcc---CCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCC
Q 020561 215 EFMPRGSLENH-----------------LFRR---SLPLPWS-IRMKIALGA---------AKGLAFLHEE-----AERP 259 (324)
Q Consensus 215 E~~~~gsL~~~-----------------l~~~---~~~l~~~-~~~~i~~qi---------~~gL~yLH~~-----~~~~ 259 (324)
||++|..+... |+.. ..+++.. ....+..++ ...+..+-.. .+..
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99998665321 1111 1111211 111111111 1112222211 1224
Q ss_pred eEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 260 ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
++|+|+.|.|||++.++ +.|+||..|...
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 89999999999998877 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0015 Score=59.60 Aligned_cols=32 Identities=31% Similarity=0.403 Sum_probs=27.1
Q ss_pred CCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 257 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
+.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 34699999999999998766568999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00032 Score=63.48 Aligned_cols=147 Identities=23% Similarity=0.247 Sum_probs=83.2
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC-cceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~lv 213 (324)
+.|..|-...||+....... ..+.++..+++|+..... ....+..+|..++..+.... ..++++++. . .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 45666777789988653210 012235689999876543 22234567887777775322 345555543 2 468
Q ss_pred EEecCCCChHHH-----------------HhccCCC--------CC--HHHHHH--------------------------
Q 020561 214 YEFMPRGSLENH-----------------LFRRSLP--------LP--WSIRMK-------------------------- 240 (324)
Q Consensus 214 ~E~~~~gsL~~~-----------------l~~~~~~--------l~--~~~~~~-------------------------- 240 (324)
+||++|..+... |++.... .+ +.....
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 999988766431 1111111 01 101101
Q ss_pred HHHHHHHHHHHHHh------cCCCCeEeCCCCCCcEEEcCC----CcEEEEeecccccC
Q 020561 241 IALGAAKGLAFLHE------EAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDG 289 (324)
Q Consensus 241 i~~qi~~gL~yLH~------~~~~~ivHrDLkp~NILl~~~----~~~kl~DFGla~~~ 289 (324)
+..++..-+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|...
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 11122223334432 133458999999999999874 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00048 Score=62.58 Aligned_cols=142 Identities=18% Similarity=0.141 Sum_probs=80.8
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC--CCcceEEEE------EE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGY------CI 205 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~------~~ 205 (324)
++.++.|....+|+.... +..+++|+..... ...++..|++++..|.. -.+.+++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t~-----------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-----------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEeC-----------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 456777777889987532 2257788775432 12445566777666632 123444432 12
Q ss_pred eCCeEEEEEEecCCCChH----H-------H---HhccCCCC-----------CHHHHH------------HHHHHHHHH
Q 020561 206 EDDQRLLVYEFMPRGSLE----N-------H---LFRRSLPL-----------PWSIRM------------KIALGAAKG 248 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~----~-------~---l~~~~~~l-----------~~~~~~------------~i~~qi~~g 248 (324)
..+..+++|||++|..+. . . ++.....+ .|.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 245678999999885432 1 1 11100000 111100 011123334
Q ss_pred HHHHHh----cCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 249 LAFLHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 249 L~yLH~----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
++++.. ..+..+||+|+.+.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 555542 2235699999999999999887778999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0013 Score=59.74 Aligned_cols=33 Identities=21% Similarity=0.422 Sum_probs=29.5
Q ss_pred CCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 258 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
..++|+|+.+.||+++..+.+-|.||+++....
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 459999999999999999889999999997653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00098 Score=61.80 Aligned_cols=161 Identities=16% Similarity=0.130 Sum_probs=102.0
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEE-----
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI----- 205 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~----- 205 (324)
.+.+.||+|+-+.+|----. ...+.|+..........+ -+..|... .||-+..-+ .|.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~------------~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rv-aWPqa~L~ 77 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV------------RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRV-AWPQATLH 77 (637)
T ss_pred CCCccccCCccceeeecchh------------hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhh-cccHHHhh
Confidence 45678999999999964211 134557776554332222 22333333 466443311 121
Q ss_pred ---eCCeEEEEEEecCCC-ChHHHHh---c--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 ---EDDQRLLVYEFMPRG-SLENHLF---R--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 ---~~~~~~lv~E~~~~g-sL~~~l~---~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
.....-+.|..+.+. .+..++. + .-....|...++.++.++.+..-||..| .+-+|+.++|+|+.+++
T Consensus 78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~ 154 (637)
T COG4248 78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDS 154 (637)
T ss_pred CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCc
Confidence 112256788887664 2333332 1 1234789999999999999999999998 88899999999999999
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~ 314 (324)
.+.|.|=..-..-.+ .......+|...|.+||.-.
T Consensus 155 ~V~LVdsDsfqi~~n---g~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 155 KVVLVDSDSFQINAN---GTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred eEEEEcccceeeccC---CceEecccCccccCCHHHhc
Confidence 999997432211111 11233457999999999765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0026 Score=58.75 Aligned_cols=145 Identities=17% Similarity=0.130 Sum_probs=81.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcc-eEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~lv 213 (324)
..|-.|-.-.+|+........ .++..|++|+.......... -.+|..++..+..-++. ++++.+.. + .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 456567888999986542111 13468999988654322222 25688888777543333 45555422 2 58
Q ss_pred EEecCCCChHHH-----------------HhccCC-----CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 020561 214 YEFMPRGSLENH-----------------LFRRSL-----PLPWSIRMKIALGA-----------------AKGLAFL-- 252 (324)
Q Consensus 214 ~E~~~~gsL~~~-----------------l~~~~~-----~l~~~~~~~i~~qi-----------------~~gL~yL-- 252 (324)
++|+++.+|... ++.... ...+.....+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987666421 111111 11122222332111 1112222
Q ss_pred --Hh-cCCCCeEeCCCCCCcEEEcC-CCcEEEEeecccccC
Q 020561 253 --HE-EAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDG 289 (324)
Q Consensus 253 --H~-~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~ 289 (324)
.. ..+..++|+||++.|||++. ++.+.|+||..|...
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 21 11234899999999999976 478999999988753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.002 Score=58.98 Aligned_cols=141 Identities=18% Similarity=0.155 Sum_probs=90.6
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--c--------------------chH----HHHHHH
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--Q--------------------GHK----EWLAEV 186 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~--------------------~~~----~~~~E~ 186 (324)
+...|..|--+.||.|.-. .|..+|||+.+..-. . .++ ....|+
T Consensus 148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4457888999999998654 377899998753210 0 011 124577
Q ss_pred HHHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCCh-HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 187 ~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
+-|.+|+...|.----+.. ....|||+|+....- .-.| ....++...+..+-.|++.-+.-|-... ++||.||
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL 291 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL 291 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence 7777776544332111111 124699999943211 1112 2345677777788888888887766533 3999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCC
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
.--|+|+ .+|.+.|+|.+-+....
T Consensus 292 SEfN~Ly-hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 292 SEFNLLY-HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred hhhhheE-ECCEEEEEEccccccCC
Confidence 9999999 57789999998876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00025 Score=63.76 Aligned_cols=135 Identities=17% Similarity=0.089 Sum_probs=90.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------------------cchHHHHHHHH
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHKEWLAEVN 187 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----------------------~~~~~~~~E~~ 187 (324)
-+.+++.||-|--+-||.+-+.+ |.+.++|.-..... -.+-...+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 36788999999999999997764 66788885322110 00123457888
Q ss_pred HHcCCC-CC-CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 188 FLGDLV-HL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 188 ~l~~l~-Hp-nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
.|+.|. |- -+.+.++ .+..++|||++.|..|.+.-+- .+..+ +...++.-+.-|-.+| +||+|.
T Consensus 163 fmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcC---ceeccc
Confidence 888875 32 2444444 4567999999999888764321 12222 2333333345566666 999999
Q ss_pred CCCcEEEcCCCcEEEEeeccccc
Q 020561 266 KTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~ 288 (324)
.-=||++++++.++++||=-...
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred chheeEEecCCCEEEeechHhhc
Confidence 99999999999999999954433
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0055 Score=56.51 Aligned_cols=73 Identities=15% Similarity=0.094 Sum_probs=47.0
Q ss_pred eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecC-------CCccchHHHHHHHHHHcCCC--CC-CcceEEEEEE
Q 020561 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-------DGLQGHKEWLAEVNFLGDLV--HL-NLVKLIGYCI 205 (324)
Q Consensus 136 ~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--Hp-nIv~~~~~~~ 205 (324)
.||.|....||++.... .+..|+||.-.. .-.-...+...|...|.... -| .+.++|.+
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-- 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-- 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--
Confidence 47999999999998532 225789986421 11223456667888876653 24 46666653
Q ss_pred eCCeEEEEEEecCC
Q 020561 206 EDDQRLLVYEFMPR 219 (324)
Q Consensus 206 ~~~~~~lv~E~~~~ 219 (324)
++....+|||+++.
T Consensus 71 D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 71 DTEMAVTVMEDLSH 84 (370)
T ss_pred ccccceehHhhCcc
Confidence 34556799999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0011 Score=61.42 Aligned_cols=131 Identities=18% Similarity=0.229 Sum_probs=76.1
Q ss_pred ceecCCCceEEEEEEEc------cCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHc------------------
Q 020561 135 SLLGEGGFGCVFKGWIE------ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG------------------ 190 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~------~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~------------------ 190 (324)
..||.|+-++||+|..+ +++...+.+.+.+.+|||+.+.+... ++.+...+|.
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~---~ir~Dl~Il~f~Akl~~~vP~l~wL~l~ 271 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEK---QIRLDLGILGFGAKLINNVPDLSWLSLP 271 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHH---HHHHHHHHHhhhhhhhhhcCccccccCc
Confidence 57999999999999765 23333355667789999998765321 1112222221
Q ss_pred ------------CCC----CCCcceEEEEE-------------EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHH
Q 020561 191 ------------DLV----HLNLVKLIGYC-------------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241 (324)
Q Consensus 191 ------------~l~----HpnIv~~~~~~-------------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i 241 (324)
+++ --|+-++..-| .......|+-+|..|-++..++.... .+++...++
T Consensus 272 ~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkv 349 (565)
T KOG1236|consen 272 LEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS--QPEALVKKV 349 (565)
T ss_pred chHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc--ChHHHHHHH
Confidence 111 00111110000 01123356777888999999885433 445566666
Q ss_pred HHHHHHHHHHHH-hcCCCCeEeCCCCCCcEEEc
Q 020561 242 ALGAAKGLAFLH-EEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 242 ~~qi~~gL~yLH-~~~~~~ivHrDLkp~NILl~ 273 (324)
+.-.+.||.-+- -.+ ++|.||.|.||++.
T Consensus 350 a~lg~~AllkMl~vDN---FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 350 AKLGVNALLKMLIVDN---FVHADLHPGNVLIR 379 (565)
T ss_pred HHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence 655555544322 234 99999999999994
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.013 Score=54.93 Aligned_cols=73 Identities=10% Similarity=0.021 Sum_probs=49.0
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------cchHHHHHHHHHHcCCC---CCCcceEEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLV---HLNLVKLIGY 203 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---HpnIv~~~~~ 203 (324)
.+.||.|....||+.... +..|+||.-..... -...+-..|...|..+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 467899999999997652 23588887642110 12344455677776553 3578889988
Q ss_pred EEeCCeEEEEEEecCC
Q 020561 204 CIEDDQRLLVYEFMPR 219 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~ 219 (324)
+. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 76 446789999976
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.005 Score=55.09 Aligned_cols=31 Identities=32% Similarity=0.459 Sum_probs=26.3
Q ss_pred CeEeCCCCCCcEEEcCCCc-EEEEeecccccC
Q 020561 259 PVIYRDFKTSNILLDADYN-AKLSDFGLAKDG 289 (324)
Q Consensus 259 ~ivHrDLkp~NILl~~~~~-~kl~DFGla~~~ 289 (324)
.+||+|+.|.|||++.++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999987555 569999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0084 Score=54.32 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=26.0
Q ss_pred CCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 258 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.++||+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 45999999999999987 6789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0078 Score=54.11 Aligned_cols=73 Identities=22% Similarity=0.283 Sum_probs=45.9
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC---CCCcceEEEEEEeCCeE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~ 210 (324)
.+.|+-|....+|+... .+..+-||+-... ....|..|..-|+.|. --.+.+++++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEEC-----------CCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 45788899999998752 3568899987622 2345777887777773 45678899988888888
Q ss_pred EEEEEecCCC
Q 020561 211 LLVYEFMPRG 220 (324)
Q Consensus 211 ~lv~E~~~~g 220 (324)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.013 Score=53.76 Aligned_cols=143 Identities=16% Similarity=0.212 Sum_probs=77.9
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCc-ceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~lv 213 (324)
+.|..|-...+|+....... ..+..|++|+........ -.-.+|..++..+..-++ .++++++. .+ +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Ee
Confidence 34555777789988654311 023478899876543211 122568888887765444 34555542 22 58
Q ss_pred EEecCCCChHH--------------H---HhccCC-----CCCHHHHHHHHHHH----------------------HHHH
Q 020561 214 YEFMPRGSLEN--------------H---LFRRSL-----PLPWSIRMKIALGA----------------------AKGL 249 (324)
Q Consensus 214 ~E~~~~gsL~~--------------~---l~~~~~-----~l~~~~~~~i~~qi----------------------~~gL 249 (324)
.+|+++..|.. . |+.... +..+.....+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 99987765521 0 111111 11122222222221 1111
Q ss_pred HH---HH-hcC-CCCeEeCCCCCCcEEEcC-CCcEEEEeeccccc
Q 020561 250 AF---LH-EEA-ERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 288 (324)
Q Consensus 250 ~y---LH-~~~-~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~ 288 (324)
.. +. ..+ +.-++|.||.+.|||+++ ++.++++||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 11 111 123799999999999974 57899999998865
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0053 Score=56.25 Aligned_cols=74 Identities=19% Similarity=0.176 Sum_probs=56.1
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
..+.|++|++- |++|.- + ....+++.+.++.+.+.-+.-+-.+ .+.=||||...||||+ +|+|.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 34567888875 556542 2 2346788888888877766666553 5689999999999999 999999999999
Q ss_pred ccC
Q 020561 287 KDG 289 (324)
Q Consensus 287 ~~~ 289 (324)
+.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 853
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0013 Score=67.89 Aligned_cols=134 Identities=22% Similarity=0.229 Sum_probs=95.3
Q ss_pred HHHHHHHcCCCCCCcceEEEEEEeCCeE----EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 020561 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 258 (324)
Q Consensus 183 ~~E~~~l~~l~HpnIv~~~~~~~~~~~~----~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ 258 (324)
..|...+.++.|+|++.++.+....-.. .+..++|..-++...+. .-...+..+.+.+..++..||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~-- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS-- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence 4467778888999999999987665332 24457888888888884 4457888999999999999999999975
Q ss_pred CeEeCCCCCC---cEEEcCCCcEEEE--eecccccCCCCCccceeeccccccCccccccccc-------cceEEEec
Q 020561 259 PVIYRDFKTS---NILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLK 323 (324)
Q Consensus 259 ~ivHrDLkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlG 323 (324)
..|.-|... +...+..+.+.++ ||+..+.++...... ...-+..|.+||.... ..|+|++|
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 555544444 4444566677777 998888776544321 1233556778887762 25999887
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.67 E-value=9.9e-05 Score=77.61 Aligned_cols=141 Identities=13% Similarity=-0.024 Sum_probs=98.0
Q ss_pred HHHHHHHHcCCCCCCcceEEEEEEe--CCeEEEEEEecCCCChHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 020561 182 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEA 256 (324)
Q Consensus 182 ~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~ 256 (324)
.+.|...++.+.|+++...+.-... ....|.+++||.+|.+.+.|.+.. .++...-+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4456666777889998877654432 345689999999999999986532 23333333333344366666666543
Q ss_pred C--CCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc----cc-ceEEEecC
Q 020561 257 E--RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TA-LELFCLKC 324 (324)
Q Consensus 257 ~--~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~-~DiwSlGc 324 (324)
. .-.+|++||+-|.+|..+..+|++++|+.+...... .......+++.|++|++.. ++ .|+|.+||
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 2 236899999999999999999999999999433321 1233456788999998775 33 89998665
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.017 Score=53.96 Aligned_cols=75 Identities=19% Similarity=0.200 Sum_probs=49.3
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecC------CCccchHHHHHHHHHHcCCC--CC-CcceEEEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH------DGLQGHKEWLAEVNFLGDLV--HL-NLVKLIGYC 204 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--Hp-nIv~~~~~~ 204 (324)
.+.||.|.-.-||++.+.. .+..|+||.-.. .-.-..++...|.++|+.+. -| .+.++|.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 4678999999999998632 134788886421 11233466777888887653 34 56667654
Q ss_pred EeCCeEEEEEEecCC
Q 020561 205 IEDDQRLLVYEFMPR 219 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~ 219 (324)
++....+|||+++.
T Consensus 104 -D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 -DSVMNCCVMEDLSD 117 (409)
T ss_pred -CcHHhhHHHHhCcc
Confidence 34556789999854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.054 Score=46.70 Aligned_cols=57 Identities=26% Similarity=0.334 Sum_probs=40.0
Q ss_pred cEEEEEEecCCCccchHHHHHHHHHHcCC---CCCCcceEEEEEEeCCeEEEEEEecCCCChH
Q 020561 164 LTVAVKTLNHDGLQGHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223 (324)
Q Consensus 164 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~ 223 (324)
.++-||+-.... ...|..|+.-|..| +--++.+++......+..|+||||++-+.+.
T Consensus 40 ~~~FvK~n~~~~---~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 40 DPFFVKCNQREQ---LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cceEEEecchhh---HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 367777654321 23466676655554 4566888898888899999999999876654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.1 Score=55.20 Aligned_cols=33 Identities=42% Similarity=0.464 Sum_probs=27.0
Q ss_pred CCCeEeCCCCCCcEEEcCCC--cEE-EEeecccccC
Q 020561 257 ERPVIYRDFKTSNILLDADY--NAK-LSDFGLAKDG 289 (324)
Q Consensus 257 ~~~ivHrDLkp~NILl~~~~--~~k-l~DFGla~~~ 289 (324)
+..+||+|+.+.|||++.++ .+. |+|||.+...
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 34599999999999998775 555 9999988653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.035 Score=47.59 Aligned_cols=101 Identities=14% Similarity=0.120 Sum_probs=65.1
Q ss_pred EEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeCC-eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHH
Q 020561 165 TVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242 (324)
Q Consensus 165 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~ 242 (324)
+..+|.+..-... ...-+..+.+++++++ .|+++.. +.+ ..-+++|+|-.... . ...++
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i----------~----~~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI----------N----FSNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc----------c----hhHHH
Confidence 3445555433222 3345677888888774 4677662 233 34599999943211 0 01122
Q ss_pred HHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 243 ~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..=+.+|.-.|+.+ .+.+|+|-.|+||+-|..|.+||.|-+.
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 22246678889654 5699999999999999999999999874
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.24 Score=45.42 Aligned_cols=30 Identities=27% Similarity=0.306 Sum_probs=25.2
Q ss_pred CCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 258 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.++||+|+.+.|||++ + .+.|+||+.+...
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g 225 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARMG 225 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence 4589999999999995 4 5889999988753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.15 Score=47.81 Aligned_cols=81 Identities=14% Similarity=0.062 Sum_probs=45.2
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcc-eEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~lv 213 (324)
+.|..|-...+|++........ .-..+.|.++......... -.-.+|+.++..|...++. ++++.+. -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~---~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKD---RYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCC---ccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 4565688889999875432100 0011235555432221111 1225688899888755554 4455443 2699
Q ss_pred EEecCCCChH
Q 020561 214 YEFMPRGSLE 223 (324)
Q Consensus 214 ~E~~~~gsL~ 223 (324)
.||++|-+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999987664
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.13 Score=45.35 Aligned_cols=76 Identities=17% Similarity=0.062 Sum_probs=52.1
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHH---HHHcCCCCCCcceEEEEEEeCCeE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV---NFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~---~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
...+-.|..+.|+.++.. .|.++++|+...... +..|. ..|+..+-...|++++.- ...-
T Consensus 7 ~~~~~~g~~s~V~pv~~~----------dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~ 69 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRA----------DGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERG 69 (253)
T ss_pred CCCCCCCcceEEEEEEcC----------CCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccc
Confidence 345667999999999754 477999998864432 22333 557777878889999854 3345
Q ss_pred EEEEEec-CCCChHHHH
Q 020561 211 LLVYEFM-PRGSLENHL 226 (324)
Q Consensus 211 ~lv~E~~-~~gsL~~~l 226 (324)
.|++|.+ ++.+|.+..
T Consensus 70 AlLLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 70 ALLLERLDPGRSLASLP 86 (253)
T ss_pred hhhhhhccCCCchhhcc
Confidence 7888998 555675543
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.54 Score=45.00 Aligned_cols=84 Identities=12% Similarity=0.072 Sum_probs=47.6
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcc-eEEEEEEeCCeEE
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRL 211 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~ 211 (324)
.++.|..|-.-.+|+........ ...+.+++.|.+++......... .-.+|..++..+..-+|. ++++.+. -+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GG 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CC
Confidence 34567677778899987653210 00112356899998765432211 224577777666544443 3455442 24
Q ss_pred EEEEecCCCCh
Q 020561 212 LVYEFMPRGSL 222 (324)
Q Consensus 212 lv~E~~~~gsL 222 (324)
.|.||++|-+|
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 67899987644
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.036 Score=46.36 Aligned_cols=29 Identities=28% Similarity=0.383 Sum_probs=25.8
Q ss_pred eEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 260 ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
.+|+|+.|.||++..++ ++|+||+.|...
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 69999999999998777 999999988653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 324 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 371 bits (956), Expect = e-130
Identities = 82/220 (37%), Positives = 122/220 (55%), Gaps = 27/220 (12%)
Query: 107 EEELKVAS-RLRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVK 159
+ L+V+ R F+F +LK T NF + +GEGGFG V+KG++
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------ 55
Query: 160 PGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215
TVAVK L + + +++ E+ + H NLV+L+G+ + D LVY
Sbjct: 56 -----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 216 FMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273
+MP GSL + L + PL W +R KIA GAA G+ FLHE I+RD K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ AK+SDFGLA+ + +T +++R++GT Y APE +
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL 207
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-125
Identities = 81/226 (35%), Positives = 127/226 (56%), Gaps = 16/226 (7%)
Query: 93 TTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEE 152
+ + +NS L V + DL+ AT NF + L+G G FG V+KG + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 153 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212
G VA+K + QG +E+ E+ L H +LV LIG+C E ++ +L
Sbjct: 63 ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 213 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
+Y++M G+L+ HL+ ++ + W R++I +GAA+GL +LH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
ILLD ++ K++DFG++K G E D+TH+ST V GT GY PEY +
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-110
Identities = 87/205 (42%), Positives = 129/205 (62%), Gaps = 15/205 (7%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
+L++F+ +L++A+ NF +++LG GGFG V+KG + +GT VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65
Query: 175 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 230
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMT 315
D THV+T V GT G+ APEY+ T
Sbjct: 186 YKD-THVTTAVRGTIGHIAPEYLST 209
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-62
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 40/237 (16%)
Query: 96 NAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
+ +S ++ +L + + + G FGCV+K +
Sbjct: 2 GHHHHHHSSGVD-----------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---- 46
Query: 156 APVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNLVKLIGYCIEDD----Q 209
VAVK +Q + W E V L + H N+++ IG
Sbjct: 47 -------NEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96
Query: 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER-------PVIY 262
L+ F +GSL + L + W+ IA A+GLA+LHE+ + +
Sbjct: 97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTALEL 319
RD K+ N+LL + A ++DFGLA G + +GT Y APE + A+
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-52
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
++ L N + L+G G +G V+KG E VAVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47
Query: 178 GHKEWLAEVN--FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS 230
+ ++ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDADYNAKLSDFG 284
W ++A +GLA+LH E R + +RD + N+L+ D +SDFG
Sbjct: 108 SD--WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 285 LAK------DGPEGDKTHVSTRVMGTYGYAAPEYVMTALELFCLK 323
L+ G++ + + +GT Y APE + A+ L +
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 179
N+++ E +G+GGFG V KG + ++ + VA+K+L +G
Sbjct: 18 DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61
Query: 180 ------KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+E+ EV + +L H N+VKL G +V EF+P G L + L ++ P+
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKD 288
WS+++++ L A G+ ++ + P+++RD ++ NI L A AK++DFGL++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ- 177
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTALELFCLKC 324
H + ++G + + APE + E + K
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKA 209
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-46
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ DL + + +G G FG V + W +G+ VAVK L
Sbjct: 36 WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPW 235
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
R+ +A AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 296 HVSTRVMGTYGYAAPE 311
S GT + APE
Sbjct: 196 --SKSAAGTPEWMAPE 209
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-46
Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 32/195 (16%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ ++++ +G G FG V K W VA+K + + +
Sbjct: 7 YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSI 237
K ++ E+ L + H N+VKL G C+ LV E+ GSL N H +
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTH 296
M L ++G+A+LH + +I+RD K N+LL A K+ DFG A D
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQT 158
Query: 297 VSTRVMGTYGYAAPE 311
T G+ + APE
Sbjct: 159 HMTNNKGSAAWMAPE 173
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 38/204 (18%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
F +L L +G GGFG V++ W G VAVK HD +
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46
Query: 180 ----KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ E L H N++ L G C+++ LV EF G L L + +P
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP 104
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--------ADYNAKLSDFGLAK 287
I + A+ A+G+ +LH+EA P+I+RD K+SNIL+ ++ K++DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPE 311
E +T + G Y + APE
Sbjct: 165 ---EWHRTTKMSAA-GAYAWMAPE 184
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 31/201 (15%)
Query: 129 RNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
R FRP L LG+G FG K TG + +K L + + +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------DGP 290
A G+A+LH +I+RD + N L+ + N ++DFGLA+
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 291 EGDKTHVSTRVMGTYGYAAPE 311
+ V+G + APE
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPE 192
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 33/197 (16%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
F L T+ L E G ++KG W G + VK L
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLP 234
+++ E L H N++ ++G C + +MP GSL N L + +
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
S +K AL A+G+AFLH E + + ++++D D A++S +
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161
Query: 295 THVSTRVMGTYGYAAPE 311
+ S M + APE
Sbjct: 162 SFQSPGRMYAPAWVAPE 178
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-43
Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 36/226 (15%)
Query: 98 ESNSSTSKLEEELKVASRLRKFT------FNDLKLATRNFRPESLLGEGGFGCVFKG-WI 150
E N S + AS+ F F L++ +G+G FG V+ G W
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW- 54
Query: 151 EENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208
+G VA++ ++ + K + EV H N+V +G C+
Sbjct: 55 --HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
++ +L + + + L + +IA KG+ +LH + ++++D K+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159
Query: 269 NILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPE 311
N+ D + ++DFGL G + G + APE
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ + R +G G FG V+KG W +G VAVK LN
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ + EV L H+N++ +GY Q +V ++ SL +HL
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ IA A+G+ +LH + +I+RD K++NI L D K+ DFGLA + +H
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 298 STRVMGTYGYAAPE 311
++ G+ + APE
Sbjct: 179 FEQLSGSILWMAPE 192
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-42
Identities = 50/192 (26%), Positives = 77/192 (40%), Gaps = 31/192 (16%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 190
+G+G +G V++G W G VAVK + + K W E +
Sbjct: 13 LECVGKGRYGEVWRGSW---QGE---------NVAVKIFSS---RDEKSWFRETELYNTV 57
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N++ I + Q L+ + GSL ++L + L ++I L A
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 299
GLA LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 300 RVMGTYGYAAPE 311
+GT Y APE
Sbjct: 176 PRVGTKRYMAPE 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-42
Identities = 47/192 (24%), Positives = 74/192 (38%), Gaps = 31/192 (16%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 190
+G+G +G V+ G W E VAVK W E+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ H N++ I I+ Q L+ ++ GSL ++L +S L +K+A +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 299
GL LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 300 RVMGTYGYAAPE 311
+GT Y PE
Sbjct: 205 TRVGTKRYMPPE 216
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 31/192 (16%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 190
+ +G+G FG V++G W E VAVK + + + W E +
Sbjct: 47 QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N++ I +D+ Q LV ++ GSL ++L + +K+AL A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 299
GLA LH E + +RD K+ NIL+ + ++D GLA D
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 300 RVMGTYGYAAPE 311
+GT Y APE
Sbjct: 210 HRVGTKRYMAPE 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 62/168 (36%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 187
R + LGEG FG V + P GTG VAVK L D G Q W E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H +++K G C + LV E++P GSL ++L R S+ L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQI 143
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ +
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-33
Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ + +
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-33
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + S LG+G FG V + P+ TG VAVK L H G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L +VK G ++ LV E++P G L + L R L S + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KG+ +L R ++RD NIL++++ + K++DFGLAK P +V
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 13/160 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ I+RD N L+ K+SDFG++++ +G
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 187
R + LGEG FG V + P TG VAVK+L + G + E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++K A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
KG+ +L R ++RD N+L+++++ K+ DFGL K
Sbjct: 136 CKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 19/188 (10%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLN 172
+ LR + K LG G FG V+KG WI E + VA+K L
Sbjct: 7 ALLRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELR 53
Query: 173 HD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 231
+ +KE L E + + + ++ +L+G C+ L+ + MP G L +++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+ + + AKG+ +L +R +++RD N+L+ + K++DFGLAK
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 292 GDKTHVST 299
+K + +
Sbjct: 170 EEKEYHAE 177
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVH 194
LGEG FG V +G + GT L VAVKT+ D + +E+L+E + D H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 195 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALG 244
N+++L+G CIE + +++ FM G L +L + R P I ++ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A G+ +L + R ++RD N +L D ++DFGL+K GD
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAA 246
++V+L+G + L++ E M RG L+++L P S +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
G+A+L ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 19/163 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+G F +FKG V +K L+ + + + + L H
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
+LV G C+ D+ +LV EF+ GSL+ +L + + + W + + A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129
Query: 254 EEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLAKD 288
E +I+ + NILL + + KLSD G++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FGCV+ G T G + AVK+LN + ++L E + D H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 196 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N++ L+G C+ + L+V +M G L N + + + L AKG+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A + ++RD N +LD + K++DFGLA+D + +
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
LG G FG V+KG WI E + VA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 49/180 (27%), Positives = 71/180 (39%), Gaps = 21/180 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIA 242
+V+ G C E L+V+E+M G L L + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
A G+ +L A ++RD T N L+ K+ DFG+++D D V R M
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 128 TRNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 180
R F+ L LG G FG V KG WI E + + V +K + G Q +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ AKG+ +L E +++R+ N+LL + +++DFG+A P DK + +
Sbjct: 120 WGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 24/255 (9%)
Query: 51 GSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEEL 110
G + S + S S + + +A + ++ +
Sbjct: 24 GILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVV 83
Query: 111 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 170
S L + ++G G FGCV+ G T G + AVK+
Sbjct: 84 IGPSSLI------VHF-------NEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKS 124
Query: 171 LNHD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFR 228
LN + ++L E + D H N++ L+G C+ + L+V +M G L N +
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + L AKG+ FL A + ++RD N +LD + K++DFGLA+D
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241
Query: 289 GPEGDKTHVSTRVMG 303
+ + V +
Sbjct: 242 MYDKEFDSVHNKTGA 256
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-29
Identities = 53/181 (29%), Positives = 77/181 (42%), Gaps = 22/181 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K VAVK L L K++ E L +L H +
Sbjct: 23 LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MKI 241
+VK G C + D ++V+E+M G L L + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 302 M 302
M
Sbjct: 196 M 196
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVH 194
LG+G FG V + + G+ + VAVK L D + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 195 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 243
++ KL+G + + +++ FM G L L R P+++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A G+ +L + R I+RD N +L D ++DFGL++ GD
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 191
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
L E+ ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V+ G + + A+K+L+ +Q + +L E + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 196 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFL 252
N++ LIG + + ++ +M G L + +R+ + I L A+G+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
AE+ ++RD N +LD + K++DFGLA+D
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 47/204 (23%), Positives = 76/204 (37%), Gaps = 28/204 (13%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKE 181
+ + +++ LGEGGF V V+ G A+K + Q +E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREE 72
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLP 234
E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ + LG +GL +H + +RD K +NILL + L D G +
Sbjct: 133 EDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 295 THVSTRVM-------GTYGYAAPE 311
+ T Y APE
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 59/256 (23%), Positives = 100/256 (39%), Gaps = 37/256 (14%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ + T +AES+SS + +++ +RL +
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 130 N----------FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
F + L LGEG FG V E G KP +TVAVK L D
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDD 124
Query: 175 -GLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
+ + ++E+ + + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 233 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
+ A+G+ +L A + I+RD N+L+ +
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 241
Query: 278 AKLSDFGLAKDGPEGD 293
K++DFGLA+D D
Sbjct: 242 MKIADFGLARDINNID 257
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 239
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G ++V E+M GSL+ L + + G G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
++ ++RD N+L+D++ K+SDFGL++
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 29/174 (16%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
+ ++GEG FG V K I+ K G + A+K + H+++ E+ L L
Sbjct: 30 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 193 V-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------------- 238
H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 141
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 192
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 191
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
L E+ ++R+ N+LL + AK+SDFGL+K D + +
Sbjct: 452 L---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 20/160 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W G V AVK + +G E+ E + L H
Sbjct: 16 LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LVK G C ++ +V E++ G L N+L + L + M +G+AFL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I+RD N L+D D K+SDFG+ + +
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 240
N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 241 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 20/155 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W V A+KT+ +G ++++ E + L H
Sbjct: 16 IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LV+L G C+E LV EFM G L ++L R + M L +G+A+L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
E VI+RD N L+ + K+SDFG+ +
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 17/177 (9%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G +G V++G W LTVAVKTL D ++ +E+L E + ++ H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
++ I+R+ N L+ ++ K++DFGL++ GD + APE
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPE 389
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 24/183 (13%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGL--QG 178
L L + LG G FG V KG + + V AVK L ++
Sbjct: 16 KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSI 237
E LAE N + L + +V++IG C E + +LV E G L +L R + I
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ + G+ +L E ++RD N+LL + AK+SDFGL+K + +
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 298 STR 300
+
Sbjct: 176 AQT 178
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 192
LG+G FG V +G W +G ++VAVK L D L + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLA 250
H NL++L G + +V E P GSL + L + L R A+ A+G+
Sbjct: 79 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG FG V++G G + VAVKT D +K ++++E + +L H
Sbjct: 20 LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VKLIG E+ ++ E P G L ++L + SL + + +L K +A+L
Sbjct: 74 HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
++RD NIL+ + KL DFGL++
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 30/191 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
+L++ + + ++ LGE FG V+KG G AP + VA+KTL
Sbjct: 1 GKLKEISLSAVRF-------MEELGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKD 49
Query: 174 D-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
+E+ E L H N+V L+G +D +++ + G L L RS
Sbjct: 50 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 233 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
+ + A G+ +L + V+++D T N+L+ N
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN 166
Query: 278 AKLSDFGLAKD 288
K+SD GL ++
Sbjct: 167 VKISDLGLFRE 177
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 14/152 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL + +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
++ I+RD N L+ ++ K++DFGL++
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVH 194
+G G FG V+KG +G V VA+KTL + ++L E +G H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+++L G + +++ E+M G+L+ L + + + G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
A ++RD NIL++++ K+SDFGL++
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 31/181 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+GEG FG VF+ G P +P T VAVK L + ++ E + + +
Sbjct: 55 IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 238
N+VKL+G C L++E+M G L L S S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 239 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+ IA A G+A+L +ER ++RD T N L+ + K++DFGL+++
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 293 D 293
D
Sbjct: 228 D 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W G V A+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LV+L G C + ++ E+M G L N+L R + M + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+ ++RD N L++ K+SDFGL++ + +
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
++RD N+L+ D AK+SDFGL K+
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 36/216 (16%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
R + + +G G F V+KG E T + VA L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 187 NFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWC 135
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRV 301
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 302 MGTYGYAAPEYV--------------MTALELFCLK 323
+GT + APE M LE+ +
Sbjct: 191 IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSE 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 201 IGKGEFGDVMLGDY---RGN---------KVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
++RD N+L+ D AK+SDFGL K+
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 19/168 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 38 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALGAAKG 248
N+V+ IG ++ R ++ E M G L++ L R + P L + +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGD 293
+L E I+RD N LL AK+ DFG+A+D
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 79 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALGAAKG 248
N+V+ IG ++ R ++ E M G L++ L R + P ++ + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGD 293
+L E I+RD N LL AK+ DFG+A+D
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+GEG FG V +G L VA+KT + + ++L E + H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VKLIG E+ ++ E G L + L + SL L I A + LA+L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+ ++RD N+L+ ++ KL DFGL++ +
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL 192
+ ++G G FG V G ++ + VA+KTL + +++L E + +G
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + ++V E+M GSL++ L + + + G A G+ +L
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
++ ++RD NIL++++ K+SDFGL +
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 46/231 (19%), Positives = 93/231 (40%), Gaps = 17/231 (7%)
Query: 64 VSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFND 123
V+G + + + + R P+ +++ S++ + ++ + T+
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDY-AEIIDEEDTYTM 379
Query: 124 LKLATRNFRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQ 177
+ E + +GEG FG V +G + VA+KT +
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDS 433
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+++L E + H ++VKLIG ++ ++ E G L + L R L +
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ A + LA+L + ++RD N+L+ ++ KL DFGL++
Sbjct: 493 LILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 50/185 (27%), Positives = 64/185 (34%), Gaps = 19/185 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVN 187
+F+ S LG G +G VFK G AVK G + LAEV
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 188 FLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ H V+L E L E SL+ H LP +
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
LA LH + +++ D K +NI L KL DFGL + V G
Sbjct: 168 LALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPR 221
Query: 307 YAAPE 311
Y APE
Sbjct: 222 YMAPE 226
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 53/182 (29%), Positives = 77/182 (42%), Gaps = 33/182 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V K T TVAVK L + ++ L+E N L + H
Sbjct: 31 LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 238
+++KL G C +D LL+ E+ GSL L R S +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 239 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+ A ++G+ +L AE +++RD NIL+ K+SDFGL++D E
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 292 GD 293
D
Sbjct: 203 ED 204
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-26
Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 22/167 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + G VAVK L + ++E+ + L H
Sbjct: 54 LGAGAFGKVVEA--TAFGLGKEDAVL--KVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKI 241
N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ A+G+AFL A + I+RD N+LL + AK+ DFGLA+D
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G + NG V AVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
LV+L ++ ++ E+M GSL + L + L + + +A A+G+AF+
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
ER I+RD + +NIL+ + K++DFGLA+ + +
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
E LG+G FG V+ G W NGT V A+KTL G + +L E + L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 251
H LV+L E+ +V E+M +GSL + L L + +A A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ ++RD + +NIL+ + K++DFGLA+ E ++ + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 50/176 (28%), Positives = 73/176 (41%), Gaps = 27/176 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + + G TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 238
LN+V L+G C + +++ EF G+L +L R +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 48/214 (22%), Positives = 81/214 (37%), Gaps = 48/214 (22%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+F ++LG+G FG V K A+K + H + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLP 234
L L H +V+ +E + + E+ G+L + + +L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 235 ----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 287
W + +I L+++H + +I+RD K NI +D N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 288 ----------DGPEGDKTHVSTRVMGTYGYAAPE 311
G ++++ + GT Y A E
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 55/246 (22%), Positives = 87/246 (35%), Gaps = 22/246 (8%)
Query: 73 SKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFR 132
S S + A+ + ++ S + E + + K + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
+ +G G FG V + TG AVK + L+ + E+ L
Sbjct: 62 HQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGL 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
+V L G E + E + GSL L ++ LP + A +GL +L
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 253 HEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYA 308
H +++ D K N+LL +D A L DFG A G + GT +
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 309 APEYVM 314
APE VM
Sbjct: 224 APEVVM 229
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+G FG V+ G W NGT V A+KTL G + +L E + L H
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
++RD + +NIL+ + K++DFGLA+ + +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 52/176 (29%), Positives = 71/176 (40%), Gaps = 26/176 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + G TVAVK L L + ++E+ L L H
Sbjct: 31 LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 238
+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
E LG G FG V+ + N V AVKT+ G + +LAE N + L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAF 251
H LVKL ++ ++ EFM +GSL + L P + + A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ +R I+RD + +NIL+ A K++DFGLA+
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 37/207 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+F P LG GGFG VF+ A+K + + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 189 LGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLP 234
L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 287
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 288 ---DGPEGDKTHVSTRVMGTYGYAAPE 311
T +GT Y +PE
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPE 200
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 43/176 (24%), Positives = 65/176 (36%), Gaps = 31/176 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V G + VAVK L + ++E+ + L H
Sbjct: 53 LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 238
N+V L+G C L++E+ G L N+L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 239 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 45/263 (17%), Positives = 80/263 (30%), Gaps = 28/263 (10%)
Query: 68 STHYESKSTNDTSRDQPA----AAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFND 123
S S T D +I + ++ SS E ++ T +
Sbjct: 2 SPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT--E 59
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+L ++ LLGEG F V++ + K +K
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEA--TQGDLNDAK--NKQKFVLKVQKPANPWEFYIGT 115
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRM 239
+ L + +K + + +LV E G+L N + +P + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----------DADYNAKLSDFGLAKD 288
A+ + +H+ +I+ D K N +L D L D G + D
Sbjct: 176 SFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 289 GPEGDKTHVSTRVMGTYGYAAPE 311
K + T T G+ E
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVE 255
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 36/200 (18%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+F+ L+G GGFG VFK G T +K + ++ + +E V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNNEKAERE----VKA 57
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSL 231
L L H+N+V G D + EF +G+LE + RR
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---S 171
Query: 292 GDKTHVSTRVMGTYGYAAPE 311
TR GT Y +PE
Sbjct: 172 LKNDGKRTRSKGTLRYMSPE 191
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-24
Identities = 40/186 (21%), Positives = 70/186 (37%), Gaps = 19/186 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
+ +GEG FG G +K +N + KE EV
Sbjct: 25 KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGA 245
L ++ H N+V+ E+ +V ++ G L + ++ + + +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +H+ R +++RD K+ NI L D +L DFG+A+ + GT
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTP 189
Query: 306 GYAAPE 311
Y +PE
Sbjct: 190 YYLSPE 195
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 56/233 (24%), Positives = 83/233 (35%), Gaps = 28/233 (12%)
Query: 84 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 143
PA A + + + ++ L + R + LG+GGF
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFA 55
Query: 144 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKL 200
F+ T A K + L + E++ L H ++V
Sbjct: 56 KCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 201 IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259
G+ ED+ + +V E R SL RR R G +LH
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161
Query: 260 VIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPE 311
VI+RD K N+ L+ D K+ DFGLA K +G++ V GT Y APE
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 63/196 (32%), Positives = 78/196 (39%), Gaps = 29/196 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
+ FR +LG+GGFG V A TG A K L ++ K
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L E L + +V L Y E L LV M G L+ H++ R
Sbjct: 231 ALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 241 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
I G L LH E ++YRD K NILLD + ++SD GLA PEG
Sbjct: 290 FYAAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342
Query: 296 HVSTRVMGTYGYAAPE 311
RV GT GY APE
Sbjct: 343 K--GRV-GTVGYMAPE 355
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 26/186 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 195 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 249
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 250 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 306 GYAAPE 311
Y P+
Sbjct: 180 EYLHPD 185
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 32/209 (15%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 182
++L R +L EGGF V++ + G+G A+K L + + ++
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 183 LAEVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 232
+ EV F+ L H N+V+ + L+ + +G L L + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDG 289
L +KI + + +H + P+I+RD K N+LL KL DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 290 PEGDKTHVSTRVM-------GTYGYAAPE 311
P+ + ++ T Y PE
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPE 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 49/226 (21%), Positives = 85/226 (37%), Gaps = 37/226 (16%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S +T + S + + E +LG+G +G V+ G
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209
+ +A+K + + + E+ L H N+V+ +G E+
Sbjct: 42 --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93
Query: 210 RLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALGAAKGLAFLHEEAERPVIYRDFK 266
+ E +P GSL L + PL + I +GL +LH+ +++RD K
Sbjct: 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ---IVHRDIK 149
Query: 267 TSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
N+L++ K+SDFG +K + + GT Y APE
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-23
Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 26/186 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 195 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 249
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 250 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 306 GYAAPE 311
Y P+
Sbjct: 180 EYLHPD 185
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 28/192 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
NFR E +G G F V++ G+ VA+K + L K + E+
Sbjct: 33 NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLP----WSIRM 239
+ L L H N++K IED++ +V E G L + ++ +P W +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++ L +H R V++RD K +N+ + A KL D GL + T +
Sbjct: 144 QLCSA----LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHS 195
Query: 300 RVMGTYGYAAPE 311
V GT Y +PE
Sbjct: 196 LV-GTPYYMSPE 206
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-23
Identities = 44/247 (17%), Positives = 84/247 (34%), Gaps = 27/247 (10%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ S+ R ++ + +++ +S + R
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-----R 56
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +G GG VF+ V A+K +N + Q + E+
Sbjct: 57 IYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 188 FLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
+L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 107 YLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKN 163
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + +H+ +++ D K +N L+ D KL DFG+A + V +G
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 305 YGYAAPE 311
Y PE
Sbjct: 220 VNYMPPE 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-23
Identities = 51/194 (26%), Positives = 73/194 (37%), Gaps = 34/194 (17%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 185
R + LG+GGF F+ T A K + L + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM----- 239
++ L H ++V G+ ED+ + +V E R SL RR +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEA 117
Query: 240 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHV 297
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 118 RYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 298 STRVMGTYGYAAPE 311
GT Y APE
Sbjct: 175 LC---GTPNYIAPE 185
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 39/201 (19%), Positives = 74/201 (36%), Gaps = 45/201 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 184
L +G F + E++ A+K L+ +++
Sbjct: 39 LNQGKFNKIILC--EKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 185 -----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 231
E+ + D+ + + G I + + ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+P + I +++H E+ + +RD K SNIL+D + KLSDFG ++ +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 292 GD-KTHVSTRVMGTYGYAAPE 311
K GTY + PE
Sbjct: 205 KKIKG-----SRGTYEFMPPE 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-22
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAP 157
+LE + + RL F K L +F S LG G G VFK +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP----- 56
Query: 158 VKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
+GL +A K ++ + + + E+ L + +V G D + + E
Sbjct: 57 ----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
M GSL+ + +++ +P I K+++ KGL +L E+ +++RD K SNIL+++
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
KL DFG++ + + ++ V GT Y +PE
Sbjct: 170 EIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 200
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 21/187 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 186
+F+ +LLG+G F V++ TGL VA+K ++ + EV
Sbjct: 12 DFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H ++++L Y ED + LV E G + +L R P +
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGT 304
G+ +LH +++RD SN+LL + N K++DFGLA + +K + GT
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GT 175
Query: 305 YGYAAPE 311
Y +PE
Sbjct: 176 PNYISPE 182
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 20/192 (10%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
++ +G G +G K + G + K L++ + + ++EV
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 187 NFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 241
N L +L H N+V+ + L +V E+ G L + + + L +++
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 242 ALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
L H + V++RD K +N+ LD N KL DFGLA+ D + T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175
Query: 300 RVMGTYGYAAPE 311
V GT Y +PE
Sbjct: 176 FV-GTPYYMSPE 186
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 60/201 (29%), Positives = 77/201 (38%), Gaps = 36/201 (17%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
+ F +LG GGFG VF A TG A K LN L+ K +
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPW 235
+ E L + +V L Y E L LV M G + H++ P
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP- 289
Query: 236 SIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
R I G L LH+ +IYRD K N+LLD D N ++SD GLA +
Sbjct: 290 --RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 291 EGDKTHVSTRVMGTYGYAAPE 311
G GT G+ APE
Sbjct: 341 AGQTK-TKGYA-GTPGFMAPE 359
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 41/200 (20%), Positives = 73/200 (36%), Gaps = 22/200 (11%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
F + + R + +G GG VF+ V A+K +N +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 177 QGH--KEWLAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 231
+ E+ +L L + ++L Y DQ + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK- 122
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+ R + + +H+ +++ D K +N L+ D KL DFG+A
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178
Query: 292 GDKTHVSTRVMGTYGYAAPE 311
+ V +GT Y PE
Sbjct: 179 DTTSVVKDSQVGTVNYMPPE 198
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 22/180 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 192
LG+G FG V+ + + +A+K L L+ + EV L
Sbjct: 16 PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+++L GY D R+ L+ E+ P G++ L ++ A L++
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H + VI+RD K N+LL + K++DFG + P + GT Y PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPE 177
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 51/196 (26%), Positives = 77/196 (39%), Gaps = 31/196 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+ + LG GGFG V + + TG VA+K + ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 189 LGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLPWSIR 238
+ L H N+V + D + LL E+ G L +L + L
Sbjct: 66 MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKT 295
+ + L +LHE +I+RD K NI+L K+ D G AK+ +G+
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 296 HVSTRVMGTYGYAAPE 311
V GT Y APE
Sbjct: 181 T--EFV-GTLQYLAPE 193
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 61/225 (27%), Positives = 87/225 (38%), Gaps = 44/225 (19%)
Query: 100 NSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK 159
S + K T ND F ++G GGFG V+ K
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMND-------FSVHRIIGRGGFGEVY---------GCRK 210
Query: 160 PGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLN---LVKLIGYCIEDDQRL-L 212
TG A+K L+ ++ + L E L + + +V + Y +L
Sbjct: 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSF 269
Query: 213 VYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFK 266
+ + M G L HL + M+ I LG L +H V+YRD K
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVYRDLK 319
Query: 267 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+NILLD + ++SD GLA D + K H V GT+GY APE
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMAPE 360
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 22/180 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGDL 192
LG+G FG V+ + +A+K L L+ L E+ L
Sbjct: 21 PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N++++ Y D +R+ L+ EF PRG L L ++ A L +
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
HE R VI+RD K N+L+ K++DFG + P + GT Y PE
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPE 182
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 38/221 (17%), Positives = 67/221 (30%), Gaps = 53/221 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------------- 174
R ++LG+ + +E TG + V
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 175 ---------GLQGHKEWLAEVNFL--GDLVHLNLVKLIGYCIEDDQRLLV---YEFMPRG 220
G++ K+ + F+ DLV K + D++ + V + PR
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 221 SLENHLFRRSL--------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272
F L L R+++ L + LA LH +++ + +I+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 244
Query: 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
D L+ F +G S G+A PE
Sbjct: 245 DQRGGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETT 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 39/268 (14%), Positives = 75/268 (27%), Gaps = 63/268 (23%)
Query: 83 QPAAAVISSTTTSNAESNSSTSKL--EEELKVASRLRKFTFNDLKLATRNFRPESLLGEG 140
Q S S A+S STS + +V S L + R ++LG+
Sbjct: 33 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP--------RTLVRGTVLGQE 84
Query: 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------------------------ 176
+ TG + V
Sbjct: 85 DPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 177 ----QGHKEWLAEVNFLGDLVHLNLVKLIGYC--IEDDQRLLVYEFMP-----RGSLENH 225
+ H ++ + + D ++++ + R +Y M G +
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L R+++ L + LA LH +++ + +I+LD L+ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+G + + G+ PE
Sbjct: 253 LV--RDGAR----VVSSVSRGFEPPELE 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 38/181 (20%), Positives = 67/181 (37%), Gaps = 22/181 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+G GG VF+ A+K +N + + E+ +L L
Sbjct: 16 QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 194 HLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+ ++L Y DQ + +V E L + L ++ + R + +
Sbjct: 66 QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+H+ +++ D K +N L+ D KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 311 E 311
E
Sbjct: 179 E 179
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
+ LG+G FG V+K TG A K + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H +VKL+G D + ++ EF P G+++ + L + + L
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
FLH + +I+RD K N+L+ + + +L+DFG++
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 29/183 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G VFK + TG VA+K L E+ L
Sbjct: 11 IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H NLV L+ + LV+E+ ++ + L R +P + I + + F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYA 308
H+ I+RD K NIL+ KL DFG A+ GP V+TR Y
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 309 APE 311
+PE
Sbjct: 170 SPE 172
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 27/265 (10%), Positives = 55/265 (20%), Gaps = 51/265 (19%)
Query: 83 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 142
+ +I + ++ + + L R + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVK 199
VF A+K E L+ + +
Sbjct: 76 SVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 200 LIGYC-----------------------IEDDQRLLVYEFMPR--------GSLENHLFR 228
+D MP S + ++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + A L + +++ F N+ + D L D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYV 313
G + S+ YA E++
Sbjct: 243 -KVGTRGPASS---VPVTYAPREFL 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 51/211 (24%), Positives = 79/211 (37%), Gaps = 42/211 (19%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKT 170
V F+ F +G+G FG V V K T A+K
Sbjct: 5 VFDENEDVNFDH-------FEILRAIGKGSFGKVCI----------VQKNDTKKMYAMKY 47
Query: 171 LNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL 226
+N E E+ + L H LV L Y +D++ + +V + + G L HL
Sbjct: 48 MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 227 FR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
+ +K + + L +L + +I+RD K NILLD + +
Sbjct: 107 QQNVHFKEE---TVKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHI 156
Query: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+DF +A P + T + GT Y APE
Sbjct: 157 TDFNIAAMLPRETQI---TTMAGTKPYMAPE 184
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 42/190 (22%), Positives = 71/190 (37%), Gaps = 26/190 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F P+ +LG G G + + VAVK + + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 190 GDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ H N+++ + + + E +L+ ++ ++ + + G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 249 LAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAK--DGPEGDKTHVSTRV 301
LA LH +++RD K NIL+ A +SDFGL K + S
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 302 MGTYGYAAPE 311
GT G+ APE
Sbjct: 188 -GTEGWIAPE 196
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 67/247 (27%), Positives = 98/247 (39%), Gaps = 32/247 (12%)
Query: 72 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 131
E + T D + + + ++ E E+ +A + T N+ F
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------F 150
Query: 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNF 188
LLG+G FG V + TG A+K L + + E L E
Sbjct: 151 EYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGA 245
L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEI 257
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 304
L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGT 312
Query: 305 YGYAAPE 311
Y APE
Sbjct: 313 PEYLAPE 319
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 54/199 (27%), Positives = 78/199 (39%), Gaps = 22/199 (11%)
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESL------LGEGGFGCVFKGWI 150
N + + R D+ PE L +G G FG V+
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-- 73
Query: 151 EENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIED 207
VA+K +++ G Q +++W + EV FL L H N ++ G + +
Sbjct: 74 -------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267
LV E+ GS + L PL + GA +GLA+LH +I+RD K
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 182
Query: 268 SNILLDADYNAKLSDFGLA 286
NILL KL DFG A
Sbjct: 183 GNILLSEPGLVKLGDFGSA 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 55/254 (21%), Positives = 89/254 (35%), Gaps = 37/254 (14%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
+ + AA S+ E + + K +
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN------ 55
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAE 185
F +LG G +G VF + + TG A+K L + + E
Sbjct: 56 -FELLKVLGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 186 VNFLGDLVHLN-LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-- 240
L + LV L Y + + +L L+ +++ G L HL + ++
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIY 164
Query: 241 ---IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
I L L LH+ +IYRD K NILLD++ + L+DFGL+K+ +
Sbjct: 165 VGEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 298 STRVMGTYGYAAPE 311
GT Y AP+
Sbjct: 218 YDFC-GTIEYMAPD 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 37/221 (16%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
S ++ V K + F +LG+G FG VF +++
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQ-------FELLKVLGQGSFGKVFL--VKKISG----S 49
Query: 161 GTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFM 217
A+K L L+ E + L ++ H +VKL Y + + +L L+ +F+
Sbjct: 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 218 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
G L L + +K +AL L LH +IYRD K NIL
Sbjct: 109 RGGDLFTRLSKEVMFTEE---DVKFYLAELALA----LDHLHS---LGIIYRDLKPENIL 158
Query: 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPE 311
LD + + KL+DFGL+K+ + +K GT Y APE
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPE 196
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + + N+V + + D+ +V E++ GSL + + + I + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
L FLH VI+RD K+ NILL D + KL+DFG
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 31/223 (13%)
Query: 102 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
S+L ++ VA L+ +++L +F ++G G F V
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--------- 79
Query: 157 PV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 211
V TG A+K +N + E + E + L + + +L + +D+ L
Sbjct: 80 -VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLY 137
Query: 212 LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTS 268
LV E+ G L L + +P + R +A + A + +H ++RD K
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPD 191
Query: 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
NILLD + +L+DFG V GT Y +PE
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPE 233
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 34/195 (17%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGW---IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE- 181
+A + + + + GG G ++ + G V +K L H G +
Sbjct: 78 VAGQ-YEVKGCIAHGGLGWIYLALDRNVN-----------GRPVVLKGLVHSGDAEAQAM 125
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWS 236
+AE FL ++VH ++V++ + D+ +V E++ SL+ + LP+ +
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEA 184
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
I L L++LH ++Y D K NI+L + KL D G
Sbjct: 185 IA--YLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINS 233
Query: 297 VSTRVMGTYGYAAPE 311
+ GT G+ APE
Sbjct: 234 FGY-LYGTPGFQAPE 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 47/193 (24%), Positives = 75/193 (38%), Gaps = 20/193 (10%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 182
+++ + P LG G +G V K +G +AVK + Q K
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52
Query: 183 LAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR 238
L +++ + + V G + + E M SL+ + + +P I
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
KIA+ K L LH + VI+RD K SN+L++A K+ DFG++
Sbjct: 112 GKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166
Query: 299 TRVMGTYGYAAPE 311
G Y APE
Sbjct: 167 DIDAGCKPYMAPE 179
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 37/227 (16%)
Query: 95 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 154
A + + + + RK D F+ +LGEG F V
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLA------ 49
Query: 155 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211
+ T A+K L + + E + + L H VKL + +DD++L
Sbjct: 50 ---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105
Query: 212 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRD 264
+ G L ++ + S + I L +LH + +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155
Query: 265 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
K NILL+ D + +++DFG AK K + +GT Y +PE
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 52/190 (27%), Positives = 77/190 (40%), Gaps = 29/190 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 184
+ L+GEG +G V K ++ TG VA+K + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 301
G+ F H +I+RD K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 302 MGTYGYAAPE 311
Y APE
Sbjct: 189 ----WYRAPE 194
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 21/198 (10%)
Query: 96 NAESNSSTSKLEEELKVASRLRKFTFND-LKLATRNFRPESL------LGEGGFGCVFKG 148
+ S+ E + + F L++ P L +GEG G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 149 WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208
+ +G VAVK ++ Q + EV + D H N+V++ + +
Sbjct: 65 ---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
+ ++ EF+ G+L + + + L + + LA+LH + VI+RD K+
Sbjct: 116 ELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170
Query: 269 NILLDADYNAKLSDFGLA 286
+ILL D KLSDFG
Sbjct: 171 SILLTLDGRVKLSDFGFC 188
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 47/185 (25%), Positives = 68/185 (36%), Gaps = 19/185 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 186
+R L+G GG G V++ VA+K + + L + E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
G L ++V + + D Q + + L L RR PL + I
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIG 144
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
L H +RD K NIL+ AD A L DFG+A + T + +GT
Sbjct: 145 SALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200
Query: 307 YAAPE 311
Y APE
Sbjct: 201 YMAPE 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
F LGEG +G V+K +E TG VA+K + + +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ ++VK G ++ +V E+ GS+ + + R+ L I K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
GL +LH I+RD K NILL+ + +AKL+DFG+A
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 102 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
L + + + L ++ DL++ ++ ++G G FG V
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--------- 87
Query: 157 PVKP-GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 211
V+ T A+K L+ + + + E + + +V+L Y +DD+ L
Sbjct: 88 -VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLY 145
Query: 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+V E+MP G L N + +P W+ R A + A L +H I+RD K N+
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199
Query: 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
LLD + KL+DFG + T V GT Y +PE
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 47/237 (19%), Positives = 72/237 (30%), Gaps = 59/237 (24%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 185
T F +G G FG VFK VK G A+K G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 186 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 241
V L H ++V+ EDD L+ E+ GSL + + +R + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-------------------YNAKLSD 282
L +GL ++H +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------------TALELFCLK 323
G V G + A E + T + +
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 60/198 (30%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 239
+ E L + H L L Y + RL V E+ G L HL R R R
Sbjct: 52 TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107
Query: 240 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ I L +LH R V+YRD K N++LD D + K++DFGL K+G
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 295 THVSTRVM-GTYGYAAPE 311
T + GT Y APE
Sbjct: 161 T---MKTFCGTPEYLAPE 175
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 21/160 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 189
F +G+G FG VFKG + T VA+K ++ + + E + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAA 246
+ K G ++D + ++ E++ GS + L L IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
KGL +LH E I+RD K +N+LL KL+DFG+A
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 99 SNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 158
S+ S+ K L + + + NDL+ +G G G V+K +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48
Query: 159 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEF 216
TG +AVK + G + +K L +++ + +V+ G I + + E
Sbjct: 49 ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
M E R P+P I K+ + K L +L E+ VI+RD K SNILLD
Sbjct: 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 162
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
KL DFG++ R G Y APE
Sbjct: 163 QIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPE 194
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 31/224 (13%)
Query: 101 SSTSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
+ S L E + L ++L +F ++G G FG V
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV-------- 92
Query: 156 APV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211
V A+K LN + E + E + L + + L Y +DD L
Sbjct: 93 --VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNL 149
Query: 212 -LVYEFMPRGSLENHL--FRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKT 267
LV ++ G L L F LP + R +A + A + +H+ ++RD K
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQ---LHYVHRDIKP 203
Query: 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
NIL+D + + +L+DFG E S V GT Y +PE
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPE 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 40/190 (21%), Positives = 81/190 (42%), Gaps = 28/190 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K ++ A+K + G+ E+ L +L H N
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 197 LVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALGAAK 247
++ L + D+++ L++++ ++ H ++ + LP + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGPEGDKTHVSTRV 301
G+ +LH V++RD K +NIL+ + K++D G A+ + P + V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 302 MGTYGYAAPE 311
+ T+ Y APE
Sbjct: 197 V-TFWYRAPE 205
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-18
Identities = 58/217 (26%), Positives = 85/217 (39%), Gaps = 39/217 (17%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E V K F +LG+GG+G VF+ + + TG
Sbjct: 2 SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIF 48
Query: 167 AVKTLNHDGLQGHK---EW-LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
A+K L + + AE N L ++ H +V LI Y + +L L+ E++ G
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGE 107
Query: 222 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
L L R I++ L LH++ +IYRD K NI+L+
Sbjct: 108 LFMQLEREGIFMED---TACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQ 157
Query: 276 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPE 311
+ KL+DFGL K+ T GT Y APE
Sbjct: 158 GHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPE 191
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-18
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 23/187 (12%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWLA---- 184
++ LG GG V+ T L VA+K + + +E L
Sbjct: 13 YKIVDKLGGGGMSTVYLAE-----------DTILNIKVAIKAI-FIPPREKEETLKRFER 60
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L H N+V +I EDD LV E++ +L ++ PL +
Sbjct: 61 EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQ 119
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
G+ H+ +++RD K NIL+D++ K+ DFG+AK E T + V+GT
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGT 175
Query: 305 YGYAAPE 311
Y +PE
Sbjct: 176 VQYFSPE 182
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 184
+ LGEG + V+KG + T VA+K + + H+E +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVM 302
+GLA+ H + V++RD K N+L++ KL+DFGLA K P + V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 303 GTYGYAAPE 311
T Y P+
Sbjct: 163 -TLWYRPPD 170
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-18
Identities = 61/280 (21%), Positives = 99/280 (35%), Gaps = 50/280 (17%)
Query: 55 SSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 114
R + + + + + ++ + N + K E L S
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 115 RLRKFTFNDLKLA---TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ D A + + P+ ++G G V + V TG AVK +
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIM 127
Query: 172 NHDGLQGHKEWLA--------EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
+ E L E + L + H +++ LI E + LV++ M +G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG- 185
Query: 222 LENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNIL 271
E LF + K+AL ++FLH +++RD K NIL
Sbjct: 186 -E--LFDY-------LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
LD + +LSDFG + G+K GT GY APE
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPE 269
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 41/218 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
++ + ++G G V VA+K +N + Q + L E+
Sbjct: 16 DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IAL 243
+ H N+V + D+ LV + + GS+ + + + IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 244 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVST 299
+GL +LH+ I+RD K NILL D + +++DFG+ A GD T
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 300 R--VMGTYGYAAPEYV----------------MTALEL 319
R +GT + APE + +TA+EL
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 48/195 (24%), Positives = 74/195 (37%), Gaps = 21/195 (10%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 181
+ + +G G +G V K + +G +AVK + + K+
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66
Query: 182 WLAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWS 236
L +++ + +V+ G + + E M S + +P
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
I KI L K L L E +I+RD K SNILLD N KL DFG++ + +
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180
Query: 297 VSTRVMGTYGYAAPE 311
TR G Y APE
Sbjct: 181 AKTRDAGCRPYMAPE 195
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G VFK E T VA+K + L E L E+ L +
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+V+L D + LV+EF + L+ + + L I KGL F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
H R V++RD K N+L++ + KL++FGLA+ P + V+ T Y
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 310 PE 311
P+
Sbjct: 170 PD 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 59/183 (32%), Positives = 82/183 (44%), Gaps = 26/183 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LGEG F V+K + T VA+K + K+ L E+ L +
Sbjct: 18 LGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N++ L+ LV++FM LE + SL L S L +GL +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGYA 308
LH+ +++RD K +N+LLD + KL+DFGLAK P TH V TR Y
Sbjct: 128 LHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYR 179
Query: 309 APE 311
APE
Sbjct: 180 APE 182
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.2 bits (199), Expect = 2e-17
Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 28/182 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K + G T A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
H+ R V++RD K N+L++ + K++DFGLA+ P TH ++ T Y A
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 310 PE 311
P+
Sbjct: 169 PD 170
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 57/228 (25%)
Query: 114 SRLRKFTFNDLKLATRNFRPESL---------LGEGGFGCVFKGWIEENGTAPVKPGTGL 164
SR + F F DL + ++ P++L LG G G V + T
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161
Query: 165 TVAVKTLNHDGLQGHKEWLA--------EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
VA++ ++ A E+ L L H ++K+ + + + +V E
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFK 266
M G E LF + + L + +LHE +I+RD K
Sbjct: 221 MEGG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266
Query: 267 TSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
N+LL + D K++DFG +K E T GT Y APE
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K K G VA+K + L E + E++ L +
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+V LI + LV+EFM + L+ L L S +G+A
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
H+ +++RD K N+L+++D KL+DFGLA+ P TH V+ T Y A
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187
Query: 310 PE 311
P+
Sbjct: 188 PD 189
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 53/187 (28%), Positives = 77/187 (41%), Gaps = 31/187 (16%)
Query: 113 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
A L + + L+ F L+G G +G V+KG + TG A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58
Query: 173 HDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE-- 223
G +E E+N L H N+ G DDQ LV EF GS+
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 224 -NHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279
+ +L W IA +GL+ LH+ VI+RD K N+LL + K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 280 LSDFGLA 286
L DFG++
Sbjct: 170 LVDFGVS 176
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 58/274 (21%), Positives = 97/274 (35%), Gaps = 41/274 (14%)
Query: 55 SSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 114
SS + + + S + S A V S+ + S + + +
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 115 RLRKFTFNDLKLATRNFR------PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
F + +LG G FG V K + TGL +A
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAA 119
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL----- 222
K + G++ +E E++ + L H NL++L E + LV E++ G L
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRII 178
Query: 223 -ENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYN 277
E++ ++ MK G+ +H + +++ D K NIL
Sbjct: 179 DESYNLTELDTILF-----MKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQ 227
Query: 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
K+ DFGLA+ +K V GT + APE
Sbjct: 228 IKIIDFGLARRYKPREKLKV---NFGTPEFLAPE 258
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 61/253 (24%), Positives = 94/253 (37%), Gaps = 28/253 (11%)
Query: 68 STHYESKSTNDTSRDQPAAAVI-SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKL 126
+ E + N + + A+ T EE+ N ++
Sbjct: 279 LSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRM 338
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 183
+F +LG+G FG V + GT AVK L D + + +
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTM 389
Query: 184 AEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 240
E L L +L C + RL V E++ G L H+ + P
Sbjct: 390 VEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAV 445
Query: 241 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A GL FL + +IYRD K N++LD++ + K++DFG+ K+ T T
Sbjct: 446 FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---T 499
Query: 300 RVM-GTYGYAAPE 311
+ GT Y APE
Sbjct: 500 KTFCGTPDYIAPE 512
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 35/245 (14%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLG 138
+ TT N + EE K A R+ L ++F ++G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 139 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-H 194
G + V T A++ + + + ++ E + H
Sbjct: 62 RGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAK 247
LV L C + + RL V E++ G L H+ R R LP + I+L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA--- 165
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYG 306
L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 218
Query: 307 YAAPE 311
Y APE
Sbjct: 219 YIAPE 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LG G + V+KG + TG+ VA+K + D +E + E++ + +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALGAAK 247
L H N+V+L +++ LV+EFM + +++ + L ++ +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVMGTY 305
GLAF HE +++RD K N+L++ KL DFGLA P + V+ T
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172
Query: 306 GYAAPE 311
Y AP+
Sbjct: 173 WYRAPD 178
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 63/234 (26%), Positives = 89/234 (38%), Gaps = 42/234 (17%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
NA + ++ S +D F ++G+G FG V
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLA- 57
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCI 205
+ AVK L + KE ++E N L V H LV L +
Sbjct: 58 --------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSF 108
Query: 206 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAER 258
+ +L V +++ G L HL R R P R + IA L +LH
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---L 158
Query: 259 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPE 311
++YRD K NILLD+ + L+DFGL K+ E + T T GT Y APE
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-17
Identities = 51/206 (24%), Positives = 75/206 (36%), Gaps = 45/206 (21%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
E +LG G G V G VAVK + + L E+ L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63
Query: 191 DLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWSIRMKIA 242
+ H N+++ YC E R + E +L ++ +L L
Sbjct: 64 ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 243 L-GAAKGLAFLHEEAERPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAK- 287
L A G+A LH +I+RD K NIL+ + +SDFGL K
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 288 --DGPEGDKTHVSTRVMGTYGYAAPE 311
G +T+++ GT G+ APE
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPE 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 57/231 (24%), Positives = 87/231 (37%), Gaps = 33/231 (14%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
++ S + + K + T + F LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59
Query: 150 IEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCI 205
VK +G A+K L+ + K+ L E L + LVKL +
Sbjct: 60 --------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSF 110
Query: 206 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAFLHEEAERPV 260
+D+ L +V E++ G + +HL R P + R +I L +LH +
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDL 162
Query: 261 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
IYRD K N+L+D +++DFG AK T + GT APE
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPE 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 56/221 (25%), Positives = 84/221 (38%), Gaps = 42/221 (19%)
Query: 103 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 162
T+ + + D F +LG+G FG V + GT
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVMLS---------ERKGT 44
Query: 163 GLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFM 217
AVK L D + + + E L L +L C + RL V E++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 103
Query: 218 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
G L H+ + P IA+G L FL + +IYRD K N++
Sbjct: 104 NGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVM 153
Query: 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPE 311
LD++ + K++DFG+ K+ T T+ GT Y APE
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE 191
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 32/192 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 184
NF+ +GEG +G V+K + TG VA+K + L E +
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIR---LDTETEGVPSTAIR 51
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 241
E++ L +L H N+VKL+ +++ LV+EF+ + ++ +P +
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSY 108
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVST 299
+GLAF H V++RD K N+L++ + KL+DFGLA+ P TH
Sbjct: 109 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--- 162
Query: 300 RVMGTYGYAAPE 311
V+ T Y APE
Sbjct: 163 EVV-TLWYRAPE 173
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 60/217 (27%), Positives = 81/217 (37%), Gaps = 42/217 (19%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E + S K D F +LG+G FG VF T
Sbjct: 2 ELNKERPSLQIKLKIED-------FILHKMLGKGSFGKVFLA---------EFKKTNQFF 45
Query: 167 AVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
A+K L D + + + E L H L + + + L V E++ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104
Query: 222 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
L H+ L R I LG L FLH + ++YRD K NILLD D
Sbjct: 105 LMYHIQSCHKFDLS---RATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKD 154
Query: 276 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPE 311
+ K++DFG+ K+ GD T GT Y APE
Sbjct: 155 GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE 188
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 33/154 (21%), Positives = 51/154 (33%), Gaps = 19/154 (12%)
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHL 195
G V TG V V+ +N + E++ H
Sbjct: 36 GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFL 252
N+V I D++ +V FM GS + L + + IA G K L ++
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAYILQGVLKALDYI 144
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
H ++R K S+IL+ D LS
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 59/248 (23%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 81 RDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEG 140
R A +A + S+ ++ KV + + + ++ ++G G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65
Query: 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200
FG V++ + + +G VA+K + LQ + E+ + L H N+V+L
Sbjct: 66 SFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 201 IGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
Y +D+ L LV +++P + H R LP + LA+
Sbjct: 113 R-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYA 308
+H + +RD K N+LLD D KL DFG AK G+ + +R Y Y
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223
Query: 309 APEYVMTA 316
APE + A
Sbjct: 224 APELIFGA 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 4e-16
Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 37/198 (18%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW- 182
K + ++F+ LG G FG V ++ G A+K L + + K+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVE 51
Query: 183 --LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 238
E L + H ++++ +D Q++ ++ +++ G L + L + + P P
Sbjct: 52 HTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---V 107
Query: 239 MK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
K + L L +LH + +IYRD K NILLD + + K++DFG AK P+
Sbjct: 108 AKFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
Query: 294 KTHVSTRVMGTYGYAAPE 311
T + GT Y APE
Sbjct: 161 YT-----LCGTPDYIAPE 173
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 53/261 (20%), Positives = 85/261 (32%), Gaps = 30/261 (11%)
Query: 62 SSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSN-AESNSSTSKLEEELKVASRLRKFT 120
+ G S E + D+ T + V +++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 121 FNDLKLATRNFRP----ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
+++ + LG G FG V + + TG A K +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHE 195
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
+ E+ + L H LV L +D++ +++YEFM G E LF +
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNK 251
Query: 237 IRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGP 290
+ A+ + GL +H E ++ D K NI+ KL DFGL
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 291 EGDKTHVSTRVMGTYGYAAPE 311
V GT +AAPE
Sbjct: 309 PKQSVKV---TTGTAEFAAPE 326
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 31/197 (15%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
L ++F ++G G + V T A+K + + + ++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDW 55
Query: 183 -LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 238
E + H LV L C + + RL V E++ G L H+ R R LP + R
Sbjct: 56 VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113
Query: 239 M---KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+I+L L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 296 HVSTRVM-GTYGYAAPE 311
T GT Y APE
Sbjct: 167 ---TSTFCGTPNYIAPE 180
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 53/204 (25%), Positives = 82/204 (40%), Gaps = 46/204 (22%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 179
N+ P+ +LG G V + + T AVK ++ + +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 180 KEWLA-EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+E EV+ L + H N+++L + LV++ M +G E LF +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--E--LFDY-------L 115
Query: 238 RMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
K+ L K + LH+ +++RD K NILLD D N KL+DFG +
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPE 311
G+K GT Y APE
Sbjct: 173 QLDPGEKL--REVC-GTPSYLAPE 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 47/196 (23%), Positives = 70/196 (35%), Gaps = 48/196 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 188
LG G G V + T VA+K ++ A E+
Sbjct: 18 LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---A 245
L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116
Query: 246 AK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 117 KLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 296 HVSTRVMGTYGYAAPE 311
T GT Y APE
Sbjct: 174 --RTLC-GTPTYLAPE 186
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 33/190 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+G+G F V + + TG AVK ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALG 244
L H ++V+L+ D L +V+EFM L + +R+ S M+ L
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A L + H + +I+RD K +LL + KL FG+A E RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194
Query: 302 MGTYGYAAPE 311
GT + APE
Sbjct: 195 -GTPHFMAPE 203
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 61/222 (27%), Positives = 85/222 (38%), Gaps = 42/222 (18%)
Query: 102 STSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 161
S E + + ++ F +LG+G FG V
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLA---------RVKE 46
Query: 162 TGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEF 216
TG AVK L D + + + E L H L +L C + RL V EF
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 217 MPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+ G L H+ + R R + I L FLH+ + +IYRD K N+
Sbjct: 106 VNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----LMFLHD---KGIIYRDLKLDNV 155
Query: 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPE 311
LLD + + KL+DFG+ K+G T T GT Y APE
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE 194
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 48/186 (25%), Positives = 75/186 (40%), Gaps = 33/186 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G +G V T + A+K + + + + L EV L L H
Sbjct: 45 LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N++KL + ED + LV E G L + + R ++ +K L
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSG--- 148
Query: 249 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +LH + +++RD K N+LL + D K+ DFGL+ K +GT
Sbjct: 149 VTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTA 202
Query: 306 GYAAPE 311
Y APE
Sbjct: 203 YYIAPE 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 33/187 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LGEG +G V+K T TVA+K + L+ +E + EV+ L +
Sbjct: 42 LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+++L + + L++E+ L+ ++ ++ + + G+ F
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--GPEGDKTHVSTRVMGT 304
H R ++RD K N+LL + K+ DFGLA+ P TH ++ T
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-T 200
Query: 305 YGYAAPE 311
Y PE
Sbjct: 201 LWYRPPE 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 34/187 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
LG+G FG V TG AVK ++ ++ + L EV L L
Sbjct: 34 LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAK 247
H N++KL + ED LV E G L + + R +S ++ L
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSG-- 138
Query: 248 GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ ++H + +++RD K N+LL D N ++ DFGL+ K +GT
Sbjct: 139 -ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191
Query: 305 YGYAAPE 311
Y APE
Sbjct: 192 AYYIAPE 198
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 49/197 (24%), Positives = 76/197 (38%), Gaps = 44/197 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------------HDGLQGHKEWLA 184
LG G +G V + A+K + + ++ E +
Sbjct: 44 LGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 185 -EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 238
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAAN 150
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 294
MK L + +LH + +++RD K NILL ++ N K+ DFGL+ + K
Sbjct: 151 IMKQILSG---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 295 THVSTRVMGTYGYAAPE 311
+GT Y APE
Sbjct: 205 LR---DRLGTAYYIAPE 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 46/198 (23%), Positives = 70/198 (35%), Gaps = 39/198 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 184
+ S LG G FG V+ V V VK + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 185 ---EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRM 239
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RL 127
Query: 240 KIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
L + + +L + +I+RD K NI++ D+ KL DFG A G
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 294 KTHVSTRVMGTYGYAAPE 311
+ GT Y APE
Sbjct: 185 LFYTFC---GTIEYCAPE 199
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 28/187 (14%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGD 191
LLGEG +G V + E T AVK L L+ A E+ L
Sbjct: 12 LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 192 LVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALGAAK 247
L H N+++L+ E+ Q++ +V E+ G E + + + P+ + L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL--ID 120
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGT 304
GL +LH + ++++D K N+LL K+S G+A D S G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GS 174
Query: 305 YGYAAPE 311
+ PE
Sbjct: 175 PAFQPPE 181
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 46/225 (20%), Positives = 76/225 (33%), Gaps = 64/225 (28%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
+G+G +G V ++ T A+K +N + ++ EV +
Sbjct: 34 IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------ 244
L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 85 LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 245 --------------------------AAK-------GLAFLHEEAERPVIYRDFKTSNIL 271
+ L +LH + + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 272 LDADYNA--KLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPE 311
+ + KL DFGL+K G+ ++T+ GT + APE
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 46/232 (19%), Positives = 78/232 (33%), Gaps = 29/232 (12%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRP----ESLLGEGGFGCV 145
+ + + +K+ +++ + LG G FG V
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67
Query: 146 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205
+ V+ TG K +N E++ + L H L+ L
Sbjct: 68 HRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 206 EDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFLHEEAERPVI 261
ED + L+ EF+ G L + + + M+ A GL +H E ++
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIV 171
Query: 262 YRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ D K NI+ + K+ DFGLA + V T +AAPE
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPE 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 51/185 (27%), Positives = 73/185 (39%), Gaps = 30/185 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 247
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 307 YAAPE 311
Y APE
Sbjct: 173 YVAPE 177
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 48/193 (24%), Positives = 72/193 (37%), Gaps = 48/193 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG G F VF + TG A+K + E+ L + H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------AAK- 247
N+V L E LV + + G E LF R I + G A+
Sbjct: 67 NIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LERGVYTEKDASLV 111
Query: 248 ------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVS 298
+ +LHE +++RD K N+L + + ++DFGL+K G +
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 299 TRVMGTYGYAAPE 311
+ GT GY APE
Sbjct: 165 STACGTPGYVAPE 177
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 34/193 (17%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193
E +LGEG V + T AVK + EV L
Sbjct: 18 EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 194 -HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAA 246
H N+++LI + E++ R LV+E M GS+ +H+ +R ++ ++ A
Sbjct: 69 GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASA- 123
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 302
L FLH + + +RD K NIL + K+ DF L GD + +ST +
Sbjct: 124 --LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 303 ----GTYGYAAPE 311
G+ Y APE
Sbjct: 179 LTPCGSAEYMAPE 191
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 36/234 (15%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S T ++ + + L++ KV L + + ++G G FG VF+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAK 60
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI---- 205
+ E+ VA+K + LQ + E+ + + H N+V L
Sbjct: 61 LVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLK-AFFYSNG 105
Query: 206 --EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 260
+D+ L LV E++P H + +P + + LA++H +
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGI 162
Query: 261 IYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPE 311
+RD K N+LLD KL DFG AK G+ + +R Y Y APE
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPE 211
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 30/202 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
F+ E + G+G FG V G + TG++VA+K + D ++E L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71
Query: 188 FLGDLVHLNLVKLIGYCI-------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSI 237
L L H N+V+L D L +V E++P + +RR + P +
Sbjct: 72 DLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD-GPEGDKT 295
+ + LH + V +RD K N+L++ AD KL DFG AK P
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 296 H-VSTRVMGTYGYAAPEYVMTA 316
+ +R Y Y APE +
Sbjct: 190 AYICSR----Y-YRAPELIFGN 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 111 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 170
+ R +F N + N+ + LG+G F V + V TGL A K
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61
Query: 171 LNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF 227
+N L ++ E L H N+V+L I+++ LV++ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120
Query: 228 RRSLPLPWSIR-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAK 279
R +S ++ L + +A+ H +++R+ K N+LL K
Sbjct: 121 ARE---FYSEADASHCIQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVK 171
Query: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
L+DFGLA + + + H GT GY +PE
Sbjct: 172 LADFGLAIEVNDSEAWH--GFA-GTPGYLSPE 200
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 51/192 (26%), Positives = 75/192 (39%), Gaps = 47/192 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V V+ GT + A K + ++ + E+ + L H N
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKIA 242
+++L ED+ + LV E G E LF R + MK
Sbjct: 68 IIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVST 299
L A +A+ H+ V +RD K N L D KL DFGLA G + T
Sbjct: 116 LSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRT 167
Query: 300 RVMGTYGYAAPE 311
+V GT Y +P+
Sbjct: 168 KV-GTPYYVSPQ 178
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 28/197 (14%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 183
L+ R + +LG GG V VAVK L L +
Sbjct: 10 LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56
Query: 184 A----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPW 235
E L H +V + + +V E++ +L + + P+
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTP 115
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ + +
Sbjct: 116 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 296 HVST-RVMGTYGYAAPE 311
T V+GT Y +PE
Sbjct: 173 VTQTAAVIGTAQYLSPE 189
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 51/202 (25%), Positives = 79/202 (39%), Gaps = 47/202 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 185
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG- 244
L H N+V+L E+ LV++ + G E LF I +A
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED-------I---VAREF 101
Query: 245 -----AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDG 289
A+ +A+ H +++R+ K N+LL KL+DFGLA +
Sbjct: 102 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 290 PEGDKTHVSTRVMGTYGYAAPE 311
+ + H GT GY +PE
Sbjct: 159 NDSEAWH--GFA-GTPGYLSPE 177
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 35/207 (16%), Positives = 66/207 (31%), Gaps = 25/207 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
+ R + + L G F W+E + + + ++ +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 183 LA--EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------ 234
++ + N V + + + + +L++ + RR
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------ 288
I ++IA + FLH + +++RD K SNI D K+ DFGL
Sbjct: 167 LHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 289 ----GPEGDKTHVSTRVMGTYGYAAPE 311
T +GT Y +PE
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 52/190 (27%), Positives = 75/190 (39%), Gaps = 38/190 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
LG G FG V + +GL +KT+N D Q E + E+ L L H
Sbjct: 30 LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----------MKIALG 244
N++K+ ED + +V E G E L R + + MK +
Sbjct: 81 NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A LA+ H + V+++D K NIL K+ DFGLA+ + +
Sbjct: 136 A---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA 187
Query: 302 MGTYGYAAPE 311
GT Y APE
Sbjct: 188 -GTALYMAPE 196
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 55/194 (28%), Positives = 84/194 (43%), Gaps = 38/194 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 185
N+R +G+G F V TG VA+K ++ L L E
Sbjct: 16 NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64
Query: 186 VNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
V + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 65 VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 244 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+K + + H+ + +++RD K N+LLDAD N K++DFG + + G K
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 298 STRVMGTYGYAAPE 311
G YAAPE
Sbjct: 173 FC---GAPPYAAPE 183
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 51/185 (27%), Positives = 73/185 (39%), Gaps = 30/185 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 247
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 307 YAAPE 311
Y APE
Sbjct: 173 YVAPE 177
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 51/186 (27%), Positives = 75/186 (40%), Gaps = 33/186 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N++KL ED +V E G L + + +R +S +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133
Query: 249 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 306 GYAAPE 311
Y APE
Sbjct: 188 YYIAPE 193
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 53/194 (27%), Positives = 73/194 (37%), Gaps = 49/194 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 240
N++KL ED +V E G E LF I +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHV 297
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K
Sbjct: 129 QVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 298 STRVMGTYGYAAPE 311
R+ GT Y APE
Sbjct: 181 KDRI-GTAYYIAPE 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 35/187 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 192
LG G FG V G TG VAVK LN ++ E+ L
Sbjct: 18 TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 193 VHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 247
H +++KL Y I +V E++ G L +++ + R++
Sbjct: 69 RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQ 119
Query: 248 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 305 YGYAAPE 311
YAAPE
Sbjct: 174 PNYAAPE 180
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 54/192 (28%), Positives = 81/192 (42%), Gaps = 38/192 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G VFK +N G VA+K + +Q +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 192 L---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 240
L H N+V+L + + +L LV+E + L+ +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 299
+ +GL FLH V++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178
Query: 300 RVMGTYGYAAPE 311
V+ T Y APE
Sbjct: 179 VVV-TLWYRAPE 189
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 35/193 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
++ LG G FG V G TG VAVK LN ++ E+
Sbjct: 17 HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 187 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 68 QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKES 118
Query: 245 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
G+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S
Sbjct: 119 RRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 299 TRVMGTYGYAAPE 311
G+ YAAPE
Sbjct: 176 C---GSPNYAAPE 185
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 52/245 (21%), Positives = 84/245 (34%), Gaps = 53/245 (21%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S+ S+ + K+A K ++ LLG GGFG V+ G
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES------QYQVGPLLGSGGFGSVYSG- 62
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGDLVHL--NLVKLI 201
++ L VA+K + D + E EV L + +++L+
Sbjct: 63 --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 202 GYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLH 253
+ E L+ E P L + + R ++ L + + H
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCH 166
Query: 254 EEAERPVIYRDFKTSNILLDADY-NAKLSDFGLA---KDGPEGDKTHVSTRVMGTYGYAA 309
V++RD K NIL+D + KL DFG KD GT Y+
Sbjct: 167 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-----GTRVYSP 216
Query: 310 PEYVM 314
PE++
Sbjct: 217 PEWIR 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 45/197 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 192 LVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L + M+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQ 131
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------KDGPEGDK 294
+ L GL ++H +++RD K +N+L+ D KL+DFGLA K+
Sbjct: 132 MLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 295 THVSTRVMGTYGYAAPE 311
T+ RV+ T Y PE
Sbjct: 186 TN---RVV-TLWYRPPE 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 46/195 (23%), Positives = 76/195 (38%), Gaps = 42/195 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF-------- 188
+G G +G V+K +G VA+K++ + +
Sbjct: 17 IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64
Query: 189 ---LGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSI 237
L H N+V+L+ + + ++ LV+E + R L+ LP
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTH 296
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 297 VSTRVMGTYGYAAPE 311
V+ T Y APE
Sbjct: 179 ---VVV-TLWYRAPE 189
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 34/185 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHL 195
LGEG F K V + AVK ++ ++ E+ L H
Sbjct: 19 LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 249
N+VKL D LV E + G L + ++ +S M+ + A +
Sbjct: 67 NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA---V 119
Query: 250 AFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+ +H+ V++RD K N+L + + K+ DFG A+ P ++ + T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLH 174
Query: 307 YAAPE 311
YAAPE
Sbjct: 175 YAAPE 179
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 46/192 (23%), Positives = 75/192 (39%), Gaps = 40/192 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 300 RVMGTYGYAAPE 311
+ GT + APE
Sbjct: 178 -IFGTPEFVAPE 188
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 30/185 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 249
N+V+L E+ L+++ + G L + R +S ++ L A +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEA---V 123
Query: 250 AFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
H+ V++R+ K N+LL KL+DFGLA + EG++ GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFA-GTPG 178
Query: 307 YAAPE 311
Y +PE
Sbjct: 179 YLSPE 183
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 40/192 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 300 RVMGTYGYAAPE 311
+ GT + APE
Sbjct: 178 -IFGTPEFVAPE 188
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 37/181 (20%), Positives = 66/181 (36%), Gaps = 26/181 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V + V+ + T K + G E++ L H N
Sbjct: 13 LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 252
++ L E + L +++EF+ + + + L + + L FL
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFL 118
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
H + + D + NI+ ++ K+ +FG A+ GD + + Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172
Query: 311 E 311
E
Sbjct: 173 E 173
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 64/259 (24%), Positives = 93/259 (35%), Gaps = 59/259 (22%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ S D + S ++ A + T+ L + + + +D
Sbjct: 4 HHHHSSGVDLGTENLYF---QSMSSVTASAAPGTASLVPDYWIDGS-NRDALSDF----- 54
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
F ES LG G V++ + GT A+K L K E+ L
Sbjct: 55 -FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGVL 102
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---- 244
L H N++KL E + LV E + G L F R I + G
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VEKGYYSE 147
Query: 245 --AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEG 292
AA +A+LHE +++RD K N+L D K++DFGL+K
Sbjct: 148 RDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 293 DKTHVSTRVMGTYGYAAPE 311
V GT GY APE
Sbjct: 205 VLM---KTVCGTPGYCAPE 220
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 42/185 (22%), Positives = 69/185 (37%), Gaps = 34/185 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 195
+G G + + + T + AVK ++ E E+ L H
Sbjct: 30 IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGLA 250
N++ L + +V E M G L + + R+ +S R + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKT---VE 130
Query: 251 FLHEEAERPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + V++RD K SNIL D N ++ DFG AK + + T T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTAN 185
Query: 307 YAAPE 311
+ APE
Sbjct: 186 FVAPE 190
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 40/192 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQFLKQIL 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
G+ +LH + + + D K NI+L + KL DFG+A G++
Sbjct: 119 D---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170
Query: 300 RVMGTYGYAAPE 311
+ GT + APE
Sbjct: 171 -IFGTPEFVAPE 181
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 49/207 (23%), Positives = 73/207 (35%), Gaps = 49/207 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWL 183
+R LLG+GGFG VF G + L VA+K + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 184 AEVNFL----GDLVHLNLVKLIGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSI 237
EV L H +++L+ + E + LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG------- 134
Query: 238 RMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLA---K 287
+ + H R V++RD K NIL+D KL DFG
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM 314
D P GT Y+ PE++
Sbjct: 192 DEPY--TDFD-----GTRVYSPPEWIS 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 44/189 (23%), Positives = 68/189 (35%), Gaps = 36/189 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G F V + + TG A K L E L E+ L
Sbjct: 37 LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 195 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW--------SIRMKIALGA 245
++ L + +L+ E+ G E +F LP +K L
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE- 142
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
G+ +LH + +++ D K NILL + K+ DFG+++ + +M
Sbjct: 143 --GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IM 194
Query: 303 GTYGYAAPE 311
GT Y APE
Sbjct: 195 GTPEYLAPE 203
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 51/259 (19%), Positives = 88/259 (33%), Gaps = 42/259 (16%)
Query: 67 TSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKL 126
+++ +S + P + A+ + + V S L+ +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 186
+LG G G V + T A+K L + EV
Sbjct: 62 --DYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREV 105
Query: 187 NFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-- 238
++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 106 ELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREA 163
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGPEG 292
MK A + +LH + +RD K N+L NA KL+DFG AK+
Sbjct: 164 SEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 293 DKTHVSTRVMGTYGYAAPE 311
+ ++T T Y APE
Sbjct: 218 NS--LTTPC-YTPYYVAPE 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 36/193 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
+ LGEG FG V T VA+K ++ L+ + E+
Sbjct: 10 PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 187 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
++L L H +++KL Y I + +V E+ G L +++ + RM G
Sbjct: 61 SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEG 110
Query: 245 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + H +++RD K N+LLD + N K++DFGL+ +G+ S
Sbjct: 111 RRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 299 TRVMGTYGYAAPE 311
G+ YAAPE
Sbjct: 168 C---GSPNYAAPE 177
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 40/190 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
+LG G G V + TG A+K L + EV+
Sbjct: 36 VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 195 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALG 244
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGT 139
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A + FLH + +RD K N+L + D KL+DFG AK+ + + T
Sbjct: 140 A---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC 190
Query: 302 MGTYGYAAPE 311
T Y APE
Sbjct: 191 -YTPYYVAPE 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 40/192 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 70 EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQIL 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 125 NG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 300 RVMGTYGYAAPE 311
+ GT + APE
Sbjct: 177 -IFGTPEFVAPE 187
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 25/172 (14%), Positives = 52/172 (30%), Gaps = 20/172 (11%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
R +R G ++ VA+ ++ G+ +E
Sbjct: 29 ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L+ L + + +++ L+V E++ GSL+ + P P ++
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAM 135
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGD 293
A H V S + + D + L+ + P+ D
Sbjct: 136 QSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDD 184
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 42/193 (21%), Positives = 62/193 (32%), Gaps = 37/193 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+ +G G FG T VAVK + E + E+
Sbjct: 21 RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69
Query: 189 LGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N+V+ I L ++ E+ G L + R
Sbjct: 70 HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG-------RFSEDEARF 120
Query: 247 K------GLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVS 298
G+++ H + +RD K N LLD K+ DFG +K +
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 175
Query: 299 TRVMGTYGYAAPE 311
+ V GT Y APE
Sbjct: 176 STV-GTPAYIAPE 187
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 34/190 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ LG G + VF+ N V VK L K+ E+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84
Query: 190 GDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALG 244
+L N++ L + R F + N F++ + IR M L
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG-PEGDKTH-VSTRV 301
K L + H +++RD K N+++D ++ +L D+GLA+ P + V++R
Sbjct: 141 --KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 302 MGTYGYAAPE 311
+ PE
Sbjct: 196 -----FKGPE 200
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 46/203 (22%), Positives = 76/203 (37%), Gaps = 39/203 (19%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 182
+ + + G +G V G+ VA+K + + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 183 ------LAEVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 231
L E+ L H N++ L + + +L LV E M L + + +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 232 PLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDG 289
+ ++ GL LHE A V++RD NILL + + + DF LA +D
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 290 PEGDKT-HVSTRVMGTYGYAAPE 311
+ +KT +V+ R Y APE
Sbjct: 186 ADANKTHYVTHRW-----YRAPE 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 44/229 (19%), Positives = 82/229 (35%), Gaps = 68/229 (29%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 186
++ + LG G FG V + + E +G A+K L + E+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51
Query: 187 NFLGDLVHLNLVKLIGY-------------------------------------CIEDDQ 209
+ + L H+N++KL+ Y ++
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 210 RL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDF 265
L ++ E++P + R +P + I + + + F+H + +RD
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDI 167
Query: 266 KTSNILLDA-DYNAKLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPE 311
K N+L+++ D KL DFG AK + + +R + Y APE
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 12/107 (11%)
Query: 131 FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLA 184
F + L LG G FG V + K T TVAVK L H+ ++
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMS 74
Query: 185 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRR 229
E+ L + HLN+V L+G C + L+V EF G+L +L +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 23/71 (32%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
E L + + AKG+ FL A R I+RD NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 283 FGLAKDGPEGD 293
FGLA+D +
Sbjct: 237 FGLARDIYKDP 247
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 43/227 (18%), Positives = 78/227 (34%), Gaps = 52/227 (22%)
Query: 85 AAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLAT-----RNFRPESLLGE 139
A + S + S S+ E + + K T + + + + L+G
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGDLVH 194
G +G V + VA+K + E+ L L H
Sbjct: 64 GSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNH 111
Query: 195 LNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--- 246
++VK+ I +E L +V E ++ + R + L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRTPVYLTELHIK 159
Query: 247 -------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
G+ ++H A +++RD K +N L++ D + K+ DFGLA
Sbjct: 160 TLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 52/208 (25%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 184
+G+G +G V A+K L+ L +
Sbjct: 20 EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 185 ---------------EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENH 225
E+ L L H N+VKL + +D +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 226 LFRRSLPLPWSIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283
+ L + + G + +LH + +I+RD K SN+L+ D + K++DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
G++ + +G +S V GT + APE
Sbjct: 182 GVSNE-FKGSDALLSNTV-GTPAFMAPE 207
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 47/199 (23%), Positives = 76/199 (38%), Gaps = 33/199 (16%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ ++ +G G G V VA+K L+ K E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ + + H N++ L+ +E+ Q + LV E M + + + L RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166
Query: 240 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--H 296
L G+ LH +I+RD K SNI++ +D K+ DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 297 VSTRVMGTYGYAAPEYVMT 315
V TR Y APE ++
Sbjct: 224 VVTRY-----YRAPEVILG 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 53/204 (25%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ + + +G G +G V + +G VA+K L+ K E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ L + H N++ L+ + + LV FM + L + + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121
Query: 240 KIA-----------LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
K + L KGL ++H A V++RD K N+ ++ D K+ DFGLA+
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 289 GPEGDKTH-VSTRVMGTYGYAAPE 311
+ + T V TR + Y APE
Sbjct: 175 HADAEMTGYVVTR----W-YRAPE 193
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
++ S +G G +G V + + TGL VAVK L+ + K E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 237
+ L + H N++ L+ +E+ + LV M L + L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLT-DD 132
Query: 238 RMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT- 295
++ + +GL ++H A+ +I+RD K SN+ ++ D K+ DFGLA+ + T
Sbjct: 133 HVQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG 188
Query: 296 HVSTRVMGTYGYAAPE 311
+V+TR Y APE
Sbjct: 189 YVATRW-----YRAPE 199
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 31/176 (17%), Positives = 59/176 (33%), Gaps = 25/176 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 178
R ++ +S G +++ + ++K DG
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 235
+ + L L + +G+ +D R LV +P SL+ S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156
Query: 236 SIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK 287
S R ++A L FLH E ++ + NI +D + ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 47/214 (21%), Positives = 78/214 (36%), Gaps = 50/214 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
N+ + L+G G +G V+ T VA+K +N + L K L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ L L +++L I DD +V E ++ L + +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123
Query: 241 IALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I L G F+HE + +I+RD K +N LL+ D + K+ DFGLA+
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 291 EGDKTHVSTRVMGTYGYAAP---------EYVMT 315
T++ + +V+T
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 48/215 (22%), Positives = 77/215 (35%), Gaps = 41/215 (19%)
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
+ F+ + LG GG G VF V VA+K +
Sbjct: 2 MNIHGFD----LGSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTD 48
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLI-------------GYCIEDDQRL-LVYEFMPRGS 221
Q K L E+ + L H N+VK+ + + + +V E+M
Sbjct: 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM---- 104
Query: 222 LENHLFR--RSLPLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYN 277
E L PL + +GL ++H A V++RD K +N+ ++ D
Sbjct: 105 -ETDLANVLEQGPLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLV 159
Query: 278 AKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPE 311
K+ DFGLA+ P + + T Y +P
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 50/195 (25%), Positives = 76/195 (38%), Gaps = 34/195 (17%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+R +G G +G V V TG VA+K L K E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 237
+ L + H N++ L+ ++D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 296
+ KGL ++H A +I+RD K N+ ++ D K+ DFGLA+ + + T +
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGY 185
Query: 297 VSTRVMGTYGYAAPE 311
V TR Y APE
Sbjct: 186 VVTRW-----YRAPE 195
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 40/217 (18%), Positives = 75/217 (34%), Gaps = 36/217 (16%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
+S+ L E+ V + ++ +G+GGFGC++
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA-------AWKVGLPIGQGGFGCIYLAD 55
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGDLVHLNLVKLIG-- 202
+ + G+ VK D E A+ + + +K +G
Sbjct: 56 MNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111
Query: 203 ---YCIEDDQRLLVYEF--MPR-G-SLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
D+ Y F M R G L+ ++ + ++ ++L L ++
Sbjct: 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSRK-TVLQ-LSLRILDILEYI 168
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK 287
H E ++ D K SN+LL+ + L D+GLA
Sbjct: 169 H---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 34/197 (17%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ S +GEG +G V + VA+K ++ + + L E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREI 76
Query: 187 NFLGDLVHLNLVKLIG----YCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 239
L H N++ + IE + + +V + M E L++ ++ L + +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHI 130
Query: 240 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDK 294
L +GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+ D
Sbjct: 131 CYFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 295 THVSTRVMGTYGYAAPE 311
T T + T Y APE
Sbjct: 185 TGFLTEYVATRWYRAPE 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 49/199 (24%), Positives = 78/199 (39%), Gaps = 33/199 (16%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ ++ +G G G V VA+K L+ K E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ + + H N++ L+ +E+ Q + +V E M +L + + L RM
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129
Query: 240 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKT-H 296
L G+ LH +I+RD K SNI++ +D K+ DFGLA G T +
Sbjct: 130 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 297 VSTRVMGTYGYAAPEYVMT 315
V TR Y APE ++
Sbjct: 187 VVTRY-----YRAPEVILG 200
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 44/204 (21%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ +F+ +SLLGEG +G V TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 187 NFLGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 239
L H N++ + E+ + ++ E M + L R + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHI 114
Query: 240 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPE 291
+ L + + LH + VI+RD K SN+L++++ + K+ DFGLA + +
Sbjct: 115 QYFIYQTL---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMT 315
+ M E+V T
Sbjct: 169 NSEPTGQQSGM-V------EFVAT 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 34/204 (16%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
R + LG+G +G V+K + TG VAVK + + E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 186 VNFLGDL-VHLNLVKLIGYCI-EDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMK 240
+ L +L H N+V L+ ++D+ + LV+++M E L R+ L + +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQ 112
Query: 241 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ K + +LH +++RD K SNILL+A+ + K++DFGL++ + +
Sbjct: 113 YVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 300 RVMGTYGYAAP--------EYVMT 315
+ +YV T
Sbjct: 170 PLSINENTENFDDDQPILTDYVAT 193
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 38/196 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 187
+++ +GEG FG +F+G VA+K D Q E+
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 244
G + + + E +LV + + SLE L R + ++ M A
Sbjct: 62 LAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQ 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTH 296
+ +H E+ ++YRD K N L+ + + DFG+ K D K H
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQH 169
Query: 297 VSTR----VMGTYGYA 308
+ R + GT Y
Sbjct: 170 IPYREKKNLSGTARYM 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 48/195 (24%), Positives = 70/195 (35%), Gaps = 36/195 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
NFR +G G FG + G T VA+K E F
Sbjct: 10 NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 190 GDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
L + ++ + +V E + SLE LF R+ L ++ M IA+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHV 297
+ ++H + +IYRD K N L+ N + DF LAK D K H+
Sbjct: 115 ISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHI 169
Query: 298 STR----VMGTYGYA 308
R + GT Y
Sbjct: 170 PYREHKSLTGTARYM 184
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 43/191 (22%), Positives = 68/191 (35%), Gaps = 30/191 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+R +G G FG ++ G G VA+K H + E
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58
Query: 190 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
+ + + E D ++V E + SLE LF R L ++ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 300
+ ++H + I+RD K N L+ + DFGLAK H+ R
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 301 ---VMGTYGYA 308
+ GT YA
Sbjct: 172 NKNLTGTARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 49/191 (25%), Positives = 74/191 (38%), Gaps = 30/191 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
FR +G G FG ++ G + VA+K N H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56
Query: 190 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
L + + + +E D +LV + + SLE LF R L L ++ M +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 300
+ F+H + ++RD K N L+ A + DFGLAK H+ R
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 301 ---VMGTYGYA 308
+ GT YA
Sbjct: 170 NKNLTGTARYA 180
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 29/178 (16%), Positives = 61/178 (34%), Gaps = 32/178 (17%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 183
+ +G GGFG ++ + VK + E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 184 AEVNFLGDLVHLNLVKLIG-----YC-----IEDDQRLLVYEFMPR-G-SLENHLFRRSL 231
A+ + + + + +G R +V M R G L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK 287
S +++ + L ++H E ++ D K +N+LL + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-07
Identities = 35/215 (16%), Positives = 57/215 (26%), Gaps = 43/215 (20%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK--PGTGLTVA 167
+ S+ F+ L T + +GEG FG VF+ + A +K G +
Sbjct: 2 MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHTPVA-IKIIAIEGPDLV 59
Query: 168 VKTLNHDGLQGHKE-----WLAEVNFLGDLVHLNLVKLIGYCI----------------- 205
+ + E L+ ++ + L
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 206 -------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
+DDQ +V EF G + + + I LA
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVA 177
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+RD N+LL KL K
Sbjct: 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 37/165 (22%), Positives = 59/165 (35%), Gaps = 36/165 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 195
LG G G V + T A+K L + EV
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71
Query: 196 NLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGA 245
++V+++ E+ L+V E + G L + + R ++ R MK A
Sbjct: 72 HIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEA 129
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 287
+ +LH + +RD K N+L + KL+DFG AK
Sbjct: 130 ---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 52/198 (26%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 193
++G+G FG V K + + VA+K + N H++ E+ L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151
Query: 194 HL------NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPW 235
N++ ++ C+ E LL +YE + + + LP
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP- 200
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDGPEGD 293
+R K A + L LH+ +I+ D K NILL + K+ DFG + +
Sbjct: 201 LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 294 KTHVSTRVMGTYGYAAPE 311
T++ +R Y APE
Sbjct: 257 YTYIQSRF-----YRAPE 269
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 40/203 (19%), Positives = 68/203 (33%), Gaps = 48/203 (23%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
LG G F V+ N T VA+K + D + E+ L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74
Query: 195 LNLVKLIG----YCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLP 234
+ K + + +LL + F +G H+ +L +P
Sbjct: 75 ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD------ADYNAKLSDFGLAKD 288
+I+ GL ++H +I+ D K N+L++ K++D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 289 GPEGDKTHVSTRVMGTYGYAAPE 311
E + TR Y +PE
Sbjct: 188 YDEHYTNSIQTRE-----YRSPE 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 52/215 (24%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
+ R + +SL+G+G FG V K + VA+K + N
Sbjct: 45 IVKNGEK-WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF 93
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ EV L + +V L + C+ E +L +Y+
Sbjct: 94 --LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-- 145
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
L N FR + ++ K A L FL +I+ D K NILL +
Sbjct: 146 ---LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRS 198
Query: 279 --KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
K+ DFG + + ++ +R Y +PE
Sbjct: 199 AIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 8e-06
Identities = 37/211 (17%), Positives = 77/211 (36%), Gaps = 22/211 (10%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFT---FNDLKLATRNFRPE- 134
T+R + +S+ TT++ + + L + +V S L K+ DL P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 135 -SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 191
S++ E + W N K T + ++ L + + L+ V F
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLEPAEYRKMFDRLS-V-FPPS 384
Query: 192 LVHLN---LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
H+ L + I+ D ++V + +E ++ +P SI +++ +
Sbjct: 385 -AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-SIYLEL-KVKLEN 441
Query: 249 LAFLHEEA-ERPVIYRDFKTSNILLDAD--Y 276
LH + I + F + +++ Y
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 1e-04
Identities = 52/308 (16%), Positives = 98/308 (31%), Gaps = 106/308 (34%)
Query: 5 GENGKVKKASWDSSKS-KAKKKKKKVEDEVEVEEEEET-GCWVKLRFF------------ 50
E+ + A+WD+ K K +E + V E E + +L F
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 51 --------------------GSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPA--AAV 88
S + + K +S++S S + E K + ++ A ++
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSLVEKQPK-ESTISIPSIYLELKVKLE---NEYALHRSI 449
Query: 89 ISSTTTSNAESNSSTSKLEEE----------LKVASRLRKFT-FNDLKLATRNFRPESLL 137
+ + + LK + T F + L +FR
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL---DFR----- 501
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL 197
++E + + HD W A + L L L
Sbjct: 502 -----------FLE-----------------QKIRHDSTA----WNASGSILNTLQQLKF 529
Query: 198 VKLIGYCIEDD---QRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
K Y ++D +RL+ + +F+P+ +E +L ++ ++IAL A +
Sbjct: 530 YK--PYICDNDPKYERLVNAILDFLPK--IEENLICS----KYTDLLRIALMAEDE--AI 579
Query: 253 HEEAERPV 260
EEA + V
Sbjct: 580 FEEAHKQV 587
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 52/232 (22%), Positives = 76/232 (32%), Gaps = 70/232 (30%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
D L R + LGEG FG V + VA+K + N
Sbjct: 10 VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ E+N L + V + + CI E LL +EF
Sbjct: 60 --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 277
L+ + F+ P P +A L FLHE + + D K NIL ++++
Sbjct: 112 ---LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162
Query: 278 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+++DFG A E T V+TR Y PE
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 59/232 (25%), Positives = 82/232 (35%), Gaps = 70/232 (30%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
D+ L+ R + LGEG FG V + + G G VAVK + N D
Sbjct: 5 ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ +E+ L L V+++ + CI E LL Y+F
Sbjct: 55 --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 277
++ + F P K+A K + FLH + + D K NIL +DY
Sbjct: 107 ---IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157
Query: 278 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
K+ DFG A E T VSTR Y APE
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 324 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.14 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.66 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.2 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.07 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.22 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.07 | |
| 2khx_A | 85 | Ribonuclease 3; drosha, RNA binding domain, hydrol | 92.31 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.23 | |
| 1x49_A | 97 | Interferon-induced, double-stranded RNA- activated | 91.12 | |
| 3adj_A | 76 | F21M12.9 protein; HYL1, miRNA processing, RNA bind | 90.48 | |
| 1x48_A | 88 | Interferon-induced, double-stranded RNA- activated | 90.28 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.18 | |
| 1t4n_A | 94 | Ribonuclease III; DSRBD, RNA-binding, hydrolase; N | 89.04 | |
| 3p1x_A | 75 | Interleukin enhancer-binding factor 3; structural | 88.98 | |
| 1di2_A | 69 | XLRBPA, double stranded RNA binding protein A; pro | 87.8 | |
| 1x47_A | 98 | DGCR8 protein; structural genomics, DSRM domain, N | 86.99 | |
| 1whq_A | 99 | RNA helicase A; double-stranded RNA binding domain | 86.42 | |
| 3adl_A | 88 | RISC-loading complex subunit tarbp2; TRBP2, miRNA | 86.34 | |
| 3adg_A | 73 | F21M12.9 protein; HYL1, miRNA processing mechanism | 85.99 | |
| 2l33_A | 91 | Interleukin enhancer-binding factor 3; structural | 85.74 | |
| 2l2n_A | 103 | Hyponastic leave 1; DSRBD, miRNA, RNA binding prot | 85.41 | |
| 2dix_A | 84 | Interferon-inducible double stranded RNA- dependen | 85.15 | |
| 1ekz_A | 76 | DSRBDIII, maternal effect protein (staufen); struc | 85.05 | |
| 2b7v_A | 71 | Double-stranded RNA-specific editase 1; RNA editin | 84.99 | |
| 1uil_A | 113 | Double-stranded RNA-binding motif; structural geno | 84.8 | |
| 1t4o_A | 117 | Ribonuclease III; RNT1P, DSRBD, RNA-binding, hydro | 84.78 | |
| 1whn_A | 128 | Hypothetical protein riken cDNA 2310016K04; double | 84.68 | |
| 2cpn_A | 89 | TAR RNA-binding protein 2; double-stranded RNA bin | 84.36 | |
| 2b7t_A | 73 | Double-stranded RNA-specific editase 1; RNA editin | 83.73 | |
| 1uhz_A | 89 | Staufen (RNA binding protein) homolog 2; DSRM, sta | 82.32 | |
| 2ljh_A | 114 | Double-stranded RNA-specific editase ADAR; DSRBD, | 81.77 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=374.11 Aligned_cols=181 Identities=27% Similarity=0.374 Sum_probs=162.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
...|++++.||+|+||+||+|++.. ||+.||||++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3579999999999999999999876 6889999999776555567789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+.+|||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999999999999964 46999999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.+..... .....+||+.|||||++. .++|||||||
T Consensus 219 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv 258 (346)
T 4fih_A 219 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 258 (346)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHH
Confidence 7654322 234578999999999987 4589999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=372.35 Aligned_cols=183 Identities=25% Similarity=0.340 Sum_probs=162.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|++.. +++.||||++.+.. ....+.+.+|+.+|++|+|||||++++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 479999999999999999998876 68899999997542 223467899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 999999999999999999999643 57999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+.+............+||+.|||||++. .++|||||||
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv 222 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 222 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHH
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHH
Confidence 99875543333345678999999999997 3589999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=376.66 Aligned_cols=181 Identities=27% Similarity=0.374 Sum_probs=163.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+.|++++.||+|+||+||+|++.. ||+.||||++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 3579999999999999999999876 6889999999877666667899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence 999999999999999999954 36999999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.+..... .....+||+.|||||++. .++|||||||
T Consensus 296 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv 335 (423)
T 4fie_A 296 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 335 (423)
T ss_dssp ECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHH
Confidence 7654322 234578999999999997 4589999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=373.27 Aligned_cols=182 Identities=23% Similarity=0.347 Sum_probs=154.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+++.+|+.+|++|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 589999999999999999998875 6789999999765432 24578999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
++.+|||||||+||+|.++|... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999999654 456799999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|+...... ...+..+||+.|||||++.+ ++|||||||
T Consensus 172 a~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGv 213 (350)
T 4b9d_A 172 ARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213 (350)
T ss_dssp ESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHH
Confidence 99764321 12344689999999999983 589999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=363.98 Aligned_cols=183 Identities=26% Similarity=0.414 Sum_probs=152.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||+||+|++.. .||||+++.... ...++|.+|+.+|++|+|||||+++++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345688899999999999999998653 699999975432 234679999999999999999999998
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+. ++.+|||||||++|+|.++|.....++++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCC
T ss_pred EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeec
Confidence 75 46689999999999999999877778999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
|+|+..............+||+.|||||++. .++|||||||
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv 225 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI 225 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence 9998765433333345578999999999985 2589999997
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=364.28 Aligned_cols=190 Identities=30% Similarity=0.455 Sum_probs=160.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|.+.+.||+|+||+||+|++.... ...++..||||+++.......++|.+|+.+|++|+|||||+++++|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 357888999999999999999876421 1235789999999876655567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
+.+|||||||++|+|.++|.+. ...+++.+++.|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 9999999999999999999643 246999999999999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.+||+|||+|+...............||+.|||||++. .++|||||||
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHH
Confidence 999999999998765433332333457999999999997 4689999997
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=364.19 Aligned_cols=189 Identities=28% Similarity=0.435 Sum_probs=153.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|.+.+.||+|+||+||+|++... ....++..||||+++.......++|.+|+.+|++|+|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4677888999999999999987641 112367899999998766555678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 209 QRLLVYEFMPRGSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
.+|||||||++|+|.++|.+. ..++++.+++.|+.||+.||.|||+++ ||||||||+||||+.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 999999999999999999643 246999999999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.+||+|||+|+...........+..+||+.|||||++. .++|||||||
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 9999999999999775544443445578999999999987 3589999997
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=354.64 Aligned_cols=178 Identities=28% Similarity=0.412 Sum_probs=153.0
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe---
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--- 206 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--- 206 (324)
++.+.||+|+||+||+|.+.. ++..||||.+..... ...++|.+|+.+|++|+|||||+++++|.+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred EeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 566789999999999998875 678999999975432 234578999999999999999999999875
Q ss_pred -CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcEEEEeec
Q 020561 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFG 284 (324)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFG 284 (324)
++.+|||||||++|+|.++|.+ ...+++..+..|+.||+.||+|||+++ .+||||||||+||||+ .++.+||+|||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCc
Confidence 3568999999999999999964 457999999999999999999999976 5699999999999997 47999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
+|+..... .....+||+.|||||++. .++|||||||
T Consensus 178 la~~~~~~----~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGv 217 (290)
T 3fpq_A 178 LATLKRAS----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGM 217 (290)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHH
T ss_pred CCEeCCCC----ccCCcccCccccCHHHcCCCCCcHHHHHHHHH
Confidence 99865432 234578999999999987 4589999997
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=362.39 Aligned_cols=184 Identities=28% Similarity=0.361 Sum_probs=153.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|+...+. .+++.||||+++.... ....++.+|+.+|++|+|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS------DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST------TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC------CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 47999999999999999999875432 2688999999976532 223468899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++.+|||||||+||+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999999654 57999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .....+||+.|||||++. .++|||||||
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGv 214 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 214 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHH
Confidence 87543322 234578999999999997 4589999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=352.51 Aligned_cols=179 Identities=26% Similarity=0.397 Sum_probs=145.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|++.. +|+.||||++.+... ....++.+|+.+|++|+|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 589999999999999999998765 688999999976532 22457899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++.+||||||| +|+|.+++.+ ..++++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 7899999955 457999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|+....... ....+||+.|||||++.+ ++|||||||
T Consensus 159 a~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv 200 (275)
T 3hyh_A 159 SNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred CeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence 987644322 344689999999999872 579999997
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=360.68 Aligned_cols=178 Identities=26% Similarity=0.315 Sum_probs=152.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+.|++.+.||+|+||+||+|++.. +|+.||||+++.... ..+|+.+|+.|+|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457788899999999999999875 688999999976532 247999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEeecccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAK 287 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~ 287 (324)
.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999654 57999999999999999999999988 99999999999999887 69999999999
Q ss_pred cCCCCCcc---ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKT---HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~---~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ ......+||+.|||||++. .++|||||||
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGv 244 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHH
Confidence 76543211 1123468999999999998 3589999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=355.08 Aligned_cols=184 Identities=26% Similarity=0.423 Sum_probs=146.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++++.||+|+||+||+|++.. +|+.||||+++..... ..+++.+|+.+|++|+|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 469999999999999999998875 6779999999765432 345789999999999999999999999765
Q ss_pred C------------eEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 208 D------------QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 208 ~------------~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
+ .+|||||||++|+|.+++.... ...++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence 4 3799999999999999996543 23456778899999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCcc----------ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++.+||+|||+|+........ ...+..+||+.|||||++. .++|||||||
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGv 218 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGL 218 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHH
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHH
Confidence 9999999999999876543211 1123457999999999987 3589999997
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=355.94 Aligned_cols=189 Identities=25% Similarity=0.356 Sum_probs=157.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++++++.||+|+||+||+|.+.... ...+++.||||+++.... ...++|.+|+.+|++|+|||||+++++|.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 45677889999999999999875311 112577999999975432 3346799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
+.++||||||++|+|.++|..+ ...+++..++.|+.||+.||.|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 9999999999999999999643 235899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+|+.....+........+||+.|||||++. .++|||||||
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHH
Confidence 999999999999998765433333344568999999999987 4689999997
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=353.84 Aligned_cols=198 Identities=26% Similarity=0.361 Sum_probs=166.3
Q ss_pred CHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCC-CCc
Q 020561 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH-LNL 197 (324)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H-pnI 197 (324)
....|++..++|++++.||+|+||+||+|.+...+. ..+++.||||.+...... ..+.|.+|+.+|.++.| |||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence 445566677899999999999999999998875322 225678999999765433 24578999999999965 999
Q ss_pred ceEEEEEEeC-CeEEEEEEecCCCChHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 198 VKLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 198 v~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
|+++++|..+ +.+|||||||++|+|.++|+.. ...+++..++.|+.||+.||+|||+++ ||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii 207 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 207 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence 9999999765 5689999999999999999642 235899999999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 262 HrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||||+||||+.++.+||+|||+|+..............+||+.|||||++. .++|||||||
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv 275 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 275 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHH
Confidence 99999999999999999999999999876544443444567999999999987 4689999997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=342.39 Aligned_cols=182 Identities=30% Similarity=0.377 Sum_probs=146.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|.+.+.||+|+||+||+|++. |+.||||+++..... ...+.+|+..+.+|+|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 46778899999999999999863 679999999654321 122345666677899999999999998764
Q ss_pred ----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeCCCCCCcEEEcCCCcEE
Q 020561 209 ----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 209 ----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~~k 279 (324)
.+|||||||++|+|.++|++ .++++..++.++.|++.||.|||++. .++||||||||+||||+.++.+|
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 57999999999999999965 36899999999999999999999861 23599999999999999999999
Q ss_pred EEeecccccCCCCCcc--ceeeccccccCccccccccc-----------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-----------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-----------~~DiwSlGc 324 (324)
|+|||+|+........ ......+||+.|||||++.+ ++|||||||
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gv 206 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHH
Confidence 9999999876443221 11234579999999999853 589999997
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=348.88 Aligned_cols=182 Identities=25% Similarity=0.399 Sum_probs=154.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. ||+.||||+++.... ...+++.+|+.+|+.|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 579999999999999999999875 788999999976532 223578899999999999999999998764
Q ss_pred C------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
. +.+|||||||+ |+|.++|.+ ...+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence 3 57899999995 789999954 467999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCC--ccceeeccccccCcccccccc------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~--~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|||+|+.+.... ........+||+.|||||++. .++|||||||
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~ 251 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHH
Confidence 9999998764322 112234578999999999986 3579999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=340.59 Aligned_cols=183 Identities=23% Similarity=0.302 Sum_probs=154.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 205 (324)
..+.|++++.||+|+||+||+|+++.+ ..+++.||||.+.... ...++.+|+.+|..+ +|||||++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 356899999999999999999987632 1267899999986543 235788999999988 6999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-CcEEEEeec
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG 284 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFG 284 (324)
+.+.+|||||||++|+|.+++. .+++.++..++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999983 5899999999999999999999988 9999999999999876 899999999
Q ss_pred ccccCCCCCcc--------------------------ceeeccccccCccccccccc------cceEEEecC
Q 020561 285 LAKDGPEGDKT--------------------------HVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~--------------------------~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+|+........ ...+..+||+.|||||++.+ ++|||||||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 99865432110 11234579999999999863 479999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=359.40 Aligned_cols=180 Identities=28% Similarity=0.404 Sum_probs=155.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHH---HHHHHHHcCCCCCCcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW---LAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~HpnIv~~~ 201 (324)
.++|+++++||+|+||+||+|++.. ||+.||||++.+... .....+ ..++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 4689999999999999999998875 788999999975321 111223 3446778899999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
++|.+++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999999999999654 57999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||+|+...... ..+.+||+.|||||++. .++|||||||
T Consensus 335 DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGv 379 (689)
T 3v5w_A 335 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379 (689)
T ss_dssp CCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHH
T ss_pred ccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHH
Confidence 999999765432 23468999999999996 2479999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=355.76 Aligned_cols=182 Identities=24% Similarity=0.330 Sum_probs=163.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++++.||+|+||+||+|+++. +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999998875 7889999999876655567789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC--CcEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~~kl~DFGl 285 (324)
+.+|||||||+||+|.++|.+....+++..+..++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999999999766678999999999999999999999988 9999999999999754 8999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|+.+..... ....+||+.|||||++.+ ++|||||||
T Consensus 304 a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGv 344 (573)
T 3uto_A 304 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344 (573)
T ss_dssp CEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHH
T ss_pred eeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHH
Confidence 998755432 344689999999999983 589999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.63 Aligned_cols=191 Identities=22% Similarity=0.262 Sum_probs=164.7
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCc
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI 197 (324)
+.++.+..++|+++++||+|+||+||+|++.. +++.||||++..... .....+.+|+.++..++||||
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I 136 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 44455567899999999999999999999875 677999999965321 112348899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
++++++|.+.+.+|||||||++|+|.+++.+....+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence 99999999999999999999999999999765678999999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+||+|||+|+....... ......+||+.|||||++. .++|||||||
T Consensus 214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGv 269 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269 (437)
T ss_dssp EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHH
T ss_pred EEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHH
Confidence 99999999987654332 2233468999999999986 2589999997
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=298.96 Aligned_cols=181 Identities=24% Similarity=0.382 Sum_probs=161.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
..+|++.+.||+|+||+||+|.+.. +++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999998765 6779999999766555567789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..|+|||||++|+|.+++.+. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999999999999999653 5899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .....||+.|+|||++. .++|||||||
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 204 (297)
T 3fxz_A 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (297)
T ss_dssp ECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHH
T ss_pred ecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHH
Confidence 76543322 33467999999999986 4579999997
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=299.90 Aligned_cols=185 Identities=28% Similarity=0.435 Sum_probs=160.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+........+.+.+|+.++++++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3578899999999999999998875 5779999998766555567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 9999999999999999999876778999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccc------------eeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTH------------VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~------------~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... ......||+.|+|||++. .++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 210 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI 210 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence 764432211 011457999999999987 3589999997
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=306.32 Aligned_cols=182 Identities=29% Similarity=0.357 Sum_probs=158.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++++.||+|+||+||+|+... +++.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 3579999999999999999998765 67799999997542 22345688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+.+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999999543 47899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++....... .....+||+.|||||++. .++|||||||
T Consensus 151 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 193 (337)
T 1o6l_A 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHH
T ss_pred chhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchh
Confidence 9986433221 133468999999999987 3689999997
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=305.95 Aligned_cols=181 Identities=27% Similarity=0.381 Sum_probs=159.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..+|++.+.||+|+||.||+|.+.. +|..||||++..... ...+++.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4589999999999999999998865 677999999975432 23456889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999999999554 46999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+........ ....+||+.|+|||++. .++|||||||
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 202 (328)
T 3fe3_A 161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202 (328)
T ss_dssp CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHH
T ss_pred ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHH
Confidence 987644322 34468999999999986 3589999997
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=309.26 Aligned_cols=183 Identities=31% Similarity=0.424 Sum_probs=154.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCC-CCCCcceEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~~ 202 (324)
..++|+++++||+|+||+||+|++.. +++.||||++.... ......+.+|..++..+ +||||+++++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 44689999999999999999998875 67799999997542 12235678899999988 6999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++.+.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999999544 56999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+++....... .....+||+.|||||++. .++|||||||
T Consensus 168 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 212 (353)
T 3txo_A 168 FGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGV 212 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHH
T ss_pred ccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchH
Confidence 999986433221 233468999999999987 4689999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=315.55 Aligned_cols=191 Identities=21% Similarity=0.251 Sum_probs=164.1
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCc
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI 197 (324)
+.+..+..++|++++.||+|+||+||+|++.. +++.||||++.+... .....+.+|+.++..++||||
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I 123 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe
Confidence 34444566899999999999999999998875 678999999975321 122457899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
+++++++.+.+.+|||||||++|+|.+++.+....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence 99999999999999999999999999999766668999999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc------------ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------------TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------------~~~DiwSlGc 324 (324)
+||+|||+++........ .....+||+.|||||++. .++|||||||
T Consensus 201 vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGv 258 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258 (412)
T ss_dssp EEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHH
T ss_pred EEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhH
Confidence 999999999876543221 123468999999999986 3589999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.15 Aligned_cols=182 Identities=25% Similarity=0.394 Sum_probs=157.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
.++|+++++||+|+||+||+|++.. +++.||||++++.... ....+.+|..+|.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 4579999999999999999998875 6789999999764322 234578899999877 89999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+.+.+.+|||||||++|+|..++.+. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999999643 57999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++....... .....+||+.|||||++. .++|||||||
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGv 241 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHH
Confidence 99986433221 234568999999999987 3589999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=313.68 Aligned_cols=187 Identities=23% Similarity=0.297 Sum_probs=161.0
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcce
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
++....++|+++++||+|+||+||+|++.. ++..||||++..... .....+.+|+.++..++|||||+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344556789999999999999999998875 677999999965321 12245789999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
+++++.+.+.+|||||||++|+|.+++.+ ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+|
T Consensus 134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEE
Confidence 99999999999999999999999999964 36899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
|+|||+++........ .....+||+.|||||++. .++|||||||
T Consensus 209 L~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGv 261 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261 (410)
T ss_dssp ECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHH
T ss_pred EeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchH
Confidence 9999999876543221 233568999999999986 3589999997
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=306.82 Aligned_cols=181 Identities=25% Similarity=0.343 Sum_probs=159.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++++.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+|..++|||||++++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999998875 67799999996532 12345788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..|+|||||++|+|.+++.+ ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccc
Confidence 999999999999999999999954 457999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+++....... ....+||+.|+|||++. .++|||||||
T Consensus 161 ~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~ 205 (384)
T 4fr4_A 161 IAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205 (384)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHH
T ss_pred eeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHH
Confidence 9987654332 34468999999999985 2579999997
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=302.46 Aligned_cols=181 Identities=25% Similarity=0.348 Sum_probs=158.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCCCCCcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
.+.|++++.||+|+||.||+|.+.. +|..||||++...... ..+.+.+|+.+|..++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 4579999999999999999998875 6779999999765432 246789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----c
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~ 277 (324)
+++.+.+..|||||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999999999999954 457999999999999999999999988 99999999999998777 7
Q ss_pred EEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+||+|||+++....... ....+||+.|+|||++.. ++|||||||
T Consensus 158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 206 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206 (361)
T ss_dssp EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHH
Confidence 99999999987655322 234679999999999873 589999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=299.83 Aligned_cols=179 Identities=27% Similarity=0.415 Sum_probs=157.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++++.||+|+||+||+|+... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 3579999999999999999998875 677999999975421 2345678899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..|+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecC
Confidence 999999999999999999999954 457999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++..... ....+||+.|+|||++. .++|||||||
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 191 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 191 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHH
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHH
Confidence 99876432 23467999999999987 3589999997
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=304.55 Aligned_cols=184 Identities=29% Similarity=0.432 Sum_probs=157.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCC-CCCCcceEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~ 201 (324)
+..++|++.+.||+|+||+||+|++.. +++.||||+++... ......+.+|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 456789999999999999999998875 67899999997542 12335678899999876 899999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+++.+.+.+|+|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999999999643 46899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+++........ ....+||+.|+|||++. .++|||||||
T Consensus 161 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 206 (345)
T 1xjd_A 161 DFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206 (345)
T ss_dssp CCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred EChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHH
Confidence 99999865332221 34468999999999987 3579999997
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=302.91 Aligned_cols=182 Identities=25% Similarity=0.397 Sum_probs=157.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
.++|++++.||+|+||.||+|++.. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 3579999999999999999998875 6789999999765332 234578899999887 89999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+.+.+.+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999999643 46999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|+++....... .....+||+.|+|||++.. ++|||||||
T Consensus 155 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 198 (345)
T 3a8x_A 155 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 198 (345)
T ss_dssp GGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred cccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHH
Confidence 99986433221 1344689999999999873 589999997
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.31 Aligned_cols=190 Identities=41% Similarity=0.749 Sum_probs=163.9
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEE
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
.++....++|++.+.||+|+||.||+|.+. ++..||||.+........+++.+|+.+++.++||||++++
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 101 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 334446679999999999999999999864 3679999998876655567899999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
+++...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178 (321)
T ss_dssp EECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCE
T ss_pred EEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999996433 35899999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 229 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHH
Confidence 999999998754433332234456999999999986 4689999997
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=297.22 Aligned_cols=181 Identities=20% Similarity=0.268 Sum_probs=160.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 3579999999999999999998775 67899999997543 2345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC--CCcEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl~DFGl 285 (324)
+..++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 9999999999999999999766667999999999999999999999988 999999999999987 78999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... .....||+.|+|||++. .++|||||||
T Consensus 151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 191 (321)
T 1tki_A 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHH
T ss_pred CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHH
Confidence 988755432 33457999999999986 3589999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=303.29 Aligned_cols=183 Identities=26% Similarity=0.330 Sum_probs=158.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCC-CCCCcceEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~~ 202 (324)
..++|++++.||+|+||+||+|++.. +++.||||++.... ......+.+|..++..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 45689999999999999999998875 57799999997542 12345678999999988 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++.+.+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999999999999643 46999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+++....... .....+||+.|||||++. .++|||||||
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 209 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 209 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHH
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHH
Confidence 999986433221 133468999999999987 3589999997
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=305.66 Aligned_cols=193 Identities=25% Similarity=0.393 Sum_probs=160.7
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|++++.||+|+||.||+|++..... ....++..||||+++.... ....++.+|+.+|+.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998753211 1123567899999976533 2335789999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999997543 35889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.+||+|||+++...............||+.|||||++. .++|||||||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~ 293 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHH
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHH
Confidence 999999999999999998765433322233356789999999886 3589999997
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=299.82 Aligned_cols=184 Identities=26% Similarity=0.344 Sum_probs=157.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||+||+|.+.. +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3589999999999999999998875 5779999999754332 23568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..|+|||||++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 999999999999999999984 4456999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+...............||+.|+|||++. .++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 196 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHH
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHH
Confidence 8764433332334568999999999986 2479999997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=293.41 Aligned_cols=178 Identities=27% Similarity=0.399 Sum_probs=157.6
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeE
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 210 (324)
|...+.||+|+||.||+|++.. +|+.||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 6667799999999999998865 5779999999876666667899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
++||||+++++|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence 999999999999999853 46999999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
..... .....||+.|+|||++. .++|||||||
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 229 (321)
T 2c30_A 193 KDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229 (321)
T ss_dssp SSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred cCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHH
Confidence 43221 33467999999999986 3589999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=290.34 Aligned_cols=181 Identities=28% Similarity=0.394 Sum_probs=156.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||+||+|++.. +++.||||++...... ....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 478999999999999999998875 5779999999765432 23578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..+|||||++ ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 999999999996 4777777666678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+....... ......||+.|+|||++. .++|||||||
T Consensus 149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 190 (292)
T 3o0g_A 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHH
Confidence 87643322 133457899999999885 3579999997
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=301.19 Aligned_cols=179 Identities=27% Similarity=0.333 Sum_probs=158.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++++.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+|..++||||+++++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999998875 677999999965421 2345788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..||||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++..... ....+||+.|+|||++. .++|||||||
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 226 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccH
Confidence 99876442 22357999999999986 3589999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.84 Aligned_cols=185 Identities=25% Similarity=0.414 Sum_probs=152.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+|++|+||||++++++|.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4578999999999999999999875 577999999975443 234678999999999999999999999866
Q ss_pred CC---------------------------------------------------------eEEEEEEecCCCChHHHHhcc
Q 020561 207 DD---------------------------------------------------------QRLLVYEFMPRGSLENHLFRR 229 (324)
Q Consensus 207 ~~---------------------------------------------------------~~~lv~E~~~~gsL~~~l~~~ 229 (324)
.+ ..++|||||++++|.+++.+.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 54 379999999999999999654
Q ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCcc----------ce
Q 020561 230 S--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----------HV 297 (324)
Q Consensus 230 ~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~ 297 (324)
. ...++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 3 23566778999999999999999988 999999999999999999999999999876553211 11
Q ss_pred eeccccccCcccccccc-----ccceEEEecC
Q 020561 298 STRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 298 ~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.....||+.|+|||++. .++|||||||
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 264 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHH
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHH
Confidence 23357999999999986 3589999997
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.35 Aligned_cols=183 Identities=26% Similarity=0.378 Sum_probs=153.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|++.. ++..||||.+...... ..+++.+|+.++.+++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 3579999999999999999998765 5779999998654332 235788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...+..|+||||+++++|.+++... .++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999999644 47999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++........ ......||+.|+|||++. .++|||||||
T Consensus 157 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 200 (294)
T 4eqm_A 157 IAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGI 200 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHH
T ss_pred Ccccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHH
Confidence 99876443221 123457999999999987 3589999997
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.28 Aligned_cols=188 Identities=23% Similarity=0.409 Sum_probs=158.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|.+...+. .+..||||++..... ...+.+.+|+.+++.|+||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3578999999999999999999875432 355799999976532 234578999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..||||||+++++|.+++......+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999999766678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .......+|+.|+|||++. .++|||||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 242 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHH
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHH
Confidence 876543221 1122345688999999987 3579999997
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.08 Aligned_cols=182 Identities=23% Similarity=0.314 Sum_probs=160.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+.|++.+.||+|+||.||+|.+.. ++..||+|++..........+.+|+.+|+.|+||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 3579999999999999999998875 6779999999876544556789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC--CCcEEEEeecc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 285 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl~DFGl 285 (324)
...++|||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++. .+.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999999999999766667999999999999999999999988 999999999999974 57899999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... .....||+.|+|||++. .++|||||||
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 238 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHH
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhH
Confidence 988754332 23357999999999987 3589999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=294.27 Aligned_cols=180 Identities=24% Similarity=0.341 Sum_probs=157.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCCCCCcceEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
+.|++.+.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|+.+|+.|+||||+++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 81 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 468899999999999999998875 6779999999765322 3467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----cE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NA 278 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~ 278 (324)
++...+..++|||||++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCE
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCE
Confidence 99999999999999999999999954 457999999999999999999999988 99999999999998877 89
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 158 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 205 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 205 (326)
T ss_dssp EECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred EEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHH
Confidence 9999999987654322 23457999999999987 3589999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=303.05 Aligned_cols=189 Identities=19% Similarity=0.239 Sum_probs=157.0
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC---CCCcceEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIG 202 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~ 202 (324)
+..++|++.+.||+|+||+||+|.+.... ...+++.||||++.... ..++.+|+.++..++ |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34567999999999999999999643211 12367899999997653 356777888887776 999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC----
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---- 274 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---- 274 (324)
++...+..|||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 99999999999999999999999964 3467999999999999999999999988 999999999999988
Q ss_pred -------CCcEEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 275 -------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 275 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++.+||+|||+|+..............+||+.|||||++.+ ++|||||||
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 273 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAA 273 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHH
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHH
Confidence 89999999999976543333333455789999999999873 579999997
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=311.56 Aligned_cols=182 Identities=24% Similarity=0.370 Sum_probs=142.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. +++.||||++..... ...+++.+|+.+|+.|+|||||++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp TTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 579999999999999999998875 677999999965432 234678999999999999999999999854
Q ss_pred C-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
. ..+||||||+ +++|.+++. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred CCcccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 3 5689999998 679999985 4457999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCcc-------------------------ceeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-------------------------~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||+++........ ...+..+||+.|||||++. .++|||||||
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHH
Confidence 99999876432110 1234467899999999864 3579999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=300.78 Aligned_cols=183 Identities=24% Similarity=0.325 Sum_probs=156.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----ccchHHHHHHHHHHcCCCCCCcceEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
.+.|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3579999999999999999998875 67799999986421 123467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 277 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-- 277 (324)
++.+.+..|||||||++++|.+++.+. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCC
Confidence 999999999999999999999888542 346899999999999999999999988 999999999999976654
Q ss_pred -EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 -~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++....... .....+||+.|+|||++. .++|||||||
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 221 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGV 221 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHH
Confidence 99999999987654322 133457999999999987 3589999997
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.36 Aligned_cols=199 Identities=42% Similarity=0.751 Sum_probs=167.9
Q ss_pred cccccCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCC
Q 020561 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV 193 (324)
Q Consensus 115 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~ 193 (324)
....+++.++....++|++.+.||+|+||.||+|++. ++..||||++...... ...++.+|+.+++.++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~ 85 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV 85 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence 3456888999999999999999999999999999643 3668999999765432 2346899999999999
Q ss_pred CCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcE
Q 020561 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (324)
Q Consensus 194 HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NI 270 (324)
||||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+....+|+||||||+||
T Consensus 86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 9999999999999999999999999999999996532 3599999999999999999999998212399999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 271 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|++.++.+||+|||+++........ ......||+.|+|||++. .++|||||||
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 223 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHH
T ss_pred EECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHH
Confidence 9999999999999999876543322 234456999999999986 4689999997
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=303.11 Aligned_cols=181 Identities=30% Similarity=0.429 Sum_probs=149.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHH-HcCCCCCCcceEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNF-LGDLVHLNLVKLIGYC 204 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~HpnIv~~~~~~ 204 (324)
++|++++.||+|+||+||+|++.. ++..||||++...... ....+.+|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 579999999999999999998875 5779999999765322 22456677776 5778999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+.+||||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence 9999999999999999999999643 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++....... .....+||+.|||||++. .++|||||||
T Consensus 185 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 227 (373)
T 2r5t_A 185 LCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227 (373)
T ss_dssp BCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHH
T ss_pred cccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHH
Confidence 9986432221 133468999999999987 3589999997
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=298.61 Aligned_cols=182 Identities=24% Similarity=0.373 Sum_probs=157.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|+.+++.|+||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34679999999999999999998765 6779999999765432 235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC---CcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~~kl~ 281 (324)
.+.+..|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 999999999999999999999954 457899999999999999999999988 9999999999999765 459999
Q ss_pred eecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|||++........ .....||+.|+|||++.. ++|||||||
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 218 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHH
Confidence 9999987654322 234679999999999873 589999997
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.94 Aligned_cols=181 Identities=26% Similarity=0.410 Sum_probs=152.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------------------chHH
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE 181 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--------------------------~~~~ 181 (324)
.++|++.+.||+|+||.||+|++.. ++..||||++...... ..++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 3579999999999999999998765 5779999999754321 1246
Q ss_pred HHHHHHHHcCCCCCCcceEEEEEEe--CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 020561 182 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259 (324)
Q Consensus 182 ~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 259 (324)
+.+|+.+|++++||||+++++++.+ .+..|+||||+++++|.+++. ...+++..+..++.||+.||.|||+++
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8899999999999999999999987 568999999999999988753 357999999999999999999999988
Q ss_pred eEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc--------cceEEEecC
Q 020561 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 260 ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.. ++|||||||
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 228 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHH
Confidence 99999999999999999999999999987654322 2334679999999999862 369999997
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.06 Aligned_cols=185 Identities=30% Similarity=0.417 Sum_probs=149.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.++|++.+.||+|+||.||+|+...+ ..++..||||++..... .....+.+|+.+|+.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG------ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS------TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc------CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 35799999999999999999987532 12688999999976532 223457889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+...+..|||||||++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeC
Confidence 99999999999999999999999643 46899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++....... .....+||+.|+|||++. .++|||||||
T Consensus 166 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 209 (327)
T 3a62_A 166 GLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHH
T ss_pred CcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHH
Confidence 99986433221 133467999999999986 3589999997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=305.80 Aligned_cols=183 Identities=23% Similarity=0.314 Sum_probs=157.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+.. ++..||+|++...... ..+.+.+|+.+++.|+||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 34679999999999999999998765 6789999999765432 235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~ 281 (324)
.+.+..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999999999999654 56999999999999999999999988 99999999999998 56889999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+++........ .....||+.|||||++. .++|||||||
T Consensus 156 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv 201 (444)
T 3soa_A 156 DFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201 (444)
T ss_dssp CCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred cCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHH
Confidence 99999876543321 33467999999999987 3589999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=291.31 Aligned_cols=182 Identities=29% Similarity=0.462 Sum_probs=142.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 3579999999999999999998765 6779999999765432 33678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
++..+|||||++ |+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence 999999999997 6999988643 245899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||+++....... ......||+.|+|||++. .++|||||||
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 197 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGC 197 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHH
Confidence 9999987643221 123457899999999886 3479999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=296.19 Aligned_cols=179 Identities=25% Similarity=0.355 Sum_probs=156.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.+|++.+.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.+++.++||||+++++++.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 579999999999999999998865 677999999864321 22357889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..++||||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred eCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecc
Confidence 999999999999 78999988544 46999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+........ ....+||+.|+|||++. .++|||||||
T Consensus 155 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 196 (336)
T 3h4j_B 155 SNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGI 196 (336)
T ss_dssp TBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHH
T ss_pred ceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHH
Confidence 987654322 23457999999999986 2579999997
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=299.25 Aligned_cols=176 Identities=27% Similarity=0.390 Sum_probs=151.1
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 213 (324)
.++||+|+||.||+|.+.. +|..||||++........+++.+|+.+|.+|+||||+++++++.+.+..+||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999998875 5779999999876655567899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE--cCCCcEEEEeecccccCCC
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~~~kl~DFGla~~~~~ 291 (324)
||||++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999999766667999999999999999999999988 9999999999999 6778999999999987654
Q ss_pred CCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 292 GDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 292 ~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
... ....+||+.|+|||++.. ++|||||||
T Consensus 242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 276 (373)
T 2x4f_A 242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276 (373)
T ss_dssp TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHH
T ss_pred ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHH
Confidence 332 233579999999998873 589999997
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=291.34 Aligned_cols=181 Identities=28% Similarity=0.406 Sum_probs=153.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++++.||+|+||+||+|++. +++.||||++...... ....+.+|+.++++++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 357999999999999999999875 3669999999754322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..++||||++ ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence 9999999999997 5898888776677999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
++........ .....||+.|+|||++.. ++|||||||
T Consensus 166 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 208 (311)
T 3niz_A 166 ARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred ceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHH
Confidence 9876433221 334578999999998863 479999997
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.98 Aligned_cols=189 Identities=24% Similarity=0.379 Sum_probs=159.7
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
+.+..++|++.+.||+|+||.||+|.+.. ++..||||.+...... ...++.+|+.+|++++||||+++++
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 179 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 33455789999999999999999999875 4679999999754322 2346889999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++...+..||||||+++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 180 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~D 256 (377)
T 3cbl_A 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISD 256 (377)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECc
Confidence 999999999999999999999999766667999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+++...............+++.|+|||++. .++|||||||
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 303 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGI 303 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHH
Confidence 99998754322111111223577899999987 4689999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=305.71 Aligned_cols=183 Identities=28% Similarity=0.414 Sum_probs=153.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|++.. +++.||||++..... ...+++.+|+.+|+.|+||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3589999999999999999998875 678999999975432 23467899999999999999999999997
Q ss_pred eC-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.. ...||||||+. ++|.+++. ....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 76 57899999995 69999995 4457999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCcc--------------------ceeeccccccCcccccccc------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~--------------------~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|||+++........ ...+..+||+.|+|||++. .++|||||||
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~ 240 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHH
Confidence 999999876543211 1134568999999999864 3579999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.37 Aligned_cols=182 Identities=30% Similarity=0.360 Sum_probs=149.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++++.||+|+||.||+|++.. ++..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 4679999999999999999998875 67799999997532 22235678899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
...+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+ .+ ||||||||+||||+.++.+||+||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999999999543 479999999999999999999998 77 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++....... .....+||+.|||||++. .++|||||||
T Consensus 294 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 337 (446)
T 4ejn_A 294 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred CCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHH
Confidence 99986433222 234468999999999986 4589999997
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.48 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=164.4
Q ss_pred cCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCC
Q 020561 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 196 (324)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~Hpn 196 (324)
+....+.+..++|++.+.||+|+||.||+|++.... ...+++.||||++...... ..+.+.+|+.++.++ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 445566667789999999999999999999865321 1236789999999765432 235689999999999 7999
Q ss_pred cceEEEEEEeCCe-EEEEEEecCCCChHHHHhccCC--------------------------------------------
Q 020561 197 LVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL-------------------------------------------- 231 (324)
Q Consensus 197 Iv~~~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------- 231 (324)
|+++++++...+. .++|||||++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999987654 8999999999999999965422
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCC
Q 020561 232 ---------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (324)
Q Consensus 232 ---------------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~ 290 (324)
.+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 1889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 291 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
............||+.|+|||++. .++|||||||
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 283 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHH
Confidence 544333344567899999999886 4689999997
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.80 Aligned_cols=181 Identities=29% Similarity=0.421 Sum_probs=153.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||+||+|++. ++.||||++..... ......+|+.++.+++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3468999999999999999999764 56899999965432 23456679999999999999999999987
Q ss_pred CC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEeCCCCCCcEEE
Q 020561 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE----------AERPVIYRDFKTSNILL 272 (324)
Q Consensus 207 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------~~~~ivHrDLkp~NILl 272 (324)
.. .+++|||||++|+|.+++.. ..+++..++.++.||+.||.|||+. + ||||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill 164 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL 164 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence 54 47999999999999999965 3589999999999999999999997 6 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc----------cceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------ALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------~~DiwSlGc 324 (324)
+.++.+||+|||+++...............||+.|+|||++.. ++|||||||
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 9999999999999987654333222334679999999999874 369999997
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.27 Aligned_cols=189 Identities=28% Similarity=0.419 Sum_probs=155.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++++.||+|+||.||+|++... ...++..||||++........+++.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46899999999999999999986421 2236889999999876555556789999999999999999999998653
Q ss_pred --CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
...++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5689999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ .......||+.|+|||++. .++|||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHH
Confidence 9876543221 1123345788899999987 3589999997
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=293.61 Aligned_cols=185 Identities=29% Similarity=0.469 Sum_probs=149.0
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+...+|++.+.||+|+||+||+|++. +..||||++...... ..+++.+|+.++++++||||++++++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34568999999999999999999763 568999999765432 23568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+...+..++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+.+ .+||||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEEC
Confidence 999999999999999999999996543 23899999999999999999999865 459999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+++....... ......||+.|+|||++. .++|||||||
T Consensus 182 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 227 (309)
T 3p86_A 182 DFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHH
T ss_pred CCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHH
Confidence 9999986543221 123457999999999987 4589999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=290.19 Aligned_cols=181 Identities=28% Similarity=0.421 Sum_probs=156.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 579999999999999999998875 577999999975432 3346688999999999999999999999876
Q ss_pred C--eEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE----cCCCcEE
Q 020561 208 D--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 279 (324)
Q Consensus 208 ~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~k 279 (324)
+ ..+|||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEE
Confidence 5 7899999999999999996533 34999999999999999999999988 9999999999999 7888899
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-------------ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------------TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------------~~~DiwSlGc 324 (324)
|+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 157 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 211 (319)
T 4euu_A 157 LTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (319)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHH
T ss_pred EccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHH
Confidence 999999987655432 23457999999999875 3689999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=310.88 Aligned_cols=183 Identities=33% Similarity=0.483 Sum_probs=159.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..++|++.++||+|+||.||+|++.. +|..||||++..... .....+.+|+.+|..++||||++++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 34679999999999999999998875 678999999965321 223567899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+.+.+.+|||||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999996543 35999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
||+++....... ....+||+.|||||++.. ++|||||||
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGv 373 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHH
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHH
Confidence 999988754332 334589999999999873 589999997
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=292.70 Aligned_cols=182 Identities=23% Similarity=0.243 Sum_probs=157.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|.+.. +++.||||++..... ..++.+|+.+++.| +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 3579999999999999999998765 678999999875532 34688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc-----EEEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLS 281 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----~kl~ 281 (324)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 99999999766678999999999999999999999988 999999999999998887 9999
Q ss_pred eecccccCCCCCccc-----eeeccccccCccccccccc-----cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|||+++......... ......||+.|+|||++.. ++|||||||
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 205 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH 205 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence 999998754432211 1234679999999999873 579999997
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=289.56 Aligned_cols=181 Identities=29% Similarity=0.284 Sum_probs=152.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||+||+|++.. +++.||||++...... ...++..|+..+..+ .||||++++++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3579999999999999999999875 5779999998654322 223455666666555 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..||||||+ +++|.+++......+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999999 77999999777778999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
++........ .....||+.|+|||++. .++|||||||
T Consensus 203 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~ 243 (311)
T 3p1a_A 203 LLVELGTAGA---GEVQEGDPRYMAPELLQGSYGTAADVFSLGL 243 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGTCCSTHHHHHHHHH
T ss_pred eeeecccCCC---CcccCCCccccCHhHhcCCCCchhhHHHHHH
Confidence 9987654322 23456999999999987 4579999997
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=298.18 Aligned_cols=188 Identities=23% Similarity=0.425 Sum_probs=148.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|++...+ .++..||||.++.... ...+++.+|+.++++++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 358999999999999999999876322 1466899999976532 234578999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..+|||||+++|+|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccc
Confidence 99999999999999999999776678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccc-eeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTH-VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... ......+|+.|+|||++. .++|||||||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~ 238 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHH
Confidence 8765432111 111234578899999987 3589999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=296.68 Aligned_cols=179 Identities=21% Similarity=0.254 Sum_probs=148.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||+||+|++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 579999999999999999998875 677999999976432 2367889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--EEEEeeccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLA 286 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--~kl~DFGla 286 (324)
..++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999999999999999543 46999999999999999999999988 999999999999987765 999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+....... .....||+.|+|||++.. ++|||||||
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (361)
T 3uc3_A 166 KSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHH
T ss_pred ccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHH
Confidence 85433221 233579999999999862 379999997
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=287.07 Aligned_cols=180 Identities=27% Similarity=0.403 Sum_probs=152.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||.||+|++. ++..||||.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47889999999999999999873 4679999999755322 23578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999964 999999766678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+....... ......||+.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 189 (288)
T 1ob3_A 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred cccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHH
Confidence 86543221 123357899999999885 3479999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.63 Aligned_cols=183 Identities=30% Similarity=0.449 Sum_probs=159.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.++||+|+||+||+|++.. +|+.||||++..... .....+.+|+.+|++++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3679999999999999999998865 678999999965432 2235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
.+.+.+||||||++||+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence 9999999999999999999999653 346999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|||+++........ ....+||+.|||||++.. ++|||||||
T Consensus 332 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGv 377 (543)
T 3c4z_A 332 DLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGV 377 (543)
T ss_dssp CCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHH
T ss_pred ecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchH
Confidence 99999876543321 234589999999999873 579999997
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.72 Aligned_cols=181 Identities=28% Similarity=0.384 Sum_probs=158.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..+|.+++.||+|+||.||+|++.. +|..||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999998875 678999999965422 2235788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..|||||||++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999999954 457999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
++........ ....+||+.|+|||++.. ++|||||||
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv 204 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGV 204 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHH
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHH
Confidence 9987654332 334679999999999862 589999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.13 Aligned_cols=190 Identities=27% Similarity=0.367 Sum_probs=155.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||.||+|.+.... ...++..||||++..... ....++.+|+.++++++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 457899999999999999999875321 123678999999975432 333568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC---c
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 277 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~ 277 (324)
....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+|||++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 999999999999999999996532 45899999999999999999999988 99999999999998555 5
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~ 274 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHH
Confidence 9999999997542221111223356899999999986 4689999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=287.40 Aligned_cols=186 Identities=24% Similarity=0.329 Sum_probs=158.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|.+...+... ...+..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 457899999999999999999887632100 001257999999766555567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--------EE
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AK 279 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------~k 279 (324)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999776656999999999999999999999988 999999999999988887 99
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|+|||++...... ....||+.|+|||++.. ++|||||||
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGT 206 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence 9999999765332 22458999999998874 479999997
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=291.39 Aligned_cols=184 Identities=23% Similarity=0.352 Sum_probs=148.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|++.. +++.||||++....... ..++.+|+.++.+++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 3579999999999999999998865 57799999997654322 34688999999999999999999998
Q ss_pred EeCCe----EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 205 IEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 205 ~~~~~----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
..... .|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 76543 49999999999999999644 47999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCcc-ceeeccccccCccccccccc-----cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+|||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 207 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHH
Confidence 999999876443221 11233579999999999873 589999997
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=280.66 Aligned_cols=181 Identities=23% Similarity=0.301 Sum_probs=159.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+........+++.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3578999999999999999998875 5679999999776555667899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFG 284 (324)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999999998543 46899999999999999999999988 9999999999999 788999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
++........ .....||+.|+|||++. .++|||||||
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~ 195 (277)
T 3f3z_A 155 LAARFKPGKM---MRTKVGTPYYVSPQVLEGLYGPECDEWSAGV 195 (277)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHH
T ss_pred cceeccCccc---hhccCCCCCccChHHhcccCCchhhehhHHH
Confidence 9987654332 23457999999999986 4689999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.35 Aligned_cols=183 Identities=28% Similarity=0.424 Sum_probs=144.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCC-CCCcceEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIGY 203 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~~~~~ 203 (324)
..++|++++.||+|+||.||+|.+.. +++.||||++.... .....++.+|+.++..+. ||||++++++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 45689999999999999999998875 67799999996542 223456889999999997 9999999999
Q ss_pred EEeCC--eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 204 CIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 204 ~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+...+ .+|||||||+ ++|.+++.. ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence 98654 6899999996 689999854 46899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCC-------------------ccceeeccccccCccccccccc------cceEEEecC
Q 020561 282 DFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~-------------------~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|||+|+...... .....+..+||+.|+|||++.+ ++|||||||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~ 219 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHH
Confidence 999998653211 1112334689999999999863 479999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=291.68 Aligned_cols=188 Identities=24% Similarity=0.415 Sum_probs=155.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+...+.. ....||+|.+.... .....++.+|+.++..++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35789999999999999999998764321 12358889885443 233356788999999999999999999886
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcc
Confidence 45689999999999999999766567999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...............||+.|+|||++. .++|||||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHH
Confidence 9876544333344567888999999987 3589999997
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=294.62 Aligned_cols=192 Identities=26% Similarity=0.386 Sum_probs=159.7
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
+..++|++.+.||+|+||.||+|++..... ..++..||||++...... ....+.+|+.++++++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345789999999999999999998864210 124679999999765432 245789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 99999999999999999999996532 57899999999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 262 HrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||||+|||++.++.+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 264 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHH
Confidence 99999999999999999999999998654322222233456899999999886 3689999997
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=295.38 Aligned_cols=193 Identities=26% Similarity=0.377 Sum_probs=161.4
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|++...+. .....+..||||++...... ...++.+|+.+++.+ +||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44689999999999999999998754221 11224568999999765332 235788999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
...+..++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 99999999999999999999997543 35999999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 281 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHH
Confidence 999999999999999998765543322334456889999999986 3589999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.05 Aligned_cols=181 Identities=27% Similarity=0.363 Sum_probs=157.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------chHHHHHHHHHHcCCCCCCcce
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
.++|++.+.||+|+||.||+|++.. ++..||||++...... ....+.+|+.++++++||||++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 93 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred ccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence 4679999999999999999998775 5779999999765321 2245778999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCC-ChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
+++++.+.+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp EEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcE
Confidence 999999999999999999776 99999854 457999999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 170 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 218 (335)
T 3dls_A 170 KLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218 (335)
T ss_dssp EECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHH
T ss_pred EEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHH
Confidence 9999999987655432 23357999999999986 2469999997
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.22 Aligned_cols=182 Identities=26% Similarity=0.424 Sum_probs=158.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4678999999999999999998763 55899999976543 346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence 9999999999999999999776678999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... .......||+.|+|||++. .++|||||||
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (269)
T 4hcu_A 155 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 195 (269)
T ss_dssp GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHH
Confidence 6543221 1122345788899999986 3589999997
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.69 Aligned_cols=195 Identities=41% Similarity=0.693 Sum_probs=166.1
Q ss_pred ccccCHHHHHHHhcCCCCC------ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----ccchHHHHHH
Q 020561 116 LRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE 185 (324)
Q Consensus 116 ~~~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~----~~~~~~~~~E 185 (324)
...+++.++...+.+|... +.||+|+||.||+|.+. +..||||.+.... ....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHHH
Confidence 3467888888888887766 89999999999999752 5589999986542 1224578899
Q ss_pred HHHHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeC
Q 020561 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (324)
Q Consensus 186 ~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHr 263 (324)
+.+++.++||||+++++++...+..++||||+++++|.+++.. ...++++..++.++.||+.||.|||+++ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence 9999999999999999999999999999999999999999963 2356999999999999999999999988 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 264 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 264 DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
||||+|||++.++.+||+|||++................||+.|+|||++. .++|||||||
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~ 222 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGV 222 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHH
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHH
Confidence 999999999999999999999998765433332334467999999999876 4689999997
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.92 Aligned_cols=178 Identities=22% Similarity=0.323 Sum_probs=152.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+|++++.++ .||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 4579999999999999999998875 678999999976542 345688888887 79999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC----CcEEEEe
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSD 282 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~~kl~D 282 (324)
.+..|+|||||++|+|.+++.+ ...+++..+..++.||+.||.|||+++ ||||||||+|||+... +.+||+|
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999999999999954 457999999999999999999999988 9999999999998433 3599999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+++....... .....+||+.|+|||++. .++|||||||
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 208 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGV 208 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhH
Confidence 999987644322 133467999999999987 3689999997
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=292.41 Aligned_cols=180 Identities=27% Similarity=0.328 Sum_probs=141.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+.|++.+.||+|+||.||+|++.. +++.||||++.... ..+.+.+|+.++.+|+||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 34679999999999999999998875 56799999997543 23567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCcEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DF 283 (324)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999999999954 456899999999999999999999988 999999999999975 889999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++....... .....||+.|+|||++. .++|||||||
T Consensus 196 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 238 (349)
T 2w4o_A 196 GLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHH
T ss_pred ccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHH
Confidence 99987643221 23457999999999987 3589999997
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.94 Aligned_cols=184 Identities=26% Similarity=0.333 Sum_probs=158.6
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCC-CCCCcceEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~ 201 (324)
+...+|+++++||+|+||+||+|++.. +++.||||++.... ....+.+..|..+|..+ +||||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 455789999999999999999998875 67799999997532 12335678899999988 699999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+++.+.+.+||||||+++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999999999654 46999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+++....... .....+||+.|||||++. .++|||||||
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGv 530 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHH
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHH
Confidence 9999986433222 134568999999999987 4589999997
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=279.39 Aligned_cols=183 Identities=26% Similarity=0.381 Sum_probs=159.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ...++.+|+.++.+++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34689999999999999999997763 56799999976543 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999999999766667999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
......... ......||+.|+|||++. .++|||||||
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 193 (268)
T 3sxs_A 152 RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGI 193 (268)
T ss_dssp EECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHH
T ss_pred eecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHH
Confidence 876554322 223345678899999986 4689999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=282.27 Aligned_cols=188 Identities=29% Similarity=0.431 Sum_probs=157.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.|++++.||+|+||.||+|++... ...++..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-----SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-----cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 4688899999999999999986432 123688999999975432 3346789999999999999999999999877
Q ss_pred --CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
...++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence 6689999999999999999776678999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... .......||+.|+|||++. .++|||||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 217 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGV 217 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHH
Confidence 9876554322 2233456889999999886 3589999997
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=290.67 Aligned_cols=177 Identities=31% Similarity=0.435 Sum_probs=155.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..|++.+.||+|+||.||+|++.. ++..||||++....... .+++.+|+.++++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458889999999999999998765 57799999997654322 356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..+|||||+. |+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999996 6898888666678999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+...... ....||+.|+|||++. .++|||||||
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~ 241 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHH
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHH
Confidence 9876432 2357999999999874 3589999997
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=284.55 Aligned_cols=183 Identities=27% Similarity=0.331 Sum_probs=151.4
Q ss_pred cCCCCC-ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 129 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
+.|++. +.||+|+||.||+|++.. +++.||||++.........++.+|+.++.++ .||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 467774 789999999999998765 5779999999876555567899999999885 79999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc---EEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~DF 283 (324)
.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred CCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 99999999999999999999654 46899999999999999999999988 999999999999988776 999999
Q ss_pred cccccCCCCCc-----cceeeccccccCcccccccc----------ccceEEEecC
Q 020561 284 GLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~-----~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
|++........ .......+||+.|+|||++. .++|||||||
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 214 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence 99986542211 11122346999999999985 3689999997
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=292.95 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=158.8
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+.... ...++..||||++.... ....+.+.+|+.++.+| .||||++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34578999999999999999999874311 12356789999997543 23346789999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
+...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 9999999999999999999999965432 3789999999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 262 HrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||||+|||++.++.+||+|||++................||+.|+|||++. .++|||||||
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 262 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHH
Confidence 99999999999999999999999998765433333333456788999999886 3589999997
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=294.48 Aligned_cols=185 Identities=18% Similarity=0.207 Sum_probs=157.5
Q ss_pred hcCCCCCceecCC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 128 TRNFRPESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..+|++++.||+| +||.||+|++.. ++..||||++...... ....+.+|+.+++.++|||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3579999999999 999999999875 6779999999765322 23567889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+.+.+..|||||||++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999999999653 356999999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCc-----cceeeccccccCccccccccc-------cceEEEecC
Q 020561 283 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~-----~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
||++........ ........||+.|+|||++.. ++|||||||
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 225 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHH
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHH
Confidence 999865422111 011123479999999999864 479999997
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=280.45 Aligned_cols=182 Identities=27% Similarity=0.446 Sum_probs=143.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.++.+++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 579999999999999999998765 577999999964321 22357889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 999999999999999999999766678999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... .....||+.|+|||++. .++|||||||
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (278)
T 3cok_A 159 ATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200 (278)
T ss_dssp CEECC------------------------------CTHHHHHHH
T ss_pred eeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHH
Confidence 9876533221 22357999999999987 3689999997
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.35 Aligned_cols=187 Identities=24% Similarity=0.345 Sum_probs=146.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+...+. .+..||||.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 85 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence 34689999999999999999998865322 466899999876432 2345789999999999999999999987
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.++..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence 456789999999999999999766667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ ......+|+.|+|||++. .++|||||||
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHH
Confidence 9876543221 122345788999999986 3589999997
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=278.88 Aligned_cols=180 Identities=29% Similarity=0.589 Sum_probs=154.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------hHHHHHHHHHHcCCCCCCcceE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVKL 200 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~ 200 (324)
.++|++.+.||+|+||.||+|++.. ++..||||++....... .+++.+|+.++++++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 3579999999999999999998875 57799999996543322 1578899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc---
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--- 277 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--- 277 (324)
++++.+.. ++||||+++|+|.+++......+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCS
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCc
Confidence 99986654 7999999999999999777778999999999999999999999865 55999999999999988776
Q ss_pred --EEEEeecccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 278 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 278 --~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
+||+|||+++..... .....||+.|+|||++. .++|||||||
T Consensus 166 ~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~ 216 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAM 216 (287)
T ss_dssp CCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHH
T ss_pred eeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHH
Confidence 999999999854332 33467999999999983 3579999997
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.58 Aligned_cols=192 Identities=28% Similarity=0.374 Sum_probs=160.9
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
+..++|++.+.||+|+||.||+|.+.... .+.++..||||++..... ...+++.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34578999999999999999999875311 112567999999976532 2335788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iv 261 (324)
...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 99999999999999999999996532 23889999999999999999999988 99
Q ss_pred eCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 262 HrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||||+|||++.++.+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 240 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHH
Confidence 99999999999999999999999998765543332233456788999999886 4589999997
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=291.35 Aligned_cols=188 Identities=23% Similarity=0.397 Sum_probs=151.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||+||+|++...+.. ....||+|.+.... ....+++.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35799999999999999999998753321 13357889886443 2344679999999999999999999999987
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.. .++||||+++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 54 78999999999999999877778999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...............||+.|+|||++. .++|||||||
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 207 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHH
Confidence 8765443333333456788999999986 4589999997
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=285.24 Aligned_cols=181 Identities=25% Similarity=0.353 Sum_probs=158.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCCCCCcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
.+.|++.+.||+|+||.||+|++.. ++..||||++...... ..+++.+|+.++..++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 3578999999999999999998875 5779999999765322 246789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----c
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~ 277 (324)
+++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999999999999954 457899999999999999999999988 99999999999999887 7
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||++........ .....||+.|+|||++. .++|||||||
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 206 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHH
Confidence 99999999987654322 23457999999999986 3589999997
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=291.06 Aligned_cols=188 Identities=24% Similarity=0.309 Sum_probs=160.7
Q ss_pred ccCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC----
Q 020561 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---- 193 (324)
Q Consensus 118 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---- 193 (324)
.+.+.+.....++|++++.||+|+||.||+|++.. +++.||||++.... .....+..|+.++..+.
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~ 93 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDI 93 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCST
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCC
Confidence 45555555667899999999999999999998865 57799999997432 22356778999998886
Q ss_pred -CCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 194 -HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 194 -HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
||||+++++++...+..+|||||+ +++|.+++.+.. ..+++..+..++.||+.||.|||+++ ||||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 169 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL 169 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEE
Confidence 999999999999999999999999 999999997543 46999999999999999999999988 999999999999
Q ss_pred EcC-------------------------CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEE
Q 020561 272 LDA-------------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFC 321 (324)
Q Consensus 272 l~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwS 321 (324)
++. ++.+||+|||+++..... .....||+.|+|||++. .++||||
T Consensus 170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 975 789999999999875442 22357999999999987 4689999
Q ss_pred ecC
Q 020561 322 LKC 324 (324)
Q Consensus 322 lGc 324 (324)
|||
T Consensus 245 lG~ 247 (360)
T 3llt_A 245 FGC 247 (360)
T ss_dssp HHH
T ss_pred HHH
Confidence 997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=287.72 Aligned_cols=173 Identities=25% Similarity=0.321 Sum_probs=134.3
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l 212 (324)
.+.||+|+||.||+|.+.. +++.||||++... ....+.+|+.++..+. ||||+++++++.+....||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 3789999999999998875 5779999999653 2356789999999997 9999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC---cEEEEeecccccC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 289 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~DFGla~~~ 289 (324)
|||||++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999965 457999999999999999999999988 99999999999997665 8999999999876
Q ss_pred CCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 290 PEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 290 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
..... .....+||+.|+|||++.. ++|||||||
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 197 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHH
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHH
Confidence 54322 1334578999999999873 579999997
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=289.51 Aligned_cols=181 Identities=27% Similarity=0.395 Sum_probs=149.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++++.||+|+||.||+|++.. ++..||||++....... ...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 478899999999999999998875 57799999997543221 12456799999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||++ |+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 6999999777778999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
....... ......||+.|+|||++.+ ++|||||||
T Consensus 149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 189 (324)
T 3mtl_A 149 AKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC 189 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred cccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHH
Confidence 6543322 1234578999999998863 479999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=294.44 Aligned_cols=176 Identities=23% Similarity=0.281 Sum_probs=143.7
Q ss_pred cCCCCC-ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHc-CCCCCCcceEEEEEEe
Q 020561 129 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG-DLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~~~ 206 (324)
++|.+. ++||+|+||+||+|++.. +++.||||++... ..+.+|+.++. .++||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 467666 689999999999998875 6779999999632 56778888874 4589999999999876
Q ss_pred ----CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCcE
Q 020561 207 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 278 (324)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~ 278 (324)
...+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++ ||||||||+|||++. ++.+
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccE
Confidence 567899999999999999997543 46999999999999999999999988 999999999999987 7899
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+++....... ....+||+.|+|||++. .++|||||||
T Consensus 204 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 251 (400)
T 1nxk_A 204 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHH
T ss_pred EEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHH
Confidence 9999999987643221 33467999999999986 3589999997
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=282.11 Aligned_cols=182 Identities=30% Similarity=0.443 Sum_probs=151.1
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----cchHHHHHHHHHHcCCC---CCCcc
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLV---HLNLV 198 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---HpnIv 198 (324)
..++|++.+.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+++.+. ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 45789999999999999999998765 677999999864321 11246677888877765 99999
Q ss_pred eEEEEEEeCC-----eEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 199 KLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 199 ~~~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
++++++.... ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILV 153 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 9999998765 5899999996 69999996543 34999999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 207 (308)
T ss_dssp CTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHH
T ss_pred cCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHH
Confidence 9999999999999987644322 23467999999999986 4689999997
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=290.56 Aligned_cols=190 Identities=23% Similarity=0.403 Sum_probs=141.3
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+...+. +...||||++.... ....+++.+|+.++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 345689999999999999999998765321 22379999997653 2334678999999999999999999999
Q ss_pred EEeCCeE------EEEEEecCCCChHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 204 CIEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 204 ~~~~~~~------~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
+...... ++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEE
Confidence 9887655 9999999999999998532 226899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+++...............+|+.|+|||++. .++|||||||
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 227 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHH
Confidence 999999999999998765543333333456788999999986 3589999997
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.81 Aligned_cols=192 Identities=28% Similarity=0.400 Sum_probs=162.0
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++.+.||+|+||.||+|.+... .+..++..||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 3456899999999999999999986431 1223678999999976543 2346789999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLk 266 (324)
+...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999975432 4899999999999999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 267 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 267 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||++.++.+||+|||++................||+.|+|||++. .++|||||||
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 235 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHH
Confidence 999999999999999999998776544333333456788999999886 3589999997
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.24 Aligned_cols=183 Identities=30% Similarity=0.449 Sum_probs=151.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----hHHHHHHHHHHcCCCCCCcceEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
..++|++++.||+|+||.||+|.+.. ++..||||++....... ...+.+|+.+++.++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 34689999999999999999998765 57799999997543211 24688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
+++...+..++||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999975 899999766677999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|||+++....... ......||+.|+|||++.+ ++|||||||
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 201 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHH
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHH
Confidence 9999987644322 1334579999999999852 479999997
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.02 Aligned_cols=183 Identities=22% Similarity=0.372 Sum_probs=155.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+++.+|+.++.+++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 4568999999999999999999876 356899999976543 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence 99999999999999999999765667999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .......||+.|+|||++. .++|||||||
T Consensus 168 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 209 (283)
T 3gen_A 168 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 209 (283)
T ss_dssp GGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHH
Confidence 86543221 1122345788899999987 3589999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=301.32 Aligned_cols=180 Identities=26% Similarity=0.378 Sum_probs=152.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
+.|++++.||+|+||+||+|++.. ++..||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 468999999999999999998875 677999999976532 234678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCcEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DF 283 (324)
....|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++. ++.+||+||
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 183 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDF 183 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEEC
Confidence 99999999999999999988544 56899999999999999999999988 999999999999976 455999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
|++........ ....+||+.|+|||++. .++|||||||
T Consensus 184 G~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~ 225 (494)
T 3lij_A 184 GLSAVFENQKK---MKERLGTAYYIAPEVLRKKYDEKCDVWSIGV 225 (494)
T ss_dssp TTCEECBTTBC---BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHH
T ss_pred CCCeECCCCcc---ccccCCCcCeeCHHHHcccCCCchhHHHHHH
Confidence 99987654322 33467999999999987 4589999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=282.46 Aligned_cols=181 Identities=27% Similarity=0.383 Sum_probs=151.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||.||+|.+.. ++..||||++....... .+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 578999999999999999998875 57799999986554322 3567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999999988874 4457999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
......... .....||+.|+|||++. .++|||||||
T Consensus 150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 191 (311)
T 4agu_A 150 RLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC 191 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred hhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence 876533221 23457999999999885 3579999997
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=277.41 Aligned_cols=184 Identities=26% Similarity=0.348 Sum_probs=158.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 4679999999999999999998765 577999999965432 234678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 999999999999999999984 3457999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
................||+.|+|||++.. ++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 196 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHH
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHH
Confidence 87543322222344679999999999862 489999997
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.00 Aligned_cols=181 Identities=26% Similarity=0.360 Sum_probs=154.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------cchHHHHHHHHHHcCCCC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLVH 194 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H 194 (324)
.++|++++.||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.+|++|+|
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 105 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC
T ss_pred ccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999999998875 677999999975432 223578899999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 195 pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
|||+++++++.+....|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++.
T Consensus 106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLEN 181 (504)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESS
T ss_pred CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEec
Confidence 99999999999999999999999999999998544 56999999999999999999999988 999999999999987
Q ss_pred CC---cEEEEeecccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 275 DY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 275 ~~---~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
++ .+||+|||+++....... ....+||+.|+|||++. .++|||||||
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~ 235 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGV 235 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHH
T ss_pred CCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhccCCCchHHHHHHHH
Confidence 75 699999999987654322 23457999999999987 4589999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=278.20 Aligned_cols=179 Identities=24% Similarity=0.307 Sum_probs=154.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.++..+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 4679999999999999999998875 577999999976432 2345788999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-------
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------- 274 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~------- 274 (324)
.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence 9999999999999999999999643 256899999999999999999999988 999999999999984
Q ss_pred ------------CCcEEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 275 ------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 275 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
...+||+|||++....... ...||+.|+|||++.. ++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 4479999999998765432 2359999999999862 589999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=284.93 Aligned_cols=189 Identities=28% Similarity=0.383 Sum_probs=161.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE--
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-- 205 (324)
.++|++.+.||+|+||.||+|++... ...++..||||++........+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 35899999999999999999986431 12368899999998766555567999999999999999999999887
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.....++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence 456789999999999999999765567999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... .......||+.|+|||++. .++|||||||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHH
Confidence 9876543322 1223346889999999986 3689999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.90 Aligned_cols=178 Identities=24% Similarity=0.344 Sum_probs=146.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++++.||+|+||+||+|++.. +++.||||++.... ....+++.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 3689999999999999999998775 67899999997542 223457889999999999999999999996
Q ss_pred eC------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
.. ...||||||+++ +|.+.+.. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+|
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 55 357999999965 57777632 4899999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||+++...... ..+..+||+.|+|||++. .++|||||||
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 251 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHH
Confidence 99999998765432 134468999999999987 3689999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=296.02 Aligned_cols=182 Identities=24% Similarity=0.326 Sum_probs=147.3
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------cchHHHHHHHHHHcCCCCCCc
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNL 197 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnI 197 (324)
...++|.+.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+|++|+||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 345789999999999999999998875 677999999875321 112357899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY- 276 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~- 276 (324)
+++++++. .+..|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 99999875 5568999999999999998854 457999999999999999999999988 99999999999996544
Q ss_pred --cEEEEeecccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 277 --NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 277 --~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
.+||+|||+++...... .....+||+.|+|||++. .++|||||||
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~ 332 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHH
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHH
Confidence 59999999998765432 233467999999999985 2589999997
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=289.00 Aligned_cols=181 Identities=23% Similarity=0.328 Sum_probs=149.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCC--CCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVH--LNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H--pnIv~~~~~ 203 (324)
.+.|++++.||+|+||.||+|.+. ++..||||++...... ....+.+|+.+|..|+| |||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 457999999999999999999764 3668999999765432 23568899999999986 999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+...+..|||||+ .+++|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++ ++.+||+||
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeec
Confidence 9999999999995 58899999965 457999999999999999999999988 99999999999997 678999999
Q ss_pred cccccCCCCCccceeeccccccCccccccccc----------------cceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------------ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------------~~DiwSlGc 324 (324)
|+++..............+||+.|+|||++.. ++|||||||
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~ 208 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHH
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHH
Confidence 99987755433323345679999999999853 589999997
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.81 Aligned_cols=187 Identities=24% Similarity=0.397 Sum_probs=160.9
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+.+...+|++.+.||+|+||.||+|.+.. ++..||||.+..... ..+++.+|+.+|++|+||||++++++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 33455678999999999999999999875 567999999976543 35789999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+...+..|||||||++|+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEee
Confidence 99999999999999999999999753 356899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+++....... .......+++.|+|||++. .++|||||||
T Consensus 362 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~ 407 (495)
T 1opk_A 362 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407 (495)
T ss_dssp TTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred cccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHH
Confidence 999987654322 1122345678999999987 3689999997
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.32 Aligned_cols=181 Identities=28% Similarity=0.420 Sum_probs=155.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.+.||+|+||+||+|++.. ++..||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 579999999999999999998875 577999999975432 2346688999999999999999999999876
Q ss_pred C--eEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE----cCCCcEE
Q 020561 208 D--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 279 (324)
Q Consensus 208 ~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~k 279 (324)
+ ..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEE
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEE
Confidence 5 7899999999999999996532 34999999999999999999999988 9999999999999 7788899
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc-------------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------------~~DiwSlGc 324 (324)
|+|||+++....... .....||+.|+|||++.. ++|||||||
T Consensus 157 L~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~ 211 (396)
T 4eut_A 157 LTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (396)
T ss_dssp ECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHH
T ss_pred EecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHH
Confidence 999999987654322 234579999999998752 589999997
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=278.23 Aligned_cols=182 Identities=20% Similarity=0.210 Sum_probs=157.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... ...+.+|+.++..+ +|+||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 4579999999999999999998765 577999999865432 35678999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc-----EEEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLS 281 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----~kl~ 281 (324)
....++||||+ +++|.+++.....++++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999999 99999999776667999999999999999999999988 999999999999987776 9999
Q ss_pred eecccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 206 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 206 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHH
Confidence 99999876543221 11234679999999999873 589999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=279.45 Aligned_cols=181 Identities=27% Similarity=0.343 Sum_probs=152.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 468889999999999999998775 577999999976532 3346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEE
Q 020561 208 DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLS 281 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~ 281 (324)
...++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence 999999999999999999853 2467999999999999999999999988 9999999999999 456889999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
|||++........ .....||+.|+|||++. .++|||||||
T Consensus 170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~ 213 (285)
T 3is5_A 170 DFGLAELFKSDEH---STNAAGTALYMAPEVFKRDVTFKCDIWSAGV 213 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHTTCCCHHHHHHHHHH
T ss_pred eeecceecCCccc---CcCcccccCcCChHHhccCCCcccCeehHHH
Confidence 9999987644322 23457999999999887 3589999997
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=291.91 Aligned_cols=185 Identities=28% Similarity=0.348 Sum_probs=157.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
.+|++.+.||+|+||.||+|++... +.+++.||||+++.... .....+.+|+.+|..+ +||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEccc------CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 5799999999999999999987532 12688999999975421 2235677899999999 69999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+...+..+|||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 99999999999999999999999654 46899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
|+++........ .....+||+.|+|||++. .++|||||||
T Consensus 204 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~ 250 (355)
T 1vzo_A 204 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250 (355)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred CCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHH
Confidence 999876432221 223457999999999986 2479999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=285.60 Aligned_cols=183 Identities=28% Similarity=0.411 Sum_probs=155.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.+|++++.||+|+||.||+|++.. ++..||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 579999999999999999998875 5779999998655332 23578899999999999999999999987
Q ss_pred C--------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 207 D--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 207 ~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
. +..|+||||++ ++|.+.+......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp C--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred cccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 4 46899999996 5888888776678999999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCc--cceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||+++....... ........||+.|+|||++. .++|||||||
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 217 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 217 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHH
Confidence 9999999987643221 11223457899999999885 3579999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=287.50 Aligned_cols=181 Identities=25% Similarity=0.389 Sum_probs=146.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++++.||+|+||+||+|++.. +++.||||++....... ...+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3579999999999999999998775 67799999997554322 346789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE-----cCCCcEEE
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKL 280 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl-----~~~~~~kl 280 (324)
+.+..+|||||++ |+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||+ +..+.+||
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999997 5999999543 46999999999999999999999988 9999999999999 45556999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|||+++....... ......||+.|+|||++. .++|||||||
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 226 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHH
Confidence 99999986543221 133457899999999886 3479999997
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=285.04 Aligned_cols=188 Identities=23% Similarity=0.397 Sum_probs=150.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++++.||+|+||.||+|.+...+.. ....||+|.+.... .....++.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 35899999999999999999998764321 12357888886443 3345678999999999999999999999987
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.. .++||||+++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 55 78999999999999999877778999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...............||+.|+|||++. .++|||||||
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 207 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHH
Confidence 8765443332333456788999999986 3689999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=300.51 Aligned_cols=181 Identities=26% Similarity=0.400 Sum_probs=158.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|++.. ++..||||++..... .....+.+|+.++++|+||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999998875 677999999965432 3356789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~ 281 (324)
.+.+..|+|||||.+|+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999999999999854 457999999999999999999999988 9999999999999 567899999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
|||+++....... ....+||+.|+|||++. .++|||||||
T Consensus 172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~ 215 (484)
T 3nyv_A 172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV 215 (484)
T ss_dssp CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHH
T ss_pred eeeeeEEcccccc---cccCCCCccccCceeecCCCCCcceeHHHHH
Confidence 9999987654332 23357999999999987 4689999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=289.71 Aligned_cols=189 Identities=20% Similarity=0.249 Sum_probs=152.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------hHHHHHHHHHHcCCCCCC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGDLVHLN 196 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~Hpn 196 (324)
.++|++.+.||+|+||.||+|.+...... ..++.||||++....... ...+..|+..+..++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESV----GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCC----CTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCcccc----ccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 45799999999999999999988753221 136789999987654211 123455777788999999
Q ss_pred cceEEEEEEeC----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 197 LVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 197 Iv~~~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
|+++++++... ...||||||| +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||+
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99999998775 4589999999 99999999776678999999999999999999999988 9999999999999
Q ss_pred c--CCCcEEEEeecccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 273 D--ADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 273 ~--~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+ .++.+||+|||+++........ .......||+.|||||++.. ++|||||||
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 8 8899999999999865432111 11123469999999999873 579999997
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=292.20 Aligned_cols=180 Identities=23% Similarity=0.333 Sum_probs=149.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCC--CCCcceEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV--HLNLVKLIGYC 204 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~~~~~~ 204 (324)
.+|++++.||+|+||.||+|.+. ++..||||++..... .....+.+|+.+|.+|. ||||+++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 46999999999999999999764 366899999976533 23467899999999996 59999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...+.+||||| +.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ||||||||+|||++ ++.+||+|||
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecC
Confidence 99999999999 5688999999654 47899999999999999999999988 99999999999995 5899999999
Q ss_pred ccccCCCCCccceeeccccccCccccccccc----------------cceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------------ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------------~~DiwSlGc 324 (324)
+++..............+||+.|||||++.. ++|||||||
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGv 255 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHH
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHH
Confidence 9987654333222345679999999999853 579999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=299.87 Aligned_cols=181 Identities=27% Similarity=0.389 Sum_probs=155.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||+||+|++.. ++..||||++.... ......+.+|+.+|++|+||||+++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 3579999999999999999998875 67799999986432 223467899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~D 282 (324)
+.+..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999988554 47999999999999999999999988 99999999999994 566799999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc----cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~DiwSlGc 324 (324)
||+++....... ....+||+.|+|||++.. ++|||||||
T Consensus 168 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~ 210 (486)
T 3mwu_A 168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGV 210 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGSCCCHHHHHHHHHH
T ss_pred CCcCeECCCCCc---cCCCcCCCCCCCHHHhCCCCCchhhHHHHHH
Confidence 999987644322 234579999999999873 579999997
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=279.73 Aligned_cols=182 Identities=28% Similarity=0.454 Sum_probs=143.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|++.. .||||++...... ..+.+.+|+.++++++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 45689999999999999999997643 6999999765432 235689999999999999999999965
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccce
Confidence 566789999999999999999777778999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
++................||+.|+|||++. .++|||||||
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 213 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHH
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHH
Confidence 998654433222334467999999999985 2579999997
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.03 Aligned_cols=193 Identities=25% Similarity=0.397 Sum_probs=159.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+..... ....++..||||++..... ....++.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34689999999999999999998763211 1123577999999976532 2345688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 99999999999999999999996543 24899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.+||+|||+++...............+|+.|+|||++. .++|||||||
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 247 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHH
Confidence 999999999999999998765543322233346788999999886 4589999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.35 Aligned_cols=182 Identities=27% Similarity=0.384 Sum_probs=158.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|.+.+.||+|+||.||++.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3578999999999999999998875 577999999875432 2345688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999999999988543 57899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++......... .....||+.|+|||++. .++|||||||
T Consensus 187 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 229 (335)
T 2owb_A 187 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC 229 (335)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHH
T ss_pred CceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHH
Confidence 99876433221 23457999999999986 3589999997
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.75 Aligned_cols=186 Identities=23% Similarity=0.290 Sum_probs=151.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----ccchHHHHHHHHHHcCCCCCCcceEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... ....+++.+|+.+++.++||||++++
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 94 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 45679999999999999999998765 57799999986432 23346789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhcc---------------------------------------CCCCCHHHHHHHH
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRMKIA 242 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~ 242 (324)
+++.+.+..++|||||++|+|.+++... ...+++..+..++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 9999999999999999999999998421 1123567788999
Q ss_pred HHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC--cEEEEeecccccCCCCCc--cceeeccccccCcccccccc----
Q 020561 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVM---- 314 (324)
Q Consensus 243 ~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~---- 314 (324)
.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||++.
T Consensus 175 ~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 99999999999988 99999999999998776 899999999986432111 11123457999999999986
Q ss_pred ---ccceEEEecC
Q 020561 315 ---TALELFCLKC 324 (324)
Q Consensus 315 ---~~~DiwSlGc 324 (324)
.++|||||||
T Consensus 252 ~~~~~~DiwslG~ 264 (345)
T 3hko_A 252 SYGPKCDAWSAGV 264 (345)
T ss_dssp CCCTHHHHHHHHH
T ss_pred CCCcHHHHHHHHH
Confidence 2689999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=278.17 Aligned_cols=180 Identities=27% Similarity=0.434 Sum_probs=153.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 4689999999999999999998875 567999999864321 2235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999999544 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... .....||+.|+|||++. .++|||||||
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (279)
T 3fdn_A 155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 195 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHH
Confidence 987654332 23457999999999886 3689999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=294.29 Aligned_cols=178 Identities=30% Similarity=0.467 Sum_probs=152.8
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
+..++|++.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|+.+|++++||||+++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 34568899999999999999999864 5589999997654 3467999999999999999999999987
Q ss_pred eCC-eEEEEEEecCCCChHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 206 EDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 206 ~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
... ..|||||||++|+|.+++..... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeC
Confidence 765 79999999999999999976543 4799999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++...... ....+++.|+|||++. .++|||||||
T Consensus 334 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~ 374 (450)
T 1k9a_A 334 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374 (450)
T ss_dssp TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHH
T ss_pred CCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence 9998653321 1235789999999986 3589999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.57 Aligned_cols=179 Identities=26% Similarity=0.443 Sum_probs=148.8
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
...++|++++.||+|+||+||+|.+.. ++..||||++.... ....+|+.+|+.++||||+++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheee
Confidence 456789999999999999999998875 67799999986543 22347999999999999999999985
Q ss_pred eC--------------------------------------CeEEEEEEecCCCChHHHHh---ccCCCCCHHHHHHHHHH
Q 020561 206 ED--------------------------------------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALG 244 (324)
Q Consensus 206 ~~--------------------------------------~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~q 244 (324)
.. ...++||||++ |+|.+.+. .....+++..+..++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 43 34889999997 58877775 34567999999999999
Q ss_pred HHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc------ccc
Q 020561 245 AAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TAL 317 (324)
Q Consensus 245 i~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~ 317 (324)
|+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++. .++
T Consensus 150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 999999999988 99999999999997 688999999999987644332 23457899999999876 347
Q ss_pred eEEEecC
Q 020561 318 ELFCLKC 324 (324)
Q Consensus 318 DiwSlGc 324 (324)
|||||||
T Consensus 224 DiwslG~ 230 (383)
T 3eb0_A 224 DLWSIGC 230 (383)
T ss_dssp HHHHHHH
T ss_pred hhhhHHH
Confidence 9999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=276.13 Aligned_cols=181 Identities=25% Similarity=0.390 Sum_probs=156.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4689999999999999999998875 5779999999754322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc---EEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~D 282 (324)
..+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 999999999999999999988544 56899999999999999999999988 999999999999976655 99999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++........ .....||+.|+|||++. .++|||||||
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHH
Confidence 999987654332 23357999999999987 3589999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=278.47 Aligned_cols=178 Identities=28% Similarity=0.430 Sum_probs=147.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcC--CCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||+||+|++. +..||||++... ....+.+|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 468999999999999999999763 668999999653 23455666666655 89999999999876
Q ss_pred eC----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeCCCCCCcEEEc
Q 020561 206 ED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 206 ~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~ivHrDLkp~NILl~ 273 (324)
.. ...++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ ||||||||+|||++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVK 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEEC
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEc
Confidence 53 458999999999999999943 46999999999999999999999 766 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccc--eeeccccccCccccccccc-----------cceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-----------ALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~-----------~~DiwSlGc 324 (324)
.++.+||+|||+++......... ......||+.|+|||++.. ++|||||||
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 99999999999997654332211 1223479999999999873 579999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=278.26 Aligned_cols=182 Identities=29% Similarity=0.410 Sum_probs=154.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||.+.... ...++.+|+.++..++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45689999999999999999998865 57799999997643 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999999756678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ ......||+.|+|||++. .++|||||||
T Consensus 173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 213 (314)
T 3com_A 173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGI 213 (314)
T ss_dssp EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHH
T ss_pred hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHH
Confidence 87644221 123457999999999986 4689999997
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=284.36 Aligned_cols=199 Identities=26% Similarity=0.376 Sum_probs=163.4
Q ss_pred cCHHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCC
Q 020561 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 196 (324)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~Hpn 196 (324)
+....+.+..++|++.+.||+|+||.||+|.+.... ...+++.||||++...... ....+.+|+.++.++ +|||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 344455556789999999999999999999865311 1236789999999765432 235688999999999 6999
Q ss_pred cceEEEEEEeCC-eEEEEEEecCCCChHHHHhccCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 020561 197 LVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL---------------PLPWSIRMKIALGAAKGLAFLHEEAERPV 260 (324)
Q Consensus 197 Iv~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~i 260 (324)
|+++++++...+ ..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 999999988764 48999999999999999965432 2889999999999999999999988 9
Q ss_pred EeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 261 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 261 vHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||||||+|||++.++.+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 238 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHH
Confidence 999999999999999999999999998765543333333456899999999886 3589999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=277.18 Aligned_cols=182 Identities=26% Similarity=0.375 Sum_probs=157.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.+.||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 3578999999999999999998875 577999999875432 2335688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 999999999999999999998854 347899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++......... .....||+.|+|||++. .++|||||||
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 203 (294)
T 2rku_A 161 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC 203 (294)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHH
T ss_pred CceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHH
Confidence 99876432221 23357999999999986 3589999996
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.50 Aligned_cols=195 Identities=25% Similarity=0.422 Sum_probs=160.0
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEE
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
++.+..++|++.+.||+|+||.||+|.+... ....++..||||.+..... ....++.+|+.+++.++||||++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 3344567899999999999999999987621 1112467899999975533 2335688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
+++...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999996421 45789999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 999999999999998654332222223346789999999986 3589999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.78 Aligned_cols=184 Identities=26% Similarity=0.398 Sum_probs=150.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
.++|++++.||+|+||.||+|++.. ++..||||.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 4578999999999999999998765 5779999999643 2234578899999999999999999998865
Q ss_pred ------------CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 207 ------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 207 ------------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcC
Confidence 35689999999999999999766667889999999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCCc------------cceeeccccccCcccccccc------ccceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++.+||+|||++........ ........||+.|+|||++. .++|||||||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHH
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHH
Confidence 99999999999987543210 11123457999999999876 3479999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.23 Aligned_cols=179 Identities=30% Similarity=0.467 Sum_probs=155.0
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
...+|++.+.||+|+||.||+|.+.. +++.||||.+.... ..+.+|+.++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 34579999999999999999998875 57799999997653 467889999999999999999998865
Q ss_pred ----------------CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 207 ----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 207 ----------------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 152 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN 152 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence 34589999999999999999643 357999999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.+||+|||++........ .....||+.|+|||++. .++|||||||
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred EEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence 9999999999999999987654322 23356999999999986 3589999997
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=299.80 Aligned_cols=185 Identities=27% Similarity=0.410 Sum_probs=156.6
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+.+..++|++.+.||+|+||.||+|.+.. +..||||.++... ...+.+.+|+.+|++|+||||++++++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34456789999999999999999998753 5689999997654 345789999999999999999999998
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+. .+..|||||||++|+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECS
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEee
Confidence 86 66789999999999999999643 236889999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+++....... .......+|+.|+|||++. .++|||||||
T Consensus 328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 373 (454)
T 1qcf_A 328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373 (454)
T ss_dssp TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHH
Confidence 999987643211 1122345688999999986 3589999997
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.91 Aligned_cols=176 Identities=27% Similarity=0.391 Sum_probs=147.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||.||+|.+.. +|..||||.+..... ...+++.+|+.+|+.++||||+++++++..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95 (367)
T ss_dssp SSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred ceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence 579999999999999999998865 678999999965432 223578899999999999999999999977
Q ss_pred CC------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 DD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.. ..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 63 459999999 8899999865 46899999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+|||+++..... .+..+||+.|+|||++.. ++|||||||
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 214 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHH
Confidence 999999876432 234578999999998763 589999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.48 Aligned_cols=180 Identities=24% Similarity=0.357 Sum_probs=154.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|++.. +++.||||++..........+.+|+.++..++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 3578999999999999999998875 5779999999866544456788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFG 284 (324)
+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999999999998543 46899999999999999999999988 9999999999999 788999999999
Q ss_pred ccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++....... .....||+.|+|||++.. ++|||||||
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHH
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHH
Confidence 997654321 223469999999999873 589999997
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=279.15 Aligned_cols=184 Identities=24% Similarity=0.381 Sum_probs=148.8
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC--CCCCcceEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL--VHLNLVKLIG 202 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~~~~ 202 (324)
....++|++.+.||+|+||.||+|++. +..||||++.... ...+.+|.+++..+ +||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 344578999999999999999999864 5689999986432 24455666666554 8999999999
Q ss_pred EEEeC----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeCCCCCCcEEEc
Q 020561 203 YCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLD 273 (324)
Q Consensus 203 ~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~ivHrDLkp~NILl~ 273 (324)
++... ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. ..+||||||||+|||++
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 99887 7899999999999999999543 6899999999999999999999870 11399999999999999
Q ss_pred CCCcEEEEeecccccCCCCCccc--eeeccccccCccccccccc-----------cceEEEecC
Q 020561 274 ADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-----------ALELFCLKC 324 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~-----------~~DiwSlGc 324 (324)
.++.+||+|||+++......... ......||+.|+|||++.. ++|||||||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 99999999999998664432211 1123579999999999863 279999997
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=274.76 Aligned_cols=181 Identities=25% Similarity=0.361 Sum_probs=154.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCCCCCcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
.++|++.+.||+|+||.||+|++.. ++..||||++...... ..+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 3568999999999999999998875 5779999998765322 346789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----c
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~ 277 (324)
+++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence 999999999999999999999999954 346899999999999999999999988 99999999999998877 8
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||++........ .....||+.|+|||++. .++|||||||
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 199 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHH
Confidence 99999999987654322 23356999999999987 3589999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=281.50 Aligned_cols=188 Identities=24% Similarity=0.394 Sum_probs=162.0
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEE
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
++.+..++|++.+.||+|+||.||+|.+.. ++..||||.+.... ...+++.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344456789999999999999999999876 57799999997543 33467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999653 356999999999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++........ .......||+.|+|||++. .++|||||||
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200 (288)
T ss_dssp CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHH
Confidence 9999987654332 2233345788999999987 3589999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=280.63 Aligned_cols=189 Identities=28% Similarity=0.429 Sum_probs=159.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++++.||+|+||.||+|++.. ....++..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3578899999999999999998642 11236889999999876555557899999999999999999999998765
Q ss_pred C--eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 208 D--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 208 ~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+ ..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence 4 689999999999999999776677999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... .......++..|+|||++. .++|||||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 236 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHH
Confidence 9877543321 1122345788899999986 4589999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=284.94 Aligned_cols=184 Identities=27% Similarity=0.405 Sum_probs=159.1
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------chHHHHHHHHHHcCC-CCC
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDL-VHL 195 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~Hp 195 (324)
.....+|++.+.||+|+||.||+|.+.. +|..||||++...... ..+.+.+|+.++.++ .||
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 160 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3445689999999999999999998865 5779999999765321 124578899999999 799
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
||+++++++......|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999999999999999643 46999999999999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc-----------ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlGc 324 (324)
+.+||+|||++........ .....||+.|+|||++. .++|||||||
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 293 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHH
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHH
Confidence 9999999999987654332 23467999999999875 3589999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=282.36 Aligned_cols=183 Identities=26% Similarity=0.427 Sum_probs=154.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+.|++.+.||+|+||.||+|.+.. ++..||+|++.........++.+|+.++..++||||+++++++...
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 4689999999999999999998875 5779999999876656667899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999998766677999999999999999999999988 9999999999999999999999999975
Q ss_pred cCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
..... ........||+.|+|||++. .++|||||||
T Consensus 166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 210 (302)
T 2j7t_A 166 KNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210 (302)
T ss_dssp HHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHH
T ss_pred ccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHH
Confidence 42111 01122356999999999983 3589999997
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=278.43 Aligned_cols=183 Identities=26% Similarity=0.306 Sum_probs=151.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++....... .+.+.+|+.++.+++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 3689999999999999999998765 57799999997553322 35688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
..++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999999999643 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++......... ......||+.|+|||++. .++|||||||
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 223 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTC 223 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHH
T ss_pred cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHH
Confidence 99876443211 123457999999999986 4689999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=279.21 Aligned_cols=188 Identities=26% Similarity=0.439 Sum_probs=154.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE-
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI- 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~- 205 (324)
..+|++.+.||+|+||.||+|.+..++. +...||+|.+..... ...+++.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 3468889999999999999998765322 345799999976433 23467889999999999999999999865
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.++..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence 456789999999999999999776777999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc--ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++........ .......||+.|+|||++. .++|||||||
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 220 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHH
Confidence 9876443211 1123356888999999986 3579999997
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=287.57 Aligned_cols=191 Identities=27% Similarity=0.384 Sum_probs=159.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+...+.. .....||+|.+..... ...+.+.+|+.++..+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKE----DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSS----CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcc----cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 346899999999999999999998753321 1345899999976543 2345688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
...+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 9999999999999999999999642 346899999999999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.++.+||+|||+++...............||+.|+|||++. .++|||||||
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 254 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHH
Confidence 9999999999999998654433322233456788999999886 4589999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.58 Aligned_cols=180 Identities=26% Similarity=0.414 Sum_probs=157.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3579999999999999999998865 57799999986432 12235788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999999999999654 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... .....||+.|+|||++. .++|||||||
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHH
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHH
Confidence 997654422 23357999999999987 3689999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=282.50 Aligned_cols=181 Identities=29% Similarity=0.476 Sum_probs=151.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--hHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++.+.||+|+||.||+|++.. ++..||||++....... .+.+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 579999999999999999998875 57799999986554322 3457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence 999999999999988888764 4457999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+....... ......||+.|+|||++.. ++|||||||
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~ 213 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGC 213 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHH
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHH
Confidence 87544222 1234579999999998863 479999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=293.49 Aligned_cols=174 Identities=21% Similarity=0.234 Sum_probs=145.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------cchHHHHHHHHHHcCCC------
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLV------ 193 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 193 (324)
.++|++++.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+++.|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 35788999999999999999986 367999999976532 22367888999888875
Q ss_pred ---CCCcceEEEEEE------------------------------eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHH
Q 020561 194 ---HLNLVKLIGYCI------------------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240 (324)
Q Consensus 194 ---HpnIv~~~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~ 240 (324)
|||||++++++. ..+..|||||||++|+|.+.+.+ ..+++..+..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~ 165 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS 165 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence 888888877653 26789999999999987777643 5689999999
Q ss_pred HHHHHHHHHHHHH-hcCCCCeEeCCCCCCcEEEcCCC--------------------cEEEEeecccccCCCCCccceee
Q 020561 241 IALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDGPEGDKTHVST 299 (324)
Q Consensus 241 i~~qi~~gL~yLH-~~~~~~ivHrDLkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~ 299 (324)
++.||+.||.||| +++ ||||||||+||||+.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 888 99999999999999887 8999999999875432
Q ss_pred ccccccCccccccccc----cceEEEecC
Q 020561 300 RVMGTYGYAAPEYVMT----ALELFCLKC 324 (324)
Q Consensus 300 ~~~Gt~~y~aPE~l~~----~~DiwSlGc 324 (324)
..+||+.|||||++.+ ++||||||+
T Consensus 236 ~~~gt~~y~aPE~~~g~~~~~~Diwsl~~ 264 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDGDYQFDIYRLMK 264 (336)
T ss_dssp EEECCCCTTCSGGGCCCSSHHHHHHHHHH
T ss_pred cEEEeecccChhhhcCCCccceehhhhhC
Confidence 2379999999999974 579999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=273.33 Aligned_cols=181 Identities=28% Similarity=0.403 Sum_probs=153.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 347788899999999999998775 577999999875432 234568899999999999999999999876
Q ss_pred ----CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcEEEE
Q 020561 207 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLS 281 (324)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~ 281 (324)
....++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEe
Confidence 35689999999999999999543 56899999999999999999999865 4599999999999997 78999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
|||++....... .....||+.|+|||++. .++|||||||
T Consensus 175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~ 217 (290)
T 1t4h_A 175 DLGLATLKRASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGM 217 (290)
T ss_dssp CTTGGGGCCTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHH
T ss_pred eCCCcccccccc----cccccCCcCcCCHHHHhccCCCcchHHHHHH
Confidence 999998654432 23457999999999887 4589999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=282.36 Aligned_cols=191 Identities=27% Similarity=0.458 Sum_probs=147.7
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
.+..++|.+.+.||+|+||.||+|.+..+. .++..||||.+...... ..+.+.+|+.++++++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQED------GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTT------SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccC------CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 345578999999999999999999876532 25678999999765332 2356889999999999999999999
Q ss_pred EEEeCC-----eEEEEEEecCCCChHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 203 YCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 203 ~~~~~~-----~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
++...+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 998765 35999999999999999842 3356999999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 273 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+.++.+||+|||+++...............+++.|+|||++.. ++|||||||
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 237 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHH
Confidence 9999999999999987654332222334567889999999863 579999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.39 Aligned_cols=186 Identities=27% Similarity=0.450 Sum_probs=145.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe-C
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-D 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 207 (324)
.|++.+.||+|+||+||+|.+...+. .+..||||.+..... ...+++.+|+.++++++||||+++++++.. +
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 57778899999999999998764321 245799999875432 334678999999999999999999998754 4
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence 6789999999999999999776677899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcc--ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKT--HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~--~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .......||+.|+|||++. .++|||||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 284 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHH
Confidence 66433211 1123346788999999986 3589999997
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=287.95 Aligned_cols=180 Identities=27% Similarity=0.398 Sum_probs=155.4
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 4689999999999999999998875 577999999976532 234578999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCC
Confidence 99999999999999999999653 4689999999999999999999985 7 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+...... ......||+.|+|||++.. ++|||||||
T Consensus 179 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 218 (360)
T 3eqc_A 179 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218 (360)
T ss_dssp CHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHH
T ss_pred Ccccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHH
Confidence 8754221 1233579999999999873 579999997
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=272.11 Aligned_cols=178 Identities=23% Similarity=0.331 Sum_probs=153.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|++. +..||||++..... ...+++.+|+.++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 357899999999999999999874 56899999976543 22357899999999999999999999998
Q ss_pred eC--CeEEEEEEecCCCChHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 206 ED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 206 ~~--~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+. +..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.++|+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence 87 788999999999999999975433 5899999999999999999999865 5599999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCccccccccc--------cceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
||++...... ...||+.|+|||++.. ++|||||||
T Consensus 157 ~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~ 199 (271)
T 3kmu_A 157 ADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199 (271)
T ss_dssp GGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred ccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence 9987654322 2468999999999873 489999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.52 Aligned_cols=187 Identities=28% Similarity=0.405 Sum_probs=154.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++.+.||+|+||.||+|.+.... .++..||||.+..... ...+++.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3467999999999999999999876432 2456799999976532 33467899999999999999999999876
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+ +..|+||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence 4 4578999999999999999776677999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... ......+|+.|+|||++. .++|||||||
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 202 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHH
Confidence 9876543221 123345788999999886 3589999997
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=274.46 Aligned_cols=180 Identities=28% Similarity=0.386 Sum_probs=157.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.|++++.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.++..+.||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 468899999999999999998765 577999999976543 3346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999999999999853 46899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......||+.|+|||++. .++|||||||
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 207 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHH
Confidence 7644321 123457999999999986 3579999997
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=276.83 Aligned_cols=186 Identities=22% Similarity=0.356 Sum_probs=155.9
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.|.+.++||+|+||.||+|.+..... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 46667899999999999998765332 345799999975433 23467889999999999999999999998766
Q ss_pred eE-EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 209 QR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 209 ~~-~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
.. ++||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 55 9999999999999999776778999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcc--ceeeccccccCccccccccc-----cceEEEecC
Q 020561 288 DGPEGDKT--HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
........ .......||+.|+|||++.. ++|||||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 216 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGV 216 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHH
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHH
Confidence 65432211 11233568999999999873 579999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=276.69 Aligned_cols=185 Identities=34% Similarity=0.489 Sum_probs=154.8
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC-
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 207 (324)
.|++++.||+|+||+||++.+... ...+++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 348899999999999999976532 233788999999976532 2345689999999999999999999999884
Q ss_pred -CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
...++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence 6789999999999999999553 4899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
......... .......||+.|+|||++.. ++|||||||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 225 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGV 225 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHH
Confidence 887554322 12234568899999999873 579999997
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.98 Aligned_cols=181 Identities=25% Similarity=0.372 Sum_probs=153.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCCe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 209 (324)
+|....+||+|+||.||+|.+.. ++..||||.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 45556699999999999998765 577999999987655556778999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcEEEEeeccc
Q 020561 210 RLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLA 286 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla 286 (324)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999999999997543 35678889999999999999999988 999999999999987 899999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
........ ......||+.|+|||++. .++|||||||
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 213 (295)
T 2clq_A 171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHH
T ss_pred cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHH
Confidence 87644221 123457999999999985 2579999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=273.46 Aligned_cols=182 Identities=26% Similarity=0.412 Sum_probs=157.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+++.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4578899999999999999998753 56899999976543 346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 9999999999999999999776677999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...... ........||+.|+|||++. .++|||||||
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 193 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 193 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHH
Confidence 754321 11122345788999999986 3589999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=280.00 Aligned_cols=188 Identities=24% Similarity=0.357 Sum_probs=140.2
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+..++|++.+.||+|+||.||+|.+.. ++..||||.+..... ....++.+|+.++.+++||||++++++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence 3456789999999999999999998765 567999999865432 234568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
+...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 158 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDG 158 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCC
Confidence 9999999999999999999999863 2456899999999999999999999988 99999999999999999
Q ss_pred cEEEEeecccccCCCCCc---cceeeccccccCcccccccc------ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~---~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.+||+|||++........ ........||+.|+|||++. .++|||||||
T Consensus 159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 215 (303)
T 2vwi_A 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215 (303)
T ss_dssp CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHH
T ss_pred CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHH
Confidence 999999999986543221 11123357999999999875 3589999997
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=273.21 Aligned_cols=180 Identities=32% Similarity=0.516 Sum_probs=143.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
..+|++.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 357899999999999999999864 568999998754322 23578899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC--------C
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--------D 275 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~--------~ 275 (324)
+...+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+++..+|+||||||+|||++. +
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999999984 347899999999999999999999987555899999999999986 7
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.+||+|||++....... .....||+.|+|||++. .++|||||||
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 202 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHH
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHH
Confidence 789999999998654432 22357999999999886 3589999997
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=281.71 Aligned_cols=189 Identities=23% Similarity=0.409 Sum_probs=151.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..+|++.+.||+|+||.||+|.+...+. ..+..||||.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3578888999999999999998764321 12457999999765322 23568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..+|||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 99999999999999999999776678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .......+|+.|+|||++. .++|||||||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 238 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHH
Confidence 876543211 1112235688999999986 3589999997
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=273.78 Aligned_cols=186 Identities=26% Similarity=0.383 Sum_probs=155.4
Q ss_pred hcCCCCCc-eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|.+.+ .||+|+||.||+|.+... .++..||||++..... ...+++.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 34666666 899999999999987532 1477899999976532 2346789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence 556789999999999999999766677999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+......... .......||+.|+|||++. .++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 201 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 201 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHH
Confidence 9876543321 1122345789999999986 3589999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=274.49 Aligned_cols=181 Identities=29% Similarity=0.414 Sum_probs=157.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---------cchHHHHHHHHHHcCCC-CCCc
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGDLV-HLNL 197 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-HpnI 197 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.++.++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 4689999999999999999998865 678999999975431 11346789999999996 9999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
+++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 99999999999999999999999999999643 57899999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----------ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlGc 324 (324)
+||+|||++........ .....||+.|+|||++. .++|||||||
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 217 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217 (298)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHH
Confidence 99999999987654332 23457999999999874 3689999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=279.85 Aligned_cols=185 Identities=26% Similarity=0.344 Sum_probs=154.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4689999999999999999998765 577999999976555555778999999999999999999999873
Q ss_pred ---CCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 ---DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ---~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEE
Confidence 3478999999999999999865 3567999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccc-------eeeccccccCcccccccc--------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+|||++.......... ......||+.|+|||++. .++|||||||
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 234 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHH
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHH
Confidence 9999987653211100 011235799999999875 3679999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=271.66 Aligned_cols=181 Identities=27% Similarity=0.364 Sum_probs=149.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... .....++.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4589999999999999999998875 57799999996532 12345788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecc
Confidence 9999999999999999999999644 46899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++........ .....||+.|+|||++. .++|||||||
T Consensus 157 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 199 (276)
T 2h6d_A 157 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV 199 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHH
T ss_pred cccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHH
Confidence 9987654322 22356899999999986 3589999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=279.37 Aligned_cols=181 Identities=28% Similarity=0.464 Sum_probs=151.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcE--EEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
++|++.+.||+|+||.||+|++.. ++.. ||||.+.... .....++.+|+.++.++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 578999999999999999999876 3444 5999987532 23345789999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996543 46899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++.++.+||+|||+++....... .....+++.|+|||++. .++|||||||
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 229 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred EEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHH
Confidence 9999999999999999975432111 22245788999999986 4589999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=279.63 Aligned_cols=180 Identities=25% Similarity=0.342 Sum_probs=150.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------cchHHHHHHHHHHcCCCCCCcce
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+|++++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 79 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred hhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence 4579999999999999999998875 677999999975432 11235789999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 277 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-- 277 (324)
+++++...+ .|+||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 80 IKNFFDAED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp EEEEEESSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSC
T ss_pred EeeEEcCCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCC
Confidence 999987655 899999999999999985 3457999999999999999999999988 999999999999987654
Q ss_pred -EEEEeecccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 278 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 278 -~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
+||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 155 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 207 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207 (322)
T ss_dssp CEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHH
T ss_pred eEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHH
Confidence 99999999987644321 23356999999999973 3689999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.56 Aligned_cols=184 Identities=23% Similarity=0.321 Sum_probs=153.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----ccchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 3689999999999999999998765 57799999997542 2234678999999999999999999999
Q ss_pred EE--eCCeEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 204 CI--EDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 204 ~~--~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
+. .....++||||++++ |.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence 84 446789999999776 7777754 3457999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCccccccccc-------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
+|||++................||+.|+|||++.. ++|||||||
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 201 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHH
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHH
Confidence 99999987654333333344679999999999862 579999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.84 Aligned_cols=182 Identities=26% Similarity=0.410 Sum_probs=145.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.+|++.+.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.+++.++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 479999999999999999998765 567999999975432 23356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
..+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence 99999999999999999999863 3567899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++........ ......||+.|+|||++. .++|||||||
T Consensus 180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 224 (310)
T 2wqm_A 180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHH
Confidence 999987544321 123356899999999886 3579999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=289.58 Aligned_cols=176 Identities=26% Similarity=0.419 Sum_probs=145.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC-
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 207 (324)
.+|++.+.||+|+||.||+|++.. +++.||||++.... ..+.+|+.+|+.|+|||||++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 368889999999999999999875 57799999986543 2234799999999999999999988542
Q ss_pred -----CeEEEEEEecCCCChHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-CcE
Q 020561 208 -----DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNA 278 (324)
Q Consensus 208 -----~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~ 278 (324)
..+++||||+++ +|.+.+. .....+++..+..++.||+.||.|||+++ ||||||||+||||+.+ +.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence 236799999975 6766654 34567999999999999999999999988 9999999999999955 678
Q ss_pred EEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
||+|||+++....... ....+||+.|+|||++.+ ++|||||||
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 245 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHH
Confidence 9999999987654332 234579999999999863 479999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.38 Aligned_cols=174 Identities=22% Similarity=0.326 Sum_probs=152.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEe-
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE- 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~- 206 (324)
++|++++.||+|+||.||+|++.. +++.||||++.... .+.+.+|+.++..|. ||||+++++++.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 579999999999999999998765 57799999997433 467899999999997 9999999999988
Q ss_pred -CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEeec
Q 020561 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 284 (324)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFG 284 (324)
....++||||+++++|.+++. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 567899999999999999884 3889999999999999999999988 99999999999999776 89999999
Q ss_pred ccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+++....... .....||+.|+|||++.. ++|||||||
T Consensus 177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 219 (330)
T 3nsz_A 177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 219 (330)
T ss_dssp TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHH
Confidence 9987654332 233579999999999863 579999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=283.75 Aligned_cols=187 Identities=24% Similarity=0.380 Sum_probs=150.1
Q ss_pred HHHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----------chHHHHHHHHHH
Q 020561 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFL 189 (324)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-----------~~~~~~~E~~~l 189 (324)
+.++....++|++.+.||+|+||.||+|.+. ++..||||++...... ..+++.+|+.++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 4556667789999999999999999999865 3679999998643221 125789999999
Q ss_pred cCCCCCCcceEEEEEEeC-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 020561 190 GDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 264 (324)
Q Consensus 190 ~~l~HpnIv~~~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrD 264 (324)
++++||||+++++++... ...|+||||++ |+|.+++......+++..+..++.||+.||.|||+++ |+|||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 159 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecC
Confidence 999999999999998543 36899999996 6899988776678999999999999999999999988 99999
Q ss_pred CCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 265 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 265 Lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
|||+|||++.++.+||+|||+++....... .....||+.|+|||++.. ++|||||||
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 222 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGC 222 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHH
T ss_pred CChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHH
Confidence 999999999999999999999986443221 234578999999998763 479999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=282.09 Aligned_cols=190 Identities=27% Similarity=0.372 Sum_probs=150.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||.||+|.+.... ...++..||||.+..... ....++.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 458999999999999999999864311 112677999999975432 334578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~ 277 (324)
.+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 999999999999999999997543 35899999999999999999999988 999999999999984 456
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||++................||+.|+|||++. .++|||||||
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 233 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 233 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHH
Confidence 9999999997543322222223356899999999986 4589999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=283.22 Aligned_cols=177 Identities=24% Similarity=0.350 Sum_probs=143.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.+++.++||||+++++++..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 95 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecc
Confidence 589999999999999999998765 577999999975432 223568899999999999999999999977
Q ss_pred CC------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 DD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.+ ..|+||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp CCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence 65 7899999996 57888884 35899999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+++...... ......||+.|+|||++. .++|||||||
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 214 (371)
T 2xrw_A 169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214 (371)
T ss_dssp CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred EEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHH
Confidence 9999998754322 123457999999999987 4689999997
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=300.44 Aligned_cols=184 Identities=26% Similarity=0.378 Sum_probs=149.7
Q ss_pred CCCCCc-eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 130 NFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 130 ~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++.+.+ .||+|+||.||+|.+...+ ++..||||+++.... ...+++.+|+.+|++|+|||||++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSS-------CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCC-------CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 334444 7999999999999876422 356899999976532 345789999999999999999999999876
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..+||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 5689999999999999999766677999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .......+|+.|||||++. .++|||||||
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv 527 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHH
Confidence 76543221 1112234678999999987 4589999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=286.44 Aligned_cols=176 Identities=27% Similarity=0.427 Sum_probs=136.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||.||+|.+.. +|..||||++..... ...+++.+|+.+|+.++||||+++++++..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 589999999999999999998765 678999999975432 234578899999999999999999999875
Q ss_pred C------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
. ...|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence 4 5679999999 7899998854 56999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+|||+++..... .+...||+.|+|||++.. ++|||||||
T Consensus 174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 218 (367)
T 2fst_X 174 LDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 218 (367)
T ss_dssp CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHH
T ss_pred eecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHH
Confidence 999999875432 234579999999998863 589999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=278.62 Aligned_cols=178 Identities=29% Similarity=0.478 Sum_probs=143.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHH--HcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF--LGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|++ ++..||||++.... ...+..|.++ +..++||||+++++.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 46899999999999999999975 36799999996432 2344445444 55689999999998654
Q ss_pred e-----CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEeCCCCCCcEE
Q 020561 206 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---------AERPVIYRDFKTSNIL 271 (324)
Q Consensus 206 ~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~~~~ivHrDLkp~NIL 271 (324)
. ....+||||||++|+|.+++... ..++..++.++.||+.||.|||+. + ||||||||+|||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 3 23578999999999999999553 458899999999999999999998 6 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCc------cceeeccccccCccccccccc------------cceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT------------ALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~Gt~~y~aPE~l~~------------~~DiwSlGc 324 (324)
++.++.+||+|||+++....... ........||+.|+|||++.+ ++|||||||
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 223 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHH
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHH
Confidence 99999999999999987643211 111234579999999999874 479999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.18 Aligned_cols=184 Identities=27% Similarity=0.396 Sum_probs=150.9
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+.+|++|+||||+++++++
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3455688999999999999999998863 4579999997654 2356799999999999999999999998
Q ss_pred EeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
.. +..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 324 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 324 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence 65 6789999999999999999643 356899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++........ ......+|+.|+|||++. .++|||||||
T Consensus 325 G~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~ 369 (452)
T 1fmk_A 325 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369 (452)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHH
Confidence 999876543211 122345788999999986 3589999996
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=273.70 Aligned_cols=185 Identities=28% Similarity=0.445 Sum_probs=155.9
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+.+..++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.+++.++||||++++++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 3445578999999999999999999865 25689999997654 235678999999999999999999998
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
+. .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred Ec-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECC
Confidence 76 456899999999999999996432 36899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||++......... ......+++.|+|||++. .++|||||||
T Consensus 153 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 198 (279)
T 1qpc_A 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198 (279)
T ss_dssp CTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHH
T ss_pred CcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHH
Confidence 9999876543221 122345788999999986 3579999997
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.86 Aligned_cols=178 Identities=18% Similarity=0.220 Sum_probs=145.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHH---HHHcCCCCCCcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEV---NFLGDLVHLNLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~HpnIv~~~ 201 (324)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+ .+|++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4678899999999999999998764 57799999997432 23346788999 566667899999998
Q ss_pred -------EEEEeCCe-----------------EEEEEEecCCCChHHHHhccC------CCCCHHHHHHHHHHHHHHHHH
Q 020561 202 -------GYCIEDDQ-----------------RLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAF 251 (324)
Q Consensus 202 -------~~~~~~~~-----------------~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~y 251 (324)
+++.+.+. .||||||+ +|+|.+++.... ..+++..++.|+.||+.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 66665532 78999999 689999996432 123358888999999999999
Q ss_pred HHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc----------------
Q 020561 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---------------- 315 (324)
Q Consensus 252 LH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---------------- 315 (324)
||+++ ||||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++..
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 99988 99999999999999999999999999986433 2344678 99999999763
Q ss_pred cceEEEecC
Q 020561 316 ALELFCLKC 324 (324)
Q Consensus 316 ~~DiwSlGc 324 (324)
++|||||||
T Consensus 293 ~~DvwSlG~ 301 (377)
T 3byv_A 293 SFDAWALGL 301 (377)
T ss_dssp HHHHHHHHH
T ss_pred hhhHHHHHH
Confidence 469999997
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=279.69 Aligned_cols=184 Identities=30% Similarity=0.411 Sum_probs=152.4
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
...++|++.+.||+|+||.||+|++.. ++..||||++.... .....+.+|+.++.++ +||||+++++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 345789999999999999999998865 57799999997543 2346789999999998 799999999999
Q ss_pred Ee------CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 205 IE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 205 ~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 87 46889999999999999999653 357899999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
+||+|||++........ ......||+.|+|||++. .++|||||||
T Consensus 168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 222 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHH
T ss_pred EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHH
Confidence 99999999987543221 123357999999999985 3589999997
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=282.75 Aligned_cols=186 Identities=17% Similarity=0.212 Sum_probs=147.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----------chHHHHHHHHHHcCCCCCC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHLN 196 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hpn 196 (324)
.++|++.+.||+|+||.||+|.+...+. ++..||||++...... ....+.+|+.++..+.|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3579999999999999999999875322 4668999999765321 1134678899999999999
Q ss_pred cceEEEEEEe----CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE
Q 020561 197 LVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (324)
Q Consensus 197 Iv~~~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl 272 (324)
|+++++++.. ....||||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||+
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence 9999999988 78899999999 999999996543 7999999999999999999999988 9999999999999
Q ss_pred cCCC--cEEEEeecccccCCCCCcc-----ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 DADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++ .+||+|||+++........ .......||+.|+|||++. .++|||||||
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 248 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGY 248 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHH
Confidence 8877 9999999999865432111 1113457999999999987 3589999997
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=278.23 Aligned_cols=190 Identities=22% Similarity=0.291 Sum_probs=157.0
Q ss_pred CHHHHHHHhcCCCCC-ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCC-CC
Q 020561 120 TFNDLKLATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HL 195 (324)
Q Consensus 120 ~~~~~~~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-Hp 195 (324)
.+.......+.|.+. +.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.++..+. ||
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 344445556677777 889999999999998875 577999999975432 23467899999999995 69
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
||+++++++...+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS 166 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence 9999999999999999999999999999998543 367999999999999999999999988 999999999999987
Q ss_pred ---CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 275 ---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 275 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.+||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 221 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGI 221 (327)
T ss_dssp BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred CCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHH
Confidence 78999999999987654322 23357999999999987 3589999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=282.27 Aligned_cols=181 Identities=24% Similarity=0.372 Sum_probs=153.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++++.||+|+||.||+|.+.. ++..||||++...... ...++.+|+.++.+++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred ccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 579999999999999999998765 5779999999754322 235788999999999999999999999765
Q ss_pred -----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 208 -----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 208 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp STTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred CccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 36899999996 699999854 36899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCcc-ceeeccccccCcccccccc------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+++........ ......+||+.|+|||++. .++|||||||
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 220 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence 9999876432211 1123457999999999864 3579999997
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=273.85 Aligned_cols=185 Identities=28% Similarity=0.401 Sum_probs=151.9
Q ss_pred hcCCCCCc-eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..+|++.+ .||+|+||.||+|.+... .++..||||++...... ..+++.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45788888 999999999999976532 24679999999765322 246789999999999999999999998
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence 56778999999999999999965 456999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccc-eeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.......... ......||+.|+|||++. .++|||||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 208 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 208 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHH
Confidence 998765433221 122235678999999986 3689999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.60 Aligned_cols=182 Identities=25% Similarity=0.303 Sum_probs=142.1
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hH-HHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HK-EWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~-~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|++.. +++.||||++....... .. .+.++...++.+.||||+++++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~ 75 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence 34689999999999999999998865 57799999997653222 22 344555568889999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
...+..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999996 588887753 456799999999999999999999997 8 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 201 (290)
T 3fme_A 152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHH
T ss_pred eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHH
Confidence 99999987644322 22346999999999962 3579999997
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=278.38 Aligned_cols=186 Identities=26% Similarity=0.384 Sum_probs=141.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEE-
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI- 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~- 205 (324)
..+|++.+.||+|+||.||+|++.. +++.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 4579999999999999999998865 57799999997665555567899999999996 999999999994
Q ss_pred -------eCCeEEEEEEecCCCChHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC
Q 020561 206 -------EDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (324)
Q Consensus 206 -------~~~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~ 276 (324)
.....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTS
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCC
Confidence 3345899999995 799998864 3457999999999999999999999865 4599999999999999999
Q ss_pred cEEEEeecccccCCCCCccc----------eeeccccccCcccccccc--------ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
.+||+|||+++......... ......||+.|+|||++. .++|||||||
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~ 241 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHH
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHH
Confidence 99999999998765432211 011346999999999983 3689999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=285.72 Aligned_cols=177 Identities=21% Similarity=0.356 Sum_probs=151.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC------CCCCcceEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL------VHLNLVKLIG 202 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~~ 202 (324)
.+|++++.||+|+||.||+|.+.. ++..||||++.... ....++.+|+.++..+ +|+||+++++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 479999999999999999998775 67899999997542 2234567788777665 6789999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--EE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AK 279 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--~k 279 (324)
++...+..+|||||+. ++|.+++.... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++. +|
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEE
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceE
Confidence 9999999999999995 69999986543 45999999999999999999999988 999999999999999887 99
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||+++..... ....+||+.|||||++. .++|||||||
T Consensus 243 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 243 VIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGC 287 (429)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHH
T ss_pred EeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHH
Confidence 9999999865432 22357999999999987 4589999997
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.71 Aligned_cols=182 Identities=23% Similarity=0.283 Sum_probs=150.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEE-Ee
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-IE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ..++.+|+.++..++|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 4689999999999999999998765 577999998765432 24578999999999988777666555 66
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DF 283 (324)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecC
Confidence 78889999999 99999999766678999999999999999999999988 9999999999999 78999999999
Q ss_pred cccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 284 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|+++........ .......||+.|+|||++.. ++|||||||
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence 999876543221 11234579999999999873 589999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=283.29 Aligned_cols=177 Identities=15% Similarity=0.043 Sum_probs=135.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHH---HHHHcCCCCCCcceEE-
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAE---VNFLGDLVHLNLVKLI- 201 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E---~~~l~~l~HpnIv~~~- 201 (324)
.+|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+| +.+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458889999999999999999875 5779999999876532 23456677 455666 799988865
Q ss_pred ------EEEEeC-----------------CeEEEEEEecCCCChHHHHhccCCCCCHHHH------HHHHHHHHHHHHHH
Q 020561 202 ------GYCIED-----------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALGAAKGLAFL 252 (324)
Q Consensus 202 ------~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~gL~yL 252 (324)
+++... ...|||||||+ |+|.+++......+++..+ +.++.||+.||.||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 455433 33799999998 8999999765445566666 78889999999999
Q ss_pred HhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc-------cceEEEecC
Q 020561 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 253 H~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
|+++ ||||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.. ++|||||||
T Consensus 211 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9988 999999999999999999999999999876432 113457799999999874 479999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.69 Aligned_cols=182 Identities=24% Similarity=0.394 Sum_probs=137.4
Q ss_pred CCCC-CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe--
Q 020561 130 NFRP-ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 206 (324)
Q Consensus 130 ~y~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 206 (324)
.|++ +++||+|+||+||+|++... .++..||||++..... ...+.+|+.+|+.|+||||+++++++..
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 4555 45899999999999987642 1467899999975433 3578899999999999999999999965
Q ss_pred CCeEEEEEEecCCCChHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE----cC
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DA 274 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl----~~ 274 (324)
....||||||+. ++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+|||| +.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTT
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCC
Confidence 678999999995 5888887521 235899999999999999999999988 9999999999999 77
Q ss_pred CCcEEEEeecccccCCCCCcc-ceeeccccccCccccccccc------cceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
++.+||+|||+++........ ......+||+.|+|||++.. ++|||||||
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~ 224 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 224 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHH
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHH
Confidence 899999999999876432211 12334679999999999873 479999997
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.51 Aligned_cols=186 Identities=26% Similarity=0.385 Sum_probs=156.8
Q ss_pred HHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEE
Q 020561 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
.+.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++|+||||+++++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344456788999999999999999998864 4579999997654 33567999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
++.+ +..|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEc
Confidence 9865 6789999999999999999643 346899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||+++...... ........+++.|+|||++. .++|||||||
T Consensus 406 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv 452 (535)
T 2h8h_A 406 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452 (535)
T ss_dssp CTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHH
Confidence 999998764321 11122345788999999886 3589999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=272.92 Aligned_cols=182 Identities=26% Similarity=0.354 Sum_probs=146.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE--
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-- 205 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||.+........+++.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 3579999999999999999998875 67899999998765555577899999999999999999999873
Q ss_pred ------------eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 206 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 206 ------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
.....++||||++ |+|.+++.+ .++++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 3467899999997 699999843 56899999999999999999999988 99999999999997
Q ss_pred -CCCcEEEEeecccccCCCCCc-cceeeccccccCccccccccc------cceEEEecC
Q 020561 274 -ADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 274 -~~~~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
.++.+||+|||+++....... ........||+.|+|||++.. ++|||||||
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 213 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHH
Confidence 567999999999987643211 111233467999999998752 479999997
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=268.92 Aligned_cols=182 Identities=23% Similarity=0.283 Sum_probs=153.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEE-Ee
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-IE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~ 206 (324)
.++|++.+.||+|+||.||+|++.. +++.||||++..... ..++.+|+.++..+.|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 3689999999999999999998765 577999999876543 25688999999999988866655544 66
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DF 283 (324)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 78889999999 99999999766678999999999999999999999988 9999999999999 58899999999
Q ss_pred cccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 284 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|++......... .......||+.|+|||++.. ++|||||||
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHH
Confidence 999876543221 11234579999999999874 589999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.27 Aligned_cols=176 Identities=31% Similarity=0.452 Sum_probs=142.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++.+.||+|+||.||+|.+. +..||||.+.... ..+.+.+|+.++++++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 57888999999999999999864 5589999996442 3467899999999999999999999876 4
Q ss_pred eEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc-EEEEeecc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGL 285 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-~kl~DFGl 285 (324)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+..+|+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 4799999999999999996543 24788999999999999999999943334999999999999988886 79999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+...... .....||+.|+|||++. .++|||||||
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 191 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHH
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHH
Confidence 9765432 12346999999999987 3589999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=272.26 Aligned_cols=187 Identities=28% Similarity=0.438 Sum_probs=146.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++.+.||+|+||.||+|.+..... .+..||||++..... ...+++.+|+.++.+++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCC------ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3579999999999999999998754211 234799999876432 2346788999999999999999999998
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.... .++||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccc
Confidence 8765 88999999999999999766667999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccc-eeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.......... ......+|+.|+|||++. .++|||||||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 212 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHH
Confidence 998775433221 122346788999999986 3589999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=271.69 Aligned_cols=186 Identities=24% Similarity=0.378 Sum_probs=153.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3579999999999999999998875 577999999976543 23356889999999999999999999885
Q ss_pred e--CCeEEEEEEecCCCChHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCcEEEcCCCcE
Q 020561 206 E--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 206 ~--~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~~ 278 (324)
. ....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 57899999999999999999642 345999999999999999999999865 2349999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
||+|||+++........ .....||+.|+|||++.. ++|||||||
T Consensus 156 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204 (279)
T ss_dssp EECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHH
T ss_pred EEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHH
Confidence 99999999876543211 223468999999999863 589999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=274.23 Aligned_cols=180 Identities=30% Similarity=0.454 Sum_probs=152.7
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcC--CCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~ 203 (324)
...++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|++++.. ++||||++++++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred cccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 44568999999999999999999863 669999999643 23567788888876 789999999999
Q ss_pred EEeCC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeCCCCCCcEE
Q 020561 204 CIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 204 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~ivHrDLkp~NIL 271 (324)
+...+ ..++||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +.+ |+||||||+|||
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 98876 78999999999999999965 36899999999999999999999 766 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccc--eeeccccccCccccccccc-----------cceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-----------ALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~-----------~~DiwSlGc 324 (324)
++.++.+||+|||++.......... ......||+.|+|||++.. ++|||||||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 9999999999999998654432211 1234579999999999873 489999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=276.44 Aligned_cols=182 Identities=26% Similarity=0.385 Sum_probs=151.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||.+..... ....++.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 3689999999999999999998875 678999999965432 223567899999999999999999998876
Q ss_pred C-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
. ...++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 4 67899999996 699999855 46899999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCccc--------eeeccccccCcccccccc------ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~--------~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|||+++......... ......||+.|+|||++. .++|||||||
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 211 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGC 211 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHH
Confidence 999998764322110 112357899999999875 2589999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=277.02 Aligned_cols=179 Identities=22% Similarity=0.345 Sum_probs=155.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------------hHHHHHHHHHHc
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG 190 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~ 190 (324)
.++|++.+.||+|+||.||+|.+ ++..||||.+....... ...+.+|+.++.
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999987 26799999986432211 167899999999
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHH------Hhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 020561 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 262 (324)
Q Consensus 191 ~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivH 262 (324)
+++||||+++++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ ++ |+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence 99999999999999999999999999999999998 6432 5679999999999999999999999 88 999
Q ss_pred CCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccccc-------cceEEEecC
Q 020561 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------ALELFCLKC 324 (324)
Q Consensus 263 rDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~DiwSlGc 324 (324)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++.. ++|||||||
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 240 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHH
Confidence 999999999999999999999999876443 2344679999999999862 589999997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=285.40 Aligned_cols=182 Identities=25% Similarity=0.306 Sum_probs=154.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC-CCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||.||+|++.. ++..||||++..... ..++.+|+.++..|.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 3689999999999999999998765 577999999875533 2468899999999986 666677777788
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE---cCCCcEEEEee
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 283 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DF 283 (324)
.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeC
Confidence 89999999999 99999999766678999999999999999999999988 9999999999999 68899999999
Q ss_pred cccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 284 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|+++........ .......||+.|+|||++.. ++|||||||
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGv 201 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGY 201 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHH
Confidence 999876543221 11224679999999999873 579999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.87 Aligned_cols=178 Identities=24% Similarity=0.326 Sum_probs=150.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC--------CCCcce
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--------HLNLVK 199 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~ 199 (324)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ...+.+.+|+.+++.+. ||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 3579999999999999999998765 67799999997542 23456889999999885 788999
Q ss_pred EEEEEE----eCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEc
Q 020561 200 LIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLD 273 (324)
Q Consensus 200 ~~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~ 273 (324)
+++++. .....||||||+ +++|.+++.+. ...+++..++.++.||+.||.|||++ + ||||||||+|||++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence 999987 456789999999 66777766543 35799999999999999999999997 7 99999999999998
Q ss_pred CCC-------------------------------------------------cEEEEeecccccCCCCCccceeeccccc
Q 020561 274 ADY-------------------------------------------------NAKLSDFGLAKDGPEGDKTHVSTRVMGT 304 (324)
Q Consensus 274 ~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt 304 (324)
.++ .+||+|||++...... .....||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence 775 7999999999876432 2335799
Q ss_pred cCcccccccc-----ccceEEEecC
Q 020561 305 YGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 305 ~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.|+|||++. .++|||||||
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~ 281 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTAC 281 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred CcccCChhhcCCCCCcHHHHHHHHH
Confidence 9999999987 3589999997
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=297.83 Aligned_cols=189 Identities=23% Similarity=0.349 Sum_probs=155.8
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+..++|++.+.||+|+||.||+|.+...+. .+..||||.+..... ...+++.+|+.++++++||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3445678999999999999999998865322 466899999875432 223678999999999999999999998
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+. ++..|+||||+++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 84 56789999999999999999766667999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+++........ ......||+.|||||++. .++|||||||
T Consensus 536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 580 (656)
T 2j0j_A 536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHH
Confidence 999876543322 122345788999999986 3589999997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=282.22 Aligned_cols=175 Identities=26% Similarity=0.385 Sum_probs=143.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
.+|++.+.||+|+||+||+|++.. +..||+|.+.... ....+|+.+++.++||||+++++++...+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 468999999999999999998764 3358888875443 12247999999999999999999996543
Q ss_pred ------eEEEEEEecCCCChHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcE
Q 020561 209 ------QRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNA 278 (324)
Q Consensus 209 ------~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~ 278 (324)
.+++|||||+++ |...+. .....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcE
Confidence 378999999764 444332 23567999999999999999999999988 99999999999998 79999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 230 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGC 230 (394)
T ss_dssp EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHH
Confidence 9999999987644332 23457899999999885 3579999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=278.62 Aligned_cols=175 Identities=25% Similarity=0.405 Sum_probs=148.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|.+.+.||+|+||.||+|.+.. +++.||||++...... ...++.+|+.+++.++||||+++++++..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 589999999999999999998875 6789999999765332 23578899999999999999999999987
Q ss_pred CCeE------EEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 DDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~~~~------~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.+.. |+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred cCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEE
Confidence 7655 99999996 68888773 34899999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCccccccccc------cceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------ALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~DiwSlGc 324 (324)
+|||+++..... .....||+.|+|||++.. ++|||||||
T Consensus 186 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (371)
T 4exu_A 186 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 230 (371)
T ss_dssp CSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHH
T ss_pred EecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHH
Confidence 999999865432 234578999999998863 589999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=297.37 Aligned_cols=178 Identities=28% Similarity=0.403 Sum_probs=145.5
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 212 (324)
+.||+|+||.||+|.+... .++..||||+++.... ...+++.+|+.+|.+|+|||||++++++.. +..+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 3799999999999976542 2467999999976432 224679999999999999999999999864 56889
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
|||||++|+|.+++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999999954 457999999999999999999999988 999999999999999999999999999876543
Q ss_pred Ccc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... .......||+.|+|||++. .++|||||||
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv 560 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 560 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHH
Confidence 321 1223345788999999987 3689999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=274.50 Aligned_cols=182 Identities=29% Similarity=0.408 Sum_probs=140.3
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
...++|++.+.||+|+||.||+|.+.. ++..||||++..... ...++.+|+..+..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 345689999999999999999998875 577999999865432 2346678888889999999999999997
Q ss_pred eCCe-------EEEEEEecCCCChHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeCCCCCCcEEEc
Q 020561 206 EDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 206 ~~~~-------~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~~~~ivHrDLkp~NILl~ 273 (324)
..+. .++||||+++ +|...+. .....+++..+..++.||+.||.||| +++ ||||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEe
Confidence 6443 7899999975 5555443 34567899999999999999999999 777 99999999999999
Q ss_pred C-CCcEEEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 274 A-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 274 ~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
. ++.+||+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence 6 89999999999987654332 23457899999999875 3579999997
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=269.20 Aligned_cols=177 Identities=29% Similarity=0.462 Sum_probs=144.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
..++|++.+.||+|+||.||+|.+. +..||||++.... ..+++.+|+.++++++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3468999999999999999999763 5689999997543 34678999999999999999999998765
Q ss_pred C-CeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 207 D-DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 207 ~-~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
. +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecc
Confidence 4 47899999999999999996533 23789999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++....... ....+++.|+|||++. .++|||||||
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 202 (278)
T 1byg_A 163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGI 202 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHH
Confidence 998654322 2235789999999986 3589999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=276.71 Aligned_cols=187 Identities=21% Similarity=0.324 Sum_probs=152.7
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcce
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVK 199 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~ 199 (324)
.++.+..++|++.+.||+|+||.||+|.+.. .||+|++..... ...+.+.+|+.++++++||||++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 93 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeE
Confidence 3334456789999999999999999998753 599999875432 22356788999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
+++++...+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+|
T Consensus 94 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCE
T ss_pred EEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEE
Confidence 999999999999999999999999999766667999999999999999999999988 99999999999998 67999
Q ss_pred EEeecccccCCCCCc---cceeeccccccCccccccccc--------------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT--------------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~---~~~~~~~~Gt~~y~aPE~l~~--------------~~DiwSlGc 324 (324)
|+|||+++....... ........||+.|+|||++.. ++|||||||
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 999999876432111 111223469999999999863 579999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=280.16 Aligned_cols=186 Identities=19% Similarity=0.220 Sum_probs=150.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcce---------
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK--------- 199 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~--------- 199 (324)
++|++.+.||+|+||.||+|++...+.. .....+..||||++... ..+.+|+.++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5799999999999999999988752110 00012678999999754 46789999999999999988
Q ss_pred ------EEEEEEe-CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 200 ------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 200 ------~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
+++++.. ....||||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6777776 78899999999 99999999754 367999999999999999999999988 999999999999
Q ss_pred EcCCC--cEEEEeecccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 272 LDADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 272 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
++.++ .+||+|||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 256 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGY 256 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHH
Confidence 99998 9999999999865432111 11233579999999999873 589999997
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=266.75 Aligned_cols=182 Identities=26% Similarity=0.382 Sum_probs=155.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 34689999999999999999998865 577999999865432 3346789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC---CcEEEE
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 281 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~~kl~ 281 (324)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 9999999999999999999988543 46899999999999999999999988 9999999999999754 469999
Q ss_pred eecccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
|||++........ .....||+.|+|||++. .++|||||||
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~ 210 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGV 210 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHH
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcCCCCCchhhHhHHH
Confidence 9999987644322 22346899999999987 3579999996
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=297.73 Aligned_cols=176 Identities=26% Similarity=0.440 Sum_probs=149.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++.+.||+|+||.||+|.+... +++.||||++..... .....+.+|+.++.+++||||+++++++..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 36899999999999999999988641 467999999865432 233568899999999999999999999987
Q ss_pred CCe-----EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 207 DDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 207 ~~~-----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
.+. .||||||+++++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ .+||+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 665 7999999999999988743 6999999999999999999999988 9999999999999875 89999
Q ss_pred eecccccCCCCCccceeeccccccCccccccccc----cceEEEecC
Q 020561 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~DiwSlGc 324 (324)
|||+++..... ....||+.|||||++.+ ++|||||||
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~ 264 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTGPTVATDIYTVGR 264 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHH
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCCCCCceehhhhHH
Confidence 99999876543 23579999999999873 579999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=268.37 Aligned_cols=181 Identities=27% Similarity=0.363 Sum_probs=136.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHH-HHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVN-FLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ...++.+|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 4689999999999999999998865 5779999999765322 2345666666 778889999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
..+..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence 9999999999997 488887742 256799999999999999999999998 8 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc---------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---------~~~DiwSlGc 324 (324)
+|||+++....... .....||+.|+|||++. .++|||||||
T Consensus 168 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 217 (327)
T 3aln_A 168 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGI 217 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHH
T ss_pred ccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHH
Confidence 99999987644321 22346999999999983 3689999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=270.50 Aligned_cols=179 Identities=25% Similarity=0.378 Sum_probs=152.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCC------CcceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL------NLVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~~~ 201 (324)
.++|++.+.||+|+||.||+|.+.. .++..||||++.... ...+.+.+|+.++..++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 4589999999999999999998742 157799999997532 2335678899998888665 499999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC------
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------ 274 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~------ 274 (324)
+++...+..++||||+ +++|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccc
Confidence 9999999999999999 899999996543 46899999999999999999999988 999999999999987
Q ss_pred -------------CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 275 -------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 275 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.+||+|||+++..... .....||+.|+|||++. .++|||||||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 222 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGC 222 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHH
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHH
Confidence 678999999999875432 22357999999999987 3589999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=273.09 Aligned_cols=181 Identities=27% Similarity=0.361 Sum_probs=147.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCC----CCCC
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDL----VHLN 196 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~Hpn 196 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.++.++ +|||
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 45689999999999999999998765 5779999999765332 223456788888888 8999
Q ss_pred cceEEEEEEeCCeEEEEEEe-cCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-C
Q 020561 197 LVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-A 274 (324)
Q Consensus 197 Iv~~~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~ 274 (324)
|+++++++...+..++|||| +.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR 175 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence 99999999999999999999 7899999999653 46999999999999999999999998 99999999999999 8
Q ss_pred CCcEEEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
++.+||+|||++....... .....||+.|+|||++. .++|||||||
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 227 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHH
Confidence 8999999999998765432 23456999999999886 2589999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=272.99 Aligned_cols=185 Identities=23% Similarity=0.333 Sum_probs=149.6
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCC--CCCcce
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV--HLNLVK 199 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~ 199 (324)
+.+..++|++.+.||+|+||.||+|.+. ++..||||++..... .....+.+|+.++.++. ||||++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence 3345578999999999999999999864 366899999975433 23467889999999997 599999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
+++++...+..++||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+|
T Consensus 93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~k 166 (313)
T 3cek_A 93 LYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLK 166 (313)
T ss_dssp EEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEE
T ss_pred EEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEE
Confidence 9999999999999999 5588999999643 57899999999999999999999988 99999999999996 48999
Q ss_pred EEeecccccCCCCCccceeeccccccCccccccccc----------------cceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------------ALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------------~~DiwSlGc 324 (324)
|+|||+++...............||+.|+|||++.. ++|||||||
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~ 227 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence 999999987654332222334579999999999864 589999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=272.69 Aligned_cols=181 Identities=24% Similarity=0.341 Sum_probs=155.1
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCC--CCCcc
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLV 198 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv 198 (324)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ...++.+|+.++.++. ||||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 45689999999999999999998765 5779999999754322 1245678999999996 59999
Q ss_pred eEEEEEEeCCeEEEEEEecCC-CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCC
Q 020561 199 KLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADY 276 (324)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~ 276 (324)
++++++...+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 999999999999999999976 899999964 357899999999999999999999988 99999999999999 789
Q ss_pred cEEEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 277 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
.+||+|||+++...... .....||+.|+|||++. .++|||||||
T Consensus 188 ~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 237 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237 (320)
T ss_dssp EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred CEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHH
Confidence 99999999998765432 23357999999999886 3469999997
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=290.03 Aligned_cols=154 Identities=19% Similarity=0.173 Sum_probs=121.8
Q ss_pred CCcEEEEEEecCCCc----------cchHHHHHHHHHHcCC-CCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccC
Q 020561 162 TGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230 (324)
Q Consensus 162 t~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~ 230 (324)
+|..||||++..... ...++|.+|+++|+++ .|+||+++++++++++..|||||||+|++|.++|.+ .
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~ 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-G 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-T
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-C
Confidence 678999999976431 1234689999999999 699999999999999999999999999999999954 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccc
Q 020561 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310 (324)
Q Consensus 231 ~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aP 310 (324)
.+++.. .|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....... .....+||+.||||
T Consensus 337 ~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAP 408 (569)
T 4azs_A 337 EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVN 408 (569)
T ss_dssp CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccH
Confidence 567654 47899999999999999 99999999999999999999999999987654322 23446899999999
Q ss_pred ccccc----cceEEEecC
Q 020561 311 EYVMT----ALELFCLKC 324 (324)
Q Consensus 311 E~l~~----~~DiwSlGc 324 (324)
|++.+ ++|+||+||
T Consensus 409 E~l~g~~~~~~d~~s~g~ 426 (569)
T 4azs_A 409 ELFAENKSWNGFWRSAPV 426 (569)
T ss_dssp HHC---------------
T ss_pred HHhCCCCCCccccccccc
Confidence 99984 579999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.70 Aligned_cols=175 Identities=25% Similarity=0.402 Sum_probs=147.6
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|.+.+.||+|+||.||+|.+.. +|..||||++...... ...++.+|+.+++.++||||+++++++..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence 579999999999999999998865 6789999999764322 23568899999999999999999999987
Q ss_pred CCe------EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 DDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.+. .|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred ccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 654 499999996 68888773 35899999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|||+++..... .....||+.|+|||++. .++|||||||
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHH
T ss_pred eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHH
Confidence 999999865432 23357899999999876 3589999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=270.26 Aligned_cols=176 Identities=24% Similarity=0.312 Sum_probs=129.7
Q ss_pred hcCCCCCc-eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHH-HHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-NFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+ +||+|+||.||+|++.. +++.||||++... ....+|+ ..+..+.||||+++++++.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence 45788854 69999999999998875 5779999999653 2222333 3456678999999999987
Q ss_pred e----CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCc
Q 020561 206 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (324)
Q Consensus 206 ~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~ 277 (324)
. ....+||||||++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCC
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCce
Confidence 6 455899999999999999997543 47999999999999999999999988 999999999999976 455
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...... .....||+.|+|||++. .++|||||||
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 217 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHH
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHH
Confidence 9999999998764322 23357899999999986 3589999997
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.92 Aligned_cols=183 Identities=31% Similarity=0.431 Sum_probs=151.2
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCC---CCCCcceEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLI 201 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~~~ 201 (324)
..++|++.+.||+|+||.||+|++... +++.||||++..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 346899999999999999999987521 467999999864322 1224567788777666 899999999
Q ss_pred EEEE-----eCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC
Q 020561 202 GYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (324)
Q Consensus 202 ~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~ 275 (324)
+++. .....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 156 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence 9987 4567899999997 69999996543 45899999999999999999999988 9999999999999999
Q ss_pred CcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 276 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.+||+|||+++...... ......||+.|+|||++. .++|||||||
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 207 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 207 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHH
Confidence 999999999998764322 133457999999999986 4589999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=280.76 Aligned_cols=179 Identities=25% Similarity=0.372 Sum_probs=142.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 207 (324)
.+|.+.++||+|+||+||..... +++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 46888899999999996543222 467999999975432 3456899999999 799999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-----CCcEEEEe
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLSD 282 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~~kl~D 282 (324)
...|||||||. |+|.+++......+.+..++.++.||+.||.|||+++ ||||||||+|||++. ...+||+|
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 99999999995 6999999776666666677899999999999999988 999999999999943 33588999
Q ss_pred ecccccCCCCCcc-ceeeccccccCccccccccc--------cceEEEecC
Q 020561 283 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT--------ALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~--------~~DiwSlGc 324 (324)
||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~ 217 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHH
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHH
Confidence 9999876543211 12344679999999999862 589999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=272.37 Aligned_cols=181 Identities=24% Similarity=0.311 Sum_probs=150.8
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CC-----CcceE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL-----NLVKL 200 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~~ 200 (324)
..++|++.+.||+|+||+||+|.+.. +++.||||++.... ....++.+|+.++..+. |+ +|+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 34689999999999999999998765 57799999997532 22356778888888775 44 49999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc--CCCc
Q 020561 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYN 277 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~ 277 (324)
++++...+..+|||||++ ++|.+++.... ..+++..+..++.||+.||.|||++. .+||||||||+|||++ .++.
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCc
Confidence 999999999999999995 59999997543 56999999999999999999999532 3499999999999994 5788
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++..... .....||+.|+|||++. .++|||||||
T Consensus 200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 246 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246 (382)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHH
Confidence 999999999876442 22357999999999987 3589999997
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=264.64 Aligned_cols=181 Identities=28% Similarity=0.376 Sum_probs=137.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-hHH-HHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKE-WLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-~~~-~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++.+.||+|+||.||+|.+.. +++.||||++....... ..+ +..+..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 4578899999999999999998875 57799999997654322 223 444556788899999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
..+..++||||+ ++.+..++......+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999 5566666555567899999999999999999999995 7 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
++........ .....||+.|+|||++. .++|||||||
T Consensus 171 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 217 (318)
T 2dyl_A 171 ISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHH
T ss_pred CchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHH
Confidence 9976544321 23356999999999984 2589999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=267.96 Aligned_cols=179 Identities=23% Similarity=0.351 Sum_probs=150.9
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC------cceEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKLI 201 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~~~ 201 (324)
.++|++.+.||+|+||.||+|.+... .+..||||++.... .....+.+|+.+++.+.|++ |+.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 46899999999999999999987652 23689999997542 23456788999999887665 99999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEE--------
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-------- 272 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl-------- 272 (324)
+++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccc
Confidence 9999999999999999 677777775543 57999999999999999999999988 9999999999999
Q ss_pred -----------cCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 273 -----------DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 273 -----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+.++.+||+|||+++..... .....||+.|+|||++. .++|||||||
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 227 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred ccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHH
Confidence 56889999999999875432 23357999999999986 4589999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=271.50 Aligned_cols=178 Identities=21% Similarity=0.279 Sum_probs=150.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-----------CCC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLN 196 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpn 196 (324)
..+|++.+.||+|+||.||+|++.. ++..||||++.... .....+.+|+.++.++. |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3589999999999999999998765 57799999997542 22356788999998886 899
Q ss_pred cceEEEEEEeCC----eEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCcE
Q 020561 197 LVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNI 270 (324)
Q Consensus 197 Iv~~~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~ivHrDLkp~NI 270 (324)
|+++++++...+ ..++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ + ||||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999999988654 789999999 89999999653 35699999999999999999999997 7 99999999999
Q ss_pred EEc------CCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 271 LLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 271 Ll~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|++ ..+.+||+|||++...... .....||+.|+|||++. .++|||||||
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 223 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 223 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHH
Confidence 994 4458999999999876432 22357999999999986 3589999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=287.31 Aligned_cols=181 Identities=28% Similarity=0.418 Sum_probs=152.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
++|++.+.||+|+||.||+|.+.. +|..||||++.... ....+++.+|+.++.+++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 589999999999999999997664 57799999987643 2234578999999999999999999998765
Q ss_pred -----CCeEEEEEEecCCCChHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc--
Q 020561 207 -----DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 277 (324)
Q Consensus 207 -----~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-- 277 (324)
.+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 667899999999999999996533 36899999999999999999999988 999999999999987665
Q ss_pred -EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 -~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||++........ .....||+.|+|||++. .++|||||||
T Consensus 162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv 211 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211 (676)
T ss_dssp EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence 99999999987654332 23467999999999987 3689999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=273.46 Aligned_cols=178 Identities=26% Similarity=0.336 Sum_probs=136.0
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-CCCCcceEEEEEEeCC
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDD 208 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 208 (324)
.|...++||+|+||+||.+... +|+.||||++.... .+.+.+|+.+|.++ +||||+++++++.+.+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred eeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 3555688999999999865332 47799999986532 35678999999876 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCC-------
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------- 275 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~------- 275 (324)
..|||||||. |+|.+++...... .++..++.++.||+.||.|||+++ ||||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccccccc
Confidence 9999999995 6999999653321 123345779999999999999988 9999999999999654
Q ss_pred ------CcEEEEeecccccCCCCCcc--ceeeccccccCccccccccc------------cceEEEecC
Q 020561 276 ------YNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT------------ALELFCLKC 324 (324)
Q Consensus 276 ------~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~------------~~DiwSlGc 324 (324)
+.+||+|||+++........ .......||+.|+|||++.. ++|||||||
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~ 227 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHH
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHH
Confidence 48999999999976543221 11234579999999999853 489999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=250.87 Aligned_cols=157 Identities=13% Similarity=0.036 Sum_probs=136.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|++.. +++.||||++....... .+++.+|+.++.+++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 579999999999999999998865 67899999997654332 357899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
..+..||||||+++++|.+++.+ . .....+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred ECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-
Confidence 99999999999999999999943 2 355678899999999999999988 9999999999999999999997443
Q ss_pred cccCCCCCccceeeccccccCccccccccccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~DiwSlGc 324 (324)
|++| ...++|||||||
T Consensus 175 ---------------------~~~~--~~~~~Di~slG~ 190 (286)
T 3uqc_A 175 ---------------------TMPD--ANPQDDIRGIGA 190 (286)
T ss_dssp ---------------------CCTT--CCHHHHHHHHHH
T ss_pred ---------------------ccCC--CCchhHHHHHHH
Confidence 4444 356789999997
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=246.35 Aligned_cols=160 Identities=22% Similarity=0.290 Sum_probs=137.3
Q ss_pred cCCCCC-ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHH-cCCCCCCcceEEEEEEe
Q 020561 129 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~~~~~~~~ 206 (324)
.+|.+. ++||+|+||.||+|.+.. +++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 467776 789999999999998865 5779999999642 5677899888 66689999999999987
Q ss_pred ----CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCcE
Q 020561 207 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 278 (324)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~ 278 (324)
....+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence 677899999999999999997543 47999999999999999999999988 999999999999987 7899
Q ss_pred EEEeecccccCCCCCccceeeccccccCccccccccccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~DiwSlGc 324 (324)
||+|||++..... +....++|||||||
T Consensus 160 kl~Dfg~a~~~~~-------------------~~~~~~~DiwslG~ 186 (299)
T 3m2w_A 160 KLTDFGFAKETTG-------------------EKYDKSCDMWSLGV 186 (299)
T ss_dssp EECCCTTCEECTT-------------------CGGGGHHHHHHHHH
T ss_pred EEecccccccccc-------------------ccCCchhhHHHHHH
Confidence 9999999876432 12345789999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=263.88 Aligned_cols=177 Identities=21% Similarity=0.224 Sum_probs=136.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---chHHHHHHHHHHcCCCC-CCcc------
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVH-LNLV------ 198 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H-pnIv------ 198 (324)
.+|...++||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+.++..|.| +|+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457778899999999999999875 5779999999744322 24678999999999987 2211
Q ss_pred ---------------eEEEEEEe-----CCeEEEEEEecCCCChHHHHh------ccCCCCCHHHHHHHHHHHHHHHHHH
Q 020561 199 ---------------KLIGYCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAFL 252 (324)
Q Consensus 199 ---------------~~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~qi~~gL~yL 252 (324)
.+..++.. ....+++|+++ +++|.+++. .....+++..++.++.||+.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 11111111 12357777776 789999884 2234578889999999999999999
Q ss_pred HhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCccccccc----------c-----ccc
Q 020561 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------M-----TAL 317 (324)
Q Consensus 253 H~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l----------~-----~~~ 317 (324)
|+++ ||||||||+||||+.++.+||+|||+++..... ....+| +.|||||++ . .++
T Consensus 228 H~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 9988 999999999999999999999999999875432 334578 999999998 3 268
Q ss_pred eEEEecC
Q 020561 318 ELFCLKC 324 (324)
Q Consensus 318 DiwSlGc 324 (324)
|||||||
T Consensus 299 DvwSlGv 305 (413)
T 3dzo_A 299 DTWTLGL 305 (413)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 9999997
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=259.38 Aligned_cols=166 Identities=18% Similarity=0.249 Sum_probs=127.4
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------hHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
...++||+|+||.||+|.. .+..+++|......... .+++.+|+.+|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 3456899999999999944 35689999875433211 2457899999999999999966666
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+...+..|||||||++++|.+++.. ++.++.||+.||+|||+++ ||||||||+|||++. .+||+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEEC
Confidence 6677788999999999999999854 5689999999999999988 999999999999998 9999999
Q ss_pred cccccCCCCCccc-----eeeccccccCccccccccc-------cceEEEe
Q 020561 284 GLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT-------ALELFCL 322 (324)
Q Consensus 284 Gla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~-------~~DiwSl 322 (324)
|+++......... .....+||+.|||||++.. .+|+||.
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~ 524 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEI 524 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHH
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHH
Confidence 9999875532211 1235689999999999973 4688874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=211.34 Aligned_cols=146 Identities=14% Similarity=0.062 Sum_probs=116.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------------------chHHHHHHHHHH
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFL 189 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------------------~~~~~~~E~~~l 189 (324)
...|.+++.||+|+||.||+|.+ . +|..||||.+...... ....+.+|+.+|
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred CeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 34577779999999999999988 3 5779999999653211 234688999999
Q ss_pred cCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 020561 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (324)
Q Consensus 190 ~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~N 269 (324)
++++| +++.+++. .+..|+||||+++++|.+ +.. .....++.||+.||.|||+.+ ||||||||+|
T Consensus 159 ~~l~~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 159 QKLQG---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp HHTTT---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred HhccC---CCcCeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 99984 45555443 355699999999999988 421 224479999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc
Q 020561 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314 (324)
Q Consensus 270 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~ 314 (324)
||++ ++.+||+|||+|+. +..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999 99999999999864 34578888875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=189.90 Aligned_cols=139 Identities=17% Similarity=0.047 Sum_probs=107.2
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcE--EEEEEecCCCccc------------------------hHHHHH
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDGLQG------------------------HKEWLA 184 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~--vavK~~~~~~~~~------------------------~~~~~~ 184 (324)
|++.+.||+|+||.||+|.+.. +|.. ||||+++...... ...+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 5678899999999999998743 4668 9999875432110 125788
Q ss_pred HHHHHcCCCCCCc--ceEEEEEEeCCeEEEEEEecCC-C----ChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hcC
Q 020561 185 EVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEA 256 (324)
Q Consensus 185 E~~~l~~l~HpnI--v~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~ 256 (324)
|+.+|..|.|++| +.++.+ +..+|||||+.+ | +|.+++.. .++..+..++.||+.||.||| +.+
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988754 444442 356899999942 3 67666532 234567889999999999999 888
Q ss_pred CCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 257 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
||||||||+|||++. .++|+|||+|.....
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999999988 999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.6e-21 Score=176.59 Aligned_cols=139 Identities=13% Similarity=0.072 Sum_probs=99.7
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------chHH--------HHHHHH
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKE--------WLAEVN 187 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--------------~~~~--------~~~E~~ 187 (324)
-|+++..||+|+||.||+|... +|+.||||+++..... .... ..+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 3899999999999999999864 4779999987542110 0011 234666
Q ss_pred HHcCCCCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 020561 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (324)
Q Consensus 188 ~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp 267 (324)
.|.+|.+.++.-..-+... ..+|||||++|++|.++.. . .....++.||+.+|.|||.++ ||||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 6766654443222111112 2379999999988876542 1 224567899999999999988 99999999
Q ss_pred CcEEEcCCC----------cEEEEeecccccCC
Q 020561 268 SNILLDADY----------NAKLSDFGLAKDGP 290 (324)
Q Consensus 268 ~NILl~~~~----------~~kl~DFGla~~~~ 290 (324)
.|||++.++ .+.|+||+-+....
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999998776 38999999876644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=9.5e-15 Score=128.07 Aligned_cols=144 Identities=15% Similarity=0.006 Sum_probs=112.3
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 206 (324)
...|++...++.|+++.||++... +..+++|+..........++.+|+.+++.|. +..+.++++++..
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 356877888888999999998632 4589999987532222356889999998885 6788899999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------ 256 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------ 256 (324)
.+..|+||||++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 999999999999999987641 11223467889999999999811
Q ss_pred --------------------------CCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 257 --------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 257 --------------------------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
...++|+|++|.|||++.+..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13389999999999998766667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=9.2e-13 Score=114.71 Aligned_cols=130 Identities=18% Similarity=0.056 Sum_probs=96.0
Q ss_pred cCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC--cceEEEEEEeCCeEEEEEE
Q 020561 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYE 215 (324)
Q Consensus 138 G~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~~~~~~lv~E 215 (324)
+.|..+.||++... +|..+++|+.... ....+.+|+.+++.|.+.+ +.+++++....+..++|||
T Consensus 29 ~gg~~~~v~~~~~~----------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQ----------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp CTTSSCEEEEEECT----------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCCceEEEEecC----------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 45666999998543 3557999997654 2245778999988886444 5678888888888999999
Q ss_pred ecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 020561 216 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------------- 256 (324)
Q Consensus 216 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------------------- 256 (324)
|++|.+|. ... .. ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998884 211 12 2256777888888888643
Q ss_pred ----------------CCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 257 ----------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 257 ----------------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
...++|+|++|.|||++.++.+.|+||+.+...
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999987766779999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.3e-12 Score=117.16 Aligned_cols=142 Identities=15% Similarity=0.195 Sum_probs=105.9
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEec--CCC-ccchHHHHHHHHHHcCCC--CCCcceEEEEEEeC
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDG-LQGHKEWLAEVNFLGDLV--HLNLVKLIGYCIED 207 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~ 207 (324)
.++.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567899999999998653 3478888775 332 122346788999998887 46688999988776
Q ss_pred ---CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 020561 208 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------- 256 (324)
Q Consensus 208 ---~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---------------------------- 256 (324)
+..|+||||++|..|.+.. ...++......++.+++..|..||...
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 4589999999998875422 124678888899999999999999831
Q ss_pred ---------------------------CCCeEeCCCCCCcEEEcCCCc--EEEEeeccccc
Q 020561 257 ---------------------------ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKD 288 (324)
Q Consensus 257 ---------------------------~~~ivHrDLkp~NILl~~~~~--~kl~DFGla~~ 288 (324)
...+||+|++|.|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987653 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.6e-09 Score=96.88 Aligned_cols=137 Identities=22% Similarity=0.228 Sum_probs=100.1
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCC--cceEEEEEEeCC--
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLN--LVKLIGYCIEDD-- 208 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~~~~~~~~~~-- 208 (324)
++.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.|. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 4679999999999852 36889986532 23457889999998773 332 455555543333
Q ss_pred -eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 020561 209 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 256 (324)
Q Consensus 209 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------- 256 (324)
..|+||++++|.+|..... ..++..+...++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3589999999988875432 24677788888889999998888621
Q ss_pred ------------------------CCCeEeCCCCCCcEEEcC--CCcEEEEeecccccC
Q 020561 257 ------------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDG 289 (324)
Q Consensus 257 ------------------------~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~~ 289 (324)
...++|+|++|.|||++. ...+.|+||+.+...
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 134899999999999988 556889999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=4e-08 Score=87.93 Aligned_cols=137 Identities=20% Similarity=0.151 Sum_probs=95.1
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCC---CcceEEEEEE-eCCe
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCI-EDDQ 209 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~~~~~~~-~~~~ 209 (324)
++.++.|....||+. +..+++|+... ......+.+|+.+|..|.+. .+.+++.++. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 457888999999986 23588887532 12235788999999988642 3667777664 4456
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 020561 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------- 256 (324)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------------- 256 (324)
.|+||||++|.+|..... ..++......++.++...|..||+..
T Consensus 88 ~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 789999999988876321 12345555555566666665555422
Q ss_pred ------------------------CCCeEeCCCCCCcEEEcC---CCc-EEEEeecccccC
Q 020561 257 ------------------------ERPVIYRDFKTSNILLDA---DYN-AKLSDFGLAKDG 289 (324)
Q Consensus 257 ------------------------~~~ivHrDLkp~NILl~~---~~~-~kl~DFGla~~~ 289 (324)
+..++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 224799999999999987 455 489999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=3.7e-08 Score=86.12 Aligned_cols=137 Identities=17% Similarity=0.079 Sum_probs=96.2
Q ss_pred eecCCCce-EEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEEE
Q 020561 136 LLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 136 ~lG~G~fg-~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 213 (324)
.+..|..+ .||+..... .+..+++|+-... ....+.+|..+|+.|. +--+.++++++.+.+..|+|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 44555554 689865543 2447889976532 2356788998887774 34477889999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 020561 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------------- 256 (324)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------------- 256 (324)
||+++|.++.+.... .......+..+++..|.-||...
T Consensus 99 me~l~G~~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 999999888776532 11223345566666666666421
Q ss_pred ------------------CCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 257 ------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 257 ------------------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..-++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 012799999999999998777789999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=6.4e-08 Score=88.24 Aligned_cols=84 Identities=4% Similarity=-0.060 Sum_probs=54.5
Q ss_pred cee-cCCCceEEEEEEEc--cCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCC-C--CCcceEEEEEE
Q 020561 135 SLL-GEGGFGCVFKGWIE--ENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLV-H--LNLVKLIGYCI 205 (324)
Q Consensus 135 ~~l-G~G~fg~Vy~~~~~--~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~~~~~~~ 205 (324)
+.| +.|....+|+.... .++. ..+..+++|+..... ......+.+|+.+++.|. + ..+.+++.++.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 567 88889999987643 0000 014478888765432 111245778888888774 2 35778888776
Q ss_pred eC---CeEEEEEEecCCCChH
Q 020561 206 ED---DQRLLVYEFMPRGSLE 223 (324)
Q Consensus 206 ~~---~~~~lv~E~~~~gsL~ 223 (324)
+. +..|+||||++|..|.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 54 3568999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=2.5e-07 Score=85.68 Aligned_cols=76 Identities=13% Similarity=0.045 Sum_probs=49.5
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------cchHHHHHHHHHHcCCCC--C-CcceEEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVH--L-NLVKLIGY 203 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--p-nIv~~~~~ 203 (324)
.+.||.|.++.||++.... .+..|+||....... ....++..|.++|..+.. | .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4679999999999996543 245899998653211 123456788888877632 3 34466654
Q ss_pred EEeCCeEEEEEEecCCC
Q 020561 204 CIEDDQRLLVYEFMPRG 220 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~g 220 (324)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 345568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-06 Score=78.78 Aligned_cols=140 Identities=15% Similarity=0.176 Sum_probs=79.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCC-----CCCCcceEE-E--EEEe
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-----VHLNLVKLI-G--YCIE 206 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~-~--~~~~ 206 (324)
+.|+.|..+.||+.... +..+++|+.... ..++..|+.++..| ..|.++... + +...
T Consensus 38 ~~l~gG~~n~~~~v~~~-----------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~ 102 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH 102 (346)
T ss_dssp EECC----CEEEEEEET-----------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred eeccccccCcEEEEEeC-----------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence 45666778999998653 225899998752 23344455555443 235444311 0 1234
Q ss_pred CCeEEEEEEecCCCChH--------------HHHhc--cCC--C---------CCHHHH---------------------
Q 020561 207 DDQRLLVYEFMPRGSLE--------------NHLFR--RSL--P---------LPWSIR--------------------- 238 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~--------------~~l~~--~~~--~---------l~~~~~--------------------- 238 (324)
.+..++||+|++|..+. ..|+. ... + ..|...
T Consensus 103 ~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 182 (346)
T 2q83_A 103 GSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKED 182 (346)
T ss_dssp TTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred CCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCC
Confidence 67789999999986542 11111 100 0 112110
Q ss_pred ----------HHHHHHHHHHHHHHHh----------cCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 239 ----------MKIALGAAKGLAFLHE----------EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 239 ----------~~i~~qi~~gL~yLH~----------~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..+..++..++++|+. ..+..+||+|+.+.|||++.++.+.|+||+.+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 183 PFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 0111224445667763 12345999999999999988889999999988653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.14 E-value=1e-05 Score=72.43 Aligned_cols=136 Identities=15% Similarity=0.118 Sum_probs=89.2
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC---CCCcceEEEEEEeCCeE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 210 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~ 210 (324)
.+.|+.|.+..+|+.... +..+++|+.... ....+.+|...|+.|. ...+.+++.++...+..
T Consensus 41 ~~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-----------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEESS-----------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEEC-----------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 457899999999997642 447889987543 2456788988888774 36788899988888889
Q ss_pred EEEEEecCCCChH--------H---HHhccCC--C-------------------CCHHHHH---HHH-------------
Q 020561 211 LLVYEFMPRGSLE--------N---HLFRRSL--P-------------------LPWSIRM---KIA------------- 242 (324)
Q Consensus 211 ~lv~E~~~~gsL~--------~---~l~~~~~--~-------------------l~~~~~~---~i~------------- 242 (324)
|+||||+++..+. . .|+.... . -+|.... ++.
T Consensus 107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~ 186 (312)
T 3jr1_A 107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF 186 (312)
T ss_dssp EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence 9999999987642 1 1222111 0 1343321 111
Q ss_pred ---HHHHHHH-HHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 243 ---LGAAKGL-AFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 243 ---~qi~~gL-~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+++..+ ..|.. .....+||+|+.+.||+++.++ +.|.||.
T Consensus 187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111122 23422 1234599999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.05 E-value=2e-05 Score=69.51 Aligned_cols=79 Identities=19% Similarity=0.139 Sum_probs=55.2
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC---CCCcceEEEEEEe
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIE 206 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~ 206 (324)
...-++.+|.|..+.||+....+ |+.|.+|+...........+.+|+..|+.|. -.-+.+++++.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D----------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD----------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT----------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred CeEEEEecCCCCCeEEEEEEECC----------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence 34445779999999999998763 6789999876554443456788988887764 22355666542
Q ss_pred CCeEEEEEEecCCCCh
Q 020561 207 DDQRLLVYEFMPRGSL 222 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL 222 (324)
. .++||||++++..
T Consensus 84 ~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 D--RTLAMEWVDERPP 97 (288)
T ss_dssp T--TEEEEECCCCCCC
T ss_pred C--ceEEEEeecccCC
Confidence 2 4789999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.6e-05 Score=74.11 Aligned_cols=31 Identities=19% Similarity=0.341 Sum_probs=27.3
Q ss_pred CCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 258 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..++|+|++|.|||++.++ +.|+||+.+...
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 4499999999999998776 999999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.78 E-value=6.5e-05 Score=67.05 Aligned_cols=141 Identities=13% Similarity=0.123 Sum_probs=77.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-----CCCcceEE-E--EEEe
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----HLNLVKLI-G--YCIE 206 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~~~-~--~~~~ 206 (324)
+.|+.|....+|+..... + .+++|+..... ...++..|+.++..|. -|.++... + +...
T Consensus 28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 456778888999986532 2 58899886531 1234566777766553 23333211 0 1123
Q ss_pred CCeEEEEEEecCCCChHH--------------HHhcc--C--CC----CC---HHHHHH------------HHHHHHHHH
Q 020561 207 DDQRLLVYEFMPRGSLEN--------------HLFRR--S--LP----LP---WSIRMK------------IALGAAKGL 249 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~--------------~l~~~--~--~~----l~---~~~~~~------------i~~qi~~gL 249 (324)
.+..+++|+|++|..+.. .++.. . .+ .. |...+. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 466799999998865321 11111 1 01 11 111000 011234455
Q ss_pred HHHHhc----CCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 250 AFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 250 ~yLH~~----~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
+++... .+..+||+|+.+.|||++.+..+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 666532 123599999999999998876668999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.66 E-value=6.7e-05 Score=66.49 Aligned_cols=136 Identities=10% Similarity=0.066 Sum_probs=74.5
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCc-ceEEEEEEeCCeEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~l 212 (324)
++.|+.|....+|+. . .+++|+....... .....+|+.+++.+....+ .+++++ +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE--T-------------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee--e-------------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 678999999999998 1 5888887643211 1123467777766542222 455554 3434578
Q ss_pred EEEec-CCCChHHH------------------HhccCCCCC-----HHHHHHHHH--------------HHHHHHH----
Q 020561 213 VYEFM-PRGSLENH------------------LFRRSLPLP-----WSIRMKIAL--------------GAAKGLA---- 250 (324)
Q Consensus 213 v~E~~-~~gsL~~~------------------l~~~~~~l~-----~~~~~~i~~--------------qi~~gL~---- 250 (324)
|+||+ ++.+|... |+.....++ +.....+.. .+...+.
T Consensus 85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 99999 66544310 111111111 111111110 0111111
Q ss_pred HHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 251 FLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 251 yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.|.. ..+..++|+|+.|.||| ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1111 12234899999999999 5667889999988765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00022 Score=63.72 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=78.3
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC--CCcceEEEE-----EEeC
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGY-----CIED 207 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~-----~~~~ 207 (324)
..|+ |....||+.... .|..+++|....... ....+..|..++..|.. -.+++++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 4576 778899986432 245799999864321 23566678777766641 123333332 2235
Q ss_pred CeEEEEEEecCCCChH-----H------H---Hhc--cC------CCCCHHHH----HHH---------------HHHHH
Q 020561 208 DQRLLVYEFMPRGSLE-----N------H---LFR--RS------LPLPWSIR----MKI---------------ALGAA 246 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~-----~------~---l~~--~~------~~l~~~~~----~~i---------------~~qi~ 246 (324)
+..+++|+|++|..+. . . ++. .. ..+++... ..+ ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 6678999999875432 1 1 111 00 11121111 001 01111
Q ss_pred HHHHHHHhc----CCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 247 KGLAFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 247 ~gL~yLH~~----~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..++.+... .+..++|+|+++.|||++ + .+.|+||+.+...
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 123333221 234489999999999998 4 8999999887653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00036 Score=62.54 Aligned_cols=32 Identities=31% Similarity=0.378 Sum_probs=27.7
Q ss_pred CCeEeCCCCCCcEEEcCC----CcEEEEeecccccC
Q 020561 258 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDG 289 (324)
Q Consensus 258 ~~ivHrDLkp~NILl~~~----~~~kl~DFGla~~~ 289 (324)
..+||+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999874 68999999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00054 Score=64.49 Aligned_cols=75 Identities=13% Similarity=0.011 Sum_probs=46.1
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCc-ceEEEEEEeCCeEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~l 212 (324)
++.|+.|-...+|+..... .+..+++|+....... .-.-.+|..++..|...++ .++++++ .+ .+
T Consensus 113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EE
T ss_pred EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eE
Confidence 3568888889999987642 2357889987543211 1112578888887764444 5677766 23 35
Q ss_pred EEEecCCCCh
Q 020561 213 VYEFMPRGSL 222 (324)
Q Consensus 213 v~E~~~~gsL 222 (324)
||||++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00016 Score=67.48 Aligned_cols=81 Identities=17% Similarity=0.085 Sum_probs=49.8
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC-cceEEEEEEeCCeEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 212 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~l 212 (324)
++.|+.|-...||+......... ....+..+++|+..... ....+.+|..++..|...+ ..++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 35688888899999876421000 00124588999884321 1245667888888775333 356776553 2 38
Q ss_pred EEEecCCCCh
Q 020561 213 VYEFMPRGSL 222 (324)
Q Consensus 213 v~E~~~~gsL 222 (324)
||||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00038 Score=63.90 Aligned_cols=148 Identities=14% Similarity=0.111 Sum_probs=82.2
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l 212 (324)
++.|..|-...+|+........ .....+..+++|+.... ........+|..+++.|. +.-..++++++. + .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--cc
Confidence 3567778888999987642100 00012468899986332 223455678998887774 322356666553 3 39
Q ss_pred EEEecCCCChHH--------------H---HhccCC----CCC--HHHHHHHHHHHHH-------------------HHH
Q 020561 213 VYEFMPRGSLEN--------------H---LFRRSL----PLP--WSIRMKIALGAAK-------------------GLA 250 (324)
Q Consensus 213 v~E~~~~gsL~~--------------~---l~~~~~----~l~--~~~~~~i~~qi~~-------------------gL~ 250 (324)
||||++|.+|.. . |+.... ... +.+..++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998855431 1 111111 111 3444455444321 233
Q ss_pred HHH----hc-CCCCeEeCCCCCCcEEEcCC----CcEEEEeeccccc
Q 020561 251 FLH----EE-AERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 288 (324)
Q Consensus 251 yLH----~~-~~~~ivHrDLkp~NILl~~~----~~~kl~DFGla~~ 288 (324)
.|. .. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 21 12348999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0006 Score=62.08 Aligned_cols=82 Identities=10% Similarity=0.032 Sum_probs=43.6
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC-cceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~lv 213 (324)
..|+.|....+|+......+. ...+..+..+++|+...... .......|..++..|...+ +.++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 467788888999987542100 00001135788887754321 1112356777777764323 44666544 2 2789
Q ss_pred EEecCCCCh
Q 020561 214 YEFMPRGSL 222 (324)
Q Consensus 214 ~E~~~~gsL 222 (324)
|||++|..|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0056 Score=55.05 Aligned_cols=32 Identities=13% Similarity=0.153 Sum_probs=27.9
Q ss_pred CCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 258 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45999999999999988888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.023 Score=52.73 Aligned_cols=81 Identities=11% Similarity=-0.005 Sum_probs=46.9
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 213 (324)
+.|..|-...+|+......... .+..+..+++|+..... ...-...+|..+++.|. +.-..++++.+ .+ ++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 5677788889999876531110 00124689999865432 11112356777777764 22245566533 22 789
Q ss_pred EEecCCCCh
Q 020561 214 YEFMPRGSL 222 (324)
Q Consensus 214 ~E~~~~gsL 222 (324)
|||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.22 E-value=0.039 Score=50.73 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=24.9
Q ss_pred eEeCCCCCCcEEE------cCCCcEEEEeeccccc
Q 020561 260 VIYRDFKTSNILL------DADYNAKLSDFGLAKD 288 (324)
Q Consensus 260 ivHrDLkp~NILl------~~~~~~kl~DFGla~~ 288 (324)
++|+|+.+.|||+ +.+..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.07 E-value=0.23 Score=41.49 Aligned_cols=86 Identities=8% Similarity=0.015 Sum_probs=62.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeCCCCCCcEE
Q 020561 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 193 ~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~~~~ivHrDLkp~NIL 271 (324)
.||++ -..+-.+++.+.|.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 58888 334446677777777765343223334 24788899999988887766 5554 678889999999
Q ss_pred EcCCCcEEEEeecccccC
Q 020561 272 LDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~ 289 (324)
++.++.++|.-.|+-..+
T Consensus 117 f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL 134 (219)
T ss_dssp ECTTCCEEESCCEETTTB
T ss_pred EeCCCcEEEEEcCCcccC
Confidence 999999999999886554
|
| >2khx_A Ribonuclease 3; drosha, RNA binding domain, hydrolase, gene regulation, NUCL protein, gene regulation,nuclear protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.31 E-value=0.026 Score=39.84 Aligned_cols=27 Identities=15% Similarity=-0.077 Sum_probs=23.9
Q ss_pred cccccccccccchhhhhhccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
++.|+.|.|++|++|+|.||+.+.+.+
T Consensus 48 g~~~~~G~G~SKK~AEq~AA~~AL~~L 74 (85)
T 2khx_A 48 GERIGCGKGPSIQQAEMGAAMDALEKY 74 (85)
T ss_dssp TEECCCEEESSHHHHHHHHHHHHHTTC
T ss_pred CEEEEEEeeCCHHHHHHHHHHHHHHHH
Confidence 357899999999999999999888766
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.23 E-value=0.19 Score=41.86 Aligned_cols=95 Identities=8% Similarity=0.012 Sum_probs=67.5
Q ss_pred HHHHHcCCCCCCcceEEEEEEeCCeEEEEEEecCC-CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeC
Q 020561 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (324)
Q Consensus 185 E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHr 263 (324)
|+.+|. ..||+++.. .+-.+++.+.|.++.-+. -++.. + ..++...+++++.+|+....+++. =+|-
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 444443 368988876 456666766666665432 23322 3 357889999999999888766654 5788
Q ss_pred CCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 264 DFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 264 DLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
-|.|+||+++.++.++|.--|+-..+++
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVVDP 131 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTBSC
T ss_pred EEecceEEEcCCCCEEEEEccCccCCCC
Confidence 8999999999999999999988654433
|
| >1x49_A Interferon-induced, double-stranded RNA- activated protein kinase; structure genomics, DSRM domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=91.12 E-value=0.037 Score=40.07 Aligned_cols=28 Identities=18% Similarity=0.095 Sum_probs=24.9
Q ss_pred cccccccccccchhhhhhcccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
.+.|+.|.|++|++|+|.||+.+.+.+.
T Consensus 55 g~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 82 (97)
T 1x49_A 55 EKEFPEAKGRSKQEARNAAAKLAVDILD 82 (97)
T ss_dssp SCCCCCEEESSHHHHHHHHHHHHHHHHT
T ss_pred CEEEEEEeeCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999988774
|
| >3adj_A F21M12.9 protein; HYL1, miRNA processing, RNA binding protein, gene regulation; 3.00A {Arabidopsis thaliana} PDB: 2l2m_A | Back alignment and structure |
|---|
Probab=90.48 E-value=0.043 Score=37.71 Aligned_cols=27 Identities=11% Similarity=-0.031 Sum_probs=23.3
Q ss_pred cccccccccccchhhhhhccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
++.|+.|.|++|++|+|.||+.+.+.+
T Consensus 46 g~~~~~G~G~sKK~Aeq~AA~~al~~L 72 (76)
T 3adj_A 46 GIKYTGAATRTKKDAEISAGRTALLAI 72 (76)
T ss_dssp TEEEECCCBSSHHHHHHHHHHHHHHHH
T ss_pred CEEEEEeccCCHHHHHHHHHHHHHHHH
Confidence 356899999999999999999887655
|
| >1x48_A Interferon-induced, double-stranded RNA- activated protein kinase; structure genomics, DSRM domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=90.28 E-value=0.038 Score=39.21 Aligned_cols=29 Identities=14% Similarity=0.040 Sum_probs=25.2
Q ss_pred cccccccccccchhhhhhccccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVEVE 36 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 36 (324)
.+.|+.|.|++|++|+|.||+.+.+.+..
T Consensus 46 g~~~~~G~G~SKK~Aeq~AA~~AL~~L~~ 74 (88)
T 1x48_A 46 QTMYGTGSGVTKQEAKQLAAKEAYQKLLK 74 (88)
T ss_dssp SCEEEEEEESSHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEeecCCHHHHHHHHHHHHHHHHHh
Confidence 45789999999999999999999887743
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.18 E-value=0.045 Score=51.38 Aligned_cols=63 Identities=8% Similarity=0.087 Sum_probs=18.2
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEE------EEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV------KTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vav------K~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+.+.|| ||.||+|.+... ..+||| |........ ....+.+|..++..++|||+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4456676 999999988641 236777 665543221 22457889999999999999999887
Q ss_pred EEe
Q 020561 204 CIE 206 (324)
Q Consensus 204 ~~~ 206 (324)
...
T Consensus 213 ~~~ 215 (463)
T 3cxl_A 213 KVH 215 (463)
T ss_dssp EEE
T ss_pred EEe
Confidence 653
|
| >1t4n_A Ribonuclease III; DSRBD, RNA-binding, hydrolase; NMR {Saccharomyces cerevisiae} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=89.04 E-value=0.059 Score=38.60 Aligned_cols=26 Identities=8% Similarity=-0.146 Sum_probs=23.3
Q ss_pred cccccccccchhhhhhcccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
+++.|.|++|++|.|.||+.+.+...
T Consensus 49 ~~g~G~G~SKK~AEQ~AA~~AL~~l~ 74 (94)
T 1t4n_A 49 VLGTGVGRNIKIAGIRAAENALRDKK 74 (94)
T ss_dssp EEEEEEESSHHHHHHHHHHHHHHCHH
T ss_pred EEEEEEeCCHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999887654
|
| >3p1x_A Interleukin enhancer-binding factor 3; structural genomics, PSI-biology, protein structure initiati northeast structural genomics consortium, NESG; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.98 E-value=0.058 Score=36.96 Aligned_cols=28 Identities=18% Similarity=-0.050 Sum_probs=23.2
Q ss_pred ccccccccccchhhhhhccccccccccch
Q 020561 9 KVKKASWDSSKSKAKKKKKKVEDEVEVEE 37 (324)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 37 (324)
..| .|+|++|++|+|.||+.+.+.+...
T Consensus 45 ~~~-~G~G~SKK~Aeq~AA~~al~~L~~~ 72 (75)
T 3p1x_A 45 QKF-QGAGSNKKVAKAYAALAALEKLFPD 72 (75)
T ss_dssp EEE-EEEESSHHHHHHHHHHHHHHHHCTT
T ss_pred EEE-EEEECCHHHHHHHHHHHHHHHHHcc
Confidence 466 8999999999999999888766443
|
| >1di2_A XLRBPA, double stranded RNA binding protein A; protein-RNA complex, protein-RNA interactions, RNA-bining protein; 1.90A {Xenopus laevis} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=87.80 E-value=0.074 Score=35.70 Aligned_cols=24 Identities=17% Similarity=-0.060 Sum_probs=20.9
Q ss_pred ccccccccchhhhhhccccccccc
Q 020561 11 KKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
|+.|+|++|++|+|.||+.+.+.+
T Consensus 44 ~~~G~G~sKK~Aeq~AA~~al~~L 67 (69)
T 1di2_A 44 VETGSGTSKQVAKRVAAEKLLTKF 67 (69)
T ss_dssp EEEEEESSHHHHHHHHHHHHHHHH
T ss_pred EEEeecCCHHHHHHHHHHHHHHHH
Confidence 899999999999999998776543
|
| >1x47_A DGCR8 protein; structural genomics, DSRM domain, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=86.99 E-value=0.09 Score=38.07 Aligned_cols=28 Identities=29% Similarity=0.234 Sum_probs=24.5
Q ss_pred cccccccccccchhhhhhcccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
.+.|+.|.|++|++|+|.||+.+.+.+.
T Consensus 56 g~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 83 (98)
T 1x47_A 56 GVTYGSGTASSKKLAKNKAARATLEILI 83 (98)
T ss_dssp TEEEEEEEESSHHHHHHHHHHHHHHHHC
T ss_pred CEEEEEeeeCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999887764
|
| >1whq_A RNA helicase A; double-stranded RNA binding domain, DSRBD, DSRM, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Mus musculus} SCOP: d.50.1.1 PDB: 2rs6_A | Back alignment and structure |
|---|
Probab=86.42 E-value=0.11 Score=37.71 Aligned_cols=27 Identities=11% Similarity=-0.017 Sum_probs=24.4
Q ss_pred ccccccccccchhhhhhcccccccccc
Q 020561 9 KVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
+.|+.|+|++|++|+|.||+.+.+.+.
T Consensus 48 ~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 74 (99)
T 1whq_A 48 NYAGMGNSTNKKDAQSNAARDFVNYLV 74 (99)
T ss_dssp SCCEEEEESSHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccCCHHHHHHHHHHHHHHHHH
Confidence 578999999999999999999988774
|
| >3adl_A RISC-loading complex subunit tarbp2; TRBP2, miRNA processing, gene regulation-RNA complex; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.34 E-value=0.1 Score=36.97 Aligned_cols=24 Identities=17% Similarity=-0.082 Sum_probs=21.9
Q ss_pred ccccccccchhhhhhccccccccc
Q 020561 11 KKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
|+.|+|++|++|+|.||+.+.+.+
T Consensus 59 ~~~G~G~SKK~Aeq~AA~~AL~~L 82 (88)
T 3adl_A 59 IEIGSGTSKKLAKRNAAAKMLLRV 82 (88)
T ss_dssp EEEEEESSHHHHHHHHHHHHHHHH
T ss_pred EEEEeeCCHHHHHHHHHHHHHHHH
Confidence 899999999999999999887665
|
| >3adg_A F21M12.9 protein; HYL1, miRNA processing mechanism, RNA binding protein, gene regulation; 1.70A {Arabidopsis thaliana} PDB: 3adi_A | Back alignment and structure |
|---|
Probab=85.99 E-value=0.13 Score=34.93 Aligned_cols=27 Identities=11% Similarity=-0.036 Sum_probs=22.4
Q ss_pred ccccccccc-ccchhhhhhccccccccc
Q 020561 8 GKVKKASWD-SSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 8 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 34 (324)
++.|+.|.| ++|++|+|.||+.+.+.+
T Consensus 44 g~~~~~G~G~~sKK~Aeq~AA~~al~~L 71 (73)
T 3adg_A 44 GVRYNSLPGFFNRKAAEQSAAEVALREL 71 (73)
T ss_dssp TEEEECCSCBSSHHHHHHHHHHHHHHHH
T ss_pred CEEEEeeeccCCHHHHHHHHHHHHHHHh
Confidence 357899999 899999999998776543
|
| >2l33_A Interleukin enhancer-binding factor 3; structural genomics, northeast structural genomics consortiu PSI-biology, protein structure initiative, DRBM; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.74 E-value=0.11 Score=36.97 Aligned_cols=26 Identities=19% Similarity=-0.082 Sum_probs=22.3
Q ss_pred ccccccccccchhhhhhcccccccccc
Q 020561 9 KVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
+.| .|+|++|++|+|.||+.+.+.+.
T Consensus 55 ~~~-~G~G~SKK~AEq~AA~~AL~~L~ 80 (91)
T 2l33_A 55 QKF-QGAGSNKKVAKAYAALAALEKLF 80 (91)
T ss_dssp EEE-EEEESSHHHHHHHHHHHHHHHHC
T ss_pred EEE-EeeeCCHHHHHHHHHHHHHHHHh
Confidence 346 89999999999999998887764
|
| >2l2n_A Hyponastic leave 1; DSRBD, miRNA, RNA binding protein, plant protein; NMR {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=85.41 E-value=0.13 Score=37.52 Aligned_cols=29 Identities=10% Similarity=-0.018 Sum_probs=24.9
Q ss_pred ccccccccc-ccchhhhhhccccccccccc
Q 020561 8 GKVKKASWD-SSKSKAKKKKKKVEDEVEVE 36 (324)
Q Consensus 8 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 36 (324)
++.|+.|.| ++|++|+|.||+.+.+.+..
T Consensus 58 g~~~~~G~G~~SKK~Aeq~AA~~AL~~L~~ 87 (103)
T 2l2n_A 58 GVRYNSLPGFFNRKAAEQSAAEVALRELAK 87 (103)
T ss_dssp TEEEECCSCBSSHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEeecCCCHHHHHHHHHHHHHHHHhc
Confidence 357899999 89999999999999887753
|
| >2dix_A Interferon-inducible double stranded RNA- dependent protein kinase activator A; structure genomics, DSRM domain, hypothetical protein PRKRA; NMR {Homo sapiens} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=85.15 E-value=0.14 Score=35.89 Aligned_cols=26 Identities=15% Similarity=0.095 Sum_probs=23.3
Q ss_pred cccccccccchhhhhhcccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
.|+.|+|++|++|+|.||+.+.+.+.
T Consensus 50 ~~~~G~G~SKK~Aeq~AA~~aL~~L~ 75 (84)
T 2dix_A 50 ITCTGEGTSKKLAKHRAAEAAINILK 75 (84)
T ss_dssp EEEEECSSCTTHHHHHHHHHHHHHHH
T ss_pred EEEEeeeCCHHHHHHHHHHHHHHHHh
Confidence 67999999999999999999887764
|
| >1ekz_A DSRBDIII, maternal effect protein (staufen); structure, protein/RNA, protein DSRBD, RNA hairpin; NMR {Drosophila melanogaster} SCOP: d.50.1.1 PDB: 1stu_A | Back alignment and structure |
|---|
Probab=85.05 E-value=0.1 Score=35.70 Aligned_cols=25 Identities=12% Similarity=-0.038 Sum_probs=21.7
Q ss_pred cccccccccchhhhhhccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
.|+.|.|++|++|+|.||+.+.+.+
T Consensus 49 ~~~~G~G~sKK~Aeq~AA~~aL~~L 73 (76)
T 1ekz_A 49 IVTEGEGNGKKVSKKRAAEKMLVEL 73 (76)
T ss_dssp EEEEECCCSTTSSSHHHHHHHHHHH
T ss_pred EEEEEeeCCHHHHHHHHHHHHHHHH
Confidence 6899999999999999998876544
|
| >2b7v_A Double-stranded RNA-specific editase 1; RNA editing, RNA-binding protein, hydrolase; NMR {Rattus norvegicus} SCOP: d.50.1.1 PDB: 2l2k_B | Back alignment and structure |
|---|
Probab=84.99 E-value=0.14 Score=34.60 Aligned_cols=24 Identities=13% Similarity=-0.031 Sum_probs=20.5
Q ss_pred cccccccccchhhhhhccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
.| .|+|++|++|+|.||+.+.+.+
T Consensus 43 ~~-~G~G~SKK~Aeq~AA~~al~~L 66 (71)
T 2b7v_A 43 FF-EGSGRNKKLAKARAAQSALATV 66 (71)
T ss_dssp EE-EEEESSHHHHHHHHHHHHHHHH
T ss_pred EE-EEeeCCHHHHHHHHHHHHHHHH
Confidence 45 8999999999999999877654
|
| >1uil_A Double-stranded RNA-binding motif; structural genomics, DSRM, riken structural genomics/proteomics initiative, RSGI RNA binding protein; NMR {Mus musculus} SCOP: d.50.1.1 PDB: 2rs7_A | Back alignment and structure |
|---|
Probab=84.80 E-value=0.14 Score=38.02 Aligned_cols=29 Identities=10% Similarity=-0.097 Sum_probs=25.2
Q ss_pred ccccccccccccchhhhhhcccccccccc
Q 020561 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
+.+.|+.|.|++||+|+|.||+.+...+.
T Consensus 70 ~~~~~~~G~G~SKK~AEq~AA~~AL~~L~ 98 (113)
T 1uil_A 70 GRRIFAREHGSNKKLAAQSCALSLVRQLY 98 (113)
T ss_dssp TEEEEEECCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEeeCCHHHHHHHHHHHHHHHHH
Confidence 45688999999999999999999887664
|
| >1t4o_A Ribonuclease III; RNT1P, DSRBD, RNA-binding, hydrolase; 2.50A {Saccharomyces cerevisiae} SCOP: d.50.1.1 PDB: 1t4l_B 2lbs_B | Back alignment and structure |
|---|
Probab=84.78 E-value=0.14 Score=38.09 Aligned_cols=26 Identities=8% Similarity=-0.146 Sum_probs=23.5
Q ss_pred cccccccccchhhhhhcccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
.++.|.|++|++|.|.||+.+.+...
T Consensus 51 ~~g~G~G~SKK~AEQ~AA~~AL~~l~ 76 (117)
T 1t4o_A 51 VLGTGVGRNIKIAGIRAAENALRDKK 76 (117)
T ss_dssp EEEEEEESSHHHHHHHHHHHHHHCHH
T ss_pred EEEEEEeCCHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999987664
|
| >1whn_A Hypothetical protein riken cDNA 2310016K04; double-stranded RNA binding domain, DSRBD, DSRM, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=84.68 E-value=0.15 Score=38.75 Aligned_cols=28 Identities=14% Similarity=-0.055 Sum_probs=24.6
Q ss_pred ccccccccc-ccchhhhhhcccccccccc
Q 020561 8 GKVKKASWD-SSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 8 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 35 (324)
.+.|+.|+| ++|++|+|.||+.+.+.+.
T Consensus 65 g~~~g~G~G~~SKK~AEQ~AA~~AL~~L~ 93 (128)
T 1whn_A 65 EQKYQSTLWDKSKKLAEQTAAIVCLRSQG 93 (128)
T ss_dssp TEEEEESSCBSSHHHHHHHHHHHHHHHHT
T ss_pred CEEEEEEeccCCHHHHHHHHHHHHHHHHh
Confidence 467899999 9999999999999987764
|
| >2cpn_A TAR RNA-binding protein 2; double-stranded RNA binding domain, DSRBD, DSRM., structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=84.36 E-value=0.13 Score=36.40 Aligned_cols=25 Identities=16% Similarity=-0.092 Sum_probs=22.4
Q ss_pred ccccccccchhhhhhcccccccccc
Q 020561 11 KKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
|+.|+|++|++|+|.||+.+.+.+.
T Consensus 60 ~~~G~G~SKK~Aeq~AA~~AL~~L~ 84 (89)
T 2cpn_A 60 IEIGSGTSKKLAKRNAAAKMLLRVS 84 (89)
T ss_dssp EEEEEESSHHHHHHHHHHHHHHHHH
T ss_pred EEEeeeCCHHHHHHHHHHHHHHHHH
Confidence 8999999999999999998887663
|
| >2b7t_A Double-stranded RNA-specific editase 1; RNA editing, RNA-binding protein, hydrolase; NMR {Rattus norvegicus} SCOP: d.50.1.1 PDB: 2l3c_A | Back alignment and structure |
|---|
Probab=83.73 E-value=0.17 Score=34.36 Aligned_cols=25 Identities=20% Similarity=0.022 Sum_probs=20.7
Q ss_pred ccccccccccchhhhhhccccccccc
Q 020561 9 KVKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
+.| .|.|++|++|+|.||+.+.+.+
T Consensus 45 ~~~-~G~G~SKK~Aeq~AA~~al~~L 69 (73)
T 2b7t_A 45 QVF-EGSGPTKKKAKLHAAEKALRSF 69 (73)
T ss_dssp SEE-EEEESSHHHHHHHHHHHHHHHH
T ss_pred EEE-EeecCCHHHHHHHHHHHHHHHH
Confidence 346 8999999999999998876554
|
| >1uhz_A Staufen (RNA binding protein) homolog 2; DSRM, staufen homolog 2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=82.32 E-value=0.19 Score=35.57 Aligned_cols=25 Identities=16% Similarity=-0.108 Sum_probs=22.7
Q ss_pred ccccccccchhhhhhcccccccccc
Q 020561 11 KKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
|+.|.|++|++|+|.||+.+.+.+.
T Consensus 50 ~~~G~G~SKK~Aeq~AA~~AL~~L~ 74 (89)
T 1uhz_A 50 VATGTGPNKKIAKKNAAEAMLLQLG 74 (89)
T ss_dssp EEEEEESSHHHHHHHHHHHHHHHHT
T ss_pred EEEEeeCCHHHHHHHHHHHHHHHHh
Confidence 8999999999999999999887764
|
| >2ljh_A Double-stranded RNA-specific editase ADAR; DSRBD, DSRBM, editing, hydrolase; NMR {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=81.77 E-value=0.21 Score=37.09 Aligned_cols=27 Identities=15% Similarity=0.028 Sum_probs=23.2
Q ss_pred cccccccccccchhhhhhcccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
++.| .|.|++||+|+|.||+.+.+.+.
T Consensus 74 g~~~-~G~G~SKK~AEq~AA~~AL~~L~ 100 (114)
T 2ljh_A 74 GQKY-LGQGRSKKVARIEAAATALRSFI 100 (114)
T ss_dssp TEEE-EEEESSHHHHHHHHHHHHHHHHC
T ss_pred CEEE-EeeeCCHHHHHHHHHHHHHHHHH
Confidence 3567 89999999999999998887664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 324 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-51
Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 18/188 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+G G FG V+KG VAVK LN Q + + EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L H+N++ +GY Q +V ++ SL +HL + IA A+
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ +LH + +I+RD K++NI L D K+ DFGLA +H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 308 AAPEYVMT 315
APE +
Sbjct: 173 MAPEVIRM 180
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-49
Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 17/193 (8%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 182
++L +F S LG G G VFK +GL +A K ++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164
Query: 303 GTYGYAAPEYVMT 315
GT Y +PE +
Sbjct: 165 GTRSYMSPERLQG 177
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 2e-48
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 119 FTFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
FTF D A R F E ++G G FG V G ++ G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 170 TLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
TL + +++L+E + +G H N++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + G A G+ +L + ++RD NIL++++ K+SDFGL++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 289 GPEGDKTHVSTRV---MGTYGYAAPEYVMT 315
+ T + APE +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-48
Identities = 41/187 (21%), Positives = 74/187 (39%), Gaps = 15/187 (8%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
++ LG G FG V G VA+K + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ +L H LV+L G C + ++ E+M G L N+L +++ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+ +L + ++RD N L++ K+SDFGL++ + D+ S ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 309 APEYVMT 315
PE +M
Sbjct: 169 PPEVLMY 175
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-47
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 20/194 (10%)
Query: 128 TRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
TR+ PE LG+G FG V+K T + A K ++ + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L +LH + +I+RD K NIL D + KL+DFG++ +
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 302 MGTYGYAAPEYVMT 315
+GT + APE VM
Sbjct: 171 IGTPYWMAPEVVMC 184
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-46
Identities = 51/210 (24%), Positives = 77/210 (36%), Gaps = 31/210 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
N +LG G FG V K G + VAVK L +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------- 231
+ L H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 232 ------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L + + A AKG+ FL + ++RD N+L+ K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
A+D V + APE +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 14/196 (7%)
Query: 123 DLKLATRNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 180
L L N + LG G FG V +G + VA+K L + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
E + E + L + +V+LIG C + + +LV E G L L + +P S +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 299
+ + G+ +L E+ ++RD N+LL + AK+SDFGL+K G + +
Sbjct: 114 LLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 300 RVMGTYGYAAPEYVMT 315
+ APE +
Sbjct: 171 AGKWPLKWYAPECINF 186
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 14/187 (7%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 188
++ LGEG +G V V T VAVK ++ + + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L H N+VK G+ E + + L E+ G L + + +P + G
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT Y
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 309 APEYVMT 315
APE +
Sbjct: 173 APELLKR 179
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 2e-44
Identities = 51/219 (23%), Positives = 82/219 (37%), Gaps = 31/219 (14%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 179
L+ N +GEG FG VF+ + VAVK L +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-------- 231
++ E + + + N+VKL+G C L++E+M G L L S
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 232 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
PL + ++ IA A G+A+L E R ++RD T N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
K++DFGL+++ D + PE +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 2e-44
Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 22/191 (11%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 184
+ F +G G FG V+ VA+K +++ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV FL L H N ++ G + + LV E+ + + + PL + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHG 123
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A +GLA+LH +I+RD K NILL KL DFG A + +GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174
Query: 305 YGYAAPEYVMT 315
+ APE ++
Sbjct: 175 PYWMAPEVILA 185
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-44
Identities = 49/202 (24%), Positives = 80/202 (39%), Gaps = 27/202 (13%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D F LG+G FG V+ + + +A+K L L
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 44
Query: 177 ---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KF 103
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
Query: 294 KTHVSTRVMGTYGYAAPEYVMT 315
+T + GT Y PE +
Sbjct: 161 RTT----LCGTLDYLPPEMIEG 178
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-44
Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 17/187 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V+ G+ VAVK+L +LAE N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 248
L H LV+L + ++ E+M GSL + L S + L + + +A A+G
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+AF+ ER I+RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT 177
Query: 309 APEYVMT 315
APE +
Sbjct: 178 APEAINY 184
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-44
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 104 SKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 163
S L EL A + + L + +F ++G G FGCV+ G + +N G
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIV---HF--NEVIGRGHFGCVYHGTLLDND------GKK 55
Query: 164 LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGS 221
+ AVK+LN G ++L E + D H N++ L+G C+ + L+V +M G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
L N + + + L AKG+ FL + ++RD N +LD + K++
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 172
Query: 282 DFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMT 315
DFGLA+D E D H T + A E + T
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 7e-44
Identities = 56/205 (27%), Positives = 79/205 (38%), Gaps = 26/205 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
LG G FG V + +K +TVAVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------S 230
L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
L L + + AKG+AFL + I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMT 315
V + APE +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN 221
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-44
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+G G FG V G+ VA+KT+ ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H LV+L G C+E LV+EFM G L ++L + + + L +G+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
A+L E VI+RD N L+ + K+SDFG+ + + D+ ST +A+
Sbjct: 115 AYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWAS 170
Query: 310 PEYVMT 315
PE
Sbjct: 171 PEVFSF 176
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-43
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 14/191 (7%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 185
++ R LG+G FG V +G + G ++VAVK L D L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
VN + L H NL++L G + ++ V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGT 304
A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 305 YGYAAPEYVMT 315
+ + APE + T
Sbjct: 178 FAWCAPESLKT 188
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-43
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
++ ++ + + LG G +G V++G V LTVAVKTL D +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTM 55
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPW 235
+ +E+L E + ++ H NLV+L+G C + ++ EFM G+L ++L +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + +A + + +L ++ I+RD N L+ ++ K++DFGL++ GD
Sbjct: 115 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 170
Query: 296 HVSTRVMGTYGYAAPEYVMT 315
+ APE +
Sbjct: 171 TAHAGAKFPIKWTAPESLAY 190
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-43
Identities = 45/186 (24%), Positives = 86/186 (46%), Gaps = 10/186 (5%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 189
F+ +LG G FG V+KG G + VA+K L + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ + ++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+L + R +++RD N+L+ + K++DFGLAK +K + + + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 310 PEYVMT 315
E ++
Sbjct: 182 LESILH 187
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-43
Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 23/189 (12%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ + +G+G FG V G G VAVK + +D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAA 246
+ L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+ + +L ++RD N+L+ D AK+SDFGL K+ T
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165
Query: 307 YAAPEYVMT 315
+ APE +
Sbjct: 166 WTAPEALRE 174
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-42
Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 15/185 (8%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGD 191
+ LG G FG V KG+ + TVAVK L ++ E LAE N +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V++IG C E + +LV E G L +L + + +++ + G+ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 310
L E ++RD N+LL + AK+SDFGL+K + T + AP
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 311 EYVMT 315
E +
Sbjct: 180 ECINY 184
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-42
Identities = 50/192 (26%), Positives = 75/192 (39%), Gaps = 22/192 (11%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
R + + +G G F V+KG + T + VA L L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 187 NFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 118
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRV 301
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 119 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173
Query: 302 MGTYGYAAPEYV 313
+GT + APE
Sbjct: 174 IGTPEFMAPEMY 185
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-42
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 25/198 (12%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + AE+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 189 LGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
L H N++ I +D+ Q LV ++ GSL ++L R + +K+AL
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALS 108
Query: 245 AAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HV 297
A GLA LH E + + +RD K+ NIL+ + ++D GLA T
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 298 STRVMGTYGYAAPEYVMT 315
+GT Y APE +
Sbjct: 169 PNHRVGTKRYMAPEVLDD 186
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 20/195 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
++ +G G +G K + G + K L++ + + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 242
L +L H N+V+ I+ L V E+ G L + + + + L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 243 LGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
L H + V++RD K +N+ LD N KL DFGLA+ T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKA 173
Query: 301 VMGTYGYAAPEYVMT 315
+GT Y +PE +
Sbjct: 174 FVGTPYYMSPEQMNR 188
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-41
Identities = 43/193 (22%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
++ + ++G G FG V+KG ++ + + VA+KTL + + ++L
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVM 302
G A G+ +L ++RD NIL++++ K+SDFGL++ + + T+ ++
Sbjct: 118 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 303 GTYGYAAPEYVMT 315
+ APE +
Sbjct: 175 IPIRWTAPEAISY 187
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-40
Identities = 44/194 (22%), Positives = 73/194 (37%), Gaps = 16/194 (8%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 181
K +F+ +LGEG F V + T A+K L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
E + + L H VKL +D++ + G L ++ + +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFY 113
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L +LH + +I+RD K NILL+ D + +++DFG AK K +
Sbjct: 114 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 302 MGTYGYAAPEYVMT 315
+GT Y +PE +
Sbjct: 171 VGTAQYVSPELLTE 184
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-40
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 37/219 (16%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
+ +ND+K + ++GEG FG V K I+++G + A+K +
Sbjct: 2 TIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKE 47
Query: 174 DGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 231
H+++ E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 48 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107
Query: 232 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
L + A A+G+ +L + + I+RD NIL+ +Y
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 164
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
AK++DFGL++ K T + A E +
Sbjct: 165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNY 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-40
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ R E LG+G FG V+ G VA+KTL + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKG 248
L H LV+L ++ +V E+M +GSL + L L + +A A G
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+A++ ++RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWT 181
Query: 309 APEYVMT 315
APE +
Sbjct: 182 APEAALY 188
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-40
Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 17/196 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
LG+G FG V++G VK VA+KT+N ++ E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIRM 239
+ + ++V+L+G + L++ E M RG L+++L P S +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++A A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 300 RVMGTYGYAAPEYVMT 315
+ + + +PE +
Sbjct: 194 KGLLPVRWMSPESLKD 209
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-39
Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 12/187 (6%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+GEG FG V +G L VA+KT + +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ H ++VKLIG ++ ++ E G L + L R L + + A +
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
LA+L + ++RD N+L+ ++ KL DFGL++ + + +++ +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWM 176
Query: 309 APEYVMT 315
APE +
Sbjct: 177 APESINF 183
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (352), Expect = 2e-39
Identities = 45/188 (23%), Positives = 69/188 (36%), Gaps = 17/188 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
++ LG G FG V + + TG A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H LV L +D++ +++YEFM G L + + ++ KGL
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
+H E ++ D K NI+ + KL DFGL V GT +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 191
Query: 308 AAPEYVMT 315
AAPE
Sbjct: 192 AAPEVAEG 199
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (352), Expect = 3e-39
Identities = 42/187 (22%), Positives = 71/187 (37%), Gaps = 17/187 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V + V+ TG K +N E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H L+ L + + +L+ EF+ G L + + + + + A +GL
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
+H E +++ D K NI+ + + K+ DFGLA + T +
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194
Query: 308 AAPEYVM 314
AAPE V
Sbjct: 195 AAPEIVD 201
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 16/188 (8%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + + N+V + + D+ +V E++ GSL + + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
L FLH VI+RD K+ NILL D + KL+DFG + ++GT +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 308 AAPEYVMT 315
APE V
Sbjct: 183 MAPEVVTR 190
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-38
Identities = 54/204 (26%), Positives = 78/204 (38%), Gaps = 25/204 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 188
+ LG G FG V + K T TVAVK L H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 189 LGDLVH-LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SL 231
L + H LN+V L+G C + L ++ EF G+L +L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
L + + AKG+ FL R I+RD NILL K+ DFGLA+D +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMT 315
+ APE +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD 210
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-36
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 188
LGEG FG V E G KP VAVK L D + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------------- 232
+ + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
L + A A+G+ +L + I+RD N+L+ D K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 293 DKTHVSTRVMGTYGYAAPEYVMT 315
D +T + APE +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFD 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 1e-35
Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 26/197 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 180
N+ P+ +LG G V + + T AVK ++ G + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 181 EWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
L EV+ L + H N+++L + LV++ M +G L ++L + L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 113
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KI + + LH+ +++RD K NILLD D N KL+DFG + G+K
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167
Query: 300 RVMGTYGYAAPEYVMTA 316
V GT Y APE + +
Sbjct: 168 EVCGTPSYLAPEIIECS 184
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (325), Expect = 2e-35
Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 23/192 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
+F ++G GGFG V+ K TG A+K L+ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 187 N---FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
+ +V + D+ + + M G L HL + + +R A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAA 114
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
GL +H R V+YRD K +NILLD + ++SD GLA D + +G
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167
Query: 304 TYGYAAPEYVMT 315
T+GY APE +
Sbjct: 168 THGYMAPEVLQK 179
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 43/192 (22%), Positives = 79/192 (41%), Gaps = 16/192 (8%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 186
+ S +GEG +G V + + VA+K ++ Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALG 244
L H N++ + + ++ + L++ ++ L
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMG 303
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T +
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 304 TYGYAAPEYVMT 315
T Y APE ++
Sbjct: 175 TRWYRAPEIMLN 186
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-34
Identities = 52/190 (27%), Positives = 74/190 (38%), Gaps = 19/190 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
+F +LG+G FG VF T A+K L D + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 187 NFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H L + + V E++ G L H+ S A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD GT
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 306 GYAAPEYVMT 315
Y APE ++
Sbjct: 168 DYIAPEILLG 177
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-34
Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 20/185 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 190
LGEG F V+K T VA+K + K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+L H N++ L+ LV++FM LE + SL L S L +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH+ +++RD K +N+LLD + KL+DFGLAK ++ + T + T Y AP
Sbjct: 115 YLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 311 EYVMT 315
E +
Sbjct: 170 ELLFG 174
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-33
Identities = 35/188 (18%), Positives = 67/188 (35%), Gaps = 18/188 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V + V+ + T K + G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
H N++ L ++ ++++EF+ + + + L + + L
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
FLH + + D + NI+ ++ K+ +FG A+ GD + + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169
Query: 308 AAPEYVMT 315
APE
Sbjct: 170 YAPEVHQH 177
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 5e-33
Identities = 40/186 (21%), Positives = 65/186 (34%), Gaps = 14/186 (7%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ +LG G F V T VA+K + L+G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ H N+V L L+ + + G L + + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH+ + LD D +SDFGL+K D V + GT GY A
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVA 177
Query: 310 PEYVMT 315
PE +
Sbjct: 178 PEVLAQ 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (303), Expect = 5e-33
Identities = 42/193 (21%), Positives = 74/193 (38%), Gaps = 21/193 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 187
+ +LG GG V VAVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L H +V + + +V E++ +L + + P+ +++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 302
A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+ + V+
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 303 GTYGYAAPEYVMT 315
GT Y +PE
Sbjct: 176 GTAQYLSPEQARG 188
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 45/194 (23%), Positives = 71/194 (36%), Gaps = 25/194 (12%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 184
++ LLG GGFG V+ G ++ L VA+K + D + E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 185 EVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
EV L + +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ + H V++RD K NIL+D + KL DFG K V T
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169
Query: 302 MGTYGYAAPEYVMT 315
GT Y+ PE++
Sbjct: 170 DGTRVYSPPEWIRY 183
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (301), Expect = 2e-32
Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 21/190 (11%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 185
++F+ LG G FG V G A+K L + + K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +IYRD K NILLD + + K++DFG AK P+ T GT
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165
Query: 306 GYAAPEYVMT 315
Y APE V T
Sbjct: 166 DYIAPEVVST 175
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 15/188 (7%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
NF+ +GEG +G V+K TG VA+K + D + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+VKL+ +++ LV+EF+ + + +P + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ + V+ +
Sbjct: 114 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169
Query: 308 AAPEYVMT 315
A +
Sbjct: 170 APEILLGC 177
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 3e-30
Identities = 38/201 (18%), Positives = 68/201 (33%), Gaps = 23/201 (11%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
+L++ R +R +G G FG ++ G G VA+K H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGD-----K 294
+ ++H + I+RD K N L + DFGLAK +
Sbjct: 110 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 295 THVSTRVMGTYGYAAPEYVMT 315
+ + GT YA+ +
Sbjct: 167 YRENKNLTGTARYASINTHLG 187
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-30
Identities = 55/194 (28%), Positives = 75/194 (38%), Gaps = 18/194 (9%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+ E L + H L L D+ V E+ G L HL R
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 302 MGTYGYAAPEYVMT 315
GT Y APE +
Sbjct: 166 CGTPEYLAPEVLED 179
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-29
Identities = 44/194 (22%), Positives = 72/194 (37%), Gaps = 26/194 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 184
+ LG G F V K + TGL A K + + + ++
Sbjct: 12 YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTR 300
G+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 301 VMGTYGYAAPEYVM 314
+ GT + APE V
Sbjct: 176 IFGTPEFVAPEIVN 189
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (280), Expect = 2e-29
Identities = 33/195 (16%), Positives = 61/195 (31%), Gaps = 24/195 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ +GEG FG +F+G VA+K + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L + + Y ++ ++ + SLE+ L A +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADY-----NAKLSDFGLAKDGPEGD-----KTHVST 299
+H E+ ++YRD K N L+ + DFG+ K +
Sbjct: 115 QSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 300 RVMGTYGYAAPEYVM 314
+ GT Y + +
Sbjct: 172 NLSGTARYMSINTHL 186
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 8e-29
Identities = 51/199 (25%), Positives = 79/199 (39%), Gaps = 24/199 (12%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 182
A + + + +GEG +G VFK +NG G VA+K + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 236
+A + L H N+V+L C LV+E + + +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 170
Query: 297 VSTRVMGTYGYAAPEYVMT 315
T V+ T Y APE ++
Sbjct: 171 ALTSVVVTLWYRAPEVLLQ 189
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (274), Expect = 1e-28
Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 18/187 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +GEG +G V+K G T A+K + + + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+VKL + +LV+E + L+ L L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+A+ H+ R V++RD K N+L++ + K++DFGLA+ + + + T Y
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWY 166
Query: 308 AAPEYVM 314
AP+ +M
Sbjct: 167 RAPDVLM 173
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-28
Identities = 44/195 (22%), Positives = 73/195 (37%), Gaps = 27/195 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
++ ++G G FG V++ +G VA+K + D + E+ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67
Query: 190 GDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKI 241
L H N+V+L + ++ LV +++P H R LP
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTR 300
+ LA++H + +RD K N+LLD D KL DFG AK G+ +
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182
Query: 301 VMGTYGYAAPEYVMT 315
+ Y A
Sbjct: 183 ICSRYYRAPELIFGA 197
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-28
Identities = 47/198 (23%), Positives = 76/198 (38%), Gaps = 25/198 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 187
+ + +G+G FG VFK TG VA+K + + + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
L L H N+V LI C LV++F S
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIK 120
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS- 298
++ GL ++H +++RD K +N+L+ D KL+DFGLA+ + +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 299 -TRVMGTYGYAAPEYVMT 315
T + T Y PE ++
Sbjct: 178 YTNRVVTLWYRPPELLLG 195
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-27
Identities = 38/188 (20%), Positives = 63/188 (33%), Gaps = 29/188 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
+LG G G V + T A+K L + EV
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 195 LNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGL 249
++V+++ L+V E + G L + + R +I + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178
Query: 307 YAAPEYVM 314
Y APE +
Sbjct: 179 YVAPEVLG 186
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 3e-27
Identities = 55/226 (24%), Positives = 85/226 (37%), Gaps = 24/226 (10%)
Query: 95 SNAESNSSTSKLEEELKVASR--LRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIE 151
+ A+ S ++E L A L+K+ A + F LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV--- 60
Query: 152 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDD 208
+G A+K L+ + K+ L E L + LVKL ++
Sbjct: 61 ------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
+V E++ G + +HL R A +LH +IYRD K
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
N+L+D +++DFG AK T + GT APE ++
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIIL 211
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 8e-26
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 17/187 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +GEG +G VFK T VA+K + D L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+V+L D + LV+EF + + I K
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GL F H R V++RD K N+L++ + KL++FGLA+ + + + + T Y
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWY 167
Query: 308 AAPEYVM 314
P+ +
Sbjct: 168 RPPDVLF 174
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-25
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 20/214 (9%)
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
++ EL+ A+ T + K+ NF +LG G +G VF TG
Sbjct: 5 VKHELRTAN----LTGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKL 54
Query: 166 VAVKTLNHDGL----QGHKEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRG 220
A+K L + + + E L + LV L + + L+ +++ G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
L HL +R L LH+ +IYRD K NILLD++ + L
Sbjct: 115 ELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVL 170
Query: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+DFGL+K+ + + GT Y AP+ V
Sbjct: 171 TDFGLSKEFVADETER-AYDFCGTIEYMAPDIVR 203
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 2e-25
Identities = 36/189 (19%), Positives = 68/189 (35%), Gaps = 26/189 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ LG G + VF+ + V VK L K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPV---KKKKIKREIKIL 83
Query: 190 GDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+L N++ L + R LV+E + + L
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
K L + H +++RD K N+++D + +L D+GLA+ G + + +
Sbjct: 140 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 306 GYAAPEYVM 314
+ PE ++
Sbjct: 194 YFKGPELLV 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-25
Identities = 49/192 (25%), Positives = 74/192 (38%), Gaps = 28/192 (14%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 188
+R +G G +G V V TG VA+K L K E+
Sbjct: 20 YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 189 LGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L + H N++ L+ D+ LV FM G+ L + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-- 182
Query: 303 GTYGYAAPEYVM 314
Y APE ++
Sbjct: 183 ---WYRAPEVIL 191
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (230), Expect = 4e-22
Identities = 41/194 (21%), Positives = 67/194 (34%), Gaps = 27/194 (13%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
+ ++ +G G G V + VA+K L+ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ G+ LH +I+RD K SNI++ +D K+ DFGLA+ T
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177
Query: 301 VMGTYGYAAPEYVM 314
+ T Y APE ++
Sbjct: 178 YVVTRYYRAPEVIL 191
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 3e-20
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 185
++ S +G G +G V + TGL VAVK L+ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 186 VNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 126 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 301 VMGTYGYAAPEYVM 314
Y APE ++
Sbjct: 183 -----WYRAPEIML 191
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.9 bits (206), Expect = 7e-19
Identities = 38/212 (17%), Positives = 67/212 (31%), Gaps = 33/212 (15%)
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ D + + LG G F V+ N T VA+K + D +
Sbjct: 9 PYKDAR-----YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-T 53
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---------------EFMPRGSLEN 224
+ E+ L + + K +LL + E + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 225 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 283
+P +I+ GL ++H +I+ D K N+L++ D L
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+A G T + T Y +PE ++
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 1e-15
Identities = 25/158 (15%), Positives = 50/158 (31%), Gaps = 16/158 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
L+GEG VF + E+ G VK + K + G +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 195 LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L KL G + + ++ E + L ++ + +A
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ R +++ D N+L+ + + DF + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 324 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.85 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.99 | |
| d1qu6a2 | 89 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 95.78 | |
| d1x48a1 | 76 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 95.75 | |
| d1x49a1 | 85 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 92.36 | |
| d1qu6a1 | 90 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 91.82 | |
| d1x47a1 | 85 | Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | 91.29 | |
| d1o0wa2 | 69 | RNase III, C-terminal domain {Thermotoga maritima | 90.31 | |
| d2b7va1 | 71 | dsRNA-specific editase 1 {Rat (Rattus norvegicus) | 86.86 | |
| d2b7ta1 | 73 | dsRNA-specific editase 1 {Rat (Rattus norvegicus) | 86.58 | |
| d2dixa1 | 73 | Interferon-inducible double stranded RNA-dependent | 85.44 | |
| d1ekza_ | 76 | Staufen, domain III {Fruit fly (Drosophila melanog | 83.78 | |
| d2cpna1 | 76 | TAR RNA-binding protein 2 {Human (Homo sapiens) [T | 81.19 | |
| d2dmya1 | 84 | Spermatid perinuclear RNA-binding protein {Human ( | 80.47 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=354.54 Aligned_cols=184 Identities=26% Similarity=0.348 Sum_probs=160.1
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+++.+|+.+|++|+|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3579999999999999999998875 678999999976543 234568999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++..|||||||++|+|.++|. ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhh
Confidence 999999999999999999994 4457999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+...........+..+||+.|||||++. .++|||||||
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGv 194 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHH
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHH
Confidence 9875544333345578999999999986 2479999997
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=347.99 Aligned_cols=180 Identities=24% Similarity=0.382 Sum_probs=161.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++++.||+|+||+||+|++.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 479999999999999999998765 67899999998765555678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.+|||||||++|+|.+++.+ ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhee
Confidence 99999999999999998854 36999999999999999999999988 99999999999999999999999999997
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ....+||+.|||||++. .++|||||||
T Consensus 166 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 204 (293)
T d1yhwa1 166 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (293)
T ss_dssp CCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHH
T ss_pred ecccccc--ccccccCCCccChhhhcCCCCCchhceehHhH
Confidence 6543322 34468999999999997 3589999997
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=350.78 Aligned_cols=182 Identities=26% Similarity=0.425 Sum_probs=162.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
+.|++++.||+|+||+||+|++.. ++..||||++........+++.+|+.+|++|+|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999875 67799999998776666678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..|||||||++|+|.+++.+...++++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 999999999999999998776678999999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeccccccCcccccccc----------ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM----------TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~----------~~~DiwSlGc 324 (324)
..... ......+||+.|||||++. .++|||||||
T Consensus 160 ~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGv 203 (288)
T d2jfla1 160 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 203 (288)
T ss_dssp CHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHH
T ss_pred cCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHH
Confidence 53211 1123467999999999984 3589999997
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=342.46 Aligned_cols=179 Identities=26% Similarity=0.430 Sum_probs=159.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|++.. +++.||||++.... .....++.+|+.+++.++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 579999999999999999998875 67799999986432 223467889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++..|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999999999999643 47999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+...... .....||+.|||||++. .++|||||||
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGv 192 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 192 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhH
Confidence 98765432 23468999999999997 4689999997
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=345.03 Aligned_cols=183 Identities=28% Similarity=0.440 Sum_probs=152.6
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
+..++|++++.||+|+||+||+|++.. .||||+++.... ...+.|.+|+.+|++++|||||+++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 445789999999999999999997542 699999975432 334678999999999999999999998
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+. .+.++||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence 75 45689999999999999999777778999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
|+|+...............||+.|||||++. .++|||||||
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv 197 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI 197 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHH
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHH
Confidence 9998765544333345578999999999985 2479999997
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=346.77 Aligned_cols=183 Identities=25% Similarity=0.340 Sum_probs=156.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|++|+|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 579999999999999999998875 67799999996532 123357899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence 999999999999999999998543 57999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+..............+||+.|||||++. .++|||||||
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGv 198 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHH
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhH
Confidence 99875543333344568999999999987 3589999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=353.49 Aligned_cols=181 Identities=27% Similarity=0.395 Sum_probs=158.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++++.||+|+||+||+|++.. +|+.||||+++.... ....++.+|+.+|++|+|||||+++++|.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35689999999999999999998865 688999999976533 23467899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
+++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+ ++ ||||||||+||||+.++.+||+|||
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCC
Confidence 999999999999999999999654 469999999999999999999997 47 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|+..... .....+||+.|||||++. .++|||||||
T Consensus 151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 191 (322)
T d1s9ja_ 151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191 (322)
T ss_dssp CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHH
T ss_pred CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHH
Confidence 99865322 133468999999999997 4689999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=339.91 Aligned_cols=185 Identities=24% Similarity=0.392 Sum_probs=147.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. +|+.||||.+...... ..+.+.+|+.+|++|+|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999998875 6789999999766432 23568899999999999999999999865
Q ss_pred --CCeEEEEEEecCCCChHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEeCCCCCCcEEEcCCCcEE
Q 020561 207 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAE--RPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 207 --~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~--~~ivHrDLkp~NILl~~~~~~k 279 (324)
.+.+|||||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+. .+||||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 4568999999999999999863 34679999999999999999999998642 3499999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|||+|+....... .....+||+.|||||++. .++|||||||
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv 202 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCH
Confidence 999999998654322 234468999999999987 3589999997
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=346.07 Aligned_cols=182 Identities=29% Similarity=0.356 Sum_probs=160.7
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
.++|++++.||+|+||+||+|++.. +|+.||||++++.. .....++.+|+.+|++++|||||++++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 3579999999999999999998875 68899999997542 22346788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+++.+|||||||++|+|.+++.+ ...+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecc
Confidence 999999999999999999999854 457899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|+....... .....+||+.|||||++. .++|||||||
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGv 193 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHH
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhh
Confidence 9997654322 234568999999999997 4689999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-47 Score=348.09 Aligned_cols=181 Identities=24% Similarity=0.332 Sum_probs=162.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++++.||+|+||+||+|++.. +|+.||||++........+.+.+|+.+|++|+|||||++++++.+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 589999999999999999998875 68899999998776555677899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc--CCCcEEEEeeccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGLA 286 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~~kl~DFGla 286 (324)
.+|||||||++|+|.+++.+....+++..+..|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999999999999766678999999999999999999999988 99999999999995 4678999999999
Q ss_pred ccCCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
+....... .....||+.|||||++.+ ++|||||||
T Consensus 174 ~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGv 213 (350)
T d1koaa2 174 AHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 213 (350)
T ss_dssp EECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHH
T ss_pred eecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhH
Confidence 98755332 334679999999999873 589999997
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-48 Score=344.10 Aligned_cols=189 Identities=25% Similarity=0.405 Sum_probs=164.3
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEE
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 201 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 201 (324)
++|++..++|++.+.||+|+||+||+|.+.. +++.||||+++.+. ...++|.+|+.+|++|+|||||+++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCC
Confidence 3444556789999999999999999999876 57799999997654 3456799999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 202 GYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
++|.+++..|||||||++|+|.+++.+ ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||
T Consensus 80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl 156 (287)
T d1opja_ 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 156 (287)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEE
Confidence 999999999999999999999999965 3467999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+|+........ ......||+.|||||++. .++|||||||
T Consensus 157 ~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv 204 (287)
T d1opja_ 157 ADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204 (287)
T ss_dssp CCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred ccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHH
Confidence 999999976553322 233456899999999987 3689999997
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-47 Score=347.11 Aligned_cols=181 Identities=23% Similarity=0.318 Sum_probs=162.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++++.||+|+||+||+|++.. +|+.||||+++.........+.+|+.+|++|+|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 479999999999999999998775 67899999998766555567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc--CCCcEEEEeeccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGLA 286 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~~kl~DFGla 286 (324)
.+|||||||++|+|.+++.+...++++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999999999999988776778999999999999999999999988 99999999999997 6789999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .....||+.|||||++. .++|||||||
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 216 (352)
T d1koba_ 177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 216 (352)
T ss_dssp EECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHH
T ss_pred eecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHH
Confidence 98765432 34467999999999987 3579999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-47 Score=342.91 Aligned_cols=177 Identities=29% Similarity=0.411 Sum_probs=156.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..|+.++.||+|+||+||+|++.. +++.||||++....... .+++.+|+.+|++|+|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 348999999999999999998875 67899999997665432 346889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++..|||||||++|+|..++. ...++++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCEEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccc
Confidence 9999999999999999876663 4467999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc--------ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~DiwSlGc 324 (324)
|+..... ...+||+.|||||++. .++|||||||
T Consensus 162 a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGv 202 (309)
T d1u5ra_ 162 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202 (309)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHH
T ss_pred ccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHH
Confidence 9875432 2357999999999985 3589999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=333.67 Aligned_cols=179 Identities=28% Similarity=0.404 Sum_probs=152.6
Q ss_pred CCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe--
Q 020561 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 206 (324)
Q Consensus 131 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 206 (324)
|++.+.||+|+||+||+|++.. ++..||+|.+..... ...+++.+|+++|++|+|||||+++++|.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 3566789999999999998875 677999999875432 233568999999999999999999999875
Q ss_pred --CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc-CCCcEEEEee
Q 020561 207 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDF 283 (324)
Q Consensus 207 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DF 283 (324)
...+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ .+||||||||+||||+ .++.+||+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence 35689999999999999999543 57999999999999999999999876 5699999999999996 5789999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~DiwSlGc 324 (324)
|+|+...... ....+||+.|||||++. .++|||||||
T Consensus 160 Gla~~~~~~~----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGv 200 (270)
T d1t4ha_ 160 GLATLKRASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGM 200 (270)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHH
T ss_pred CcceeccCCc----cCCcccCccccCHHHhCCCCCCcCchhhHHH
Confidence 9998754322 33568999999999987 4589999997
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=334.10 Aligned_cols=181 Identities=27% Similarity=0.418 Sum_probs=150.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++++.||+|+||+||+|++.. +..||||+++... ...++|.+|+.++++++|||||+++++|..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 578899999999999999998763 5689999997644 34578999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
..+||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence 999999999999999999777778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCccccccccc-----cceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
....... ......||+.|||||++.. ++|||||||
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv 190 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHH
Confidence 6543322 2233579999999999883 589999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-47 Score=340.24 Aligned_cols=180 Identities=23% Similarity=0.344 Sum_probs=142.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.|++++.||+|+||+||+|++.. +++.||||++...... ....+.+|+.+|++|+|||||++++++.++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG 79 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 569999999999999999998875 6789999999765432 235678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFG 284 (324)
+.+|||||||+||+|.++|.+ ...+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+|||
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred CEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccc
Confidence 999999999999999999954 457999999999999999999999988 99999999999994 57899999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|+....... ....+||+.|||||++. .++|||||||
T Consensus 156 ~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGv 197 (307)
T d1a06a_ 156 LSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 197 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHH
T ss_pred eeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhH
Confidence 9987644322 33467999999999987 4589999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-46 Score=338.96 Aligned_cols=178 Identities=28% Similarity=0.424 Sum_probs=158.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|++.. +|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 579999999999999999999875 67899999996532 223467899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+++.+|+|||||+||+|..++. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCeeeeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 9999999999999999999885 4457899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+..... ....+||+.|||||++. .++|||||||
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGv 189 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 189 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHH
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccch
Confidence 9986543 23468999999999987 4689999997
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-46 Score=337.26 Aligned_cols=187 Identities=25% Similarity=0.407 Sum_probs=148.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
++|++.++||+|+||+||+|++...+. ....||||.+..... ...++|.+|+.+|++|+|||||++++++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 568888999999999999999875432 234689999875433 3345799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..+||||||++|+|.+++......+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999999999776778999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccce---eeccccccCccccccccc-----cceEEEecC
Q 020561 288 DGPEGDKTHV---STRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~---~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
.......... .....||+.|||||++.. ++|||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gv 221 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGI 221 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchH
Confidence 7654322211 122457999999999873 589999997
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=331.19 Aligned_cols=180 Identities=24% Similarity=0.340 Sum_probs=158.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------cchHHHHHHHHHHcCCCCCCcceEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
+.|++++.||+|+||+||+|++.. +|+.||||++++... ...+.+.+|+.+|++|+|||||++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 579999999999999999999875 678999999975432 12467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC----cE
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NA 278 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~ 278 (324)
++.+++.+|||||||++|+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccce
Confidence 999999999999999999999999654 47999999999999999999999988 99999999999998776 59
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||+|+....... .....||+.|||||++. .++|||||||
T Consensus 157 kl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGv 204 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 204 (293)
T ss_dssp EECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred EecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhH
Confidence 9999999988754332 33457999999999987 4589999997
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=332.90 Aligned_cols=184 Identities=27% Similarity=0.440 Sum_probs=157.3
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 204 (324)
++..++|++.+.||+|+||+||+|.++ ++..||||+++... ...++|.+|+.+|++++|||||++++++
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 344568999999999999999999875 35689999997654 3356799999999999999999999987
Q ss_pred EeCCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
. ++..|||||||++|+|.+++... ..++++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence 5 45679999999999999987543 246999999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+|+....... .......||+.|||||++. .++|||||||
T Consensus 154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gv 198 (272)
T d1qpca_ 154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198 (272)
T ss_dssp TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHH
T ss_pred cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHH
Confidence 99998755332 2234467999999999987 3589999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=329.14 Aligned_cols=185 Identities=26% Similarity=0.389 Sum_probs=156.1
Q ss_pred cCCCCCce-ecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~-lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|.+.+. ||+|+||+||+|.++..+ ++..||||+++.... ...++|.+|+.+|++|+|||||++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 46667775 999999999999876432 356899999976543 334679999999999999999999999865
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence 5689999999999999998766678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ .......||+.|||||++. .++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv 200 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchH
Confidence 987554322 2223457899999999987 3689999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=338.33 Aligned_cols=191 Identities=26% Similarity=0.384 Sum_probs=158.6
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCC-CCCCcceEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 204 (324)
..++|+++++||+|+||+||+|++...+. ......||||.+..... .....+.+|+.+|.++ +|||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 44689999999999999999999875321 11345799999865432 3345789999999998 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivH 262 (324)
.+.+.+|||||||++|+|.++|.... ..+++..++.|+.||+.||.|||+++ |||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999999999999996542 34889999999999999999999988 999
Q ss_pred CCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 263 rDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||||+|||++.++.+||+|||+|+...............||+.|||||++. .++|||||||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gv 254 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhH
Confidence 9999999999999999999999998765544433344567899999999987 3589999997
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-46 Score=338.29 Aligned_cols=178 Identities=28% Similarity=0.341 Sum_probs=158.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++++.||+|+||+||+|+++. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 579999999999999999998875 67899999996532 223457899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+....++||||+.+|+|.+++.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999999999999654 47999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+..... .....||+.|||||++. .++|||||||
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGv 226 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhH
Confidence 9987543 23467999999999997 3589999997
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=322.03 Aligned_cols=181 Identities=23% Similarity=0.381 Sum_probs=161.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++++.||+|+||+||+|+++ ++..||||.++.... ..++|++|+.++++++|||||+++++|.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 58999999999999999999975 366899999986543 3568999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999999998777778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 289 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
....... ......||+.|||||++. .++|||||||
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~ 189 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccch
Confidence 6543322 233467999999999987 4689999997
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=327.25 Aligned_cols=188 Identities=23% Similarity=0.411 Sum_probs=152.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
+.|++.++||+|+||.||+|.++..+. .....||||.+...... ...+|.+|+.+|++|+|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 468888999999999999998875321 12347999999765432 235689999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..++|||||.+++|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999998777778999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
........ .......||+.|||||++. .++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gv 201 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 201 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHH
Confidence 76543222 1223456899999999887 3589999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-45 Score=336.34 Aligned_cols=179 Identities=28% Similarity=0.407 Sum_probs=154.4
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHH---HHHHHHHcCCCCCCcceEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW---LAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~HpnIv~~~~ 202 (324)
++|+++++||+|+||+||+|++.. ||+.||||++..... .....+ .+|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 589999999999999999998875 678999999964322 112223 34577888999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEe
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D 282 (324)
++.+++.+|||||||++|+|.++|.+. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999999999999654 57899999999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|+...... ....+||+.|||||++. .++|||||||
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGv 194 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHH
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHH
Confidence 99999765432 23457999999999986 3479999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=323.87 Aligned_cols=178 Identities=28% Similarity=0.403 Sum_probs=147.7
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEeCCeEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 212 (324)
+.||+|+||+||+|.+...+ +++.||||+++.... ...+++.+|+.+|++|+|||||+++++|.+ +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-------SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccCC-------cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 46999999999999876422 467899999975432 224579999999999999999999999865 45789
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCCC
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~ 292 (324)
|||||++|+|.+++.+ ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 85 vmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 9999999999999854 457999999999999999999999988 999999999999999999999999999976544
Q ss_pred Ccc-ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 293 DKT-HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 293 ~~~-~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
... .......||+.|||||++. .++|||||||
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv 198 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 198 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchh
Confidence 322 2223457999999999987 4689999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=328.71 Aligned_cols=180 Identities=21% Similarity=0.270 Sum_probs=159.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeCC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 208 (324)
++|++++.||+|+||+||+|.+.. +++.||||+++.... ....+.+|+.+|+.++|||||++++++.+++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 579999999999999999998875 688999999976543 2356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC--CCcEEEEeeccc
Q 020561 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGLA 286 (324)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl~DFGla 286 (324)
.+|||||||+||+|.++|......+++.++..|+.||+.||+|||+++ ||||||||+|||++. ...+||+|||++
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 999999999999999999766668999999999999999999999988 999999999999974 458999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+....... .....||+.|||||++. .++|||||||
T Consensus 152 ~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGv 191 (321)
T d1tkia_ 152 RQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191 (321)
T ss_dssp EECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHH
T ss_pred hccccCCc---ccccccccccccchhccCCCCCchhhcccHHH
Confidence 98754332 33457999999999987 3579999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-45 Score=322.04 Aligned_cols=180 Identities=29% Similarity=0.419 Sum_probs=158.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------hHHHHHHHHHHcCCC-CCCcc
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLV-HLNLV 198 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-HpnIv 198 (324)
++|++++.||+|+||+||+|++.. +++.||||++....... .+++.+|+.+|++|+ |||||
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 589999999999999999998865 67899999997653221 235889999999997 99999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
++++++.+++.+|||||||++|+|.++|.. ..++++..+..++.||+.||+|||+++ ||||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 999999999999999999999999999964 457999999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc-----------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----------~~~DiwSlGc 324 (324)
||+|||+++....... .+...||+.|+|||++. .++|||||||
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGv 203 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccch
Confidence 9999999998755332 34467999999999986 2479999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=329.18 Aligned_cols=181 Identities=29% Similarity=0.442 Sum_probs=156.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---ccchHHHHHHHHHHc-CCCCCCcceEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-DLVHLNLVKLIGYC 204 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~ 204 (324)
++|++++.||+|+||+||+|++.. +++.||||++.+.. ....+.+.+|+.++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999998875 68899999997532 122345677777765 68999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeec
Q 020561 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (324)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG 284 (324)
.+++.+|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 999999999999999999999954 457899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+++....... ..+...||+.|||||++. .++|||||||
T Consensus 149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 191 (320)
T d1xjda_ 149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191 (320)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhH
Confidence 9987654332 234468999999999998 3689999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=325.89 Aligned_cols=177 Identities=30% Similarity=0.420 Sum_probs=149.0
Q ss_pred CCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----hHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 133 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+++||+|+||+||+|++.. +|+.||||+++...... .+++.+|+.+|++++|||||++++++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 35789999999999998765 67899999997543221 24688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
+..|||||||.++++..++ .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 73 ~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp TCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccc
Confidence 9999999999887666554 55667999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
........ ....+||+.|||||++. .++|||||||
T Consensus 149 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv 189 (299)
T d1ua2a_ 149 SFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189 (299)
T ss_dssp TTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHH
T ss_pred ccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcch
Confidence 76543322 33457999999999986 3579999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=326.73 Aligned_cols=187 Identities=24% Similarity=0.399 Sum_probs=154.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|+++++||+|+||+||+|.+...+.. ....||||.++... ....+++.+|+.+|++|+|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4799999999999999999998754321 23469999986543 33456899999999999999999999999865
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~ 287 (324)
..+++|||+.+|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 567889999999999999877788999999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 288 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
...............||+.|||||++. .++|||||||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gv 201 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 201 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHH
Confidence 876544443344457999999999986 4689999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=323.02 Aligned_cols=187 Identities=24% Similarity=0.346 Sum_probs=148.3
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
..++|++++.||+|+||+||+|++...+. ++..||||.++..... ..+.+.+|+.+|++++|||||++++++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34689999999999999999998875332 4568999998654333 2456899999999999999999999985
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
++.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence 56789999999999999998777778999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|+........ ..+...||+.|||||++. .++|||||||
T Consensus 155 a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGv 197 (273)
T d1mp8a_ 155 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 197 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred heeccCCcce-eccceecCcccchhhHhccCCCCCccccccchH
Confidence 9876543222 233457899999999987 3589999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=326.37 Aligned_cols=177 Identities=23% Similarity=0.282 Sum_probs=151.6
Q ss_pred hcCCCCCc-eecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcC-CCCCCcceEEEEEE
Q 020561 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD-LVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~ 205 (324)
.++|+++. +||+|+||+||+|++.. +++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 35788774 69999999999999875 6789999999642 567889998765 48999999999987
Q ss_pred e----CCeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC---CCc
Q 020561 206 E----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (324)
Q Consensus 206 ~----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~ 277 (324)
+ ...+|||||||+||+|.++|.+. ...+++.++..|+.||+.||+|||+++ ||||||||+|||++. .+.
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccc
Confidence 6 46689999999999999999754 357999999999999999999999988 999999999999975 567
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+|+....... ....+||+.|||||++. .++|||||||
T Consensus 153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGv 201 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201 (335)
T ss_dssp EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHH
T ss_pred ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhch
Confidence 99999999987655432 33467999999999987 3589999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=325.35 Aligned_cols=196 Identities=26% Similarity=0.371 Sum_probs=153.0
Q ss_pred HHHHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcce
Q 020561 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVK 199 (324)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~ 199 (324)
..|.+..++|++++.||+|+||.||+|.+...+. ..+++.||||.++..... ..+.+.+|+.++.++ +|||||.
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 4444556789999999999999999998865321 236779999999765432 335678888888777 6899999
Q ss_pred EEEEEEeC-CeEEEEEEecCCCChHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeC
Q 020561 200 LIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (324)
Q Consensus 200 ~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHr 263 (324)
+++++..+ +.+++|||||++|+|.++|... ...+++..++.++.||+.||.|||+++ ||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 99988765 4689999999999999999643 235889999999999999999999988 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 264 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 264 DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||+||||+.++.+||+|||+|+...............||+.|||||++. .++|||||||
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv 224 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHH
Confidence 999999999999999999999998765544333344568999999999987 4689999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=322.34 Aligned_cols=182 Identities=31% Similarity=0.454 Sum_probs=153.5
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|.+.. +++.||||+++.... ....++.+|+.+|++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 589999999999999999999875 677999999965432 234678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..|||||||.++.+..........+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence 99999999999654444333345567999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+........ .....||+.|+|||++. .++|||||||
T Consensus 150 ~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGv 191 (298)
T d1gz8a_ 150 RAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191 (298)
T ss_dssp HHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred eeccCCccc--ceeecccceeeehhhhccccCCCccccccccch
Confidence 876443222 33457999999999876 4589999997
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.3e-44 Score=318.15 Aligned_cols=183 Identities=23% Similarity=0.347 Sum_probs=149.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---hHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||+||+|++.. +++.||||+++...... ..++.+|+.+|+.++|||||++++++.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence 579999999999999999998875 68899999997654332 346899999999999999999999998
Q ss_pred eCC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEE
Q 020561 206 EDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (324)
Q Consensus 206 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~ 281 (324)
..+ .+|||||||+|++|.+++... .++++.+++.|+.||+.||+|||+++ ||||||||+|||++.++.++|+
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred eccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 754 379999999999999988544 57999999999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCCc-cceeeccccccCcccccccc-----ccceEEEecC
Q 020561 282 DFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++........ .......+||+.|||||++. .++|||||||
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGv 202 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchH
Confidence 9999886543322 12234468999999999987 3589999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=322.98 Aligned_cols=181 Identities=27% Similarity=0.393 Sum_probs=150.0
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.++|++++.||+|+||+||+|++.. +..||||+++... ...+.|.+|+.+|++++|||||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 4689999999999999999998864 4579999997554 34578999999999999999999999985 4
Q ss_pred CeEEEEEEecCCCChHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
+..++|||||++|+|..++... ...+++.+++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence 5689999999999999988643 356999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+........ ......||+.|||||++. .++|||||||
T Consensus 161 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Gi 202 (285)
T d1fmka3 161 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 202 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred hhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchH
Confidence 876543322 233457999999999987 4589999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=324.34 Aligned_cols=194 Identities=26% Similarity=0.389 Sum_probs=162.0
Q ss_pred HHHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCCCCCCcceEEE
Q 020561 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIG 202 (324)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~ 202 (324)
+++..++|++++.||+|+||+||+|++.... ...++..||||+++..... ..+++.+|+.+|++++||||+++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 4445678999999999999999999876321 1225679999999765433 2457999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERP 259 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 259 (324)
+|...+..++||||+++|+|.++|.... ..+++..++.|+.||+.||+|||+++
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--- 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence 9999999999999999999999986421 24889999999999999999999988
Q ss_pred eEeCCCCCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 260 ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||||||||+||||+.++.+||+|||+|+...........+...||+.|||||++. .++|||||||
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gv 230 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchh
Confidence 9999999999999999999999999998664433333344567999999999987 3689999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=316.96 Aligned_cols=179 Identities=25% Similarity=0.345 Sum_probs=153.0
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------chHHHHHHHHHHcCCC--CCCcceE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLVKL 200 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~~ 200 (324)
++|++.++||+|+||+||+|++.. +++.||||++...... ...++.+|+.+|++++ |||||++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence 579999999999999999998875 6789999999754321 1234678999999987 8999999
Q ss_pred EEEEEeCCeEEEEEEecCC-CChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-CCcE
Q 020561 201 IGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNA 278 (324)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~ 278 (324)
++++.+++..|+||||+.+ ++|.+++.+ ...+++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence 9999999999999999976 577777744 457999999999999999999999988 999999999999985 4799
Q ss_pred EEEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||+|+...... .+...||+.|||||++. .++|||||||
T Consensus 151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGv 198 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198 (273)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCccccccccee
Confidence 999999998764432 34468999999999986 2479999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=313.20 Aligned_cols=186 Identities=28% Similarity=0.445 Sum_probs=147.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---cchHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
++|++.+.||+|+||.||+|++..... ....||||+++.... ...++|.+|+.+|++++|||||++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 579999999999999999998764321 345799999876532 22357899999999999999999999996
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
+ +..++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchh
Confidence 5 5678999999999999988776678999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccce-eeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHV-STRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.......... .....||+.|||||++. .++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHH
Confidence 998755433222 23356888999999987 3589999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=317.99 Aligned_cols=193 Identities=28% Similarity=0.411 Sum_probs=164.9
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIG 202 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~ 202 (324)
.+..++|+++++||+|+||.||+|++... .+..+++.||||+++..... ...++.+|+.+++++ +|||||++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34457899999999999999999987531 11236789999999765433 335688999999999 6999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 020561 203 YCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (324)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDL 265 (324)
++.+.+..+||||||++|+|.++|.+.. ..+++..++.++.||+.||+|||+++ ||||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDL 171 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 171 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence 9999999999999999999999996432 25899999999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 266 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
||+|||++.++.+||+|||+++...............||+.|||||++. .++|||||||
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence 9999999999999999999999876655444455578999999999987 3589999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=313.85 Aligned_cols=183 Identities=27% Similarity=0.460 Sum_probs=152.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCC-CCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 206 (324)
++|++.++||+|+||+||+|.+...+. ...||||.+.... ....+.+.+|+.+|.++ +|||||+++++|.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE-------EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCe-------EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 578899999999999999999876321 1257888886443 23446799999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NIL 271 (324)
.+.++||||||++|+|.++|.+. ...+++..++.++.||+.||.|||+++ ||||||||+|||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence 99999999999999999999643 357999999999999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 272 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.++.+||+|||+++....... .....||+.|+|||.+. .++|||||||
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGv 214 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 214 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred EcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHH
Confidence 99999999999999986543222 22346899999999997 4589999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=311.43 Aligned_cols=176 Identities=30% Similarity=0.459 Sum_probs=145.2
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEe-
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 206 (324)
.++|++++.||+|+||.||+|++. |..||||+++... ..+.+.+|+.++++++|||||++++++.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 457888999999999999999874 5589999997543 34679999999999999999999999865
Q ss_pred CCeEEEEEEecCCCChHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl 285 (324)
.+.+||||||+++|+|.++|.... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccc
Confidence 456899999999999999996532 45899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 286 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++..... .....+|+.|||||++. .++|||||||
T Consensus 150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~ 188 (262)
T d1byga_ 150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 188 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHH
Confidence 9875432 22346899999999987 4689999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=310.07 Aligned_cols=182 Identities=27% Similarity=0.483 Sum_probs=153.2
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-ccchHHHHHHHHHHcCCCCCCcceEEEEEEe-CCeEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRL 211 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~~ 211 (324)
.++||+|+||+||+|++...+. +...||||.++... ....++|.+|+++|++|+|||||++++++.. ++..+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 4789999999999999875321 34579999997543 3334679999999999999999999999876 46899
Q ss_pred EEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccCCC
Q 020561 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~ 291 (324)
+|||||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999999877778889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcc--ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 292 GDKT--HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 292 ~~~~--~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.... .......||+.|+|||++. .++|||||||
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGi 222 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHH
Confidence 3221 1223357899999999987 3589999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-42 Score=308.36 Aligned_cols=180 Identities=26% Similarity=0.377 Sum_probs=151.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++. +|+.||||+++..... ..+++.+|+.+|++++|||||++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999999875 4679999999765322 24679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
++..+++|||+.++.+..+. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 99999999999766555554 55678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
......... .....|++.|+|||++. .++|||||||
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv 189 (286)
T d1ob3a_ 148 RAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred eecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence 875443221 23346899999999986 4589999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=316.26 Aligned_cols=193 Identities=25% Similarity=0.408 Sum_probs=160.8
Q ss_pred HHHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEE
Q 020561 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (324)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~ 203 (324)
.+..++|++.+.||+|+||+||+|.+.... +..++..||||+++.... .....+.+|+.++++++|||||+++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 344578899999999999999999875310 112356899999975533 223468999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~ 274 (324)
+..++..++|||||++|+|.+++... ...+++..+..++.|++.||.|||+++ ||||||||+|||++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence 99999999999999999999998632 235789999999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 275 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
++.+||+|||+|+...............||+.|||||.+. .++|||||||
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHH
Confidence 9999999999998765443333334457899999999987 4689999997
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=311.29 Aligned_cols=194 Identities=26% Similarity=0.386 Sum_probs=157.1
Q ss_pred HHhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-chHHHHHHHHHHcCC-CCCCcceEEEE
Q 020561 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (324)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 203 (324)
+..++|++++.||+|+||.||+|+....++. ...++..||||+++.+... ...++.+|+..+.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 3456899999999999999999987643211 1124568999999765432 336788999999888 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~ 268 (324)
|.+++..++|||||++|+|.++|..+. ..+++.+++.++.||+.||+|||+++ ||||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 999999999999999999999996432 35899999999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 269 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
|||++.++.+||+|||+++...............||+.|||||++. .++|||||||
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHH
Confidence 9999999999999999999765544333344567999999999987 3689999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=308.45 Aligned_cols=180 Identities=30% Similarity=0.435 Sum_probs=146.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHH--HHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|.+.+.||+|+||.||+|++. |+.||||+++... ..++.+ |+..+..++|||||++++++.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~ 68 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence 46778899999999999999863 6799999996542 233444 5555567899999999999987
Q ss_pred CC----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCcEEEcCCCc
Q 020561 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-----AERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 207 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-----~~~~ivHrDLkp~NILl~~~~~ 277 (324)
++ .+|||||||++|+|.++|.+. ++++..++.++.|++.||.|||+. ..++||||||||+||||+.++.
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 54 589999999999999999653 689999999999999999999974 1234999999999999999999
Q ss_pred EEEEeecccccCCCCCcc--ceeeccccccCccccccccc-----------cceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-----------ALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-----------~~DiwSlGc 324 (324)
+||+|||+++........ .......||+.|||||++.. ++|||||||
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 999999999876443321 12234679999999999862 479999997
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=309.36 Aligned_cols=183 Identities=30% Similarity=0.391 Sum_probs=151.6
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCC---CCCCcceEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLIG 202 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~~~~ 202 (324)
.++|++++.||+|+||+||+|++... +++.||||+++.... .....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 36899999999999999999987642 356899999865422 2234567888877665 7999999999
Q ss_pred EEEe-----CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCc
Q 020561 203 YCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (324)
Q Consensus 203 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~ 277 (324)
+|.. ....+++||||.++.+..........+++..+..++.||+.||+|||+++ ||||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 9863 34689999999888776666566678999999999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 278 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+||+|||+++...... ......||+.|||||++. .++|||||||
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~ 203 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 203 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHH
Confidence 9999999998654322 234568999999999987 4689999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=313.56 Aligned_cols=176 Identities=26% Similarity=0.416 Sum_probs=146.3
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCCcceEEEEEEeC--
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-- 207 (324)
+|+.+++||+|+||+||+|++.. +|+.||||++..... ...+|+.+|++|+||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 57888999999999999999875 678999999976532 234799999999999999999998643
Q ss_pred ----CeEEEEEEecCCCChHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEE
Q 020561 208 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKL 280 (324)
Q Consensus 208 ----~~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl 280 (324)
.++|||||||+++.+..+.. .....+++..+..|+.||+.||+|||+++ ||||||||+|||++.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence 35789999997654333322 34567999999999999999999999988 99999999999999775 8999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|||+++....... ....+||+.|+|||++. .++|||||||
T Consensus 165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~ 211 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211 (350)
T ss_dssp CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccce
Confidence 99999987654332 23457999999999876 3589999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=307.79 Aligned_cols=174 Identities=22% Similarity=0.322 Sum_probs=150.8
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~ 207 (324)
++|++++.||+|+||+||+|++.. +++.||||+++... .+++.+|+.+|..+. ||||+++++++...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999998865 68899999997543 467889999999996 99999999999754
Q ss_pred --CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCC-cEEEEeec
Q 020561 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 284 (324)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFG 284 (324)
..+++|||||.+++|..+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence 5689999999999997764 36899999999999999999999988 99999999999998655 69999999
Q ss_pred ccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|+....... ....+||+.|+|||++. .++|||||||
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 218 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 218 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhh
Confidence 9987654332 33467999999999976 3479999997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=310.93 Aligned_cols=182 Identities=23% Similarity=0.352 Sum_probs=149.1
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cchHHHHHHHHHHcCCCCCCcceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 207 (324)
.+|++++.||+|+||+||+|.+.. +|+.||||++..... ...+++.+|+.+|+.|+||||+++++++..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 469999999999999999998765 678999999975442 2345789999999999999999999999765
Q ss_pred C----eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 208 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 208 ~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
. ..+++|+|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred cccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 3 23455566679999999954 36899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCcc-ceeeccccccCcccccccc------ccceEEEecC
Q 020561 284 GLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|+|+........ ......+||+.|+|||++. .++|||||||
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 201 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence 999876443211 1123467999999999985 4579999997
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=311.42 Aligned_cols=177 Identities=27% Similarity=0.391 Sum_probs=147.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++++.||+|+||+||+|.+.. +|+.||||+++..... ..+++.+|+.+|+.|+|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 3589999999999999999998875 6789999999764332 2357889999999999999999999998
Q ss_pred eCC------eEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEE
Q 020561 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (324)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k 279 (324)
..+ .+||||||| +.+|..++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 765 469999999 6678777743 46999999999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
|+|||+|+..... .+...||+.|||||++. .++|||||||
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchH
Confidence 9999999876543 23467999999999986 4689999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-41 Score=299.81 Aligned_cols=182 Identities=20% Similarity=0.211 Sum_probs=155.5
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCC-CCcceEEEEEEe
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 206 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~ 206 (324)
.++|++++.||+|+||+||+|++.. +++.||||++..... ...+.+|++++..|.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 3579999999999999999999875 678999999865432 2457889999999975 899999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcC-----CCcEEEE
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 281 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~~kl~ 281 (324)
....++||||| +++|.+++......+++..+..++.|++.||+|||+++ ||||||||+|||++. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 78999999777778999999999999999999999988 999999999999964 5789999
Q ss_pred eecccccCCCCCcc-----ceeeccccccCccccccccc-----cceEEEecC
Q 020561 282 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----ALELFCLKC 324 (324)
Q Consensus 282 DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-----~~DiwSlGc 324 (324)
|||+|+........ ......+||+.|||||++.. ++|||||||
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhH
Confidence 99999876432211 12334689999999999873 479999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-41 Score=297.82 Aligned_cols=181 Identities=28% Similarity=0.376 Sum_probs=157.7
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. +++.||||+++.... ....++.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 479999999999999999999875 677999999965533 234678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEeeccc
Q 020561 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (324)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla 286 (324)
.+..++|||++.+++|..++ .....+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence 99999999999998888777 45567899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 287 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+........ .....+++.|+|||++. .++|||||||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~ 190 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccch
Confidence 987554322 23346788999999876 3589999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=304.00 Aligned_cols=183 Identities=27% Similarity=0.394 Sum_probs=149.2
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--cchHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. +|+.||||++..... ....++.+|+.+|++|+||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 589999999999999999999875 677999999865432 234678999999999999999999998865
Q ss_pred --------CCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcE
Q 020561 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (324)
Q Consensus 207 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~ 278 (324)
.+..|+|||||.++.+.. +......+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ----------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred ccccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 345899999997765554 4455667999999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCCcc--ceeeccccccCcccccccc------ccceEEEecC
Q 020561 279 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 279 kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
||+|||+++........ ......+||+.|+|||++. .++|||||||
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv 210 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence 99999999876542211 1123357999999999986 4579999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=307.75 Aligned_cols=185 Identities=28% Similarity=0.349 Sum_probs=158.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cchHHHHHHHHHHcCCCC-CCcceEEEE
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVH-LNLVKLIGY 203 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H-pnIv~~~~~ 203 (324)
++|++++.||+|+||+||+|+...+ +.+|+.||||.++.... ...+++.+|+.+|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECcc------CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 5799999999999999999987543 23788999999975432 223568899999999976 899999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEEEee
Q 020561 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF 283 (324)
+.+....++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeec
Confidence 99999999999999999999999544 46788999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCccceeeccccccCcccccccc-------ccceEEEecC
Q 020561 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TALELFCLKC 324 (324)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~DiwSlGc 324 (324)
|+++........ ......|++.|+|||.+. .++|||||||
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~ 220 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHH
Confidence 999876543322 233467999999999985 2579999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-40 Score=295.87 Aligned_cols=181 Identities=22% Similarity=0.250 Sum_probs=150.3
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC-cceEEEEEEeC
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIED 207 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~ 207 (324)
++|++++.||+|+||+||+|++.. +++.||||++..... ..++.+|+++++.++|+| |+.+..++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 469999999999999999998865 678999999876532 256889999999998766 55556666788
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc---CCCcEEEEeec
Q 020561 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFG 284 (324)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFG 284 (324)
+..++||||| +++|.+.+......+++..++.++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 8999999999 67787777666778999999999999999999999988 99999999999985 45579999999
Q ss_pred ccccCCCCCcc-----ceeeccccccCcccccccc-----ccceEEEecC
Q 020561 285 LAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 285 la~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|+........ .......||+.|||||++. .++|||||||
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 201 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCH
Confidence 99976543221 1233468999999999987 3589999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-40 Score=300.43 Aligned_cols=177 Identities=24% Similarity=0.352 Sum_probs=140.9
Q ss_pred cCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEEe
Q 020561 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (324)
Q Consensus 129 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 206 (324)
++|++++.||+|+||+||+|++.. ||+.||||++...... ...++.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 579999999999999999998875 6889999999765432 23468899999999999999999999964
Q ss_pred C------CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 207 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 207 ~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
. ..+|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred ccccccCceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 3 678999999965 4555553 35899999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
+|||+++....... .+..+||+.|+|||++. .++|||||||
T Consensus 161 ~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~ 206 (355)
T d2b1pa1 161 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred echhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccc
Confidence 99999887654332 34467999999999997 4689999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=301.01 Aligned_cols=178 Identities=25% Similarity=0.396 Sum_probs=148.8
Q ss_pred hcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--chHHHHHHHHHHcCCCCCCcceEEEEEE
Q 020561 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (324)
Q Consensus 128 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 205 (324)
.++|++++.||+|+||+||+|++.. +|+.||||++...... ..+++.+|+.+|+.|+|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3579999999999999999998875 6889999999765432 2356889999999999999999999986
Q ss_pred eC-----CeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEcCCCcEEE
Q 020561 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (324)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl 280 (324)
.. ...+++|+|+.+|+|.+++.. .++++..+..++.||+.||+|||+++ ||||||||+|||++.++.+|+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence 43 344677788889999999843 46999999999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCCccceeeccccccCcccccccc------ccceEEEecC
Q 020561 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TALELFCLKC 324 (324)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~DiwSlGc 324 (324)
+|||++...... .....||+.|+|||++. .++|||||||
T Consensus 163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv 207 (348)
T d2gfsa1 163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207 (348)
T ss_dssp CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHH
T ss_pred cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhH
Confidence 999999865432 23457999999999866 4689999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-34 Score=262.93 Aligned_cols=177 Identities=21% Similarity=0.240 Sum_probs=142.6
Q ss_pred CCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-----------CCCcc
Q 020561 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLNLV 198 (324)
Q Consensus 130 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv 198 (324)
+|++++.||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+.+++.++ ||||+
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 59999999999999999999875 688999999976532 2356788998888775 57899
Q ss_pred eEEEEEEe--CCeEEEEEEecCCCChHHHH--hccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCcEEEc
Q 020561 199 KLIGYCIE--DDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 199 ~~~~~~~~--~~~~~lv~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~ivHrDLkp~NILl~ 273 (324)
++++++.. ....+++|+++..+...... ......+++..+..++.||+.||+|||+ .+ ||||||||+||||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 160 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeee
Confidence 99988754 46677888877655443332 2345678999999999999999999998 66 99999999999997
Q ss_pred CCC------cEEEEeecccccCCCCCccceeeccccccCcccccccc-----ccceEEEecC
Q 020561 274 ADY------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TALELFCLKC 324 (324)
Q Consensus 274 ~~~------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~DiwSlGc 324 (324)
.++ .++|+|||.+...... ....+||+.|+|||++. .++|||||||
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 217 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred ccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHH
Confidence 665 3999999999865432 23357999999999887 4589999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=8.7e-26 Score=188.00 Aligned_cols=134 Identities=17% Similarity=0.149 Sum_probs=104.6
Q ss_pred CCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------------------chHHHHHHHHHHcCCC
Q 020561 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFLGDLV 193 (324)
Q Consensus 132 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~ 193 (324)
.+++.||+|+||+||+|.+. +|+.||||+++..... ......+|...+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 35689999999999999875 4779999987532110 0123456888999999
Q ss_pred CCCcceEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcEEEc
Q 020561 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (324)
Q Consensus 194 HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ivHrDLkp~NILl~ 273 (324)
|++++..+++. . .+++|||+++..+.+ ++......++.|++.+|.|||+++ |+||||||+|||++
T Consensus 73 ~~~v~~~~~~~--~--~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWE--G--NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEE--T--TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCcceEEEec--C--CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeee
Confidence 99999988653 2 379999998765533 334445678999999999999988 99999999999998
Q ss_pred CCCcEEEEeecccccCCC
Q 020561 274 ADYNAKLSDFGLAKDGPE 291 (324)
Q Consensus 274 ~~~~~kl~DFGla~~~~~ 291 (324)
++ .++|+|||+|+....
T Consensus 138 ~~-~~~liDFG~a~~~~~ 154 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGE 154 (191)
T ss_dssp TT-EEEECCCTTCEETTS
T ss_pred CC-CEEEEECCCcccCCC
Confidence 65 599999999987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.85 E-value=1.1e-08 Score=87.01 Aligned_cols=145 Identities=14% Similarity=0.007 Sum_probs=96.9
Q ss_pred HhcCCCCCceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEE
Q 020561 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (324)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 205 (324)
....|+..+..+-++.+.||+... .+..+.||+...........+.+|...+..|. +--+.+++.+..
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 335666555544445578998753 24468889886554333445778888876664 444678888888
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 020561 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA----------------------------- 256 (324)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~----------------------------- 256 (324)
.++..++||++++|.++.+..... .....++.+++..|..||+..
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred cCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 889999999999998876544211 112234455555555566421
Q ss_pred ---------------------------CCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 257 ---------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 257 ---------------------------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
...++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01279999999999998776677999998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=3.3e-06 Score=70.77 Aligned_cols=131 Identities=19% Similarity=0.089 Sum_probs=82.1
Q ss_pred eecCCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC--CCCcceEEEEEEeCCeEEE
Q 020561 136 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLL 212 (324)
Q Consensus 136 ~lG~G~f-g~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~~~~~l 212 (324)
.+..|.. +.||+.... .+..+++|....... ..+..|+..|+.|. ...+.+++.+..+++..++
T Consensus 17 ~~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECT----------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeC----------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 4445543 678987643 355688898755432 34567777776553 3346778888888888999
Q ss_pred EEEecCCCChHHHHhccCCCCCHHHHHHHHHHHHHH--------------------------------------------
Q 020561 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG-------------------------------------------- 248 (324)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~g-------------------------------------------- 248 (324)
||++++|.++.+.. .... .++.++...
T Consensus 84 v~~~i~G~~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp EEECCSSEETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEeeecccccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence 99999886653210 0000 011122222
Q ss_pred -------HHHHHhcC----CCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 249 -------LAFLHEEA----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 249 -------L~yLH~~~----~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
+..+.... ...+||+|+.|.|||++.+..+-|+||+.+..
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22332221 12279999999999998876678999998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=6e-06 Score=74.17 Aligned_cols=78 Identities=13% Similarity=0.031 Sum_probs=49.3
Q ss_pred CceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-------CccchHHHHHHHHHHcCCC---CCCcceEEEE
Q 020561 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-------GLQGHKEWLAEVNFLGDLV---HLNLVKLIGY 203 (324)
Q Consensus 134 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~ 203 (324)
.+.||.|....||+..... +++.|+||.-... ......+...|.++|..+. ...+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 3568999999999987654 3568999965321 1122345667888776552 2446667654
Q ss_pred EEeCCeEEEEEEecCCCCh
Q 020561 204 CIEDDQRLLVYEFMPRGSL 222 (324)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL 222 (324)
+++..++|||++++..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 45556899999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.31 E-value=0.00034 Score=62.29 Aligned_cols=80 Identities=18% Similarity=0.084 Sum_probs=51.4
Q ss_pred ceecCCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCC-CCCcceEEEEEEeCCeEEEE
Q 020561 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (324)
Q Consensus 135 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 213 (324)
+.|+.|-.-.+|+........ +.+.....|.+++.... .......+|..+++.+. +.-..++++++. + ++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence 578888889999998765321 11223456777776532 22234567888888775 433457777664 2 689
Q ss_pred EEecCCCCh
Q 020561 214 YEFMPRGSL 222 (324)
Q Consensus 214 ~E~~~~gsL 222 (324)
|||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.0011 Score=57.21 Aligned_cols=134 Identities=15% Similarity=0.122 Sum_probs=74.9
Q ss_pred eEEEEEEEccCCCccccCCCCcEEEEEEecCCCccchHHHHHHHHHHcCCCCCC-----cceE--EEEEEeCCeEEEEEE
Q 020561 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-----LVKL--IGYCIEDDQRLLVYE 215 (324)
Q Consensus 143 g~Vy~~~~~~~~~~~~~~~t~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-----Iv~~--~~~~~~~~~~~lv~E 215 (324)
-.||++... .|..|++|+..... ....++..|...+..|.... .+.. -..+...+..+.+++
T Consensus 36 N~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 579998764 36689999886542 33466778888876664211 1111 112345677889999
Q ss_pred ecCCCChH-----HH---------Hhc----c----CCCCCH-------------------HHHHHHHHHHHHHHHHHHh
Q 020561 216 FMPRGSLE-----NH---------LFR----R----SLPLPW-------------------SIRMKIALGAAKGLAFLHE 254 (324)
Q Consensus 216 ~~~~gsL~-----~~---------l~~----~----~~~l~~-------------------~~~~~i~~qi~~gL~yLH~ 254 (324)
+++|..+. .+ ++. . ...++. .....+...+...++.+..
T Consensus 105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 184 (325)
T d1zyla1 105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 184 (325)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99763221 11 110 0 011111 1111122222223333332
Q ss_pred ----cCCCCeEeCCCCCCcEEEcCCCcEEEEeecccccC
Q 020561 255 ----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (324)
Q Consensus 255 ----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~ 289 (324)
..+..+||+|+.|.|||++.+ ..++||+-+...
T Consensus 185 ~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 185 HWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp HCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred hccccCCceeecCCCCcccEEEeCC--ceEEechhcccC
Confidence 223458999999999999743 458999988753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.99 E-value=0.0013 Score=56.33 Aligned_cols=32 Identities=28% Similarity=0.271 Sum_probs=27.8
Q ss_pred CCCeEeCCCCCCcEEEcCCCcEEEEeeccccc
Q 020561 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (324)
Q Consensus 257 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~ 288 (324)
+.++||+|+.+.|||++.+...-|.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34699999999999999887778999998864
|
| >d1qu6a2 d.50.1.1 (A:91-179) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.78 E-value=0.00059 Score=47.18 Aligned_cols=33 Identities=24% Similarity=0.120 Sum_probs=28.4
Q ss_pred ccccccccccccchhhhhhccccccccccchhh
Q 020561 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEE 39 (324)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 39 (324)
+++.|+.|.|++|++||+.||+.+..++..+..
T Consensus 53 ~g~~~~~g~G~sKK~Akq~AA~~Al~~L~~~~~ 85 (89)
T d1qu6a2 53 GQKEYSIGTGSTKQEAKQLAAKLAYLQILSEET 85 (89)
T ss_dssp ETTBCCEEEESSHHHHHHHHHHHHHHHHHHCCC
T ss_pred CCccccccccchHHHHHHHHHHHHHHHHHccCC
Confidence 466899999999999999999999988865543
|
| >d1x48a1 d.50.1.1 (A:8-83) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.75 E-value=0.00057 Score=45.70 Aligned_cols=32 Identities=13% Similarity=0.038 Sum_probs=27.9
Q ss_pred ccccccccccccchhhhhhccccccccccchh
Q 020561 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEE 38 (324)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 38 (324)
++++|+.|+|++|++|+|.||+.+.+.+..+.
T Consensus 38 ~~~~~~~g~G~sKK~Aeq~AA~~Al~~L~~~~ 69 (76)
T d1x48a1 38 GQTMYGTGSGVTKQEAKQLAAKEAYQKLLKSP 69 (76)
T ss_dssp SSCEEEEEEESSHHHHHHHHHHHHHHHHHHSC
T ss_pred CCEEeCCcCccHHHHHHHHHHHHHHHHHHccC
Confidence 45789999999999999999999999886543
|
| >d1x49a1 d.50.1.1 (A:8-92) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.36 E-value=0.01 Score=40.15 Aligned_cols=31 Identities=19% Similarity=0.158 Sum_probs=26.2
Q ss_pred ccccccccccccchhhhhhccccccccccch
Q 020561 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEE 37 (324)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 37 (324)
+++.|+.|+|++|++|+|.||+.+.+.+..+
T Consensus 47 ~g~~~~~g~g~sKK~Aeq~AA~~aL~~L~~~ 77 (85)
T d1x49a1 47 DEKEFPEAKGRSKQEARNAAAKLAVDILDNE 77 (85)
T ss_dssp SSCCCCCEEESSHHHHHHHHHHHHHHHHTTT
T ss_pred CceEeeccccccHHHHHHHHHHHHHHHHHHc
Confidence 3567899999999999999999998777543
|
| >d1qu6a1 d.50.1.1 (A:1-90) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.82 E-value=0.012 Score=40.31 Aligned_cols=31 Identities=26% Similarity=0.241 Sum_probs=26.0
Q ss_pred ccccccccccccchhhhhhccccccccccch
Q 020561 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEE 37 (324)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 37 (324)
+++.|+.|+|++|++|++.||+.+.+.+..+
T Consensus 53 ~~~~~~~g~G~sKK~Aeq~AA~~aL~~L~~~ 83 (90)
T d1qu6a1 53 DGREFPEGEGRSKKEAKNAAAKLAVEILNKE 83 (90)
T ss_dssp SSSCCCEEECCSSHHHHHHHHHHHHHHHHSC
T ss_pred CceeeeccCCCcHHHHHHHHHHHHHHHHHhh
Confidence 3457899999999999999999998877543
|
| >d1x47a1 d.50.1.1 (A:8-92) Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Dgcr8 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.29 E-value=0.013 Score=39.64 Aligned_cols=27 Identities=30% Similarity=0.204 Sum_probs=23.7
Q ss_pred cccccccccccchhhhhhccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
++.|+.|+|++|++|+|.||+.+.+.+
T Consensus 49 g~~~~~g~G~sKK~Aeq~AA~~AL~~L 75 (85)
T d1x47a1 49 GVTYGSGTASSKKLAKNKAARATLEIL 75 (85)
T ss_dssp TEEEEEEEESSHHHHHHHHHHHHHHHH
T ss_pred CEEEecCCcchHHHHHHHHHHHHHHHH
Confidence 457899999999999999999887655
|
| >d1o0wa2 d.50.1.1 (A:168-236) RNase III, C-terminal domain {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: RNase III, C-terminal domain species: Thermotoga maritima [TaxId: 2336]
Probab=90.31 E-value=0.018 Score=37.14 Aligned_cols=26 Identities=23% Similarity=0.294 Sum_probs=22.0
Q ss_pred cccccccccccchhhhhhcccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEV 33 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 33 (324)
++.|+.|+|++|++|+|.||+.+.+.
T Consensus 42 ~~~~~~g~g~sKK~Aeq~AA~~aL~~ 67 (69)
T d1o0wa2 42 GKTIATGKGRTKKEAEKEAARIAYEK 67 (69)
T ss_dssp TEEEEEEEESSHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEeCCHHHHHHHHHHHHHHH
Confidence 35678999999999999999877654
|
| >d2b7va1 d.50.1.1 (A:1-71) dsRNA-specific editase 1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-specific editase 1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=86.86 E-value=0.045 Score=35.43 Aligned_cols=26 Identities=15% Similarity=0.075 Sum_probs=20.8
Q ss_pred cccccccccccchhhhhhccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
+..| .|.|++|++||+.||+.+.+.+
T Consensus 41 ~~~~-~g~G~SKK~Ak~~AA~~aL~~L 66 (71)
T d2b7va1 41 GQFF-EGSGRNKKLAKARAAQSALATV 66 (71)
T ss_dssp SCEE-EEEESSHHHHHHHHHHHHHHHH
T ss_pred CEEE-EecCCCHHHHHHHHHHHHHHHH
Confidence 3456 7999999999999998776543
|
| >d2b7ta1 d.50.1.1 (A:1-73) dsRNA-specific editase 1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-specific editase 1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=86.58 E-value=0.047 Score=35.55 Aligned_cols=26 Identities=23% Similarity=0.106 Sum_probs=21.0
Q ss_pred cccccccccccchhhhhhccccccccc
Q 020561 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
++.| .|.|++|++|||.||+.+.+..
T Consensus 44 ~~~~-~g~G~SKK~Aeq~AA~~aL~~l 69 (73)
T d2b7ta1 44 GQVF-EGSGPTKKKAKLHAAEKALRSF 69 (73)
T ss_dssp SSEE-EEEESSHHHHHHHHHHHHHHHH
T ss_pred CEEE-EcCCCcHHHHHHHHHHHHHHHH
Confidence 3466 8999999999999998776544
|
| >d2dixa1 d.50.1.1 (A:7-79) Interferon-inducible double stranded RNA-dependent protein kinase activator A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Interferon-inducible double stranded RNA-dependent protein kinase activator A species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.44 E-value=0.058 Score=35.06 Aligned_cols=26 Identities=15% Similarity=0.095 Sum_probs=22.4
Q ss_pred cccccccccchhhhhhcccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
.++.|.|++|++|+|.||+.+.+.+.
T Consensus 44 ~~~~g~g~sKK~Aeq~AA~~al~~L~ 69 (73)
T d2dixa1 44 ITCTGEGTSKKLAKHRAAEAAINILK 69 (73)
T ss_dssp EEEEECSSCTTHHHHHHHHHHHHHHH
T ss_pred EEEEeccccHHHHHHHHHHHHHHHHH
Confidence 46889999999999999998877664
|
| >d1ekza_ d.50.1.1 (A:) Staufen, domain III {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Staufen, domain III species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=83.78 E-value=0.062 Score=35.22 Aligned_cols=25 Identities=12% Similarity=-0.038 Sum_probs=21.3
Q ss_pred cccccccccchhhhhhccccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDEVE 34 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (324)
.++.|+|++|++|+|.||+.+.+.+
T Consensus 49 ~~~~g~G~SKK~Aeq~AA~~al~~L 73 (76)
T d1ekza_ 49 IVTEGEGNGKKVSKKRAAEKMLVEL 73 (76)
T ss_dssp EEEEECCCSTTSSSHHHHHHHHHHH
T ss_pred eEeeeccCcHHHHHHHHHHHHHHHH
Confidence 4688999999999999998876654
|
| >d2cpna1 d.50.1.1 (A:150-225) TAR RNA-binding protein 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: TAR RNA-binding protein 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.19 E-value=0.11 Score=33.98 Aligned_cols=23 Identities=17% Similarity=-0.028 Sum_probs=19.3
Q ss_pred cccccccccchhhhhhccccccc
Q 020561 10 VKKASWDSSKSKAKKKKKKVEDE 32 (324)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~ 32 (324)
.++.|.|++|++|+|.||+.+.+
T Consensus 52 ~~~~g~G~SKK~Aeq~AA~~aL~ 74 (76)
T d2cpna1 52 FIEIGSGTSKKLAKRNAAAKMLL 74 (76)
T ss_dssp EEEEEEESSHHHHHHHHHHHHHH
T ss_pred eeeccccccHHHHHHHHHHHHHH
Confidence 45789999999999999986643
|
| >d2dmya1 d.50.1.1 (A:8-91) Spermatid perinuclear RNA-binding protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Spermatid perinuclear RNA-binding protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.47 E-value=0.12 Score=34.42 Aligned_cols=26 Identities=15% Similarity=-0.111 Sum_probs=21.7
Q ss_pred ccccccccccchhhhhhcccccccccc
Q 020561 9 KVKKASWDSSKSKAKKKKKKVEDEVEV 35 (324)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (324)
..| .|.|++|++|||.||..+.+.+.
T Consensus 50 ~~~-~g~G~SKK~Aeq~AA~~aL~~L~ 75 (84)
T d2dmya1 50 TTY-EASGPSKKTAKLHVAVKVLQAMG 75 (84)
T ss_dssp EEE-EEEESSHHHHHHHHHHHHHHHHT
T ss_pred EEE-EcCCCCHHHHHHHHHHHHHHHhC
Confidence 355 68999999999999998877663
|